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SUMMARY
Tendons transmit tensile load from skeletal muscles to bone. They fundamentally 
consist of densely packed longitudinal collagen fibres separated by rows of tendon 
fibroblasts. The cells have extensive cell-cell contacts, longitudinally within the 
rows and between rows via cell processes. This thesis explores how cell-cell 
interactions and the cytoskeleton relate to matrix secretion and organisation in 
developing chicken tendons and cell cultures.
In initial developmental stages, indicated by tenascin and type I collagen 
expression, cells were associated with cadherins, vinculin and connexin 32, and 
the presence of actin fibres. Subsequently, type III collagen delineated early 
fascicular structure, and later still connexin 43 appeared, relating to mechanical 
loading and formation of a cellular regulatory network. In culture, monolayers laid 
down minimal matrix, high density micromass cultures laid down more and pellet 
cultures produced an extensive matrix, although 75% of their collagen was lost to 
the medium. Micromasses and pellets expressed similar cytoskeletal and cell 
junctional markers to the in vivo tendons; monolayers differed with early 
expression of connexin 43. TGF0, bFGF and PDGF singly or in combination had 
minor effects on collagen production and deposition and had no effect on cell 
junctional or cytoskeletal components.
Finally, a novel suspension culture system was developed to allow large numbers 
of cells to interact and deposit matrix without interference from medium changes. 
After establishing that ceils aggregated rapidly in suspension culture, suspensions 
were placed in dialysis tubes contained within 50ml sterile plastic tubes and 
cultured on rollers, with medium being changed only in the large tubes, leaving the 
cell suspensions undisturbed. This produced structures up to 3cm in length, with 
good cell and matrix organisation and seeming to incorporate more collagen into 
the extracellular matrix than pellet cultures. This could form the basis for a simple 
scaffold-free tissue engineering approach for tendons and ligaments.
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CHAPTER ONE 
General Introduction
INTRODUCTION
The musculoskeletal system functions to provide mechanical support to and permit 
movement of, the body. The connective tissues involved in this system, in 
particular tendon, ligament, cartilage and bone, all resist the associated 
mechanical loads by producing a specific extracellular matrix (ECM), varying 
according to tissue type and strain experienced. The focus of this thesis is tendon, 
and in particular how tendon cells interact with one another and deposit organised 
extracellular matrix, in development and in tissue culture.
1.1 TENDON STRUCTURE AND FUNCTION
Fundamentally, tendons connect muscle to bone and function to transfer tensile 
loads generated by the muscle to bone. Not all muscles have tendons however, 
where a muscle simply holds two pieces of bone together. Its origin and insertion 
can be directly into the bone, without intervening tendinous tissue, for example in 
the hip. Where tendons are present they have a variety of functions associated 
with the primary one of force transfer, which relate to more general anatomical or 
biological function, as reviewed by Benjamin and Ralphs (2000), and summarised 
below. Firstly, tendons allow muscles to be remote from their site of action. 
Particularly in the limbs, the major flexor and extensors are too bulky to fit within 
the hand or foot, and so are positioned proximally with long tendons connecting 
them to their site of action. Secondly, they allow muscles to act through a confined 
space, for example the carpal tunnel, and permit change in direction of pull, 
tendons may wrap around a bony pulley such as the malleolus in the foot. Thirdly, 
tendons form part of the muscle. The tendon unit and muscle part can be matched 
in length with the required amount of movement, so that excessive amounts of 
expensive muscle tissue do not have to be maintained unnecessarily. Also, the 
mechanical properties of tendon are matched to the muscle-tendon unit. Tendons 
have different stretching properties according to the function of their muscle- 
tendon unit. An important function is an extreme variation on this. Strained tendons 
act as elastic energy stores, for example the Achilles tendon in man can reduce 
muscle input during movement. It is also possible for tendons to focus the pull of 
several muscles onto a single site, alternatively, they can allow one muscle to act 
on several sites. Tendons can support or even form part of the joint capsule, this 
occurs in the knee joint and in the joints of the fingers. Tendons extend from their 
junctions with the muscle, the myotendinous junction, to their attachment to bone, 
the enthesis. In between, they have a variety of forms, ranging from round, through 
to oval and finally to the extremely flattened aponeurosis, according to the muscle
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and bone shape and function. Loading generally occurs uniaxially along the long 
axis of the tendon, and the collagen rich ECM is aligned in this direction.
Figure 1.1. The hierarchical structure of tendon: organisation from whole tendon to 
collagen substructure. Modified from Kastelic, 1978.
Tendons run through tissues, and therefore have to be contained within 
specialised spaces within those tissues. At the simplest, there are spaces in the 
loose connective tissues, where the tissue simply forms a hollow tube for the 
tendon to run through; the connective tissue boundary is referred to as the 
paratenon. The main components of the paratenon include type I and type III 
collagen and elastic fibrils (Kvist et al, 1985) and the inner surface is lined with 
synovial cells (Jozsa and Balint, 1979). In a number of sites structures have to be 
more sophisticated, such as where tendon press on bony pulleys, run through 
confined spaces and/or undergo extensive movements. In these circumstances 
there may be a synovial bursa between tendon and bone, or a full scale synovial 
sheath. These consist of 2 thin layers, parietal and visceral, enclosed between 
these layers is a fluid for lubrication. The majority of tendons do not have a proper 
sheath and are surrounded by the paratenon, often confused with the tendon 
sheath and is essential for smooth tendon gliding and function.
In regions of extensive movement in the joints, tendons and their sheaths are 
retained by retinacula, ligaments that wrap around them and bond them to the 
bone, preventing bowstringing. Within their sheaths tendons generally have a
TENDON
tropocollagen
epitenon
fibroblasts crimp endotenon
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complex hierarchical structure. The whole tendon is enclosed by the epitenon, 
which consists of a dense connective tissue layer that contains a braided network 
of collagen fibres and protects the tendon, similar to a coaxial cable. (Reviewed by 
Benjamin and Ralphs, 2000). The outer surface of the epitenon is continuous with 
the synovial cell layer of the paratenon and the inner layer is continuous with the 
endotenon. Within the epitendon, the main body of the tendon itself is divided into 
longitudinal bundles of cells and matrix, the fascicles, by the endotenon (Elliott, 
1965; Jozsa et al, 1991). The fascicles carry the loading of the tendon, and are 
surrounded by the endotenon which is a thin reticular network of connective tissue, 
with a crisscross pattern of collagen (Elliot, 1965, Kastelic et al, 1978; Rowe, 
1985), this connective tissue layer has high levels of hydrated proteoglycans 
between the endotenon and collagen fascicles to improve binding (Rowe, 1985). 
The blood vessels present in tendon, although small and relatively sparse, are 
present in the endotenon layer together with tendon innervation (Elliot, 1965; Hess 
et al, 1989; Benjamin and Ralphs, 1997). This connective tissue part of the tendon 
often has a delicately layered collagen pattern, however, it can also become quite 
dense, forming layers upon layers of collagen wrapped around the fascicles.
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Figure 1.2 Histological section of tendon (LS). Haematoxylin / Eosin stain 
(Courtesy of Dr J. Ralphs).
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Collagen fibres have also been reported to lie transversely and horizontally, with 
longitudinal fibres crossing over one another forming plaits and spirals (Chansky 
and larrotti, 1991; Jozsa et al, 1991). This variation in collagen fibre orientation 
provides the tendon with an increase capacity for dealing with rotational, 
transverse and horizontal forces (Fan et al, 1997). The ratio of longitudinal versus 
horizontal fibres ranges from 10:1 to 26:1 dependant on tendon location (Jozsa et 
al, 1991). The majority of type I collagen fibres run parallel and longitudinally with 
rows of tendon fibroblasts positioned between them. These fibroblasts have a 
complex shape and relationship with the collagen fibre bundles (McNeilly et al,
1996).
Tendons consist of various specialised regions, namely the myotendinous 
junctions, connecting the muscle fibres to the tendon proper, the enthesis or 
osteotendinous junction, connecting tendon to bone and the wrap-around regions 
where tendons change the direction of their ‘puli’, due to a pulley system.
1.2 TENDON CELLS
The resident cells in tendons are arranged in evenly spaced longitudinal rows 
separated by the parallel bundles of ECM and have been characterised as either 
elongated tenocytes or more rounded tenoblasts (Kannus, 2000; Chuen et al, 
2004). To date there are no specific markers to distinguish these cells and they are 
often treated as the same population, referred to as tendon fibroblasts. The 
differences between these cells are described below to allow the reader a 
complete overview of cell populations in tendon. For this purpose, the tenoblasts 
can read as young tendon fibroblasts and tenocytes as mature tendon fibroblasts. 
In developing tendons, tenoblasts synthesise and deposit matrix and as the tendon 
matures they either undergo apoptosis or differentiate into tenocytes (Ippolito et al, 
1980; Jozsa et al, 1991). Tenoblasts are often considered as activated tenocytes 
regarding matrix synthesis or intrinsic healing (Davidson et al, 1997). The size of 
tenoblasts can vary in length from 20-70pm and between 8-20pm in width, with 
ovoid nuclei (Ippolito et al, 1980). The morphological features of young tenoblasts 
have features suggesting active matrix synthesis (Kannus, 2000), with well 
developed rough endoplasmic reticulum and Golgi, although there are few 
mitochondria in the cytoplasm (Moore and De Beaux, 1987). The mitochondria do 
however have well defined cristae (Ippolito et al, 1980), suggesting an efficient 
energy producing system. There are also fewer actin filaments detectable in 
tenocytes than in tenoblasts (Jozsa and Balint, 1979, Ippolito et al, 1980).
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As development proceeds and the matrix to cell ratio increases, more tenoblasts 
adapt into tenocytes. They increase in length and decrease in width and each cell 
has less cytoplasm as the nucleus takes up almost the entire length of the cell 
(Ippolito et al, 1980). The ratio of inter-conversion between tendon fibroblast states 
has been suggested to govern the tendon response to exercise or trauma (Chuen 
et al, 2004). However, both tendon cell states are active in matrix production 
(Jozsa et al, 1991; O'Brien, 1992). Tenocytes have been shown to be located 
evenly throughout the tendon in longitudinal parallel rows (Chuen et al, 2004) 
whereas tenoblasts appear in clusters in the peripheral region of the tendon, 
devoid of collagen fibre anchorage (Chuen et al, 2004). This location together with 
the increased level of MMP-1 produced by tenoblasts suggests a role for this 
population in a migratory response to injury (Stamenkovic, 2003). It is possible 
these cells belong to the epitenon of peripheral endotenon, whose cells are also 
known to migrate to injury sites (Manske and Lesker, 1984). In the remainder of 
this thesis the cells of tendon will be referred to as tendon fibroblasts.
Tendon cell metabolism
Tendon fibroblasts have been shown to utilise all three of the metabolic pathways 
used by eukaryotic cells, namely the Kreb s cycle, glycolysis pathway and the 
pentose phosphate shunt (Tipton et al, 1975 and 1978; Jozsa et al, 1979; Kvist et 
al, 1987). During development all three pathways are active, reflecting the energy 
requirements of tissue morphogenesis and growth (Jozsa et al, 1979). During 
maturation, metabolic activity involving the aerobic Kreb s cycle and pentose shunt 
pathway decreases and the anaerobic glycolytic pathway predominates (Hess et 
al, 1989; Kannus and Jozsa, 1991). This increase in anaerobic activity correlates 
with an over all decrease in the metabolic activity of mature tendon (Kannus, 
2000). Sustained periods of load and tension subject mature tendons to low 
oxygen levels, as blood vessels are squeezed preventing blood flow, and the use 
of the glycolytic pathway compensates for ischemia and prevents necrosis during 
these periods (Kannus, 2000). However, this low metabolic rate, results in a slow 
rate of recovery after activity or in the repair processes (Vailas et al, 1978; 
Williams, 1986).
In transverse section mature tendon fibroblasts are stellate and thin (see fig. 1.3). 
They have lateral, sheet-like cytoplasmic processes extending around collagen 
fibre bundles and are in contact with processes of cells in adjacent rows through 
gap junctions (Jozsa et al, 1991; McNeilly et al, 1996; Ralphs et al, 2002). This
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multitude of intercellular contacts creates a communicating network that allows the 
tendon fibroblasts to respond to stimuli and coordinate these responses e.g. 
increased load (McNeilly et al, 1996; Benjamin and Ralphs, 2000).
Figure 1.3 An interpretation of the 
three-dimensional structure of 
tendon, showing clearly the stellate 
shape of the cells at cross-section 
(yellow) and the longitudinal
collagen (green) spanning multiple
cell lengths. (Courtesy of Dr JR 
Ralphs)
Other tendon associated cells make up between 5-10% of cellular elements, these 
include synovial and vascular cells (Kannus, 2000). The epitenon and endotenon 
each contain a distinct cell population, as does the paratenon. Each cell population 
can be isolated and have been shown to react differently to various treatments or 
injury (Fujita et al, 1992; Wojciak and Crossan, 1993; Tsuaki et al, 2000; Klein et 
al, 2001,2002).
Fibrocartilage cells
In regions where the tendon is wrapped around a bony or fibrous pulley
fibrocartilaginous regions of tendon are present (Vogel and Koob, 1989; Benjamin
and Ralphs, 2004). These regions protect the tendon from being damaged by 
compressive loading against the pulley (Ralphs et al, 1991), for example the 
peroneus longus grooving the cuboid bone. There are three types of fibrocartilage 
present in tendons these can affect cells of the epitenon, endotenon and of the 
tendon sheath showing the complexity of this tissue specialisation (Benjamin et al, 
1995). The fibrocartilaginous cells lie in lacunae like chondrocytes in articular 
cartilage (Merrilees and Flint, 1980). Fibrocartilage also has a structural role in 
other areas including the menisci of the knee joint (Adams and Muir, 1981) and the 
intervertebral disc (Humzah and Soames, 1988).
1.3 TENDON STRUCTURAL MACROMOLECULES
Tendon matrix consists primarily of type I collagen. It constitutes over 95 % of the 
entire collagen content, with the rest being a mixture of types III, V, VI, IX 
(Gelberman et al, 1988; Vogel and Koob, 1989), XII and XIV (Walchli et al, 1994).
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Matrix composition varies in specialised regions of tendons. The enthesis and 
other fibrocartilaginous regions may contain type II collagen and aggrecan 
(Waggett et al, 1998) and the myotendinous junctions are rich in tenascin 
(Jarvinen et al, 2003). Proteoglycans found in tendon include decorin, biglycan, 
fibromodulin and lumican. In fibrocartilaginous regions the composition of collagen 
and proteoglycans vary to the tendon proper. Also aggrecan and versican have 
been found in areas of tendon under compression (Vogel et al, 1994). There is an 
increase in aggrecan, and type II collagen mRNA is present, thought to be 
associated with the compressive loads that this region is subjected to (Waggett et 
al, 1998). Fibronectin and thrombospondin-1 are ubiquitous in tendon (Josza et al, 
1989; Kannus et al, 1998). Immunohistochemistry showed both to be prominent in 
the ECM of the anatomical sites where firm bindings are needed, for example 
between muscle fibres and fibre bundles, between the collagen fibres of a tendon 
and at myotendinous junctions, osteotendinous junctions and articular cartilage 
(Kannus et al, 1998).
1.3.1 Collagens
Collagens are the main structural components of all ECMs. There are at present 
27 collagens identified (Mayne and Brewton, 1993; Myllyharju and Kivirikko, 2001; 
Sato et al, 2002; Pace et al, 2003). Collagen is characterised by its triple helical 
structure. The triple helical domain comprises of three polypeptide chains, each 
with a left-handed helical configuration wound around each other to form a right- 
handed super helix. There is a glycine amino acid at each third residue and this, 
the smallest amino acid, is vital in the establishment of a stable helix as it is the 
only amino acid with a side chain small enough to fit in the core of the helix with 
out distorting it. In the repeating sequence Gly-X-Y, the X is nearly always proline 
residue and the Y hydroxyproline. It is the hydroxy group from this amino acid that 
is essential in the formation of hydrogen bonds that stabilise the triple helix.
Fibrillar Collagens
Type I, II and III collagen are the major fibrillar collagens and provide structural 
integrity and mechanical strength for all connective tissues. Together these 
collagens account for 80% of total collagens in the body (Jozsa et al, 1989). All 
these collagen types assemble intracellularly into a procollagen triple helix 
formation (Birk and Zycband, 1994). The procollagen is synthesised as 300nm 
long molecules in the rough endoplasmic reticulum (McLaughlin and Bullied, 1998; 
Lamande and Bateman, 1999; Canty and Kadler, 2002). Procollagen is then
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strengthened by covalent lysine-derived crosslinks between the monomers as a 
result of the enzyme lysyl oxidase (Eyre et al, 1984). Procollagen molecules are 
then secreted from the cell. The propeptides at the N- and C- termini that prevent 
self-assembly intracellularly, are cleaved by specific procollagen N-proteinases (or 
ADAMTS-2) and a procollagen C-proteinase, which is identical to BMP-1 (Kessler 
et al, 1996; Li et al, 1996; Leung et al, 1979; Prockop and Fertala, 1998). When 
the C- and N termini have been cleaved the secreted collagen molecules from the 
cell self-assemble into triple helical fibrils extracellularly (Fessler and Fessler, 
1978), with the characteristic repeating banded sequence at 67nm (Kadler et al,
1996). Cleavage of the C-terminus alone is enough to induce collagen self- 
assembly (review Kadler, 1996). Collagens with incomplete cleavage are present 
in the developing chick tendon (Fleischmajer et al, 1983 and 1987), and are 
thought to be involved in fibril diameter regulation (Fleischmajer et al, 1983 and 
1987, 1988).
Type I collagen is the most common fibril-forming collagen of the body. It is found 
mainly in fibrous tissue and has varying organisations to meet the differing 
functions of these tissues. In skin it forms a sheet-like structure, in bone it is 
reinforced by calcium hydroxyapatite, but in tendon it has a rope-like structure 
(Birk and Zycband, 1993). Type I collagen interacts with the protein cores of the 
proteoglycans decorin and fibromodulin, which are involved in regulating fibrillar 
diameter (Schonherr et al, 1995a, b) and can also form heteropolymers with type 
III collagen (Fleischmajer et al, 1990). The production of type III collagen is 
essential for normal type I collagen fibrillogenesis (Lui et al, 1997). Type III 
collagen is found throughout tendon proper, in the endotenon, in unmineralised 
fibrocartilage regions (Kumagai et al, 1994) and in the epitenon (Murphy et al,
1997). Type III collagen fibres are thinner than type I fibres, resulting in a more 
compliant tissue (Borel and Monboisse, 1993). Type II collagen, the major collagen 
in cartilage (90% of total collagen), provides resistance to compressive force, 
supports chondrocyte adhesion and possibly influences the differentiated 
phenotype of chondrocytes (Lemare et al, 1998). It forms a network of fibrils that 
contain proteoglycans, due to a higher content of hydroxylysine and glycosyl and 
galactosyl residues compared to type I collagen (Mayne et al, 1989). It is not 
generally distributed in tendon (Waggett et al, 1998), but can be observed in 
regions of fibrocartilage (Ralphs et al, 1991). There are two splice variants, type 
IIA and type IIB (Ryan and Sandell, 1990). Type IIA is expressed in pre-
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chondrogenic tissue, whereas type MB is expressed only in chondrogenic tissues 
(Sandell et al, 1990; Nah et al, 2001; McAlinden et al, 2002).
The minor fibrillar collagens are type V and type XI collagens. Type V collagen is 
associated with types I, II and III collagen, forming heterotypic fibrils with each 
(Keene et al, 1987; Fleischmajer et al, 1990). Type V collagen is involved in 
regulating type I fibril diameter by forming the core of type I fibrils (Lindsenmayer 
et al, 1990). It is widespread in virtually all connective tissues and occurs as non­
banded fibrils with small diameters. Type XI collagen is found mainly in 
cartilaginous tissue (von der Mark, 1999), but is also seen in developing tissues 
where it forms cross-type heterotrimers with type V (Balmain et al, 1995; Nalin et 
al, 1995; Yoshioka et al, 1995; Fichard et al, 1995). It is found in the same fibrils as 
type II (Vaughan, 1998) forming the core of type II collagen heterofibrils (von der 
Mark, 1999), and thought to influence the fibril diameter. The section of the type II 
fibril combined with type XI collagen is possibly where the fibril interacts with 
matrix proteoglycans (Smith et al, 1985). Both types V and XI collagen have large 
N-terminal non-collagenous domains. The incorporation of these non-collagenous 
domains into heterotypic fibrils is suggestive of involvement in collagen assembly, 
growth and diameter regulation (Fessler et al, 1985).
Short Chain Collagens
Types VIII and X collagen are distinguished by shorter helical domains than the 
fibril-forming collagens and have globular extensions at one or both ends 
(Sutmuller et al, 1997). They both form hexagonal lattice structures and have 
distinct distributions. Type VIII is found primarily in a specialised membrane 
produced by endothelial cells in the cornea, called the Descemet's membrane 
(Sawada et al, 1990), although it is also associated with type IV collagen. Type X 
collagen is found in hypertrophic cartilage (Schmid and Lisenmayer, 1985), and is 
thought to be involved in growth plate development and calcified cartilage 
formation (Kwan et al, 1989; Kirsch and von der Mark, 1992; Alini et al, 1994). 
However, it has also been suggested that type X collagen interacts with type II 
collagen to prevent calcification (Poole et al, 1989). It has been described in the 
tendon enthesis or ligament bone-interface, where fibrocartilage cells undergo 
hypertrophic changes as bone grows into the enthesis (Niyibizi et al, 1996; Ralphs 
and Benjamin, 2000).
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FACIT collagens
Fibril Associated Collagens with an Interrupted Triple helix (FACIT) collagens act 
mainly as molecular linkers between fibril forming collagens and other ECM 
molecules (Shaw and Olsen, 1991). FACIT collagens include type IX, XII, XIV, XVI 
and XIX collagen. Type IX collagen has been shown to co-localise with type II 
collagen (von der Mark, 1999) and is involved in type II fibrillogenesis (Eyre et al, 
1987). It binds covalently to type II collagen and acts to stabilise the network. It 
can also form heterotypic fibrils with type XI collagen. Type IX collagen is found in 
cartilage and fibrocartilage, such as the intervertebral disc, and is thus a possible 
component of tendon fibrocartilage. Both IX and XII can be glycanated with 
chondroitin/dermatan sulphate GAG side-chains and classified as proteoglycans 
(Koch et al, 1992).
Type XII collagen is associated with type I collagen and located in the skin, 
perichondrium, periosteum, and tendon, among others (von der Mark, 1999). Type 
XII collagen is also found in the developing chick, prior to hatching in tissues 
exposed to high mechanical stresses, ie. tendon and ligament (Dublet and Van der 
Rest, 1991; Walchli et al, 1994). It is localised at the surface of tendon collagen 
fibrils (Khang etal, 1993).
Type XIV collagen is mainly found in tissues rich in type I collagen, also where 
high mechanical stresses are involved. Type XIV collagen has been shown to take 
over the role from type XII collagen (Walchli et al, 1994) and is the predominant 
FACIT protein in virtually all tissues. Type XIV collagen has been found in 
developing tendon with type XII collagen (Dublet and Van der Rest, 1991), and is 
thought to be involved with regulating fibril formation much the same as type V 
collagen (Linsenmayer et al, 1990). It does this by stabilising the immature 
collagen fibrils during early fibril growth phase (Young et al, 2000). Type XIV 
collagen is also known to bind to decorin (Font et al, 1993) and is present in its 
proteoglycan form in cartilaginous tissues (Watt et al, 1992). Type XVI collagen is 
found in a variety of tissues, including the heart, kidneys, intestine, ovaries, testes, 
eyes, arterial walls and smooth muscles (Lai and Chu, 1996). Type XIX collagen 
has only been characterised at cDNA and genomic levels, but is expressed in 
fibroblastic cell lines (Myers et al, 1994). The roles of type XVI (Lai and Chu,
1996), type XIX (Myer et al, 1997) and type XX collagen (Koch et al, 2001) have 
not been established.
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Type VI and VII Collagen
Type VI collagen is essentially a glycoprotein with a collagenous central domain, it 
is often refered to as a microfibrillar collagen. Its functions involve binding cells to 
fibrillar collagens, decorin and hyaluronan (Bindanst et al, 1992; Kielty et al, 1992; 
Pfaff et al, 1993). In tendon type VI collagen has a wide distribution in the ECM, 
whereas in articular and fibrocartilage it appears in the pericellular region of the 
matrix, close to the cell and aids in the chondrocyte attachment to the matrix 
(Poole et al, 1992). Type VII is a major component of anchoring fibrils attaching 
basement membranes of multilayered epithelia to the underlying connective 
tissues (Sakai et a, 1986).
Membrane bound and MULTIPLEXIN collagens
Membrane bound, or transmembrane collagens include types XVII and XIII. They 
each have intracellular domains and are involved in cell adhesion and possibly 
signal transduction (Kadler, 2002). Type XVII collagen is located in 
hemidesmosomes and its mutations have been linked to the cause of non-lethal 
blistering of the skin where tissue separates from the cutaneous basement 
membrane zone (Gatalica et al, 1997). Type XIII collagen has been found in the 
skin epidermis, placenta, intestine, bone, cartilage and striated muscle and others, 
although only in cDNA and genomic levels (Peltonen et al, 1997). Research using 
mouse models indicate that type XIII is a transmembrane component of focal 
adhesion sites (Peltonen et al, 1999).
Types XV, XVI and XVIII collagens are MULTIPLEXIN (multiple triple helix 
domains and interruptions) collagens. These are non-fibrillar collagens, type XV 
collagen has only been identified at cDNA and genomic levels, whereas type XVIII 
collagen has been isolated in a Western blot from extracts of mouse embryonic 
stem cells (Muragaki et al, 1995). Type XV collagen is widespread and has been 
found in the basement membrane zones of the placenta, adrenal glands, kidneys, 
heart, skeletal muscle and gonads (Myers et al, 1996). The distribution of type 
XVIII collagen is more specific and its three variants are expressed in a tissue 
specific manner, including the liver, lungs kidneys, heart, brain and skeletal muscle 
(Muragaki et al, 1995; Myers et al, 1996).
1.3.2 Elastin
Elastin is a hydrophobic protein of the ECM known to give tissues their elastic 
qualities. It is widely distributed, but most abundant in artery walls, lungs,
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intestines and skin. Elastin has many external linkages making it a stable protein. 
As with most structural proteins other roles have been found for elastin, an elastin 
receptor has been identified and there are now known to be various biological 
properties of elastin and elastin-derived peptides (Debelle and Tamburro, 1999; 
Gosline et al, 2002). Elastin generally exists as an amorphous element surrounded 
by a rim of microfibrils (Karrer and Cox, 1960; Haust, 1965). Elastin fibrillogenesis 
occurs close to the cell surface and it is thought that the microfibrils act as a 
scaffold for the elastin to be deposited (Robert et al, 1971; Cleary et al, 1981; 
Cleary and Gibson, 1983).
In tendon development elastin appears as fibrillar tracts at the periphery of the 
tendon, and fibrillin appears a little later (Ros et al, 1995). Elastin becomes more 
widespread with the onset of muscle contraction and has been suggested that it 
helps to maintain the structural integrity of developing tendons (Benjamin and 
Ralphs, 2000). In adult tendon the elastin content is approximately 1-2% of tendon 
dry mass (Kannus, 2000) and in healing there is an increase in elastin deposition 
(Gigante et al, 2003).
1.3.3 Non-collagenous components of the ECM
Extracellular matrix molecules that surround collagens are soluble polymers and 
these include: glycoproteins, glycosaminoglycans (GAGs), proteoglycans.
Glycoproteins
Glycoproteins are multifunctional proteins with carbohydrates attached covalently 
to the peptide portion of the molecule. They interact with cells and the surrounding 
matrix molecules. A subgroup of matrix glycoproteins is involved in cell adhesive. 
In tendon these include; fibronectin, vitronectin, laminin, tenascins, 
thrombospondins (cell-matrix interactions modulators), von Willebrand factor 
(collagen associated), undulin (type XIV collagen a1 chain fragment), osteonectin 
and osteopontin (each found in calcifying regions of tendon) (Miller and McDevitt, 
1988; Jozsa et al, 1991; Maillard et al, 1992; Usui et al, 1992; Ehnis et al, 1997; 
Kannus et al, 1998; Halverson et al, 2003).
Fibronectin
Fibronectin is a widely distributed adhesive glycoprotein. Its general functions 
include controlling cellular migration throughout development and wound healing, 
and in regulation of cell growth and differentiation (Burton-Wurster et al, 1997). It is
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composed of 2 large subunits joined by disulphide bonds near the C-terminus. 
Along the 2 subunits are multiple binding sites for GAGs, collagens and cells 
(Akiyama et al, 1981). Levels of fibronectin synthesis increase in healing tendon 
(Williams et al, 1984). Fibronectin and its isomers have the potential to participate 
in cell signalling through the integrin binding RGD sequence (arginine, glycine, 
aspartate; Pierschbacher and Ruoslahti, 1984), and whilst they are thought to be 
critical in chondrocyte biology and matrix organisation (Burton-Wurster et al,
1997), little is known about its role in tendon. However, vitronectin is seen in the 
ECM of the myotendinous and osteotendinous junctions (Kannus et al, 1998).
Tenascins
The tenascin family have 5 known members, tenascin C, R, X, Y and W (Erickson, 
1993; Weber et al, 1998; Chiquet-Ehrismann, 2004). This glycoprotein family is 
thought to be involved in the migration of cells, and can act as an anti-adhesive 
agent (Chiquet-Ehrismann et al, 1988). However, tenascin has been shown to 
encourage adhesion with certain cell types, e.g. endothelial cells (Sriramarao et al,
1993). The N-terminus is responsible for the anti-adhesion properties, while the C- 
terminus is involved in its adhesive qualities (Spring et al, 1989). Tenascin-C is the 
most studied of the family and is upregulated in tendon during embryonic 
development, but present throughout and into mature tissue (Hurie et al, 1990; 
Ros et al, 1995; Kardon, 1998). Tenascin-C is the first identifiable ECM component 
of developing tendons (Hurie et al, 1990). Experiments performed with tenascin 
transgenic knockout models have shown that in the absence of tenascin-C 
tendons will still form with accurate structure and morphology (Kardon, 1998). It is 
also interesting to note that it is found in ECM of connective tissue regions where 
especially high forces are transmitted from one tissue type to another, for example 
at tissue-tissue boundaries, such as the myotendinous junction (Erickson and 
Bourdon, 1989; Kannus etal, 1998).
Laminins occur mainly in the basement membranes (Beck et al, 1990), and are the 
first glycoproteins to appear during development (Leivo et al, 1980). They have an 
important role in the development of the myotendinous junction (Pedrosa et al,
2000). Laminins are involved in cell adhesion, migration and differentiation (Timpl 
et al, 1983: Dziadek et al, 1995: Ryan and Christiano, 1996). There are 6 isoforms 
of laminin, each with distinct biological functions.
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The thrombospondin family of glycoproteins are involved in cell adhesion 
interactions. Thrombospondin 1 and 2 are closely related and form subgroup A, 
whereas thrombospondin 3, 4 and 5 (more commonly known as cartilage 
oligomeric matrix protein) form subgroup B (Adams, 2001). Cartilage oligomeric 
matrix proteins or COMP consists of 5 identical coiled glycoprotein subunits joined 
by disulphide bonds (Efimov et al, 1996). Initially discovered in cartilage its 
distribution is now known to be more widespread, including expression in tendon, 
ligament, meniscus, vasculature, skeletal muscle, bone, eye, heart and placenta 
(Fang et al, 2000; Muller at al, 1998; Vogel and Meyers, 1999; Reissen et al, 
2001). Experiments on COMP in tendon have identified a possible function as a 
response and resistance to load (Smith et al, 1997). COMP expression in tendon 
is affected by age, disease and exercise (DiCesare et al, 1994; Smith et al, 1997; 
Delot et al, 1998; Smith et al, 1999; Cherdchutham et al, 1999; Smith et al, 2002).
Glycosaminoglycans
GAGs consist of repeating disaccharide units. GAGs with specific physiological 
significance include; hyaluronan, dermatan sulphate, chondroitin sulphate, 
heparan, heparan sulphate and keratan sulphate. Each has a wide range of 
functions including providing structural integrity for cells and creating spaces for 
migratory cells. In tendon the concentration of GAG is lower than in any other 
connective tissue (Kannus, 2000), being approximately 0.2% of the total dry mass, 
and being elevated to 3.5-5% in fibrocartilaginous regions (Merrilees and Flint, 
1980). In tendon the majority of GAG is dermatan sulphate (60%), whereas in the 
fibrocartilaginous regions it is chondroitin sulphate (Merrilees and Flint, 1980). 
Hyaluronic acid (HA) comprises 6% of the total GAG in tendon. Heparan sulphate 
GAGs have been located at the myotendinous junction of tendon and are 
implicated in biological processes such as growth factor signalling, cell adhesion 
and wound healing (Jarvinen et al, 1991; Nakato and Kimmata, 2002).
Proteoglycans
Proteoglycans are a large and diverse family of molecules. They are a subclass of 
glycoproteins and each has one or more GAG side-chains attached the their core 
proteins. They are involved in multiple biological processes and their distribution is 
ubiquitous. In tendons, an increase in the levels of proteoglycans is often related to 
tendon pathology (Benazzo et al, 1996). In the ECM, they can be divided into two 
groups; large aggregating proteoglycans and small leucine-rich proteoglycans 
(SLRPs; Kolset et al, 2004).
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Large proteoglycans
The large aggregating proteogycans are part of the hyaluronan binding family 
(Roughley and Lee, 1994), this is due to their ability to bind to hyaluronan non- 
covalently and form supramolecular aggregates (Margolis and Margolis, 1994). 
This group comprises of aggrecan, versican, neurocan and brevican. Neurocan 
and brevican are unique to nervous tissue (Milev et al, 1998).
Aggrecan is a large aggregating proteoglycan with a protein core of 250-300 kDa, 
with around 100 chondroitin sulphate chains and 50 keratan sulphate chains. It 
aggregates with HA and binds water so the tissue becomes hydrated and fills 
interstitial spaces to resist compression (Watanabe and Yamada, 2002). Some 
proteoglycans, including aggrecan, can trap up to 50 times their own weight in 
water, this can also aid the diffusion of water soluble molecules and the migration 
of cells (Karpakka et al, 1991). Aggrecan accounts for approximately 10% of the 
dry weight of cartilage and is found in small amounts in the tendon proper, but in 
larger amounts in fibrocartilaginous regions of tendon (Waggett et al, 1998). It is 
thought that its roles overlap somewhat with versican.
Like aggrecan, versican can bind to HA forming supramolecular aggregates that 
bind to link protein, an ECM molecule of cartilage (Roughley and Lee, 1994). 
Certain domains of versican promote chondrocyte proliferation by destabilizing cell 
adhesion (Zhang et al, 1999) and it can inhibit mesenchymal chondrogenesis, 
though not condensation (Zhang et al, 1998). The roles of versican include 
regulation of cell motility, growth and differentiation (Perides et al, 1992). Versican 
is found in mid-region of tendon and ligament, but also in fibrocartilaginous regions 
(Cambell et al, 1996; Waggett et al, 1998; Moriggl et al, 2001).
Small leucine-rich proteoglycans
The second group of proteoglycans are the small leucine-rich proteoglycans 
(SLRP's), each playing an important role in matrix metabolism and collagen 
fibrillogenesis (Hocking et al, 1998). Included in this group are decorin, biglycan, 
fibromodulin and lumican, each characterised by a leucine-rich core protein (lozzo 
et al, 1997) and differentiated from each other due to the number and type of GAG 
chains each has attached.
Decorin is so named because it decorates collagen fibrils (Krusius and Ruoslahti, 
1986). It has a short core protein with a molecular weight of 40kDa with one of
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either chondroitin sulphate or dermatan sulphate as its GAG chain attached to its 
N-terminus (Weber et al, 1996; lozzo, 1998). In bone the GAG is predominantly 
chondroitin 4-sulphate, whereas in tendon and cartilage a dermatan sulphate chain 
is most common (Cheng et al, 1994). Its distribution is wide in connective tissues 
and it binds to types I, II, III, V, VI and type XIV collagen (Vogel et al, 1984; 
Bidanset et al, 1992; Whinna et al, 1993; Hedbom and Heinegard, 1993; Font et 
al, 1993). The core protein of decorin binds to type I collagen near the C-terminus 
(Keene et al, 2000), near to major intermolecular cross-linking sites of collagen 
heterotrimers. Decorin binding therefore, has the potential to affect the cross- 
linking of collagen (Svensson et al, 1995). The characteristic horseshoe shape that 
decorin forms creates a large concave surface that is the correct diameter to 
accommodate one triple helix collagen fibril (Schonherr et al, 1995; Weber et al, 
1996). Decorin prevents collagen fibrils from aggregating laterally (Birk et al, 1995) 
through binding to types I and VI collagen (Weber et al, 1996; Wiberg et al, 2001), 
and can inhibit types I and type II collagen fibrillogenesis in vitro (Vogel et al, 1984; 
Bidanset et al, 1992). In decorin null mice, collagen fibrils have irregular contours 
and thin fibrils abnormally fuse with thicker fibrils causing the skin to become 
fragile with disorganised collagen-fibril morphology (Danielson et al, 1997). 
Decorin also binds to the growth factor TGFp resulting in its selective inactivation 
(Yamaguchi et al, 1990). As TGFp functions include the regulation of cell 
differentiation, growth and matrix synthesis (lozzo et al, 1998), the binding of 
decorin to TGFp has a substantial regulatory role, acting to sequester the growth 
factor extracellularly (Hildebrand et al, 1994).
Biglycan has two chondroitin sulphate or dermatan sulphate chains GAG chains 
and similar leucine-rich repeats to decorin (Hocking et al, 1998; lozzo, 1998). Its 
role still remains unclear, although it is known to bind TGFp (Hildebrand et al, 
1994) and type I and VI collagen in vitro (Schonherr et al, 1995; Wiberg et al,
2001). Biglycan knockout mice have defective bone formation with a diminished 
capacity to produce marrow stromal cells (Young et al, 2003). Biglycan is found in 
greater quantities in fibrocartilaginous regions of tendon (Robbins and Vogel, 
1994) and tends to be found in the pericellular matrix of dividing cells, in cartilage 
(Knudson and Knudson, 2001). However, chickens and other avian species lack 
biglycan and use a differentially expressed glycosylated form of decorin 
(Johnstone et al, 1993).
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Fibromodulin and Lumican are structurally similar to decorin and biglycan although 
they contain keratan-sulphate GAG chains instead of chondroitin and dermatan 
sulphate chains (Knudson and Knudson, 2001). Fibromodulin and lumican bind to 
the same binding site on a type I collagen fibril, distinct from that of decorin (Yoon 
and Halper, 2004). Lumican has been found in tendon and in tendon fibrocartilage 
(Ezura et al, 2000). It affects the spacing and diameter of collagen fibrils and is 
important in comeal transparency (Rada et al, 1993) - lumican null mice have 
opaque corneas with abnormally thick collagen fibres (Chakravarti et al, 1998). 
Fibromodulin also has the ability to regulate collagen fibril formation (Ezura et al,
2000) and like decorin inhibits assembly of type I and type III collagen fibrils 
(Hedbom and Heinegard, 1989). It is found in many tissues including tendon, but is 
more abundant in cartilage (Hedlund et al, 1994). Fibromodulin knockouts alone 
show a reduction in tendon stiffness, irregularly contoured collagen and more 
fibrils with a smaller diameter (Svensson et al, 1999). Lumican knockouts show 
irregular collagen fibril contours not only in tendon but also in the cornea and skin, 
forming collagen fibrils with an increased diameter (Chakravarti et al, 2000; 
Chakravarti, 2002). Double fibromodulin and lumican knock-outs are smaller than 
the wild-type mice and show extreme tendon weakness (Chakravarti et al, 2003). 
The tendons have unusually high frequencies of collagen fibrils with too large or 
too small a diameter. It has been suggested that fibromodulin is required in early 
fibrillogenesis to stabilise collagen fibril intermediates with small diameters, 
whereas lumican is needed at a later stage to prevent the lateral growth of the 
fibrils (Chakravarti, 2002).
1.3.4 Inorganic Components
Certain elements of the ECM that are often overlooked are the inorganic 
components, which make up 0.2% of tendon dry mass (Kannus, 2000). Most 
inorganic components are present in trace levels, between 0.02 and 120ppm 
(Spadaro et al, 1970). Calcium has the highest concentration, with an increase at 
the insertion, and in calcifying tendons - levels increase 10-20 fold (Jozsa et al,
1989). Other inorganic ions found in tendon include magnesium, manganese, 
cadmium, cobalt, copper, zinc, nickel, lithium, lead, fluoride, phosphorus and 
silicon. These are all known to be important in growth, development and normal 
tendon metabolism, as in other tissues (Schor et al, 1973). The precise functions 
of these trace elements are mostly unknown, but copper is important for collagen 
crosslinking (Farquharson et al, 1989), manganese has a role in enzymatic 
reactions and calcium is important in the development of the osteotendinous
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junction (Minor, 1980). Zinc and nickel have roles in the interaction of COMP with 
types I and II collagen (Rosenberg et al, 1998).
1.4 CYTOSKELETON
The cytoskeleton of eukaryotic cells is a dynamic intracellular system of protein 
polymers constructed throughout the cytoplasm, controlling cell shape, internal 
spatial organisation and motility. The three prominent components of this cellular 
arrangement are actin microfilaments, intermediate filaments and microtubules. 
These systems, although composed of different proteins, are in constant 
interaction with each other.
1.4.1 Actin subunits and assembly
Actin is one of the most highly conserved eukaryotic proteins (Egelman and 
Orvala, 1995) and makes up 5% of all intracellular protein. It plays an active role in 
many cellular functions, including cell movement, change of cell shape and particle 
movement (transport of particles and receptors over the cell surface, vesicle 
transport and intracellular pathogens), cell division and muscle contraction 
(Kabsch and Vanderkerckhove, 1992; Cramer et al, 1994; Furukawa and 
Fechheimer, 1997). There are three actin isoforms, a-, p- and y- actin (Kabsch et 
al, 1990), which express 6 actin isoforms in mammals (Vandekerckhove and 
Weber, 1978; Herman, 1993). Alpha actins are found in muscle and in 
myofibroblasts, as a-smooth muscle actin (Premdas et al, 2001), whereas p-actins 
and most y-actins are found in non-muscle cells (Vandekerckhove and Weber, 
1978: Herman et al, 1993). Alpha-smooth muscle actin is expressed by many, 
possibly all, connective tissue cells (Kinner et al, 2001; Kinner and Spector, 2002; 
Kinner et al, 2002).
In non-muscle cells, actin occurs as globular actin monomer (G-actin), or as 
polymerised filaments (F-actin), particularly concentrated just beneath the plasma 
membrane. Actin filaments are dynamic, polymerising and depolymerising in 
response to the cellular environment and the presence of other controlling proteins 
(Bonder et al, 1983; Egleman and Orvola, 1995). Actin structure, assembly and 
function are based on the assembly dynamics of the actin filament. Filaments 
initially assemble at a nucleation protein and then assemble directionally (Welch, 
1999; Mullins and Pollard, 1999). Structure and intracellular environment 
determine that they are assembled at one end, the positive end, and disassemble
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at the other, the negative end, converting ATP to ADP + Pj and instigating a 
‘treadmilling’ effect (Wegner, 1976; Neuhaus et al, 1983; Cleveland et al, 1982; 
Carlier et al, 1989; Carlier et al, 1992; Pollard et al, 2000).
Actin organisation and function in non-muscle cells
The cellular organisation of actin is controlled by its interactions with other 
proteins, for example profilin, thymosin, and actobindin. Each sequester G-actin or 
actin dimers, creating a cytoplasmic actin pool (Carlsson et al, 1977; Lambooy and 
Kom, 1988; Safer et al, 1991; Vancompemolle et al, 1992; Goldschmidt-Clermont 
et al, 1992; Bubb et al, 1998). Actin can be released from these proteins by others, 
for example profilin, which releases actin from thymosin, allowing its participation 
in filament assembly (Pantaloni and Carlier, 1993).
There are essentially three possible 3-D arrays of filamentous actin: gel-like 
network, tight parallel bundles and contractile bundles, the structures being formed 
by association between actin and different binding proteins. Gel-like networks 
support the plasma membrane and potentially determine cell shape. They are 
formed by interactions of actin filaments with the actin binding protein filamin, 
which is a flexible molecule that links filaments where they cross one another (Tu 
et al, 2003). These flexible links between crossing fibres result in the formation of 
the gel. Gel characteristics can be changed by ion concentration (Ishiura and 
Okada, 1979). At low concentration the gel is quite stable, whereas at higher 
concentration it is more likely to flow. The changes between forms is referred to as 
‘gel to sol’ or ‘sol to gel’ transitions and in associated with movements at the cell 
surface. These may also be affected by enzymatic cleavage of actin filaments by 
enzymes such as gelsolin, enhancing sol formation (Yin and Stossel, 1979; Yin et 
al, 1981a and b; McGough et al, 2003). Fibrous arrays of actin filaments take two 
forms. Firstly, tightly packed bundles with parallel, similarly orientated filaments are 
formed by binding proteins such as fascin, fimbrin and villin. These support 
membrane structures such as microvilli (Bartles, 2000; Kureishi et al, 2002; 
Passey et al, 2004). Secondly, actin filaments can form contractile filaments, or 
actin stress fibres. These are arranged in an anti-parallel fashion, but are more 
widely spaced than actin bundles (Furukawa and Fechheimer, 1997). The actin 
related proteins associated with stress fibres are predominantly a-actinin and 
tropomyosin, which allow space for myosin molecules to bind between filaments 
(Langanger et al, 1986). The initiation of actin stress fibre formation begins with 
the binding of tropomyosin to stabilise the filaments. Tropomyosin excludes filamin
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binding and allows a-actinin to bind to its barbed end (Weihing, 1985), and 
promotes myosin II binding. There are two types of myosin molecule binding to 
actin in non-muscle cells, myosin I and II. In essence, myosin I moves vesicles 
along normal actin filaments and it is myosin II that slides the filaments across 
each other creating the stress fibre (Cramer, 1999). The actin stress fibre 
contraction mechanism is based on the hydrolysis of ATP and they form as a 
response to tension generated across of the cell (Cheney et al, 1993).
Actin in connective tissues
Actin, in particular a-smooth muscle actin, is associated with a wide range of 
connective tissue cells (Menard et al, 2000; Premdas et al, 2000; Kinner and 
Spector, 2001). Tendon cells in vivo contain orientated stress fibres linked cell to 
cell along the cell row by adherens junctions (Ralphs et al, 2002). These hold cells 
together along the line of principal strain, and may also be involved in 
mechanotransduction. Mechanical strain applied to tendon cells in vitro produces 
an increase in n-cadherin, vinculin and tropomyosin, indicating the cells increase 
the strength of their attachments (Ralphs et al, 2002).
In vivo, actin stress fibres direct the initial elongation of the cells and control the 
subsequent deposition of an orientated matrix in the developing annulus fibrosus 
of the intervertebral disc (Hayes et al, 1999). Thus, the actin cytoskeleton may 
have this role in the development of tendon. Fibroblasts cultured in monolayer, 
have fibronectin and tenascin orientated at the cell surface. If the cytoskeleton is 
disrupted with disrupted this is lost (Domnina et al, 1996). Tendon cells embedded 
into a collagen matrix initially orientate to the collagen, but newly synthesised 
collagen appears to be orientated by the cells and associated with the cytoskeletal 
orientation (Matsumoto et al, 1998). Chondrocytes show a fine network of actin 
fibres (Benjamin et al, 1994), rather than the large filaments seen in fibroblasts. If 
chondrocytes express actin stress fibres in vitro, they lose their phenotype and 
become more fibroblastic (Benya et al, 1982; Mallein-Gerin et al, 1991).
Mechanotransduction is the process by which cells convert mechanical stimuli into 
biochemical signals, and often involves the actin cytoskeleton. The role of actin in 
mechanotransduction has been investigated in the microvilli of the proximal tubule 
and small intestine, the hair cells of the inner ear and the cellular processes of 
osteocytes (Weinbaum, 2001, Yuefeng et al, 2004). Microvilli and osteocyte cell 
processes have the same actin related proteins, fibrin and a-actinin (Tanaka-
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Kamoka et al, 1998). ‘Bending’ of microvilli is thought to be sufficient to activate ion 
channels at the tip or amplified stress at the cytoplasmic terminus of the actin 
bundle, where it is anchored into intermediate filaments (Weinbaum, 2001). 
Osteocyte cell processes are housed in mineralised canaliculi surrounded by a 
fluid annulus, containing pericellular matrix. The fluid drag from the annulus 
produces a tension on the transverse fibres in the pericellular matrix, which is then 
transmitted across the membrane of the cell process to the axial actin filaments in 
the cytoskeleton of the cell process (Weinbaum, 2001, Yuefeng et al, 2004), 
enabling cells to respond to external loading. Actin is also associated with integrin 
binding-based outside-in mechanical signalling (Juliano et al, 2004) via tyrosine 
kinase and phosphorylation of junctional intermediates such as FAK and paxillin 
(Turner, 2000; Wozniak et al, 2004).
1.4.2 Intermediate filaments
Intermediate filaments are structurally distinct from actin and microtubules, and 
their diameter falls between these two, hence their name. In vertebrates, 
cytoplasmic intermediate filaments can be grouped into 3 classes, 1) keratin 
filaments (McLean and Lane, 1995), 2) vimentin and vimentin-related filaments 
(Vikstrom et al, 1992) and 3) neurofilaments (Geisler et al, 1982). Actin and 
microtubules are made of globular subunits, whereas intermediate filaments are 
made of long fibrous subunits. They have repeated sequences of amino acids 
called heptad repeats, and form an extended a helix, although the amino-head and 
carboxy-tail terminals are non-a-helical (Stewart, 1993). To form intermediate 
filaments two monomers become ‘coiled-coil’ dimeric structures, due to the heptad 
repeats (which contain a greater than average number of hydrophobic residues) in 
the helical rod. This dimer associates with another, in an anti-parallel manner, 
creating a non-polarised tetramer, unlike actin and microtubules, whose functions 
depend on polarity (Steiner and Parry, 1985). Final stages of intermediate filament 
aggregation show the tetramers binding to an intermediate filament and aligning 
themselves along the axis of the filament, then packing together in a helical 
formation that is 10nm in diameter (Fuchs and Weber, 1994). The terminals at 
either end may function to let the filaments interact with other components of the 
cell, therefore allowing the filaments orientation within the cell (Fuchs and Weber,
1994).
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Intermediate filaments provide the cell with mechanical stability, and can withstand 
greater forces than actin filaments or microtubules due to the overlapping arrays of 
subunits (Janmey, 1991; Stewart, 1993). Vimentin null mice show no obvious 
defects and can reproduce successfully (Colucci-Guyon et al, 1994), indicating 
possible compensatory roles between intermediate filaments. Intermediate 
filaments are also responsible for connections between actin and microtubules 
(Chang and Goldman, 2004). In tendons, vimentin-based intermediate filaments 
are especially prominent in pressure resisting tendon fibrocartilage (Ralphs et al,
1991) and are a dynamic feature of chondrocytes, changing their expression 
rapidly as pressure conditions vary on the tissue (Durrant et al, 1999).
1.4.3 Microtubules
Microtubules are the largest structures of the cytoskeleton and consist of linear, 
tubular polymers of tubulin, a globular protein. There are three tubulin isomers, a , 
p and y (Bums et al, 1991). Microtubules consist of a and p polypeptides, during 
nucleation an a  and p tubulin molecule join to form a heterodimer (Amos and 
Baker, 1979). These attach to the other dimers and form oligomers, which then 
elongate and produce the protofilaments. Similarly to actin filaments, microtubules 
have positive and negative ends (Bergen and Borisy, 1980) and therefore show 
characteristic ‘treadmilling’ dynamics (Cleveland et al, 1982). The negative ends 
are anchored to a microtubule organising centre, which is usually a centrosome 
(Brinkley et al, 1985) of which y-tubulin is a part (Job et al, 2003). Microtubules 
function to provide intracellular tracks for the cell and transport vesicles, granules 
and organelles around the cytoplasm (Kreis et al, 1990). An important function of 
microtubules within cells is their role in the mitotic spindle in the separation of 
chromosomes during anaphase in mitosis (Lambert and Schmitbenner, 1982: 
Gorbsky et al, 1988). They are also the predominant components of cilia and 
flagella vital for the propulsion of debris of movement of small protazoa and of 
course sperm (Gibbons, 1981; Burgess et al, 1991). Chondrocytes often have a 
non-motile stereocilia extending into their ECM, possibly involved in a homeostatic 
feedback loop from the external environment to the cytoskeleton (Poole et al, 
1985).
1.5 CELL JUNCTIONS
Direct cell-cell junctions, or cell-matrix junctions are fundamental to the 
construction and maintenance of tissue and organs. There are three categories of
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such junctions: anchoring junctions, linking cells to one another and to the ECM; 
gap junctions, allowing cells to directly pass signals from one another, and sealing 
or tight junctions that seal spaces between cells.
1.5.1 Anchoring Junctions
In addition to being components of the anchoring junctions outlined above, various 
membrane proteins are associated with general cell adhesive behaviour, to other 
cells or to the matrix. These may be a short-lived interaction or become stabilised 
into adherens junctions. These first interactions are vital in cell recognition and 
attachment. Cell-cell adhesion does not just stick cells together but organizes cells 
into 3-D patterns (Gumbiner et al, 2000), and prior to any communication between 
cells they must first form an adhesive bond. Here the super-family of cell adhesion 
molecules namely cadherins is focused on, with a comment on integrins.
Cadherins are transmembrane glycoproteins with an extracellular N-terminal and 
an intracellular C-terminal, generally passing through the cell membrane once. The 
N-terminal consists of cadherin domains, these vary in number each homologous 
to one another. The C-terminal binds through a protein complex to cytoskeletal 
actin (Pavalko and Otey, 1994; Steinberg and McNutt, 1999). There are five 
different classes of cadherin; type I or classical, to which e, p and n-cadherin 
belong, type II, desmosomal, protocadherins seven-pass transmembrane and 
flamingo cadherins (Angst et al, 2001). There are other members of the cadherin 
family that do not fit neatly into these groups e.g. T-, KSP- and Ll-cadherin 
(Wheelock and Johnson, 2003).
The key feature of the extracellular domain is that they bind to the same cadherin 
type as the adjacent cells, via an extracellular recognition site, the HAV tripeptide 
sequence histidine, alanine and valine or HAV, at the n-terminal (Blaschuk et al, 
1990). Either side of this sequence are ca2+ binding regions (cadherin binding is 
ca2+ dependant) which control the specificity of the cadherin binding. Synthetic 
peptides containing this sequence can interrupt normal cell-cell adhesion by 
competing with endogenous cadherins for binding (Blaschuk et al, 1990, 1994; 
Johnson et al, 1999; Knudsen et al, 1998, Takechi, 1990). The intracellular C- 
terminal is highly conserved and is the site of interaction between the cadherin and 
the actin cytoskeleton. A number of proteins including catenins, vinculin and focal 
adhesion kinases mediate this attachment, which is essential for cadherin
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clustering and the construction of an adherens junction if the interaction persists 
(Wheelock and Johnson, 2003).
There are many members of the cadherin super-family with different members 
having a degree of tissue specific expression. In connective tissues the 
predominant cadherin is n-cadherin, initially described in neural cells (Brakenbury, 
1988; Rutishauser, 1989; Takeichi, 1990). It is expressed by tendon fibroblasts 
(Ralphs et al, 2002), where it is upregulated in response to mechanical loading, 
and pre-chondrocytes (DeLise and Tuan, 2002), where it is involved in cell 
condensation and chondrogenesis. Generally, in development cadherins are 
important in cell sorting, concentrating cells of particular types to allow tissue 
formation (Wheelock and Johnson, 2003).
To link the transmembrane cadherin molecules to the actin cytoskeleton a complex 
intracellular junction is formed, included at this complex are catenins, p-catenin, y- 
catenin (also known as plakoglobin) a-catenin and p120 catenin (Stappert and 
Kemler, 1994; Aberie et al, 1994; Hulsken et al, 1994; Jou et al, 1995; Pokutta and 
Weis, 2000; Rubinfeld et al, 1995; Yap et al, 1995; Anastasiadis and Reynolds,
2000). The proteins a-actinin, vinculin, nectin, afadin and ZO-1 (PDZ protein) all 
play key roles in forming adherens junctions (Knudsen et al, 1995; Rimm et al, 
1995; Watabe-Uchida et al, 1998; Weiss et al, 1998; Shimizu and Takai, 2003; 
Okabe et al, 2004).
Cadherin activity is mainly regulated by protein phosphorylation, which is a 
response to a variety of signals including growth factors (Shibamoto et al, 1994; 
Dumstrei et al, 2002), hormones (Blaschuk et al, 1994) and signals from gap 
junctions (Maschhoff and Baldwin 2000). Cell-cell interactions can be affected in 
terms of their strength by modulating the expression level or altering the activity. If 
you increase the cadherin content the adhesion ability of the cells will increase 
(Wheelock and Johnson, 2003). Cadherins are not solely involved in cell adhesion 
they can indirectly cause a change in cell shape and polarity (Reinsch and 
Karsenti, 1994; Harris and Peifer, 2004; Johnson and McConnell, 2004). The 
signalling pathways activated by the formation of adherens junctions include those 
regulated by GTPases, receptor tyrosine kinases and the Wnt pathway (Wheelock 
and Johnson, 2003). Cell interactions mediated by cadherins are also a pre­
requisite for many other membrane receptor interactions, including gap junctional
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formation (Frenzel and Johnson, 1996) and tight junction formation (Tsukita et al,
2001), discussed later.
Junctions between cells and matrix
Integrins are cell adhesion molecules, however these cell surface molecules are 
involved in cell-matrix interactions. Integrins are produced by a wide variety of 
cells, and most cell types express several different types of integrin. They exist as 
non-covalently bound a-integrin and p-integrin heterodimers. The combination of a 
and p integrins determines the binding capabilities of the dimmer (Ruoslathi and 
Pierschbacher, 1987). Integrins vary from other cell surface receptors in that they 
bind to their ligands with a low affinity, and that they are usually present at a large 
concentration at the cell surface. However, they only bind to their ligands when 
they gather at a region of the cell surface above a threshold concentration 
(Berman et al, 2003).
In addition to roles in matrix adhesion, integrins can be involved in cell-cell binding 
(Martin-Bermudo and Brown, 2000), integrins can bind ECM to the cell surface, 
notably fibronectin (Hemler, 1990), but also other components, such as laminin, 
collagens, entactin, tenascin, thrombospondin, von Willebrand and vitronectin 
(Hemler, 1990; Rouslahti and Pierschbacher, 1987). Fibronectin fibril formation is 
prevented at cell surfaces if integrin binding is blocked (Darribere et al, 1990). This 
can have roles in general ECM organisation as actin-associated integrin 
orientation of fibronectin at the cell surface, which can also interact with collagen 
(Hayes et al, 1999). The adhesive roles of integrins are also involved in 
mechanotransduction. Application of load to integrins at the cell surface causes 
changes at the integrin/actin interface, resulting in signal transduction processes, 
such as the phosphorylation of FAK and other integrin/actin associated proteins 
(Cary and Guan, 1999; Wozniak et al, 2004).
Growth factors regulate integrin expression these can include TGFp, IGF-1, bFGF 
and PDGF (Loeser, 1994 and 1997; Sepp et al, 1994; Brooks et al, 1994; 
Kirchberg et al, 1995). Tendon cells treated with bFGF and PDGF show an 
increase in the regulation of integrins in vitro (Harwood et al, 1999), and at the 
myotendinous junction integrins have been associated as having vital roles in 
development (Swadison and Mayne, 1989; Miosge et al, 1999; Ferguson et al, 
2003; Nawrotzki et al, 2003).
25
Focal Contacts are junctions allowing the actin cytoskeleton of the cell to interact 
with the ECM, arranged in a similar fashion to adherens junctions but with 
cadherins substituted for integrins within the junctional complex. They act as 
anchors for the cell and relay signals involved in cell motility and survival (Schaller,
2001). They consist of a complex of integrins, and multiple intracellular attachment 
proteins, including talin, paxillin, vinculin and a-actinin, it is a-actinin that binds 
directly to the actin filaments (Critchley et al, 1999; Critchley, 2004; Nayal et al, 
2004).
Desmosomal junctions use cadherins, namely desmoglein and desmocollin, to 
form plaques connecting the intermediate filaments of adjacent cells, rather than 
the actin cytoskeleton of adherens junctions (Garrod et al, 1996). Desmosomes 
are prominent cellular structures especially in tissue that experience mechanical 
stress (Wheelock and Johnson, 2003). These junctions function to resist stretch 
and play a structural and tension-bearing role in the cell. Hemidesmosomes use 
integrins to attach the intermediate filaments to ECM molecules (Jones et al, 1994; 
Green and Jones, 1996). Their best known function is to mediate the adhesion of 
epithelial cells to the basal lamina (Briggaman and Wheeler, 1975; Gipson et al, 
1983). No desmosomal junctions or their associated proteins have been identified 
within tendon (Ralphs, personnel communication).
1.5.2 Gap junctions
Gap junctions provide intercellular communication between cells within tissues and 
organs. Comprised of 6 transmembrane proteins called connexins, forming a 
hemi-channel called a connexon. A gap junction forms when two connexons on 
adjacent cell membranes become aligned creating a continuous aqueous pore 
(Unwin, 1986). The connexins rise above the surface of the cell, and create a 2-4 
nm gap between the cell membranes, hence the name ‘gap’ (Goodenough et al, 
1996). Connexins have been classified into two main subgroups, a and p 
dependant on similarities in the amino acid sequence (Willecke et al, 2002). 
However, the numerical names of the connexins are more widely used referring to 
the molecular weight of the sequence in kilodaltons (Goodenough et al, 1996).
Gap junctions allow inorganic ions and other small water-soluble molecules, for 
2+ 3example Ca , IP or cAMP, sugars, amino acids and nucleotides (anything up to 
1000Da), to passively diffuse between the cytoplasm of adjacent cells (Warner et
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al, 1995). The diffusion of these metabolites and nutrients depends on channel 
type, connexin 32 channels are more permeable to adenosine than connexin 43 
channels, but ATP passes more readily through connexin 43 channels (Goldberg 
et al, 2002). This means the cells are communicating electrically and metabolically 
with each other (Kumar et al, 1996). However, it is important to note that these 
junctions are relaying signals, not originating them.
Connexins are generally regulated by phosphorylation. The primary region to 
undergo phosphorylation is the C-terminal of the protein (Lampe and Lau, 2004), 
The permeability of gap junctions is governed by cytosolic pH and calcium levels, if 
the pH level increases or the Ca2+ level decreases, gap junctional permeability will 
increase (Bennett and Verelis, 1992). Calcium dependant cell adhesion molecules, 
(CAMs) namely cadherins are found localised with gap junctions, and the 
formation of adherens junctions are known to be a prerequisite for gap junctional 
formation (Musil et al, 1990; Jongen et al, 1991; Meyer et al, 1992; Fujimoto et al, 
1997; Segretain and Falk, 2004). There are in fact several proteins present at both 
adherens and gap junctions, indicating their subcellular domains are tightly 
regulated and that they both may play a role in cytoskeletal anchorage (Giepmans, 
2004), discussed later.
Physiological roles of gap junctions and connexins
Connexin knock-out mice have outlined many aspects of connexin and gap 
junction function. The cellular functions of gap junctions include the propagation of 
actions potentials in electrically excitable tissues, including the myocardium 
(Gourdie et al, 1992; Reaume et al, 1995), communicating between smooth 
muscle (Brink et al, 1998) and relaying information across synapses (Bruzzone et 
al, 1997; Houlden et al, 2004). Connexin 43 knockout mice die, as connexin 43 is 
required for normal heart development (Reaume et al, 1995; reviewed in Barker 
and Gourdie, 2002). Knock-in mouse lines, where connexin 43 gene is replaced 
with connexin 32 or 40 rescued the lethality of connexin 43 deficient mice, 
although they retained distinct morphological and functional defects (Plum et al, 
2000). Connexin 50 can compensate for connexin 46 in the prevention of 
cataracts, but is required for normal ocular growth (White, 2002). Connexin 32 
mutations are associated with x-linked Charcot-Marie tooth disease, a mild 
peripheral neuropathy associated with myelin disfunction (Houlden et al, 2004), but 
connexin 32 knock-out mice show a decrease in connexin 26, suggesting connexin 
32 has a stabilising effect on connexin 26.
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Extensively studied in bone, connexin 43 and 45 are expressed by osteoblasts and 
osteocytes, where they are involved in bone cell differentiation and remodelling 
(Lecanda et al, 1998; Upham et al, 2003; Thi et al, 2003; Borke et al, 2003). 
Although no specific roles for the different connexin networks have been 
determined, one type can compensate for the other (Minkoff et al, 1999). In 
cartilage, the cells are normally isolated from one another by an extensive matrix, 
however, chondrocytes in precartilaginous mesenchymal condensations express 
connexin 43 (Schwab et al, 1998; Zhang et al, 2002). They also re-express 
connexin 43 when they come into contact with one another, in vivo, in cell clusters 
that are characteristic of osteoarthritis or in vitro (Donahue et al, 1995; Loty et al, 
2000; Hellio Le Graverand et al, 2001).
Connexin expression in fibroblasts has shown connexin 43 and 45 are present in 
the outer annulus of the intervertebral disc (Bruehlmann et al, 2002), connexin 43 
is expressed by corneal stromal cells (Clover et al, 1996; Laux-Fenton et al, 2003) 
and by synovial fibroblasts (Kolomytkin et al, 1997 and 2002). Connexin 32 and 43 
are found in tendon and the periodontal ligament (McNeilly et al, 1996; Yamaoka 
et al, 2000). In tendon connexin 32 and 43 coordinate cellular response to 
mechanical load and have very specific distributions (McNeilly et al, 1996; Ralphs 
et al, 1998; Waggett et al, 1999). The lateral cell processes radiating from the 
stellate shaped tendon fibroblasts communicate with the adjacent cell rows using 
gap junctions comprising of connexin 43, known to be regulated by mechanical 
strain (Banes et al, 1995a). Conversely, the gap junctions located within the 
longitudinal cell rows themselves consist of connexin 32 and 43 (McNeilly et al, 
1996). Both connexins 32 and 43 can only form homomeric connexons (Elfgang et 
al, 1995), implying these connexins have different functions. The functions appear 
to be associated with sensing load and modulating collagen synthesis, collagen 
synthesis is stimulated by communication via connexin 32, but inhibited by 
communication via connexin 43 (Waggett et al, submitted; Waggett et al, 2001). 
Connexin 26 mRNA has been identified within tendon (Banes et al, 1995a), 
although none has been found at the protein level (Ralphs et al, 2002), suggesting 
either protein levels are too low, or connexin 26 is not translated.
Connexins are associated with other cell-cell junctions and electron micrographs 
show distinct tight junctional strands found surrounding gap junctional plaques 
(Kojima et al, 1999). Precipitation experiments show connexin 32 is associated 
with occulin, ZO-1 and claudins, proteins that form the core of tight junctions, see
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below (Kojima et al, 2001). ZO-1 is associated with other connexins; 43, 45, 50,
39.1 and 36 (Giepmans and Moolenaar, 1998; Giepmans et al, 2001a, b; Barker et 
al, 2002; Kausalya et al, 2001; Laing et al, 2001; Neilsen et al, 2002 and 2003; Li 
et al, 2004).
1.5.3 Tight Junctions
Tight junctions fuse epithelial or endothelial cells forming continuous selective 
barriers, although more recently they have been found in myelinated cells 
(Gonzalez-Mariscal et al, 2003). The three integral proteins of tight junctions are 
occulin (ZO-1), junction adhesion molecules (JAM) and the claudin family of 
proteins (Schneeberger and Lynch, 2004). Tight junctions play a role in 
maintaining the concentration differences of ions, water, and small hydrophilic 
molecules between cells, and are involved in organising morphogenesis, cell 
polarity, cell proliferation and differentiation (Schneeberger and Lynch, 2004). 
Tight junctions are often seen in conjuncture with adherens, desmosomes and gap 
junctions (Gumbiner, 1987), as discussed above.
1.6 TENDON DEVELOPMENT
There are relatively few studies on the development of tendon, particularly in 
comparison with studies on cartilage. There are however, similarities between the 
two. From a mesenchymal origin the cells condense, increasing cell-cell contacts 
and inter-cellular communication (Hall and Miyake, 2000). This process has been 
extensively studied in cartilage, demonstrating important roles for gap junctions 
and cadherin based adhesion (Coelho and Kosher, 1991; Wolpert, 1992; 
Zimmermann, 1984; Oberlender and Tuan, 1994; Tavella et al, 1994; Hall and 
Miyake, 2000; DeLise et al, 2000; DeLise and Tuan, 2002a, b). There is very little 
information however, about cellular communication between tendon progenitors 
during condensation (Hall and Miyake, 2000). In contrast to cartilage, cells in 
tendon primorda retain contact with adjacent cells through ever lengthening cell 
processes, whereas in the cartilage primordia cells are completely pushed apart, 
breaking the cell-cell contacts.
1.6.1 Tendon development and morphogenesis
The development of tendon is best known in the limbs. The most commonly used 
species is chick, although extensive work has also been carried out on mouse 
embryos with the advent of gene knock-out experiments. In early development, 
tendons develop from the mesoderm, formed at the trilaminar germ disc stage.
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The mesoderm forms the paraxial lateral plate and intermediate mesoderm. 
Tendon development is dependant on the paraxial mesoderm that accumulates 
bilaterally to the neural tube and notochord (Pourquie, 2001). It is the 
segmentation of the paraxial mesoderm, from rostral to caudal in direction that 
produces the somites (Pourquie, 2001). Until recently the somite was thought to 
differentiate further into sclerotome, myotome and dermomyotome (Christ and 
Ordahl, 1995). Recent experiments have brought to light another segment of the 
somite that lies dorsally to the sclerotome. (Brent et al, 2003). It has been named 
the syndetome and it is thought to give rise to future tendon cells of the axial 
skeleton. Tendon progenitors become incorporated into the limb mesenchyme as 
development proceeds (Oldfield and Evans, 2003). In the developing chick limb- 
bud, a tenascin-rich sheet of ECM accumulates beneath the ectodermal basal 
lamina (Hurie et al, 1990). This is called the mesenchymal lamina, and provides a 
scaffold for the assembly of pre-tendinous mesenchymal cells. This is not present 
in mammalian development, but the specialised nature of this region is shown by 
the expression of eya and six genes, marking it out in the same place (Riou et al,
2002). These cells will eventually segregate and align to form individually and 
anatomically distinct tendons (Ros et al, 1995, Kardon et al, 1998; reviewed by 
Benjamin and Ralphs, 2000).
In the developing limb, tendon progenitors lie in the dorsal and ventral regions, 
which become extensor and flexor tendons respectively, with cartilage progenitors 
positioned centrally (Schramm and Solursh, 1990; Schweitzer et al, 2001). These 
blastemas can be subdivided into proximal, intermediate and distal parts (Kardon, 
1998). These differ in their initial structure and association with the early 
musculature. The distal primordia differentiate independently of the musculature, 
but require interactions with it later, or these regions of tendon degenerate (Kieny 
and Chevalier, 1979; Kardon, 1998). The proximal and intermediate primordia 
require closer interactions with muscle, possibly involving FGF4 (Edom-Vovard et 
al, 2001). Tendon cells become orientated on an organised tenascin scaffold in the 
intermediate and distal primordia, and tenascin expression is upregulated in 
proximal primordia (Kardon, 1998). As cell rows form, orientated matrix is 
deposited. This may be based around the tenascin pattern as above, but also, in 
other highly organised fibrous structures cytoskeletal architecture, cell interactions 
and cell orientation are also important (Hayes et al, 1999).
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1.6.2 Collagen fibrillogenesis in tendon development
Collagen fibril formation in developing tendon involves a hierarchy of extracellular 
compartments, created by fibroblasts (Trelstad, 1982; Trelstad and Birk, 1984; Birk 
and Zycband, 1993). Collagen segments are intermediates in collagen fibril 
assembly in soft connective tissue. There are indications that the ends of 
developing collagen fibrils show distinct differences involving long and short 
tapered ends throughout stages of development (Birk et al, 1989, 1990). This 
pattern was found in numerous tissues including the skin and cornea, 
demonstrating it as a general mechanism in the growth and morphogenesis of 
connective tissues (Birk and Trelstad, 1984; Birk et al, 1991; Ploetz et al, 1991).
The recent studies of Canty et al, (2004), into collagen deposition in developing 
tendon has provided evidence of vesicles carrying procollagen fibrils, with 28nm in 
diameter, being targeted to specific areas of the plasma membrane. These 
vesicles are well known (Hirschberg et al, 1998; Toome et al, 1999; Polishchuk et 
al, 2000), but the areas of plasma membrane are a relatively new observation. 
Termed Tibripositiors’, these plasma membrane protrusions have a significant role 
in collagen deposition, essentially their ability to allow collagen nucleation within 
the lumen at the base of the fibripositior, well within the cell, and collagen 
deposition at the tip into intercellular spaces formed between tendon cells. They 
are present in early tendon development but only for a short period (Canty et al, 
2004).
When collagen fibrils are secreted from the fibroblast they remain in close 
proximity with the cell membrane, and self-aggregates into collagen fibres. The 
first extracellular compartment consists of 2-3 fibrils, in a series of narrow channels 
created by the membrane of the fibroblasts, running from deep within the 
cytoplasm, often associated with the Golgi region, out to the ECM. These channels 
fuse laterally and the fibril segments aggregate and form longer fibrils. The second 
ECM compartment defined is also close to the cell surface. The region is 
determined by one or more fibroblasts, where collagen fibres coalesce to form fibril 
bundles. Between 12 and 15 days of development, collagen assembly is 
predominantly tapered end-end attachments (Birk et al, 1995). This yields longer 
collagen fibrils without increasing the diameter. The third compartment for collagen 
fibrillogenesis has boundaries formed from 2-3 adjacent fibroblast membranes. 
This enables the cells to physically position and organise the collagen 
macroaggregates within the matrix (Birk and Zycband, 1993).
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There is a dramatic increase in collagen fibril diameter at 17 days of development 
(Brodsky et al, 1982; Eikenberry et al, 1984; Birk et al, 1990) that is consistent with 
the increase of mechanical strength of developing tendon (Ros et al, 1995). At this 
stage there is no cell proliferation to facilitate an increase in the matrix:cell ratio 
(Nurminskaya and Birk, 1998). This also correlates with a remarkable decrease in 
fibril-associated decorin, which occurs between 16-19 days of development in the 
chick (Birk et al, 1995). This lack of fibril-associated decorin allows lateral 
assembly of the collagen fibrils. Coinciding with this point of development is a 
reduction in the expression of the FACIT collagen type XIV, (Young et al, 2000) 
together with a decrease in type XII collagen (Zhang et al, 2003). Type XIV 
collagen is restricted to immature collagen fibrils suggestive of stabilisation of early 
collagen fibril segments allowing only end-to-end growth (Young et al, 2000). The 
decrease and the spatial shift of type XII collagen expression, shows that it 
becomes associated with endotenon of developing fascicles (Zhang et al, 2003) 
and corresponds with type III collagen shift of expression to the endotenon (Birk 
and Mayne, 1997). Both decorin and type XIV collagen play a regulatory role in 
collagen fibrillogenesis, but type XII collagen has a functional role in integrating 
fascicles into functional units with type III collagen (Keene et al, 1991; Young et al, 
2000; Schuppan et al, 2001). Gene expression of TGFp and IGF-1 are increased 
at this stage, possibly inducing the increased expression of type I, VI and XI 
collagen observed (Nurminskaya and Birk, 1998). Also fibromodulin expression is 
increased, possibly to replace decorin and to help stabilise the maturing fibrils 
(Nurminskaya and Birk, 1998; Ezura et al 2000). Lateral fusion predominates as 
development proceeds (Fleischmajer et al, 1998), with collagen diameter 
regulation from surface decorin and type V collagen (Birk et al, 1990: Weber et al,
1996).
1.6.3 Markers of tendon differentiation
A problem in studies of tendon development and differentiation is that there is no 
clear marker for tendon. In cartilage, there are matrix markers such as type II 
collagen, aggrecan, and the transcription factor sox9 (Benya et al, 1982; Asou et 
al, 2002), in tendon matrix components are expressed by numerous other 
connective tissues and there does not seem to be an ‘exclusive’ transcription 
factor marker either. An important indicator is therefore structure, with cell rows 
and parallel matrix, in the correct anatomical position. However, some matrix and 
molecular markers are useful up to a point, and these are outlined below.
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The transcription factor scleraxis can be used as an early stages marker before 
tendon primordia become recognisable by other means. It is a marker of ligament 
as well, and is expressed in other connective tissues (Cserjesi et al, 1995; 
Schweitzer et al, 2001), but can serve as an early marker, if not an exclusive one. 
In tendon development there are 4 phases of scleraxis expression (summerised in 
Oldfield and Evans, 2003). The first is at Hamburger and Hamilton (HH) stage 21 
(day 3.5), cells in the proximo-medial region of the limb bud begin to express 
scleraxis. The expression is superficial in the dorsal and ventral domains of the 
limb, and it is too early to identify tendon cells using tenascin as a marker (Kardon,
1998). The second stage occurs between HH stages 25-27 (4.5-5 days), here the 
scleraxis-expressing cells join together in a proximal-dorsal fashion and begin to 
form the first fibrous elements of tendons. The third stage, at HH28 (5.5 days), and 
true tendon fibres can be seen, with fibres becoming more elongate, nearer to 
mature tendon structure. The final stage occurs at HH31 (7 days) where scleraxis 
expression is present throughout the tendon (Schweitzer et al, 2001).
Other transcription factors may be expressed in tendon related regions include pea 
3 and Erm, regulating scleraxis expression in the syndetome (Brent and Tabin, 
2004), sixl, six2 (Oliver et al, 1995), Eya1 and Eya2 (Xu et al, 1997). Six1 and 
Eya2 expression is restricted to the dorsal extensor tendons of the digits, whereas 
six2 and Eya1 are seen ventrally, and precede the expression of Eya 2 (Oliver et 
al, 1995). Another factor involved in tendon development is the LIM homeodomain 
transcription factor (Lmxlb). In Lmxlb knockout mice the ventral-dorsal 
asymmetry caused by the six genes is lost (Dreyer et al, 2004). They are useful 
markers of regions of early tendon, therefore, if not of tendon tissue itself.
Extracellular matrix markers are tenascin, and a range of collagens including types 
I, III and VI, and various small proteoglycans. Tenascin is the earliest marker of 
these, although later than scleraxis (Kardon, 1998). The others become clearer 
later, although it is only because of their relationship to tendon structure that they 
can be used, as types I and III collagen, for example, as expressed prominently in 
the mesenchyme from which they are derived (Hurie et al, 1990; Ros et al, 1995). 
Growth factors and other signal related molecules are also specifically associated 
with tendon at some stage. Eph-A4, a tyrosine-kinase receptor is expressed in the 
proximal portion of the tendon, and in the body of the tendon in later development 
(Patel et al, 1996: D'Souza and Patel, 1999). The follistatin gene is expressed in a 
ventral-distal fashion and restricted to the tendon periphery (D’Souza and Patel,
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1999). Follistatin encodes a protein that acts as an antagonist to some TGF(3 
superfamily members, including BMP-2, BMP-4 and Activin (Reviewed in Patel,
1990). This is important as BMP-2 and BMP-4 induce chondrogenesis (Merino et 
al, 1998). Conversely, other members of the TGF|3 superfamily, namely growth 
and differentiation factors (GDF) 5, 6 and 7 have been shown to induce tendon 
development (Wolfman et al, 1997). Consequently, follistatin could have a 
regulatory role in GDF's during tendon development.
1.7 TENDON REPAIR
Tendons may be damaged in a number of ways. They may be crushed or fully or 
partially severed; they may be surgically cut, tom by excessive loading or 
damaged in disease, for example tendonitis. Tendon repair is promoted by intrinsic 
factors (endotenon and epitenon cells) and extrinsic factors (e.g. neutrophils and 
marcrophages; Potenza, 1962; Gelberman et al, 1984; Manske et al, 1984; and 
Jaibaji et al, 2000). There are three recognised stages in the process: 
inflammation, proliferation and remodelling (Frank et al, 1999). Overuse injuries, or 
tendinosis, caused by repeated low-level traumas, tend not to initiate an 
inflammatory response (Frank et al, 1999).
Inflammation phase
Tendon injury often results in the rupture of a blood vessel, causing inflammation 
that can last for up to 4 days post-injury (Wojciak and Crossan, 1993). Blood 
vessels, blood plasma and tissue fluids accumulate at the injury site. Platelets 
enter and bind to exposed collagen fibres stimulating clotting (Rao, 1993), filling 
the wound. Fibrin and fibronectin are present from one hour after injury and form 
cross-links with collagen (Lehto et al, 1990), producing a glue-like plug that 
prevents haemorrhage and provides some degree of continuity between the 
damaged tendon ends. Fibronectin enhances the migration and adhesion of cells 
(Wojciak-Stothard et al, 1997). The deposition of platelets also brings a supply of 
growth factors to the site, e.g. PDGF and TGFp (Mast, 1997; Anitua et al, 2004). 
Within hours, white blood cells migrate to the injured area and macrophagocytic 
inflammatory cells clear the area of necrotic tissue and debris (Wojciak and 
Crossen, 1993). When the wound area is clear of debris, the proliferation phase 
begins.
Proliferation/Granulation phase
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During the proliferation/granulation stage there is an accumulation of fibroblasts, 
myofibroblasts and epithelia at the wound site (Gelberman et al, 1985). 
Angiogenesis commences and the newly formed capillaries communicate with the 
existing capillary network (Fenwick et al, 2002). Nascent tendon fibroblasts at the 
damaged end of the tendon begin to both proliferate and synthesise new matrix 
allowing for granular tissue formation (Williams, 1985). Tendon cells from the 
epitenon, endotenon or tendon proper have varying capacities for proliferation, 
matrix synthesis and migration and possibly different roles in healing. 
Investigations into these differences found epitenon cells are bigger and 
synthesise increased amounts of a-smooth muscle actin and vinculin (Ragoowansi 
et al, 2003). They also produced more MMP-2 and MMP-9 compared to 
endotenon cells, it was recommended that the epitenon cells should be specifically 
targeted to inhibit or treat tendon adhesions (Ragoowansi et al, 2003). Fibroblasts 
from the synovial sheath were taken and compared with fibroblasts from the 
endotenon. It became apparent that synovial fibroblasts are more active and have 
a greater capacity to produce matrix metalloproteases, implying a better ability to 
degrade matrix and consequently have a greater ability to migrate (Khan et al, 
1998). Experimentation on sheath, epitenon and endotenon fibroblasts in vitro 
investigated their reactions to the TGF{3 isoforms 1, 2 and 3. There were small 
differences between cell type and growth factor treatments, but a general increase 
in types I and III collagen and a decrease in cellular proliferation was observed 
(Klein et al, 2002). Myofibroblasts present at the wound site, function to produce 
granulation tissue, but also help to contract the granular tissue aiding wound 
closure (Hinz and Giabbiani, 2003).
In the early stages of this phase tendon fibroblasts increase the production of 
GAGs, proteoglycans, vitronectin, fibronectin and types III, IV, V and VI collagen 
(Clark, 1996; Birk et al, 1997). The production of type III collagen at this time has 
been shown to stabilise the repair process due to its ability to form rapid crosslinks 
(Liu et al, 1995). Granulation tissue is well vascularised, highly cellular and poorly 
organised relative to the ordered ECM of normal tendon (Williams, 1985). 
Approximately 2 weeks after injury, the granulation tissue has matured, the scar is 
stronger and the collagen fibres begin to become aligned with those of the 
uninjured tendon (Clark, 1996). It is in this later stage of healing that type I 
collagen is synthesised (Leadbetter et al, 1992). The proliferative stage overlaps 
considerably with the final stage in tendon repair, the maturation and remodelling 
stage.
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Remodelling phase
The remodelling phase is the longest and can last for a year or more. The number 
of macrophages, fibroblasts, myofibroblasts and capillaries decrease slowly, as 
does their synthetic activity (Mast, 1997; Molloy et al, 2003). The scar becomes 
denser and vascularity decreases with the concentration of GAGs (Lin et al, 2004). 
Type I collagen predominates and is densely packed to increase tensile strength 
(Jaibaji, 2000; Clark, 1996; Eckes, 2000). The type I collagen fibres remodel 
themselves until the tendon forms a strong permanent structure (Leadbetter et al,
1992). After 5-6 months the tendon fibroblasts or tenoblasts de-differentiate to less 
active tenocytes. Other experiments have shown that it is not until 12 months after 
tendon rupture that the tendon begins to recover some degree of organisation in 
its collagen fibrils (Bruns et al, 2000).
Although this repair process seems efficient, there are still biochemical and 
mechanical deficiencies that will persist indefinitely (Leadbetter et al, 1992) and 
the tendon will always be more susceptible to further damage (Mast, 1997). The 
ultimate tensile strength of the repaired tendon can be decreased by as much as 
30% of its original value. This decrease is due to alterations in collagen type and 
distribution, PG content and cellularity (Gelberman et al, 1988; Hyman and Rodeo,
2000). This may sound less than ideal, however, in most cases it represents a 
perfectly adequate repair. Experiments have shown in vivo the natural reparative 
state of the tendon to be 48% tensile strength after 15 days (Reddy et al, 2001). 
Normal activity studies have shown that rabbits use up to 40% of the tendon 
tensile strength. So it is fair to suggest 100% recovery may not be necessary.
The natural healing process, even though it may take over a year, if accompanied 
with the appropriate exercise program (Stanish, 1984; Alfredson et al, 1998), will 
see most injuries fully recover (Paavola et al, 2000). However, where a tendon 
injury has complications (bums, crush injuries or sections of the tendon missing), 
the natural healing process is inadequate for a satisfactory recovery. Surgical 
procedures for ligament/tendon replacement have been developed over decades. 
Reviews presenting a concise evaluation of these methods for anterior cruciate 
ligament or flexor tendon repair, autograft, allograft or synthetic graft provide 
ample information on this subject (Wilson and Sammut, 2003; Sherman and 
Banffy, 2004). Together with an explanation of the role of the vasculature in these 
systems (Fenwick et al, 2002), it is possible to assess the current clinical standing
36
on this speciality. However, the response of tendon to these techniques is another 
large area of research.
1.7.1 Growth factors in connective tissue repair
The release of growth factors (i.e. TGFp, bFGF, PDGF, VEGF and IGF-1) and 
other chemotactic factors is highly influential in tendon repair. Each growth factor 
is required at specific times during the repair process (Molloy et al, 2000; Hsu and 
Chang, 2004). A short summary is presented here, with more details being given 
in chapters 5 and 6.
Insulin-like growth factor (IGF)
The growth factor IGF-1 has important actions during the inflammation and 
proliferative stages of tendon repair (Molloy et al, 2003). IGF-1 promotes cell 
proliferation and cell migration, in addition to increased matrix synthesis (Grazul- 
Bilska et al, 2003). It follows that with the elevated IGF-1 concentrations apparent 
during inflammation there is a corresponding increase in IGF receptor expression 
(Tsuzaki et al, 2000). IGF-1 has also been shown to be important in conjunction 
with other growth factors (Lynch et al, 1989). PDGF acts synergistically with IGF 
resulting in an increase in cellular proliferation (Tsuzaki et al, 2000). In vivo use of 
IGF-1 can increase the rate of Achilles tendon healing and reduce inflammation 
(Kurtz et al, 1999). Additionally, application of IGF and bFGF to healing tendons 
showed a statistically significant increase in the tensile strength of tendons (Letson 
and Dahners, 1994).
Transforming growth factor
The superfamily of TGF is large and includes BMPs and GDFs. The prototypical 
member, TGF0-1, is important at all stages of tendon repair (Tsubone et al, 2004). 
TGFp-1 is involved in the regulation of cell migration, proteinase expression, 
fibronectin binding, termination of cell proliferation and the stimulation of collagen 
synthesis (Chang et al, 2000; Bennet and Schultz, 1993; Natsu-ume et al, 1997 
and Wojciak and Crossen, 1994). As with IGF receptors, TGFp receptors are also 
up-regulated at the cell surface during tendon healing (Ngo et al, 2001). 
Coincidently, the up-regulation of TGF0 receptors corresponds with the peak of 
types I and III collagen synthesis within scar tissue (Eckes et al, 2000), reiterating 
its role in collagen synthesis. Increased levels of TGFp are associated with 
adhesion formation in healing tendons in vivo (Chan et al, 1997) and neutralisation 
of TGFp activity using antibodies can improve post-operation range of motion in
37
tendon (Chang et al, 2000). A study using cartilage derived morphogenic protein 2 
(CDMP-2/GDF-6) showed stimulation of matrix synthesis in healthy and 
osteoarthritic chondrocytes (Bobaczk et al, 2002). Injections of CDMP-2, or the 
use of GDF-5/CDMP-1 coated sutures applied to damaged Achilles tendons 
resulted an increase in the tensile strength, thickness and density (Forslund and 
Aspendberg, 2001; Rickert et al, 2001). Subjects treated with GDF-5/CDMP-1 saw 
chondrogenic material within the tendon a month after repair (Rickert et al, 2001).
Basic fibroblast growth factor
BasicFGF/FGF-2 is a stimulator of angiogenesis (Gabra et al, 1994), cellular 
migration and cell proliferation (Folkman and Klagsbrun, 1987). Increased 
expression of bFGF has been noted from the time of injury throughout the healing 
process and is mainly produced by fibroblasts at the wound edge (Chang et al,
1998). bFGF has been shown to increase type III collagen synthesis and cell 
proliferation in vivo (Chan et al, 2000). bFGF on a fibrin gel implanted into a medial 
collateral ligament defect, resulted in an increase in the early repair stages (Fukui 
et al, 1998). However, higher doses of bFGF had adverse effects and caused 
delays in the maturation of the scar tissue. Type I procollagen levels were also 
down regulated in all bFGF treated groups (Fukui et al, 1998). Other experiments 
using medial collateral ligament defects, confirmed the influence of bFGF on the 
early stages of repair, producing an increase in amount of granulation tissue with 
superior collagen orientation at 6-24 weeks (Kobayashi et al, 1997). This study 
also demonstrated that although bFGF only affects the early stages of ligament 
repair, the subsequent stages have increased speed and efficiency (Kobayashi et 
al, 1997). VEGF is active slightly later than other growth factors in tendon repair. 
Its expression is seen to increase during the proliferation and remodelling stages 
and is a known stimulator of angiogenesis (Jackson et al, 1997).
Platelet-derived growth factor
PDGF levels are elevated from early stages of tendon repair and this growth factor 
is known to induce the synthesis of IGF-1 (Lynch et al, 1989) and TGF|3 (Pierce et 
al, 1989). It has been shown to stimulate collagenous and non-collagenous protein 
synthesis, and through IGF-1 stimulation, increase cell proliferation (Abrahamsson,
1997). Interestingly, combined PDGF and TGFp treatment results in poor healing 
in ligaments (Hildebrand et al, 1998). Additionally, using defects in the medial 
collateral ligament of rabbits, PDGF treatment increased the rate of healing in a 
dose dependant manner (Hildebrand et al, 1998). Experimental work concentrating
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on other methods of growth factor delivery has used gene transfer of PDGF on 
ligamentous tissue, resulting in an increase in matrix synthesis (Nakamura et al,
1998).
1.8 CELL AND TISSUE CULTURE AND TISSUE ENGINEERING
Reports of tissues being grown outside of the body began to appear in scientific 
literature in the mid-1880's. A report by Roux (1885) is the most commonly used 
citation; he described the maintenance of chick embryonic tissue in warm saline. 
Two years later Arnold described the survival and migration of frog leukocytes in 
saline, and then in 1903, Jolly showed the survival and division of salamander 
leukocytes, in what he described as ‘hanging-drop cultures’. Harrison (1907) and 
Carrel (1912) developed tissue culture as a method of studying animal cells free 
from systemic variations.
In later years, methods for supporting mammalian cells were developed, as their 
normal and pathological development was nearer to that of human cells. The use 
of human tissue was highly influenced by the demonstration that human tumours 
could give rise to continuous cell lines (e.g. HeLa: Gey et al, 1952). The period 
between early tissue culture experiments and the later culturing of human cells 
lines, was marked by important developments in tissue culture, including the first 
use of the proteolytic enzyme trypsin to suspend attached cells in culture (Rous 
and Jones, 1916). The development of dedicated culture flasks allowed 
developments in technique for cell culture scale-up and the microscopic evaluation 
of cells in culture (Carrel and Baker, 1931, 1932). After that came the development 
of the roller tube technique for cell suspensions (Gey, 1933) and of a chemically 
defined growth medium (Fischer, 1948). Later, important experiments saw the 
observation of contact inhibition, where cells mobility in a monolayer ceases when 
contact is made with adjacent cells (Abercrombie, 1954), and that human 
fibroblasts die after a finite number of passages in monolayer culture (Hatflick and 
Moorhead, 1961).
Tissue culture technology evolved rapidly with applications developing to meet a 
range of scientific and medical problems. Although tissue culture has limitations, 
its major advantages include the control of the external environment, whether it is 
pH; temperature; osmotic pressure; or 0 2 or C02 content. When the contamination 
issues of early tissue culture had been resolved, investigators were able to apply 
themselves to the nutritional requirements of cells. As indicated above, tissue
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culture media was developed (Fischer, 1948), honed from early experiments using 
buffered saline solutions or plasma clots. The discovery that nutrient requirements 
differ from cell type to cell type, led to the development of many different media, 
with a variety of supplements usually being necessary for reliable cell growth. The 
most common additive was, and still is, serum (Olmsted, 1967; Honn et al, 1965), 
although, serum-free fully defined systems have been developed, they tend to 
have very restricted applications (Birch and Pirt, 1971; Ham and McKeehan, 1978; 
Bames and Wolfe, 1980).
As with all scientific procedures there are disadvantages. These include the 
constant difficulties in maintaining aseptic conditions, the relatively poor yield of 
cells from tissue and their phenotypic instability. It is also important to note that 
there are major differences in cell behaviour in vitro compared with the in vivo 
situation. The cells in vitro lack systemic influences and homeostatic regulation 
from the endocrine and the nervous system. This results in cellular metabolism 
being more constant. Cells are also no longer in a three dimensional (3-D) 
environment, and lack the cell-cell/cell-matrix interactions which occur in vivo. Two 
dimensional (2-D) culture systems can cause the differentiated properties of cells 
to be lost; this can make it difficult to compare cultured cells with the functionality 
of the cells as in the original tissue. Different culture methods are examined in 
more detail below, comparing standard 2-D with more sophisticated 3-D culture 
methods.
1.8.1 Monolayers
The primary method of growing cells in vitro is as a monolayer. It is a cheap and 
simple method of culturing cells and most cells can be grown in this way. Cells 
plated in a tissue culture dish need to adhere to a substrate in order to survive and 
proliferate, by mitosis, to cover the entire area of the dish. Each cell has contact 
with adjacent cells forming adhesive and communicating junctions.
The 2-D organisation of this culture system enables the studies of some aspects of 
cell behaviour, but these are often clearly abnormal. It is important to remember 
that these cells are in an alien environment - they have been taken from 3-D 
systemic surroundings, treated relatively harshly with enzymes and plated in a 2-D 
context. However, monolayers have their uses. They are convenient for cytological 
and immunological observations of cells, and ideal for cell multiplication and large 
scale expansion of cell numbers (Freshney, 1983).
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Connective tissue cells often require more sophisticated systems if they are to 
behave in any way similar to the in vivo situation. This is most easily shown with 
chondrocytes, where the differentiated state of the cells is monitored by expression 
of type II collagen, aggrecan and sox9 (Benya et al, 1978; Grundmann et al, 1980; 
Kypriotou et al, 2003). Chondrocytes require 3-D culture systems if the phenotype 
is to be maintained (van Osch et al, 2001), plating them in a monolayer leads to a 
rapid loss of the key markers. In high cell density culture this de-differentiation is 
prevented (e.g. Lemare et al, 1998; Schulze-Tanzil et al, 2002). This is likely to be 
true of other connective tissue cells where the phenotype is more difficult to 
monitor. For example, it is not possible to tell if plated fibroblasts in monolayer are 
undergoing any type of de-differentiation. What is the differentiated state of 
fibroblasts in a monolayer culture? There are no clear markers, neither 
extracellular, cell surface nor intracellular, although, some changes in amounts of 
collagen production have been implied in fibroblast dedifferentiation (Herrmann et 
al, 1980; Quinones et al, 1986).
1.8.2 3-D Cultures
Connective tissue cells often respond well to 3-D culture systems, either simply 
placing large numbers of cells together in a cell pellet or high density spot, or by 
incorporation them into a 3-D matrix or scaffold structure. 3-D cultures generally 
enhance differentiated function in chondrocytes (van Oschet al, 2001; Shulze- 
Tanzil et al, 2002; Tallheden et al, 2004), and are applicable to other connective 
tissue cells in vitro as well (see below). Scaffold structures are many and varied, 
including aqueous gels of natural material (e.g. collagen, alginate, agarose and 
hyaluronic acid) or produced synthetically (e.g. poly-ethylene oxide, poly-vinyl 
alcohol and poly-acrylic acid) (Drury and Mooney, 2003).
3-D cultures and tissue engineering
3-D culture systems and scaffold structures lend themselves to tissue engineering 
applications. Tissue engineering is defined as The development and subsequent 
replacement of diseased or damaged living tissue with living tissue designed and 
constructed for the needs of each individual to restore, maintain and improve 
function’ (Langer and Vacanti, 1993). A 3-D cell-seeded scaffold is therefore a 
possible repair method. This type of engineered construct has the longest history 
in developing skin replacements, and a number of products are available. 
Fibroblasts and keratinocytes are grown on a range of scaffolds to represent the 
complexity of the living skin in vivo (Bell et al, 1983); one layered skin
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replacements; epidermal or dermal, and a composite of these, for example 
Apligraf© (Organogenesis Inc. FDA approval in 1998). An additional skin product, 
Myskin, uses cultured keratinocytes grown onto a chemically defined plasma 
polymerised surface and has been used with relative success for bums patients 
and non-healing diabetic foot ulcers (Higham at al, 2003; Moustafa et al, 2004).
More recently much effort has been aimed at producing tissue engineered 
cartilage for the repair of defects (e.g. Sams and Nixon, 1995; Standing and 
Langer, 1999; Allemann et al, 2000; Glowacki and Mizuno, 2001). Scaffold based 
systems have a number of advantages. The scaffold gives a degree of intrinsic 
strength to the tissue construct, aiding handling and allowing surgical implantation 
and rapid function. Scaffolds can also be created to modify the behaviour of cells 
within the construct, perhaps by incorporating growth factors within the material to 
control phenotype (Edelman et al, 1991; Malhoney and Saltzman, 1999) or to 
affect the interaction of the implant with the host, e.g. vascularisation (Peters et al, 
1998; Epstein et al, 2001; Richardson et al, 2001). They also have disadvantages 
in that their breakdown products may be deleterious to the host, or they may 
promote unforeseen host responses, or immune responses.
Another approach is to use scaffold free systems, where connective tissue cells 
produce their own matrix, forming an ‘endogenous’ scaffold. The advantage of this 
is that no exogenous materials are introduced, but the downside is that it is likely 
to be more difficult to control the characteristics of the material. The simplest 
method of culturing cells in a 3-D culture system without a scaffold is the 
micromass. The vast majority of micromass experiments have been to investigate 
chondrogenesis. Developed in 1977, micromasses have been used in vitro to 
mimic the tight packing of embryonic cartilage (Ahrens et al, 1977; Paulsen et al, 
1988; Daniels et al, 1996). Other non-scaffold based constructs have investigated 
various suspension and gyrating culture systems, using cells from the liver, 
chondrocytes and cardiac fibroblasts (Kelm et al, 2004). Similarly to micromass 
cultures, pellet cultures are generally used on chondocytes or to induce 
chondrogenesis and are easy to manipulate (Ahrens et al, 1977; Solursh, 1982; 
Daniels and Solursh, 1991; Xu et al, 1996; Stewart et al, 2000).
1.8.3 Bioreactors and 3-D culture
Bioreactors are a recent method of culturing cells at a large scale with or without a 
scaffold for long periods under optimal conditions. Originally bioreactors were used 
in industrial fermentation, water treatment and food processing. Now they are
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common in the production of various antibodies, vaccines, and growth factors 
(Fischer and Emans, 2000; Kipriyanov and Le Gall, 2004). An important feature 
lacking in the previously described systems is the difficultly to administer 
mechanical strain or compressive force to the systems. To grow functional tissues 
as replacements for damaged or diseased tissue, cells must experience 
mechanical loading and/or numerous chemotrophic factors similar to that occurring 
in vivo and some bioreactors have been designed to do this (Seidel et al, 2004; 
Gonen-Wadmany et al, 2004). Bioreactors also allow for continuous nutrition of 
cells and the removal of by-products (Martin et al, 2004). Although, cell-seeded 
scaffolds are widely used within bioreactors, there is also potential for pure cell 
suspensions to be added to the systems. Problems incurred with the use of 
bioreactors include long-term sterility and a limitation to the size of the cell 
construct.
Application of 3-D culture and tissue engineering to tendon and ligament
Tendon and ligaments are frequently injured, sometimes catastrophically, and slow 
to heal and thus are candidates for a tissue engineering approach to repair. Most 
works have addressed the Achilles tendon and anterior cruciate ligament (ACL). 
There are many reviews evaluating methods for anterior cruciate ligament or flexor 
tendon repair, including autograft, allograft or synthetic grafts (Wilson and 
Sammut, 2003; Sherman and Banffy, 2004). Many synthetic materials have been 
tried and tested in ACL repairs, but with limited long term success (Fu et al, 1993). 
A typical example is the Gore-Tex ligament, which has enormous strength and 
stabilises the knee in the short term, but deteriorates in the medium of long term 
(Fukubayashi and Ikeda, 2000). Most problems with permanent prostheses arise 
from poor attachment at the ligament/tendon-bone interface or a lack of host tissue 
ingrowth.
Various scaffolds have been tested to encourage tissue ingrowth using numerous 
types of polymers including carbon fibre. These constructs have a porous or 
filamentous structure in order to promote tendon or ligament ingrowth. As these 
scaffolds are not degradable and tissue ingrowth is relatively slow, a new problem 
is created. The scaffold material shields the potential re-growth tissue from 
sufficient mechanical loading, resulting in non-aligned fibrous tissue (resembling 
scar tissue) (Dunn et al, 1994). With mechanical load consistently borne by the 
implant the regenerated tissue will not remodel or mature (Yamamoto et al, 1993).
43
Consequently, biodegradable 3-D scaffolds for tendon and ligament reconstruction 
have become an expanding field. Tendon cells in 3-D have been shown to 
continue synthesis of tendon associated ECM molecules and retain their 
characteristic morphology at high cell density (Schulze-Tanzil et al, 2004). 
Collagen-based scaffolds are favoured, as collagen is the main constituent of 
tendons and ligaments. These collagen scaffolds have been shown to induce the 
deposition of ligamentous tissue in vivo (Bellincampi et al, 1998). Furthermore, to 
aid scaffold performance in tissue regeneration, fibroblasts have been seeded into 
the scaffolds (Dunn et al, 1995). Since fibroblasts play an important role in 
collagen turnover during healing, including them within the scaffold may stimulate 
earlier healing (Manske et al, 1984; Russell and Manske, 1990; Gelberman et al, 
1992), and consequently improved tissue formation.
Tendon fibroblasts have been shown to migrate along engineered collagen 
threads at similar rates to native tendon threads (Cornwell et al, 2004), allowing 
enhanced integration between engineered tissue replacements and natural 
tissues. Scaffolds that degrade rapidly result in improved strength of the 
replacement tendon or ligament (Dunn et al, 1993). Alternatively, constructs 
degrading too rapidly cause the regenerated tendon to lose its natural mechanical 
stimulus. The regenerating tendon is unable to be remodelled and the tissue 
reaches only 23% of the natural tensile strength (Qin et al, 2004). Therefore, it is 
important to understand the degradation of scaffolds and the rate of collagen 
synthesis by grafted cells and tissue integration into the host.
With the clinical goal to promote early healing and to improve long-term 
mechanical performance, these fibroblast-seeded scaffolds could provide an 
alternative to synthetic or even biological protheses. Experiments using 
mesenchymal stem cells (MSC) as an alternative to fully differentiated cells 
showed an increase in repair upon implantation into window defects in the patellar 
tendon of rabbits. Additionally, if the cell-seeded constructs were put under tension 
before implantation there was a 50-60% level of stiffness compared to that of 
normal uninjured tendons (Butler and Awad, 1999).
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AIMS
The overall aim of the work described in this thesis is to determine the importance 
of cell-cell interactions and 3-dimensional organisation of cells in matrix deposition 
by tendon cells in vivo and in vitro culturing systems. Specifically, the objectives 
are:
• To determine the timing of appearance of various types of cell-cell junction 
in developing tendons in relation to matrix deposition.
• To compare cell interactions in different 2-dimensional and 3-dimensional 
culture systems with reference to matrix secretion and deposition.
• To determine the effects on growth factors on qualitative and quantitative 
aspects of cell organisation and matrix deposition in a 3-D culture 
environment.
• To develop a novel large scale high density 3-dimensional culture system 
to examine cell interaction, matrix organisation in a system that could be 
upgraded to tissue engineering applications.
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MATERIALS AND METHODS
2.1 Source of material
To acquire tendinous material, flexor tendons were dissected from the feet of 50- 
day old Broiler chickens acquired from Tibbits Poultry farm, Castleton, South 
Wales. To prevent infection each chicken foot was washed with 70% alcohol and a 
longitudinal ventral incision made in the third phalange. The flexor digitorum 
longus tendon was aseptically dissected from the claw as far as possible into the 
palm of the foot. Between 6-10 tendons were used at each harvest.
For embryonic material chick flexor digitorum longus tendons were taken at 
various stages from white leghorn developing chicks. Fertilised eggs were 
acquired from Hollyditch Farm, UK, and incubated at37°C, 100% humidity for 6-19 
days. Embryos were removed from the eggshell, separated from the remaining 
yolk and killed by decapitation. At embryonic day 10-19 the tendons were 
dissected from the embryonic limbs. In earlier embryonic limbs the tendons were 
not dissected out.
Cartilaginous material was acquired from the metaphalangeal joint of 7-day old 
bovine animals, acquired from F. Drury and Sons Ltd, the abattoir, UK. At each 
harvest 1 0 - 2 0  full depth explants were used.
2.2 Cell isolation and culture
Cells were isolated from adult chicken tendons using a method modified from 
Banes et al. (1988). The epitenon was removed from adult tendons because they 
are known to act differently compared to fibroblasts from tendon proper in vitro 
(Banes et al, 1988). The epitenon was removed by treating the tendon in 10ml of 
0.5% collagenase (3min;Sigma), 10ml of 0.25% trypsin (15min;Sigma) and then 
scraped with a blunt scalpel. The tendon was cut into small pieces and 
sequentially digested with 10ml of 1% protease (1hr;Sigma) and 10 ml of 0.5% 
collagenase (3hrs) at 37°C. The digested tendinous material was centrifuged 
(MSE Minstril 1000) at 12 000 rpm for 5 minutes, the supernatant removed and 
cells washed in Dulbecco's Modified Eagle Medium (DMEM) (Invitrogen/GIBCO) 
containing 5% heat inactivated Foetal Bovine Serum (FBS), 1% 
antibiotic/antimitotic and L-glutamine (all tissue culture reagents from 
Invitrogen/GIBCO). This step was repeated and fibroblasts were plated on 100mm 
dishes (Costar). Incubated at 37°C, with 1 0 0 % humidity in 5% C 0 2 in air
46
atmosphere. Cells were grown to confluence and passaged after removal with 
trypsin/EDTA. Cells for experiments were used at passage 3.
Cells were also isolated from the tendons of 17 day embryos. It was not possible 
to remove the surrounding epitenon of the embryonic chick flexor digitorum longus 
tendons; they were sequentially digested in 5ml of 1% protease (30 minutes) and 
5ml of 0.5% collagenase (1 hr) at 37°C. Tendon fibroblasts were washed twice in 
DMEM as above and plated into 60mm dishes (Costar). Cells were grown and 
passaged as above.
For comparative purposes full depth chondrocytes were extracted from explants 
taken from the metaphalangeal joint of 7-day old animals. Using a modification of 
the above methods of cell isolation, using sequential digestion, 1 0  ml of 0 .1 % 
protease for 1 hour and 1 0 ml of 0.04% collagenase for 8  hours (overnight) at 37°C. 
Chondrocytes were centrifuged, washed and plated as above in DMEM+F-12 
containing 10%FBS, 1% gentamycin (Invitrogen/GIBCO), 0.5mg/ml ascorbate 
(Sigma) and 1 mg/ml glucose (Sigma). Articular chondrocytes were grown and 
passaged as above.
2.3 Fixation procedures
Special culture methods-Tention material/cells were cultured in various ways 
including monolayers, micromass and pellets see chapters 4 and 5, short-term 
suspension culture and 3-D long term suspension roller cultures, see chapter 6  
and complete embryonic specimens, see chapter 1. Each of these methods 
required differences in fixation procedures.
Tissue specimens, embryonic and adult, were prepared for labelling procedures by 
fixing in 95% industrial methylated spirits (IMS), at 4°C for 5-30 minutes dependant 
on size. Specimens were washed in phosphate buffer solution (PBS) at 4°C and 
frozen onto the cryostat chuck using Bright Instruments Cryo-M-Bed (Cryo-M-Bed, 
Ltd) compound on dry ice (-78°C). These were transferred to a Bright OTF 5000 
cryostat and sections were cut at 8-20pm on disposable knives. Sections were 
collected on histabond slides (RA Lamb).
Cell cultures used for immunolabelling procedures were fixed in 95% alcohol, at 
4°C for differing time intervals. Fibroblast monolayers and micromasses were 
washed in PBS and fixed for 2 minutes, excess alcohol was poured off, then left to 
evaporate before starting the labelling procedure (stored at -80°C). Pellets and 3-
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D long term suspension roller cultures were removed from the media and fixed for 
5-15 minutes dependant on size. They were washed in PBS and frozen onto the 
cryostat chuck with dry ice (see above). In short-term suspension cultures a cell 
sample was taken at specific time intervals and fixed in alcohol immediately. 
These cells were then dropped onto histobond slides and the alcohol evaporated 
off before starting the labelling procedures.
2.4 Immunohistochemistry
Water repellent rings were drawn around sections and selected cell cultures using 
a DAKO pen (Dako Cytomation), the specimens were re-hydrated in PBS/tween. 
Sections were preblocked using 1:20 goat serum in PBS/tween 20 (Sigma) 
(20mins) and labelled with various primary antibodies (See table 2.1). All primary 
antibodies were diluted in PBS/tween and incubated at room temperature for 1-2 
hours. Sections were washed in 3 changes of PBS/tween and then incubated with 
goat anti mouse or rabbit as appropriate. Alexafluor488 conjugated goat anti-rabbit 
immunoglobulin (Sigma) was used to detect type I collagen label. Alexafluor488 
conjugated goat anti-mouse immunoglobulin (Sigma) was used for all monoclonal 
antibodies (see table 2.1). Secondary antibodies were incubated at room 
temperature for 1 hour and washed in PBS/tween (x3). Phalloidin was used to 
directly label filamentous actin at a concentration of 5pg/ml in PBS/tween, 
incubation time 1 hour followed by washing PBS/tween as above. Labelled 
sections were mounted using Vectashield containing propidium iodide as a nuclear 
counterstain (Vector Laboratories). Sections were examined on a Leica Laborlux 
12 microscope equipped with a coolsnap digital camera (Roper Scientific) or an 
Olympus BX 61 microscope with F-View camera and SIS AnalySIS® software (Soft 
imaging system).
Controls-Two types of negative control were carried out in these investigations for 
all primary antibodies used. Control sections were processed by replacing the 
primary antibody with dilutant, thus demonstrating no non-specific binding of the 
secondary antibody is occurring. Further control sections were processed with 
mouse immunoglobulin, at 10 M9/ml (Sigma) replacing the primary antibody to 
demonstrate antibody specificity.
2.5 Biochemical Analysis
Hydroxyproline assay- Hydroxyproline is found in collagenous amino acid 
sequences and is used as an indicator of collagen content (Creemers et al, 1997).
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Preparation for hydroxyproline assay- Taken directly from culture, cell aggregates 
were digested in 125pg/ml papain overnight at 60°C. 500pl of digested material 
was hydrolysed with 500pl of hydrochloric acid, at 110°C overnight. Proteins were 
precipitated from media samples by addition of 50% ammonium sulphate (Sigma) 
relative to the sample volume, at 4°C overnight, with the addition of 
phenylmethanesulphonylfluoride (PMSF) (Sigma), ethylenediamine tetraacetic 
acid (EDTA) (Fisher Scientific) and N-ethylmaleimide (NEM) (Sigma) protease 
inhibitors. Samples were centrifuged at 21000 rpm for 30 minutes. The pellet 
formed was dissolved in 1ml PBS and 500pl were hydrolysed in 500pl of HCL (6 N) 
(Fisher Scientific), overnight at 110°C. Acid was removed by vacuum drying and 
samples were reconstituted in 500pl de-ionised distilled water. Samples were 
microcentrifuged for 1 0 mins removing any insoluble particulate matter that 
remained.
Onto a 96 well plate, triplicate 30pl aliquots of sample or standard were pippetted. 
Followed by 70pl of diluent (100ml propan-2-ol (Fisher), 50ml water) and 50pl of 
oxidant (0.7g chloramine-T, 10ml water, 50ml Stock Buffer: Stock buffer (500ml): 
28.5g sodium acetate trihydrate, 18.75g tri-sodium citrate dihydrate, 2.75g citric 
acid (all reagents from Sigma), 200ml propan-2 -ol. Solids were dissolved in 250ml 
water first, then add propan-2-ol (Fisher), then make up to final volume of 500ml 
with water). Plates were placed on a shaker at room temperature for 5mins and 
125pl of colour reagent (4-Dimethylaminobenzaldhyde) (Sigma) were added and 
mixed on a plate shaker and incubated at 70°C for 10-20mins. Samples were read 
immediately on a plate reader at an absorbance wavelength of 540nm.
Hoechst DNA assay- This is a method of determining DNA concentrations in 
aqueous buffers that is not affected by contaminating protein or RNA (Cesarone et 
al, 1980; Downs and Wilfinger, 1983). Hoechst 33258 dye solution 
(Sigma) ( 1  mg/ml) was diluted in buffer solution to a final concentration of 100pg/ml. 
Buffer solution consisted of 1mM sodium acetate (Fisher Scientific) and 0.5mM 
sodiumEDTA (Fisher Scientific). A DNA calibration curve consisted of a series of 
DNA standards (0-20 pg/ml of plasmid DNA) prepared in buffer solution. Duplicate 
50pl papain digested sample or standard were added to 1ml Hoechst dye solution. 
The DNA was measured in the fluorometer at A350 nm excitation and A450nm 
emission.
49
Antibody M/P Working
concentration
Dilution
Factor
Enzyme Antigen Specificity Reference Source
Col-1 P 17ng/ml 1 : 2 0 0 0 HC Type I 
collagen
Broad J. Cell Biol. 111: 1685 (1990) Sigma
CIICI M 1 0  mg/ml 1:5 HC Type II 
collagen
Ch, Hu, M, rat J. Cell Biol. 129: 881-892 (1995) DSHB
3B2 M 1 0  mg/ml 1:5 HC Type III 
collagen
Ch Matrix. 11:56-65 (1992) DSHB
M1-B4 M 1 0  mg/ml 1 : 1 None Tenascin Ch Cell 47: 131-139 (1986) DSHB
Cx32 M 1 ng/ml 1 : 1 0 None Connexin 32 Rat, Hu, M, Ch J. Cell Biol. 107: 1817(1988) Chemicon
Cx43 M 4ng/ml 1:50 None Connexin 43 Ch, Hu, rat, M, 
Ca
J. Cell Biol. 111:2077-2088 (1992) Chemicon
hVinl M 60ng/ml 1:400 None Vinculin Ch, Hu, M, Bo, 
dog, rat
Proc. Natl. Acad. Sci. (USA) 87:5667 (1990) Sigma
CB-1 M 1 0  mg/ml 1 : 1 None Decorin Ch Matrix. 11:412-427 (1991) DSHB
JLA20 M 1 0  mg/ml 1:4 None Actin Ch, Rat Cell Mot. Cyto. 12:216-224 (1989) DSHB
ACAM M 250ng/ml 1 : 1 0 0 None N-cadherin Ch, Hu, rat, M Dev. Biol. 139: 314(1990) Sigma
CH-19 M 70ng/ml 1:500 None Pan-cadherin Ch, Hu, rat, M Development 102: 639 (1988) Sigma
AMF-17b M 13 mg/ml 1 : 1 None Vimentin Ch, Hu, Bo, 
Dog
J. Biol. Chen. 264: 17953-17960 (1989) DSHB
M-38 M 1 0  mg/ml 1:4 None Pro-collagen Ch, Hu, J. Mol. Biol. 211, 581-594 (1990) DSHB
B3/D6 M 1 0  mg/ml 1:4 None Fibronectin Ch Dev. Biol. 139, 383-395 (1990) DSHB
Table 2.1. Primary antibodies
Abbreviation: M, monoclonal antibody; P, polyclonal antibody; HC, antibody requiring hyaluronidase pre-treatment, DSHB, 
Developmental Studies Hybridoma Bank.
Antibody Abs* Em* Source Working Dilution
Alexa Fluor® 488 goat anti­
mouse IgG
495 519 Molecular Probes 1 -IOpg/ml-used 
at 5 pg/ml
Alexa Fluor® 488 goat anti­
rabbit IgG
495 519 Molecular Probes 1 -IOpg/ml-used 
at 5 pg/nril
Table 2.2. Secondary antibodies
* Approximate absorption (Abs) and fluorescence emission (Em) maxima in nm.
CHAPTER THREE 
Matrix deposition and cell-cell interactions in 
tendon development
3.1 INTRODUCTION
Tendon development in the chick limb begins with the formation of the dorsal and 
ventral mesenchymal laminae. These tenascin-rich ECM lamina lie beneath the 
basal lamina of the ectoderm. Rodent embryos lack a mesenchymal lamina, but 
the equivalent region of mesenchyme express a number of genes, including six 
and eya, involved in tissue morphogenesis in other parts of the embryo, including 
the eye (Heanue et al, 1999; Oliver et al, 1995; Xu et al, 1997; reviewed Benjamin 
and Ralphs, 2000). Tendon fibroblasts in developing chick limb differentiate at 
embryonic day 7 (Ros et al, 1995) and begin to synthesise a distinct ECM (see 
development, chapter 1). Deposition of tenascin and type VI collagen are the initial 
ECM markers of developing tendon, type III collagen is faintly present at day 7 and 
precedes type I collagen deposition (Hurle et al, 1990). During development the 
rows of cells become pushed apart by the developing collagen fibres, though the 
cells retain contact through extended cytoplasmic processes (McNeilly et al, 1996). 
Complete tendon architecture including fascicular structure, is established by day 
14 (Keene et al, 1991; Young et al, 2000; Schuppan et al, 2001), although tendons 
remain mechanically immature (Birk and Mayne, 1997). Described earlier in 
chapter 1, at around day 17 there are changes in matrix secretion with increased 
collagen deposition and decrease in synthesis of certain collagen-associated 
proteins, for example types XII and XIV collagen (Young et al, 2000; Zhang et al, 
2003). This leads to an increase in the matrix to cell ratio (Nurminskaya and Birk, 
1998), enabling the tendons to bear the appropriate mechanical strains.
Whilst the stages of collagenous matrix development are known (Hurle et al, 1990; 
Ros et al, 1995; summary table in Edom-Vovard and Duprez, 2004), there are 
significant gaps in our understanding of cell-cell and cell-matrix interactions (Hall 
and Miyake, 2000). Cell-cell interactions are important features of tendon structure 
(McNeilly et al, 1996; Ralphs et al, 2002) and have been reported at electron 
microscopic level (Greenlee and Ross, 1967). Both gap junctions and adherens 
junctions are important in adult tendon cell behaviour (Ralphs et al, 2002; Waggett 
et al, submitted+abstract) with adherens junctions linking cells longitudinally by 
connecting their actin stress fibres (Ralphs et al, 2002), and gap junctions 
controlling collagen synthesis in response to mechanical load (Waggett et al, 
submitted). In this chapter, the formation and differentiation of recognisable tendon 
precursors is monitored by observations of ECM deposition and related to the 
expression of protein associated with cell-cell interactions, in particular cadherins 
and gap junctions.
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3.2 MATERIAL AND METHODS
To examine the developmental sequence of tendons within the chick hindlimb, 
specimens were taken from a range of developmental ages and ECM, cytoskeletal 
and cell junctional proteins were identified with immunolabelling techniques.
For tissue source and immunolabeling procedures see general materials and 
methods, (chapter 2). Fertilised eggs were incubated at 37°C, 100% humidity for 6 - 
19 days. Embryos were removed from the eggshell, separated from the remaining 
yolk and killed by decapitation. The entire hindlimb was removed from 6 - 8  day 
embryos, and flexor tendons dissected from hindlimbs of 10-19 day embryos. 
Chicks at earlier stages of development, 6 - 8  days, had the entire hindlimb 
sectioned, rather than the tendons dissected out.
Tissue was either fixed in 95% IMS, at 4°C for 5-30 minutes dependant on size (as 
described in chapter 2), or frozen unfixed for cryosectioning. Specimens were 
washed in PBS at 4°C, orientated and frozen onto the cryostat chuck, using Bright 
Instruments Cryo-M-Bed compound, on dry ice (-78°C). These were transferred to 
a Bright OTF 5000 cryostat and sections were cut at 8-10pm on disposable knives. 
Sections were collected on microscope slides ready for immunolabelling.
Immunolabelling
Sections were labelled with antibodies to ECM components (type I, II and III 
collagen, tenascin), cytoskeletal components (actin by direct phalloidin label and 
vimentin) and cell junctional components (vinculin, pan-cadherin, n-cadherin, 
connexin 32 and connexin 43), see general materials and methods, chapter 2.
52
3.3 RESULTS
Tendons were easy to identify in cryosection from day 8  onwards, but earlier than 
this identification was difficult and positive identification was rare. In some cases 
small areas of obviously organised cells, in the vicinity of the mesenchymal lamina, 
formed elongate structures and these were assumed to be very early tendon 
primordia, although the precise tendon was not identified anatomically.
Identification and distribution of ECM components
Type I collagen -  At 6  days small aggregations of cells and matrix were present 
within the mesenchyme, showing a prominent longitudinal organisation of type I 
collagen (fig 3.1 A). By 8  days, clear fibres of type I collagen were interspersed 
between rows of tendon fibroblasts (fig 3.1 B). The developing fibre bundles ran in 
a longitudinal fashion, and positive labels were present throughout the remaining 
period (fig 3.1 C, D, E, F), although its labelling pattern was never as clear as for 8  
days.
Type III collagen -  At 6  days there was enhanced labelling compared to that of the 
general mesenchyme in small orientated structures, which may have been tendon 
blastemas (fig 3.2 A). Fibres labelled with a predominantly longitudinal orientation 
were present in these structures. By 8  days, type III collagen label had become 
very prominent and highly organised (fig 3.2 B). Subsequently fibrous type III 
collagen became more spread out. In oblique section (fig 3.2 C), it was possible to 
identify areas of nuclei surrounded by type III collagen fibrils, rather than fibrils 
running in between all cells associated with the developing blastema (fig 3.2 C, D). 
By 15 days of development the type ill collagen label was restricted to 
longitudinally running bands of label (fig 3.2 E), suggesting its association with the 
developing endotenon, surrounding fascicles of tendon fibroblasts and matrix, and 
not within the fascicles themselves. This pattern continued at 17 days of 
development (fig. 3.3 F).
Tenascin- Tenascin is known to be an early marker for tendon development (Hurle 
et al, 1990), and labelling occurred in day 6  blastemas (fig 3.3 A), as elongate 
fibres within aggregates of orientated cells. This fibrous distribution became more 
evident in subsequent developmental stages, with label being associated with the 
tendon cell rows, presumably at the cell surface (fig. 3.3 B, C, D, E, F).
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Cytoskeletal components
Positive label for actin was present at all times, from the very early, tendon 
blastema at day 6 , through all of the experimental stages examined. It took the 
form of bright, longitudinally running fibres within the blastema and developing 
tendon (fig 3.4 A-F). There was little obvious organisation at E6 , but from E8  there 
were elongated cells labelling positively for actin filaments. Vimentin label was also 
present in the tendon cells at all ages, although the putative early day 6  blastemas 
were not observed in these sections, (fig 3.5 A-F).
Cell junctional components
Cadherins- Pan-cadherin and n-cadherin showed similar distributions at all stages, 
although the very early putative condensations that occur at day 6  were not 
encountered. Label was generally punctate in mesenchyme and day 8  tendon 
blastemas (figs. 3.6 and 3.7 A, B), but tended to be more diffuse in the developing 
tendon cells. There was a higher intensity of labelling in the tendon cells than in the 
surrounding mesenchyme (figs. 3.6 and 3.7 C).
Vinculin- Punctate label was present at all stages from day 6  onwards (fig 3.8 A-F), 
with labelling intensity becoming stronger at day 17, outlining the cells and 
consistent with the longitudinal orientation of the tendon (fig 3.8 F).
Connexins- Mesenchyme at 6  days labelled positively for connexin 32 , as widely 
distributed punctate spots of label between cells (fig 3.9 A). By 8  days, when 
prominent tendon blastemas were present, mesenchymal label was extremely 
bright surrounding the developing tendon (fig 3.9 B). Label was also present 
between tendon cells. With subsequent development label remained present 
between tendon cells and was especially bright in the epitenon (fig 3.9 C, D, E, F). 
Label for connexin 43 was distributed throughout the day 6  mesenchyme (fig 3.10 
A), similarly to connexin 32, although no tendon primordia could be identified at 
this age. However, in tendon blastemas label was largely absent until 12 days (fig 
3.10 D), when punctate label was present between tendon cells, this persisted at 
subsequent ages of development (fig 3.10 E, F).
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Figure 3.1. Developmental sequence of tendon in chick hindlimb; type I collagen
label from E6-E17; x40 objective lens, scale bar= 40pm.
A- 6 day- There are areas in the developing mesenchyme that labelled positively 
for type I collagen, together with a degree of organisation.
B- 8 day- Brightly labelled type I collagen fibrils are present together with a parallel 
and longitudinal orientation.
C- 10day- Type I collagen remains present, although the labelled fibrils are less 
clear than at 8  days of development. Insert- cell nuclei counterstained with 
propidium iodide.
D- 12day- Longitudinal organisation of type I collagen fibrils remains identifiable.
E- 15day- Type I collagen fibrils have a similar distribution as observed in the 12 
day tendon.
F- 17day- Type I collagen is identified in tendons at this stage of development, 
together with longitudinal orientation of the fibres.
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Figure 3.2. Developmental sequence of tendon in chick hindlimb; type III
collagen label from E6-E17; x40 objective lens, scale bar= 40pm.
A- 6 day- No clear tendon blastemas are seen in this section, but areas of 
apparently longitudinally orientated type III collagen are present.
B- 8 day- Strong, highly orientated label is present between orientated rows of 
tendon fibroblasts.
C- 10day- Type III collagen fibrils present continue to orientate longitudinally and 
can be observed between cells rows. This oblique section shows areas of multiple 
nuclei surrounded by type III collagen fibrils.
D- 12day- The type III collagen remains fibrous and longitudinal in organisation, 
but the uniform distribution becomes restricted to areas of label, it is no longer 
between every cell row.
E- 15day- Reductions in type III collagen are possibly associated with developing 
tendon fascicles. The label is present between selected cell rows, but none is seen 
within them.
F- 17day- Similarly to developmental day 15 the type III collagen is present, 
although its expression remains restricted to the developing tendon fascicles.
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Figure 3.3. Developmental sequence of tendon in chick hindlimb; tenascin label
from E6-E17; x40 objective lens, scale bar= 40pm.
A- 6 day- Tenascin label is present, showing a slight organisation in a developing 
tendon blastema.
B- 8 day- Longitudinally orientated tenascin fibrils are clear and associated with 
elongated cells of the developing tendon.
C- 10day- Longitudinally orientated tenascin fibrils are seen from day 10-17 in the 
developing tendons.
D- 12day- Tenascin
E- 15day- Tensacin
F- 17day- Tenascin
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Figure 3.4. Developmental sequence of tendon in chick hindlimb; actin label from
E6-E17; x40 objective lens, scale bar= 40pm.
A- 6 day- Bright labelled foci of labelling show actin filaments are present from day 
6  with an organisation.
B- 8  day- Actin filaments are identified running longitudinally within elongated 
tendon cells, distinctive from the surrounding mesenchyme.
C- 10day- Brightly labelled actin filaments are visible in E10 chick tendons, with a 
characteristic elongate and longitudinal orientation.
D- 12day- After 12 days of development the longitudinal orientation of the actin 
filaments remain within the developing tendon.
E- 15day- Continuing to label strongly, actin filaments are present in tendons at 15 
days.
F- 17day- An apparent increase in labelling for the longitudinal actin filaments was 
observed in tendons and can be seen as dense green labelling in the section.
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Figure 3.5. Developmental sequence of tendon in chick hindlimb; vimentin label
from E6-E17; x40 objective lens, scale bar= 40pm
A- 6 day- Developing tendon blastemas are unidentifiable at this stage however, 
vimentin is present throughout the developing limb, particularly in mesenchyme 
surrounding the cartilage blastema.
B- 8 day- Bright foci of vimentin label are present in the early tendon.
C- 10day- Clearly labelled, vimentin begins to show a degree of longitudinal 
orientation.
D- 1 2 day- Strongly labelled, with a longitudinal orientation the vimentin is present 
and remains associated with the developing tendon.
E- 15day- Subsequent developmental stages show vimentin labelling remaining 
longitudinal in orientation.
F- 17day- Vimentin
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Figure 3.6. Developmental sequence of tendon in chick hindlimb; pan-cadherin
label from E6-E17; x40 objective lens, scale bar= 40pm
A- 6 day- Punctate labelling patterns of label are clearly observed in the 
mesenchyme of the developing limb, although no tendon blastemas were present.
B- 8 day- In developing tendons, pan-cadherin labels strongly and some remnant of 
the spotted label can be observed. In other areas of the tendon the labelling is 
more diffuse.
C- 10day- Pan-cadherin labelling remains present and predominant in the tendon 
and the labelling pattern has become increasingly dispersed.
D- 12day- There was continual expression of cadherins within the developing 
tendon, although the labelling pattern remains diffuse it retained the overall 
longitudinal organisation of the tendon.
E- 15day- A continuation of the diffuse labelling is observed, also the edges of the 
section, the developing endotenon, labels less intensely than the tendon proper.
F- 17day- Pan-cadherin is present throughout the tendon following the longitudinal 
orientation of the tendon.
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Figure 3.7. Developmental sequence of tendon in chick hindlimb; n-cadherin
label from E6-E17; x40 objective lens, scale bar= 40pm.
A- 6  day- Following a similar pattern to the pan-cadherin label the n-cadherin 
labelling of the mesenchyme shows a clearly puncate label, with no tendon 
blastemas identified.
B- 8 day- n-cadherin is present, and the spotted appearance of the label is 
particularly prominent here.
C- 10day- n-cadherin remains present, but as with pan-cadherin, the labelling 
pattern becomes increasingly diffuse.
D- 12day- Strong n-cadherin label is observed within the developing tendon, with 
the cells of the developing epitenon appearing to label negatively for n-cadherin.
E- 15day- n-cadherin labelling is present in subsequent ages of development, 
although the initial puncate labelling is not resumed.
F- 17day- n-cadherin
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Figure 3.8. Developmental sequence of tendon in chick hindlimb; vinculin label
from E6-E17; x40 objective lens, scale bar= 40pm.
A- 6 day- Vinculin label is present in the mesenchyme, although none was 
associated with developing tendon blastemas.
B-8 day- Elongated cells label positively for vinculin.
C- 10day- This section was cut obliquely so the characteristic elongated tendon 
cells appear more rounded, or stellate. Vinculin is present, although its expression 
pattern was unclear.
D- 12day- Also cut at a slightly oblique angle vinculin is shown to be present at the 
periphery of the cells.
E- 15day- Vinculin can be observed between cells in longitudinal cell rows of the 
developing tendon.
F- 17day- Vinculin label appears to have increased between 15 to 17 days of 
development and there is some spotted labelling.
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Figure 3.9. Developmental sequence of tendon in chick hindlimb; connexin 32
label from E6-E17; x40 objective lens, scale bar= 40pm.
A- 6day- Connexin 32 is present in the mesenchyme as bright punctate labelling.
B- 8day- Tendons developing at day 8 showed connexin 32 is present between 
elongate cells, with labelling of the surrounding mesenchyme, directly associated 
with the tendon labelled strongly.
C- 10day- Connexin 32 remains present between the elongated tendon cells.
D- 12day- Connexin 32 continues to show positive labelling between tendon cells.
E- 15day- Connexin 32 labelling is observed within the developing tendon, 
although appears predominant at the periphery of the tendon section in the 
developing epitenon.
F- 17day- The connexin 32 labelling described at 15 days of development was 
maintained at day 17, the surrounding epitenon cells label with an increased 
intensity, affecting the exposure and causing difficulty in the identification of 
connexin 32 within the tendon.
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Figure 3.10. Developmental sequence of tendon in chick hindlimb; connexin 43
label from E6-E17; x40 objective lens, scale bar= 40pm
A- 6 day- Connexin 43 is present in the mesencyme in small, but bright foci of 
label.
B- 8 day- Tendon blastema with longitudinally orientated cells were identified, but 
remain negative for connexin 43.
C- 10day- The labelling for connexin 43 remained largely absent in the developing 
tendons.
D- 12day- The presence of connexin 43 show dotted labelling, similarly to the 
labelling mesenchyme at day 6.
E- 15day- Connexin 43 labelling follows the longitudinal orientation of the tendon. 
F- 17day- Connexin 43 is present with its characteristic puntate pattern of labelling.
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3.4 DISCUSSION
Investigations into tendon development have concentrated on its progression and 
growth in comparison with either muscle or skeletal development, and their 
reciprocal interactions during development (Kardon, 1998; Oldfield and Evans, 
2003; Edom-Vovard and Duprez, 2004; Brent et al, 2005). This chapter details cell­
cell interactions and cytoskeletal components involved in early tendon cell 
differentiation.
Early identification of tendon blastemas at day 6 has not previously been reported, 
but they are described from day 7 (Hurle et al, 1990; Ros et al, 1995). It may be 
that in some specimens examined the embryos were at late day 6, and that the 
earliest stages of the developing tendon were actually visible, certainly the putative 
blastemas have appropriate structure, matrix and cellular markers. Tenascin 
remains the easiest extracellular marker for identifying developing tendon, but it is 
also expressed by developing ligament, perichondrium and by satellite cells of 
growing nerves (Chiuet and Fambrough, 1984; Martini and Schachner, 1991; 
Werhle and Chiquet, 1990 and Wehrle-Haller et al, 1991). In later stages of 
development these structures can be clearly distinguished, however, in early 
stages, such as day 6, when any tendon primorda are extremely early in their 
development it is possible that nerves, which migrate alongside the tendons, might 
be mistaken for developing tendon (Martini and Schachner, 1991; Werhle-Haller et 
al, 1991). It remains possible to distinguish these from developing tissues labelled 
positively for tenascin, as examination under polarized light shows the collagen 
ensheathing the nerves is birefringent, whereas the embryonic tendon is not. At 
later stages of chick development the nerves do not continue to label positively for 
tenascin (Wehrle-Haller et al, 1991). However, there was no obvious evidence of 
nerve fibres within the structures, although these were not specifically labelled.
Type I collagen appears early in the developing tendon and is intensely labelled at 
8 days of development, the labelling then becomes less prominent and individual 
fibres are difficult to identify. Type I collagen labelling patterns in later stages of the 
developmental sequence are possibly due to the molecules associated with the 
surface of each collagen fibril. Small, leucine-rich proteoglycans, such as decorin, 
fibromodulin and lumican (Hedbom and Heinegard, 1993; Svensson et al, 2000) 
are known to be present in embryonic tendon (Birk et al, 1995; Ezura et al, 2000) 
and are important in controlling assembly and diameter of collagen fibrils 
(Schonherr et al, 1995; Birk et al, 1995; Weber et al, 1996; Ezura et al, 2000).
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Although, the distribution of these in relation to collagen fibrils has not been 
thoroughly studied in earlier stages of development, fibromodulin mRNA has a 6-8 
fold increase from day 14-19, and decorin mRNA increases threefold 
(Nurminskaya and Birk, 1996), indicating both are present and likely to bind the 
type I collagen fibrils present. Other molecules indirectly bound to type I collagen 
fibrils are the FACIT collagens types XII and XIV (Keene et al, 1991). The 
presence of all these molecules along a type I collagen fibril may be responsible for 
the reduced ability of the antibody to bind to the fibril, creating the diffuse labelling 
pattern observed in later stages of tendon development.
Type III collagen shows a possible orientation of label in the day 6 specimen. In 
this section it is closely associated with a developing cartilage blastema, 
suggesting that it is a developing tendon insertion. The longitudinal orientation of 
the type III collagen fibrils in day 8 clearly shows nuclei between the fibrils. When 
observed at day 10, in an oblique section, areas of more than one cell nuclei are 
encompassed by the type III collagen fibrils which are present. This is perhaps an 
early indication of the differentiation of endotenon cells in comparison with tendon 
fibroblasts and the establishment of the fascicular architecture of the tendon, type 
III collagen is associated with adult tendon (Kumagai et al, 1994; Murphy et al, 
1997) and fascicular structure (Birk and Mayne, 1997). This differential expression 
of type III collagen persists through day 12, although with the angle of section it is 
more difficult to distinguish, into the clearly restricted expression seen at 15 days 
with the development of tendon fascicles (Birk and Trelstad, 1986; Keene et al, 
1991; Birk and Mayne, 1997; Young et al, 2000; Schuppan et al, 2001). It is 
interesting to speculate that the type III collagen observed clearly in the 8 day 
tendons actually represents initial deposition of the fascicular structure and is 
followed by type I collagen expression of the tendon fascicles proper.
The presence of tenascin-C in developing tendons is well documented (Hurle et al, 
1990; Kardon, 1998), and it seems likely that this is what is labelled here. Although 
tenascin has adhesive and anti-adhesive properties, it is the anti-adhesive 
properties that predominate in tenascin-C (Chiquet-Ehrismann, 2004a, b). 
Tenascin-C is known to inhibit cell adhesion to fibronectin (Chiquet-Ehrismann et 
al, 1986; Riou et al, 1992; Orend and Chiquet-Ehrismann, 2000), implying that it 
may interfere with cell interactions with one another via cell surface fibronectin, and 
with the wider ECM. Within the developing tendon, at the cellular level, there is a 
requirement for both cell adhesion and non-adhesion. The cells form spaces for
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deposition of collagen fibres, with no cell-cell contact, bounded by regions of cell­
cell contact (Trelstad, 1982; Trelstad and Birk, 1984; Birk et al, 1991; Birk and 
Zycband, 1993). Therefore, membranes need to be kept separate between points 
of contact. The longitudinally running tenascin could help to maintain such 
separation. Its up regulation by mechanical strain (Chiquet-Ehrismann et al, 1994; 
Fluck et al, 2000) indicates that it will become a consistent component of loaded 
adult tendons, as well as in the developmental sequence examined here.
Actin filaments were present from the early stages of tendon development, present 
as fibres with a longitudinal orientation. Actin fibres occur as longitudinal contractile 
stress fibres in adult tendon cells in vivo, linked by adherens junctions (Ralphs et 
al, 2002). It is possible that this pattern is being established as soon as the tendon 
differentiates. However, actin stress fibres are also associated with cell orientation 
and early deposition of orientated collagen matrix, for example in the annulus 
fibrosus of the developing intervertebral disc (Hayes et al, 1999). Here, actin stress 
fibres appear, orient cells, and in later stages disband once the orientation is 
established. It may be therefore, that the actin stress fibres are involved in cell and 
matrix organisation. Unlike the intervertebral disc, however, the fibres persist in 
tendon into adulthood. In adult tendon cell stress fibre components are upregulated 
by strain (Ralphs et al, 2002) and so it could be that in development, initial 
orientational fibres are replaced by strain regulated fibres. The longitudinal 
orientation of the actin filaments may be influenced by reciprocal interactions with 
developing muscle (Kardon, 1998; Edom-Vovard et al, 2001, 2002), indicating a 
level of strain present in the developing tendon. The actin characteristic of 
connective tissue cells is alpha smooth muscle actin (Darby et al, 1990; Kim and 
Spector, 2000; Premdas et al, 2001; Kinner and Spector, 2002; Kinner et al, 2002; 
Hastreiter et al, 2004; Desmouliere et al, 2004). Whilst in the studies here we could 
not distinguish this, as phalloidin binds to all filamentous actin, it seems probable 
that the actin fibres are made of this particular actin.
The vimentin intermediate filaments in developing tendons correlate with the actin 
filaments in having an elongated orientation. In monolayer the vimentin 
intermediate filaments have been shown to have a degree of orientation 
corresponding with the direction of the cell, similar to actin stress fibres (see 
chapter 4). Intermediate filaments are known to provide the cell with mechanical 
stability and can withstand greater forces than actin stress fibres (Janmey, 1991; 
Stewart, 1993). Vimentin is present in load bearing areas of tendon, mainly areas
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of fibrocartilage formation (Ralphs et al, 1991; Rufai et al, 1992) and is present, but 
certainly not prominent in areas of tendon not under compressive forces (Ralphs et 
al, 1998). In cartilage, vimentin is predominant in deep zone chondrocytes, with 
complex distributions surrounding the nucleus and underneath the plasma 
membrane. Its function here suggests involvement in cytoskeletal responses to 
changes in mechanical conditions (Durrant et al, 1999). There is evidence that 
filamentous actin acts as a template for cytokeratin intermediate filaments (Weber 
and Bement, 2002), and it is possible that vimentin intermediate filaments can 
function similarly, hence their longitudinal arrangement in vivo. Therefore it is 
possible the function of vimentin-based intermediate filaments present in 
development tendon are involved in maintaining the mechanical stability of the 
cells at the onset of mechanical strain.
The punctate label of n-cadherin is suggestive of the presence of adherens 
junctions between cells in the early stages of tendon development. Label for pan- 
cadherin was subtly different, being more extensive at the cell surface, giving a 
less sharp punctate pattern. It is possible this is an indication of additional 
cadherins present at these stages of development. Cadherins are involved in 
adherens junctions, connecting the actin filaments of adjacent cells and are 
present in adult tendon (Ralphs et al, 2002). N-cadherin is expressed by tendon 
and ligament fibroblasts in vivo (Ralphs et al, 2002; Lin et al, 1999). N-cadherin 
has been identified in mesenchymal condensations (DeLise and Tuan, 2002 a, b) 
and is thought to play an important role in the subsequent differentiation of 
chondrocytes (Oberiender and Tuan, 1994). It is possible that n-cadherin has a 
role in cell-cell adhesion, early assembly and cell differentiation within tendon 
blastemas. This is discussed fully in chapter 6.
In later stages the labelling pattern of both cadherin antibodies became more 
diffuse, with prominent fluorescence associated with tendon cells, but no obvious 
punctate pattern. Since cadherins are organised into punctate regions between 
adult tendon cells longitudinally in their cell rows in vivo (Ralphs et al, 2002), it may 
be that this represents a stage of reorganisation of cell-cell contacts from an 
embryonic to adult phenotype. This could be associated with the onset of the 
loading of tendons by differentiated muscle. Certainly, these junctional 
components, including cadherins and vinculin, are mechanically regulated (Ralphs 
et al, 2002). Unlike the earlier stages, the identical labelling pattern for n-cadherin
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and pan-cadherin suggests either that only n-cadherin is present, or that, if others 
are present they are distributed identically.
Expression of vinculin appeared to change during the developmental period 
examined. Early on it was rather less prominent than the cadherin label, but at the 
later stages it appeared more strongly with a punctate pattern of labelling, 
reminiscent of its pattern in the adult (Ralphs et al, 2002). Vinculin is a component 
of focal adhesions between intracellular actin, cell surface integrins and the ECM 
(Critchley et al, 1999; Critchley, 2004; Nayal et al, 2004) and cell-cell actin linking 
adherens junctions (Knudsen et al, 1995; Rimm et al, 1995; Watabe-Uchida et al, 
1998; Weiss et al, 1998). It would appear that at the early stages no prominent 
focal adhesions or adherens junctions were being formed, and that the cadherins 
are involved in weak cell-cell interactions and signalling, not involving large actin 
structures. Later, the more adult pattern of strong structural attachment appears to 
be formed. Cells may be involved in various migratory and orientational events 
earlier on with their position becoming more stabilised at later stages of 
development. Vinculin expression is mechanically regulated (Ralphs et al, 2002), 
so this could be related to increased muscle contraction in development (Ros et al, 
1995; Kardon, 1998).
Gap junction distribution has been studied in developing tissues, with particular 
reference to cartilage condensations, and roles for connexin 43 have been 
demonstrated (Schwab et al, 1998; Zhang et al, 2002). Roles for connexin 32, 
however, have not been shown to date. Here, the results show connexin 32 to be a 
prominent component of interactions between mesenchymal cells, along with 
connexin 43, but they show that connexin expression changes with tendon 
differentiation. In developing tendon connexin 32 is present from when the 
blastemas first occur, whereas connexin 43 only becomes prominent later on, at 
around 12 days onwards. Both are present in adult tendons (McNeilly et al, 1996; 
Ralphs et al, 1998) and in the periodontal ligaments (Yamaoka et al, 2000), recent 
studies show that they are important in the response of tendon cells to mechanical 
load (Waggett et al, submitted; Waggett et al, 2001; personal communication). 
Connexin 32 is associated with increasing collagen secretion in response to strain, 
whereas connexin 43 inhibits it. The two connexin types work together to control 
tendon cell response to load.
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Here the connexin 32 stimulatory pathway appears predominant in early tendon, 
with connexin 43 only becoming obvious as the tendon ECM becomes well 
established. This may correspond to the onset of mechanical loading from 
muscles, as the expression of connexin 43 is mechanically regulated (Banes et al, 
1995). Interestingly, there is enhanced label for connexin 32 at the periphery of the 
tendon blastemas and in the immediate surrounding mesenchyme at 8 days. This 
would appear to relate to the separation of the tendon from its surroundings and is 
indicative of coordinated cell behaviour, possibly in the formation of the epitenon 
and early tendon sheath.
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CHAPTER FOUR 
Matrix deposition by tendon cells in culture: A 
comparison of 2-D and 3-D culture methods
4.1 INTRODUCTION
The use of various cell culture systems with connective tissue cells has been 
discussed in chapter 1. Here, the behaviour of tendon cells is examined in 
monolayer and at high density to determine details of cell growth, matrix synthesis 
and matrix deposition. The aim is to determine the extent to which 3-D 
organisation of cells is necessary for the deposition of functional tendon matrix.
Monolayer cultures are routinely used to grow many different cell types. So far as 
connective tissue cells are concerned, whilst monolayers are an effective way to 
increase cell numbers, they are not associated with differentiated function, i.e. the 
ability of cells to deposit a functional extracellular matrix. Previous studies have 
shown that fibroblasts in monolayer continue to synthesise collagens, but release 
an overwhelming majority into the culture medium, rather than depositing it into a 
matrix within the cell layer (Herrmann et al, 1980; Freiberger et al, 1980).
At present there is comparably little data on tendon fibroblasts in monolayer 
cultures and their differentiated state is relatively unknown. Studies have shown 
that tendon fibroblasts in culture continue to produce extracellular components, 
characteristically type I and type III collagens (Herrmann et al, 1980). There is 
evidence to suggest that tendon cells in monolayer do de-differentiate, the 
rationale being that they lose their ability to synthesise large amounts of collagen 
relative to other proteins (Schwarz et al, 1976; Quinones et al, 1986; Bemard- 
Beaubois et al, 1997). It was also discovered that if the lactate ion concentration 
was raised, the tendon fibroblasts could resume the initial level of collagen 
synthesis that occurs in vivo (Klein et al, 2001). However, the majority of collagens 
and other extracellular matrix components produced by fibroblasts in monolayer 
are at reduced levels to that originally synthesised in vivo and most are released 
into the media, rather than being retained by the cells (Herrmann et al, 1980). This 
investigation also noted that as the number of passages increased, so did the 
amount of cells expressing type III collagen. Further studies on collagen 
polypeptides also showed evidence of de-differentiation. Type I collagen is 
comprised of a 1 (I) and a 2 (I) chains in a 2:1 ratio (Karsenty and Park, 1995). In 
primary cultures of tendon fibroblasts, however, this ratio did not remain constant, 
but increased with trimers of a 1 (I) chains being produced simultaneously with the 
heterogenic trimers (Quinones et al, 1986). The transcription factor scleraxis has 
more recently been used to identify the differentiated state of tendon fibroblasts. 
Scleraxis expression has been researched in vivo and various in vitro systems
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(Cserjesi et al, 1995; Schweitzer et al, 2001; Schulze-Tanzil et al, 2004), although 
there are no reports of scleraxis expression in tendon fibroblast monolayer to date. 
Monolayer cultures have major interactions with the culture substrate, along with a 
degree of cell-cell interaction, with the two being impossible to separate.
Connective tissue cells often retain their phenotype when grown under conditions 
of high cell density: this is particularly evident with chondrocytes (Aherens, 1977; 
Solursh, 1982); and osteogenic cells (Gerber and ap Gwynn, 2002). When large 
numbers of chondrocytes are centrifuged to form a pellet, they deposit a typical 
cartilage matrix (Moscona and Moscona, 1952; Moscona, 1963; Solursh, 1982), 
whereas if they are grown in monolayer they do not, but instead de-differentiate 
and stop synthesising cartilage specific molecules (Grundmann et al, 1980; 
Brodkin et al, 2004). Similarly, when osteoblasts are initially plated as monolayers, 
a reduction in type I collagen expression is observed. No bone forms until large, 
highly cellular nodules had formed within the cultures (Gerber and ap Gwynn,
2002). A variant of the high density cell culture is the micromass (Ahrens et al, 
1977; Solursh, 1982; Archer et al, 1982, Daniels and Solursh, 1991). In these 
systems, a high density spot of cells is plated into a culture dish, the cells are 
allowed to adhere and then the dish is flooded with medium. The high density spot 
allows high cell densities with small numbers of cells and has been previously 
shown to successfully produce cartilage formation from mesenchymal precursors 
(Mello and Tuan, 1999; Carlberg et al, 2001; White et al, 2003; Hatakeyama et al,
2003), differentiated chondrocytes (Seghatoleslami et al, 1995; Enomoto-lwamoto 
et al, 1997; Kameda et al, 2000) and even dermal fibroblasts, in the presence of 
lactic acid (Nicoll et al, 2001). In micromasses the cells maintain their rounded 
nature and phenotype, therefore this system is predominantly used to study 
chondrogenesis. Consequently, micromasses have been important in researching 
various aspects of precartilage condensation: the molecular and genetic 
expression of cartilaginous markers, cell-cell and cell-matrix interactions and 
influences of growth factors (Oberlender and Tuan, 1994; Tavella et al, 1994; 
Gluhak et al, 1996; Stott et al, 1998; Nicoll et al, 1998; Mello and Tuan, 1999). 
Micromass cultures have not been applied to tendon research, but they offer the 
opportunity of investigating 3-D cell cultures with small numbers of cells. However, 
in a micromass, cells do still interact with the culture dish as well as one another.
To remove the cell-substrate interaction factor and concentrate on the interaction 
of cells with each other, another simple high-density culture system can be used.
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The pellet culturing system was developed to investigate cell aggregation from a 
range of tissues. It has been extensively used with chondrocytes (Moscona, 1963; 
Solursh, 1991) and is easy to use and to manipulate. This system lends itself to 
experimentation including the effects of growth and transcription factors and 
mechanical strains, generally compression (Lennon et al, 2000; Indrawattana et al, 
2004; Bai et al, 2004; Huang et al, 2004; Bosnakovski et al, 2004). A potential 
disadvantage of pellet cultures is that the central regions of the pellet have 
restricted access to the nutrients when compared to the outer layers. This is 
probably why this system is useful for chondrocytes as they have a relatively low 
metabolic rate (Archer and Francis-West, 2003; Urban and Roberts, 2003), 
although tendon cells also respond to lactate (Klein et al, 2001; see above) 
suggestive of an extent of anaerobic metabolism in their normal environment.
A new method of culturing cells at high density, initially developed to investigate 
chondrocytes and mesenchymal cells, has recently been applied to tendon 
fibroblasts. This system aims to retain tendon fibroblast phenotype and maintain 
the high levels of matrix synthesis in vivo (Schulze-Tanzil et al, 2004). Tendon 
fibroblasts were expanded (P10) and suspended at a high cell density. Cells were 
placed onto a membrane filter (pore diameter 0.2pm), on top of a stainless steel 
grid at the medium-air interface in a petri dish, and incubated for 14 days. The 
conclusions drawn were that this culturing system did indeed maintain the 
differentiated state of tendon fibroblasts, in that they retained the ability to produce 
matrix characteristic of tendon and positively expressed scleraxis (Schulze-Tanzil 
et al, 2004). This system remedied the possible nutritional problems encountered 
in central zones of pellet cultures, but as with pellet cultures this does not address 
matrix organisation. The tendon fibroblasts continue to synthesise the correct 
elements but the order and structure of these components remains difficult to 
influence. It is interesting that this system fails to recognize the known benefit of 
lactate levels in tendon cell ECM synthesis (Klein et al, 2001) indicated above. 
Also, scleraxis is characteristic of embryonic, differentiating tendon/ligament rather 
than adult ones (Schweitzer et al, 2001), although scleraxis is known to be present 
in mature tissues (Tsai et al, 2003).
The experiments outlined below were performed to determine whether cell density 
and cell-cell interaction were important in the deposition of matrix by tendon cells 
in vitro. Monolayers allow cell-cell interactions, but have large elements of cell- 
substrate interactions, they will in all likelihood be used as a preliminary stage of
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most tissue culture procedures, for purposes of cell expansion; micromasses have 
enhanced cell-cell interactions, but retain some cell-substrate interactions, 
therefore this system is only suitable for some cell types; pellet cultures have 
almost exclusively cell-cell interactions until the onset of matrix deposition, as cells 
do not adhere to the walls of the tubes used to contain them.
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4.2 MATERIALS AND METHODS
Studies on the effects of cell density and 3-D cell organisation on matrix deposition 
were conducted using monolayers, micromass and pellet cultures.
Culture procedure
For tissue source, cell isolation and maintenance in detail refer to general material 
and methods (chapter 2).
Monolayer cultures- Tendon fibroblasts isolated from 50 day old broiler chickens 
were grown in monolayer to passage 3 (P3) for 7 days, fed with DMEM/5%FBS 
every 3 days, incubated at 37°C, with 100% humidity in 5% CO2 in air atmosphere. 
At 7 days, the tendon fibroblasts were fixed with 95% alcohol at 4°C (see materials 
and methods, chapter 2).
Micromass cultures- Tendon fibroblasts, (source as above), were removed from 
P3 monolayer cultures, the cell suspension adapted to 2x107 cells/ml and 10pl 
aliquots (2x105 cells) spotted in the centre of 30mm culture dishes (Costar). The 
cells were allowed to adhere for 30 minutes and then the cultures flooded with 
DMEM/5%FBS and 1 mg/ml ascorbate (Sigma). Cultures were maintained for 1 
hour to 7 days and incubated as above.
Pellet cultures- Cell suspensions of P3 tendon fibroblasts were adjusted to 1x106 
cell/ml in DMEM/5%FBS and 1ml of suspension aliquoted into sterile 
polypropylene eppendorf tubes. The cells were gently centrifuged (2000 rpm) 
allowing pellets to form at the bottom of the tube. The pellets were fed with 1ml 
DMEM/5% FBS, 12.5mM HEPES buffer (Gibco) and 1 mg/ml ascorbate (Sigma) 
every 3 days. Tendon fibroblast pellets were incubated for time periods of 1 hour 
to 7  days as above.
Analysis
At termination the monolayers, micromasses and pellets were prepared for 
immunohistochemical labelling or electron microscopy. For immunohistochemical 
analysis, the monolayers, micromasses and pellets were fixed in 95% IMS at 4°C 
and labelled for ECM components (types I, II and III collagen and tenascin), 
cytoskeletal components (actin by direct phalloidin label, vimentin) and cell 
junctional components (vinculin, n and pan-cadherin and connexins 32 and 43) as 
described in chapter 2.
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Electron Microscopy
Transmission electron microscopy- Pellet cultures were fixed immediately in 2.5% 
glutaraldehyde, in 0.1M sodium cacodylate buffer (pH 7.4) for 2 hours at 4°C. 
Specimens were then washed in 0.1 M sodium cacodylate buffer (3x10 mins) and 
postfixed in 1% osmium tetroxide in 0.1M cacodylate buffer, for 1 hour at 4°C. 
Specimens were washed in distilled water ( 4 x 5  mins) and stained en bloc with 
0.5% uranyl acetate for 1 hour at 4°C in the dark, washed again and dehydrated 
through an ethanol series. The dehydrated specimens were infiltrated with Spurr 
resin (Agar Scientific Ltd.) overnight before being orientated in fresh resin and 
polymerised overnight at 60°C.
Semi-thin (1-2^im) longitudinal and transverse sections were cut and stained with 
toludine blue for 1-2 minutes on a hotplate, for orientational purposes, and then 
ultra-thin sections (60-90nm, silver-gold) were cut and collected on 200 copper 
mesh grids. Sections were stained in 2% aqueous uranyl acetate and Reynolds 
lead citrate (Reynolds, 1963), washed twice in distilled water and dried on filter 
paper. Sections were examined on a Philips TEM 208 electron microscope at an 
accelerating voltage of 80kV.
Scanning Electron Microscopy-PeWets were fixed in 2.5% glutaraldehyde in 0.1 M 
phosphate buffer pH 7.2-7.4 for 24 hours. Samples were washed with 0.1M 
phosphate buffer (4 X 15 mins), rinsed with distilled water ( 3 X 5  mins) and 
dehydrated in a graded series of ethanol, critical point dried (Balzers CPD 030) 
and mounted on an aluminium stub with double stick carbon tape. Samples were 
then sputter coated (Sputter coater S150B, Edwards) with gold and examined on a 
Philips scanning electron microscope XL20 operating at an accelerating voltage of 
20kV.
Some samples were sectioned directly after fixation in 2.5% glutaraldehyde to 
examine the central regions of the pellet, processing was then resumed as above. 
To investigate the identity of matrix deposited at the pellet surface pellets were 
treated with 0.5% collagenase (Sigma; see chapter 2) for time periods or 1, 2 and 
5 minutes. The pellets were directly fixed in 2.5% glutaraldehyde and processed 
as above.
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4.3 RESULTS
4.3.1 Monolayers
Extracellular matrix components
Cells in monolayer appeared elongated and flattened on tissue culture substrate. 
This environment is ideal for cell expansion, and allowed rapid cell growth. 
Immunolabels for extracellular proteins showed type I and type III collagen to be 
present in monolayers. Type I collagen had a streaky appearance and in some 
areas appeared extracellular (fig 4.1. A), whereas, type III collagen remained 
intracellular (fig 4.1. C). Type II collagen was not present in these monolayers (fig
4.1 B). Tenascin labelled at the periphery of cells outlining their boundaries (fig 4.1 
D).
Cytoskeletal components
Prominent actin fibres were present throughout the monolayers with a longitudinal 
and parallel orientation relative to the orientation of the cells (fig 4.1 E). Vimentin 
was present and, similarly to actin, showed a degree of longitudinal orientation 
governed by the orientation of the cell (fig 4.1 F).
Cell junctional components
Pan-cadherin and n-cadherin were present, seen at cell-cell borders throughout 
the monolayer (fig 4.2 A, B). Their appearance was spotted and showed signs of 
following a longitudinal orientation in conjuncture with cell orientation. Vinculin 
labelling was also observed at cell-cell boundaries (fig 4.2 C). Small collections of 
vinculin organised in a streaky parallel fashion were observed between cells and in 
areas over the superficial surface of the cell nuclei. This suggested that the cells 
were not only forming cell-cell junctions but were also involved in cell-matrix 
junctions with the substrate. Gap junctional protein connexin 32 labelled positively 
across the monolayer (fig 4.2 D). The pattern of labelling was streaky and followed 
the orientation of the cell membranes. Connexin 43 was present (fig 4.2 F), 
although its labelling was weaker in comparison to the connexin 32, and was 
punctate in nature.
4.3.2 Micromasses
Micromasses enabled cells to be studied at high density. In a micromass the 
central region is the densest, with a less dense region of cell outgrowth at the 
periphery. Culturing fibroblasts in micromasses for long periods (5-7 days) lead to
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cell migration away from the high density spot, which resulted in circular 
monolayers rather than high cell density, multilayered spots.
Collagens
Type I collagen was present in micromasses at all time points. At 1 hour of culture 
(fig 4.3 A) it appeared predominantly intracellular. The intensity of the type I 
collagen labelling appeared to increase after 7 days in culture when cells within 
micromasses became monolayers and labelling appeared extracellular (fig 4.3 E). 
Type III collagen was present, but barely detectable after 1 hour in micromass 
culture (fig 4.3 B). At 1 day in culture there was an apparent increase in label and 
some appeared to be extracellular (fig 4.3 D), this continued into 7 days of culture 
(fig 4.3 F).
Actin
Actin fibres were present and were particularly predominant in central regions of 
the micromass after 1 day (fig 4.4 A). The actin fibres had no obvious orientation 
within the culture, but were seen following the spreading membrane of the cells.
Cell junctional components
Pan-cadherin and n-cadherin were present in 1 day micromass cultures, with 
labelling generally restricted to the cell periphery (fig 4.4 B, C). Vinculin was 
present throughout the cells within the micromass cultures at the cell periphery 
with an even appearance rather than punctate, at all time points (fig 4.6 A, B, C). 
Gap junctional protein connexin 32 was present at 1 hour predominantly located in 
the central zone of the micromass (fig 4.5 A). At 1 day, connexin 32 label 
appeared to increase in intensity (fig 4.5 C), this label remained after 7days in 
culture (fig 4.5 E). Connexin 43 was possibly present after 1 hour, although label 
was faint and difficult to identify (fig 4.5 B). At 1 and 7 days connexin 43 was 
present, with a clear punctate labelling pattern (fig 4.5 D, F).
4.3.3 Pellet cultures
To investigate the behaviour of cells at high cell density with no culture substrate, 
tendon fibroblast pellets were established.
Extracellular matrix labelling
Type I collagen was present throughout the tested time intervals. It was present 
after 1 day of incubation and distributed as small foci of label, in the main part of
88
the pellet away from the periphery (fig 4.7 A). Type I collagen became more 
extensive after 2 days in culture (fig 4.7 B) and the fibrous network was prominent 
centrally in the pellet. Cells at the periphery of the pellet, orientated perpendicularly 
to the surface, showed weaker labelling for type I collagen and formed a cellular 
capsule around the pellet. Following the 2-day time period there appeared to be no 
obvious difference in type I collagen distribution. At 3, 7, 9 and 10 days, type I 
collagen remained extensively fibrous and evenly distributed in the pellet (fig 4.7 
C- F). After 14 days in culture label had diminished in the central region of the 
pellet (fig 4.7 G).
Type III collagen was present from 1 day through to 14 days in pellet culture and 
appeared to increase in intensity of labelling over time. The label was extracellular 
and fibrous after 1 day in culture (fig 4.8 A) and became extensively fibrous after 7 
days in culture (fig 4.8 B). After 14 days in culture, type III collagen remained 
intense and widespread (fig 4.8 C). At the periphery, fibrous label appeared to run 
circumferentially (fig 4.8 B).
Label for type I pro-collagen was present throughout the pellet at all time points (fig
4.8 D-F). Not all cells labelled positively and there was no recognisable pattern to 
the labelling. After 14 days in culture when the type I collagen present was waning, 
type I pro-collagen remained positive (fig 4.8 F).
It was decided to label fibronectin as it is highly involved in extracellular 
collagenous and proteoglycan interactions, and is involved in cell growth, 
differentiation and migration. Fibronectin was present in cell pellets from each time 
point. The label was fibrous and extracellular (fig 4.8 G), but became restricted to 
the pellet periphery in 7 day pellet cultures (fig 4.8 H). After 14 days in culture 
fibronectin was still detectable, although it was restricted to localised areas (fig 4.8
I).
Cytoskeletal labelling
Positively labelled filamentous actin was observed in pellets at each time point (fig
4.9 A-C), the ‘hazy’ green effect seen suggesting a gel-like filamentous 
organisation was present within the cells. No prominent actin fibres could be seen 
at this time, although in some central regions of the pellets, rounded cells had 
strong actin label at their periphery (fig 4.9 C). Vimentin was present throughout 
the pellets and at each time interval (fig 4.9 D-F). There was an apparent decrease
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in the labelling intensity of vimentin in 14day pellet cultures, although positive label 
could still be observed (fig 4.9 F).
Cell junctional labelling
Immunolabelling for n-cadherin and vinculin was positive at cell boundaries 
throughout the pellet cultures (fig 4.9 G-L). The punctate pattern of labelling for n- 
cadherin is clear at 1 day (fig 4.9 G). Connexin 32 was present at all time intervals 
and seen widely distributed throughout the pellet (fig 4.10 A-C). At 7 days it was 
possible to distinguish labelling polarity in the cells (fig 4.10 B), although this was 
not present in 1 or 14 day pellets (fig 4.10 A, C). There appeared to be a decrease 
in immunolabelling intensity for connexin 32 after 14 days in culture (fig 4.10 C). 
Connexin 43 was present although it remained sparse and appeared strongest 
between 1 and 7 days in culture (fig 4.10 D, E).
Electron microscopy
4.3.4 Scanning electron microscopy
Scanning electron microscopy (SEM) enabled the observation of the general 
structure of pellets at increased levels of magnification. The general shape after 1 
day (fig 4.11 A) showed that the superior surface of the pellet was concave and 
contained many rounded cells. Flattened cells were found elsewhere at the pellet 
periphery and extensive cell-cell contacts could be observed (fig 4.11 B). There 
were areas where matrix connections between cells were evident (fig 4.11 C), and 
cellular blebs in other regions suggesting possible cell death. After 7 days in 
culture the concave superior surface was less obvious (fig 4.12 A), it had a 
‘smoother’ appearance compared to the 1 day pellet. Outgrowths developed from 
the original pellet (fig 4.12 A). There was increased fibrous matrix deposition 
generally at the pellet surface (fig 4.12 B, C). Cells had many intricate cell 
processes and extensive cell-cell contacts (fig 4.12 C). After 2 weeks in cultures 
the outgrowths had increased in size and number (fig 4.13 A). It was evident there 
was some degree of orientation of the cells at the cell periphery (fig 4.13 B). 
Cellular contacts were still prominent (fig 4.13 C), although there was a 
considerable amount of debris of unclear origin at the pellet surface (seen in the 
right hand corner).
Sectioned pellets
SEM images of sectioned 7 day pellets showed that some pellets contained a 
small void in their upper central region, apparently formed by growth and folding
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over of the ‘rim’, seen in the earlier pellet. Apart from this region, cells were 
distributed throughout the pellet. The cells covering the pellet surface appeared 
smooth like a capsule enveloping the cells underneath (fig 4.14 B). Deposition of 
ECM is not only present on the surface (fig 4.14 A), but areas of distinctly fibrous 
ECM were found within the pellet (fig 4.14 C).
Collagenase digested pellets
To assess the nature of the surface ECM deposition, pellets were digested in 
collagenase. After 1 minute digest there was little difference in the surface fibrous 
matrix and areas of highly aligned deposited, matrix remained (fig 4.15 A, B). 
Following two minutes of collagenase digestion however, partial degradation of the 
ECM was observed and the once taut matrix appeared relaxed and loose (fig 4.15 
C, D). After 5 minutes in collagenase digest the surface ECM of the pellets was 
greatly affected and remnants of digested fibrous matrix remained at the pellet 
surface (fig 4.15 E, F).
4.3.5 Transmission electron microscopy
Transmission electron microscopy (TEM) allowed the study of the cellular 
morphology and matrix deposition in greater detail.
TEM images were taken of pellets after 1, 2, 5 and 7 days in culture. After 1 day 
cells were closely packed with cell processes visible varying in size and in regions 
of the pellet (fig 4.16 A-D). There were prominent mitochondria (with well-defined 
cristae) within the cells (fig 4.16 C), and large cytoplasmic glycogen stores (fig.
4.16 A). Fat droplets were also visible, together with lysosomal areas and regions 
of rough endoplasmic reticulum (fig. 4.16 B). There were areas within the pellet 
where it was possible to see fibrous material being deposited into intracellular 
spaces created by the cells (fig. 4.16 D).
At 2 days the TEM images show many cell processes within intercellular spaces 
(fig 4.17 B). There was a general increase in intercellular space and collagen was 
deposited into some, but not all intercellular spaces (fig 4.17 B). In some areas 
these cell processes contacted one another and cell junctions were formed (fig
4.17 B), although it was difficult to characterise which cell-cell junction had actually 
formed. Collagenous matrix was laid down between cells perpendicular to the cell 
membrane and appeared to be associated with more than one cell (fig 4.17 A). In 
some areas there appeared to be some longitudinal orientation of the collagen
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fibres. There was a dramatic increase in collagen deposition compared to 1 day 
pellets with areas of parallel and longitudinal orientation (fig 4.17 C-D).
Five day pellets showed that cell processes remained and as before, in some 
areas there was no deposition of matrix in intercellular spaces (fig 4.18 B). 
Collagen fibres associated with 2 or more cells, which were high in glycogen 
stores, were present (fig 4.18 C). The collagen fibres radiated perpendicular to the 
cell membrane and an increased amount of collagen fibres were deposited in 
some intercellular spaces. In these intercellular spaces the collagen seemed to 
have little or no overall organisation, although there were small areas showing a 
parallel orientation of collagen fibrils in bundles (fig 4.18 A). In areas where cell 
membranes became close junctional, complexes were observed with cytoskeletal 
association (fig 4.18 D).
After 7 days of incubation elongated cell processes were present and were 
associated with adjacent, orientated collagen fibres (fig 4.19 A), although some 
collagen fibres were still organised perpendicularly to the cell membrane (fig 4.19 
C). Associated with these depositions was an organised cytoskeletal component 
intracellularly, most likely to be actin (fig 4.19 C). Increasingly large amounts of 
collagen fibres were deposited in intercellular spaces, again with only small areas 
of parallel organisation (fig 4.19 B, D).
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Figure 4.1- Tendon fibroblasts monolayers, at confluence at passage 3.
Immunohistological labelling of ECM and cytoskeletal molecules present in tendon 
fibroblast monolayers. Scale bars measured in micrometres.
A-Cell monolayer. Type I collagen label
Type I collagen is present showing streaks of label, possibly between cells.
B- Cell monolayer. Type II collagen label
There is no type II collagen label.
C- Cell monolayer. Type III collagen label
Type III collagen is present, although labelling appears mostly intracellular.
D- Cell monolayer. Tenascin label
Tenascin label occurs at cell surfaces, outlining the tendon cells.
E- Cell monolayer. Phalloidin label
Filamentous actin is present with prominent longitudinal orientation of the actin 
fibres within the cells, probably actin stress fibres.
F- Cell monolayer. Vimentin label
Vimentin is present throughout the monolayers with a degree of longitudinal 
orientation, in conjuncture with the orientation of the cells.
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Figure 4.2- Tendon fibroblasts monolayers, at confluence at passage 3.
Immunohistological labelling of associated cell junctional molecules present in 
tendon fibroblast monolayers. Scale bars measured in micrometers.
A- Cell monolayer, pan-cadherin label
Pan-cadherin is present and concentrated at the cell borders.
B- Cell monolayer, n-cadherin label
n-cadherin is present with a similar distribution to pan-cadherin; concentrated at 
the cell boundaries and spotted in appearance.
C- Cell monolayer. Vinculin label
Vinculin is present and clustered into areas of short and longitudinally orientated 
parallel streaks between cell membranes. There are thin streaks seen on the 
superior surface of the monolayer indicating both cell-matrix adhesions and cell­
cell adhesions.
D- Cell monolayer. Connexin 32 label
Connexin 32 is present, with wisps of longitudinally orientated label throughout the 
monolayer.
E- Cell monolayer. Connexin 43 label
Positively labelled connexin 43 is present in patchy areas, with individual foci being 
apparent.
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Figure 4.3- Micromass experiments. Collagens present in tendon fibroblast 
micromass culture systems. Scale bars = 50pm, unless otherwise stated.
Type I collagen- A, C, E
A - 1 hour -Type I collagen is present at all time points, at 1 hour the positive label 
is intracellular.
C -1 day-After 1 day type I collagen is present but labelling was hazy.
E- 7days- Cells in culture over 7 days are increasingly flattened but still labelled 
positively for type I collagen.
Type III collagen-B, D, F
B- 1 hour-Type III collagen is faintly present in some cells within micromass 
culture.
D -1 day- Positively labelled type III collagen appears to increase in intensity.
F- 7 days- The flattened fibroblasts resemble a monolayers culture, and the cells 
label positively for type III collagen.
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Figure 4.4- Micromass experiments. Actin, pan-cadherin and n-cadherin present in 
tendon fibroblast micromass culture systems.
A- Actin label. 1 day -Actin stress fibres are present, particularly in central regions 
of the micromass where they had a no clear orientation. Scale bar = 40pm
B- Pan-cadherin. 1day -Pan-cadherin is present and label is seen predominantly 
at the cell boundaries. Scale bar = 50pm
C- N-cadherin. 1day -n-cadherin is present, following a similar pattern to pan- 
cadherin, with abundant label at the cell edge. Scale bar = 50pm
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Figure 4.5- Micromass experiments. Gap junctional molecules present in tendon
fibroblast micromass culture systems. Scale bars = 50pm, unless otherwise stated.
Connexin 32 label A, C, E
A -1 hour -Connexin 32 is faintly present.
C- 7 day - The positive connexin 32 appeared to increase in intensity.
E -1 day -Connexin 32 label continues to label positively.
Connexin 43 label B, D, F
B - 1 day- Connexin 43 is present after 1 hour in micromass culture.
D-1 hour-There appeared to be an increase in the connexin 43 present, with 
clearly identifiable puncate foci.
F-7 day -Connexin 43 continues to label positively.
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Figure 4.6- Micromass experiments. Vinculin present in tendon fibroblast
micromass culture systems. Scale bar = 50pm.
Vinculin label A, B, C.
A-1hour -Vinculin is present, with labelling characteristically focused at the cell 
periphery.
B-1day -Positive labelling for vinculin was observed.
C-7day - Cells in micromass culture for 7 days label positively for vinculin.
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Figure 4.7 Tendon fibroblasts in a pellet culture, treated with 5% FBS/DMEM.
Scale bars = 50 pm.
Type I collagen
A- 1day pellet. Positively labelled type I collagen has a fibrous nature, and 
areas at the periphery show a reduction in type I collagen.
B- 2day pellet. An apparent increase in labelling intensity for type I collagen is 
seen in the centralised region of the pellet, with a cellular rim labelling 
sparingly for type I collagen.
C- 3day pellet. Type I collagen is ubiquitously distributed throughout the pellet 
and appeared extensively extracellular and fibrous.
D- 7day pellet. There is little difference in the type I collagen distribution 
between 3 and 7 days in pellet culture, label is predominantly 
extracellularly.
E- 9day pellet. The fibrous nature of type I collagen remains consistent in the 
9 day pellet cultures.
F- 10day pellet. Type I collagen is present throughout the cell pellet, 
elongated cells at the periphery continues to show lesser type I collagen 
labelling compared to the central zone of the pellet.
G- 14day pellet. Type I collagen is sparsely present in the centre of the cell 
pellet, the general appearance shows a deterioration of type I collagen in 
the central zone of the pellet.
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Figure 4.8 Tendon fibroblasts in a pellet culture, treated with 5% FBS/DMEM.
Scale bars = 50 pm.
Type III collagen
A- 1day- Type III collagen showed extracellular, fibrous labelling patterns after 
1 day in culture.
B- 7day-Positively labelled type III collagen continued to show extensive 
extracellular labelling and an apparent increase in intensity at the pellet 
periphery.
C- 14day-Type III collagen remained extracellular and widespread in the pellet.
Type I pro-collagen
D- 1 day-isolated cells within the pellet cultures label positively for type I pro­
collagen. The sporadic labelling showed no pattern or differences between 
central and periphery zones.
E- 7day-lnfrequent type I pro-collagen remained consistent after 7 days in 
culture.
F- 14day-After 14 days in pellet culture individual cells are consistently labelling 
positive for type I pro-collagen, even in the central region of the pellet.
Fibronectin
G- 1day- Fibronectin shows positive extracellular labelling after 1 day in 
culture.
H- 7day- Fibronectin is present predominantly in the peripheral regions of the 
pellet, maintaining a fibrous appearance.
I- 14day- Areas of fibronectin remain in the 14 day pellets, showing similar 
patterns of extracellular labelling.
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Figure 4.9 Tendon fibroblasts in a pellet culture, treated with 5% FBS/DMEM.
Scale bars = 50 pm.
Actin
A- 1day-Actin is present and shows a green hazy background, indicating a gel­
like filamentous structure of actin.
B- 7day-Only selected regions of the pellet shows the ‘cloudy’ green label, 
demonstrating the gel network of actin present in the cell.
C- 14day-Rounded cells label strongly for filamentous actin, particularly in 
central regions of the pellet.
Vimentin
D- 1day-Vimentin is present from 1 day in incubation and is extensively 
observed throughout the pellet.
E- 7day- A consistent level of vimentin can be observed in the pellet.
F- 14day- There are indications that vimentin label has diminished, although 
areas of vimentin remain distinguishable, 
n-cadherin
G- 1day-n-cadherin is clear in pellets cultured for 1 day, the labelling pattern is 
predominant at the cell boundaries.
H- 7day- n-cadherin is present and widespread throughout the culture.
I- 14day-n-cadherin appears to have been reduced in 14 day cultures, 
although remnants of label are present 
Vinculin
J- 1 day-Vinculin can be observed focused at the periphery of the cells 
throughout the pellet culture.
K-7 day- Vinculin shows consistent and extensive labelling.
L- 14 day-Vinculin is present after 14 days, although a possible reduction in 
label can be observed.
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Figure 4.10 Tendon fibroblasts in a pellet culture treated with 5% FBS/DMEM.
Scale bars = 50 pm.
Connexin 32
A- 1day-Connexin 32 can be identified, but is predominant at the cell periphery.
B- 7day-Connexin 32 is present in cells showing extensive label, many cells 
label positively for connexin 32 showing a degree of cellular polarity.
C- 14day-After 14 days cells continue to label positively for connexin 32, a 
focus of connexin 32 at the pellet edge can be identified.
Connexin 43
D- 1day-Sporadically labelled connexin 43 could be observed in areas of the 
cellular pellet. There is no pattern and the areas of labelling positive are 
infrequent and difficult to identify.
E- 7day-Small areas of connexin 43 were identified and are predominantly 
found in the pellet periphery.
F- 14day-There is little or no connexin 43 present in the pellets after 14days in 
culture.
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Figure 4.11 Scanning electron micrographs
A- 1day tendon fibroblast pellet
The general pellet shape after 1-day in culture shows clear rims where the cells 
have flattened and a concave superior surface containing more rounded cells. 
Scale bar 500pm, magnification x140
B- 1day tendon fibroblast pellet
The flattened cells at the rim show a small degree of elongated orientation.
Scale bar 50pm, magnification x1000
C- 1day tendon fibroblast pellet
There is evidence of cell-matrix contacts between the more rounded cells.
Scale bar 5pm, magnification x10 000
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Figure 4.12 Scanning electron micrographs
A- 7day tendon fibroblast pellet
The pellet shape after 7 days in culture, cellular growths begin to appear and the 
concave appearance of the superior surface has begun to fill. Small outgrowth can 
be detected projecting from the pellet surface (top right).
Scale bar 200pm, magnification x51
B- 7day tendon fibroblast pellet
Closer inspection shows fibrous matrix deposited at the cell surface and elongated 
cells.
Scale bar 10pm, magnification x1000
C- 7day tendon fibroblast pellet
Elongate cell processes and contacts have developed.
Scale bar 10pm, magnification x1000
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Figure 4.13 Scanning electron micrographs
A- 14day tendon fibroblast pellet
The pellet shape is less uniform, cellular outgrowths have increased in number and 
size.
Scale bar 200pm, magnification x65 
B- 14day tendon fibroblast pellet
An increased orientation of the elongated cells is apparent, together with multiple 
cell processes.
Scale bar 20pm, magnification x800 
C- 14day tendon fibroblast pellet
The flattened cell contacts are more established. Areas of debris are present, 
although the origin is unknown.
Scale bar 5pm, magnification x3500
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Figure 4.14 Scanning electron micrographs
A- 7day tendon fibroblast pellet, transverse section
The transverse section of a pellet after 7 days in culture shows a central cavernous 
area where the cellular growth has joined superiorly.
Scale bar 200pm, magnification x250
B- 7day tendon fibroblast pellet, transverse section
There are tightly packed cells within the pellet and the flattened cells only appear at 
the surface.
Scale bar 100pm, magnification x650
C- 7day tendon fibroblast pellet, transverse section
There is matrix deposition at areas within the pellet, not only at the surface (B). 
Scale bar 5pm, magnification x12 000
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Figure 4.15 Scanning electron micrographs
A- 7day tendon fibroblast pellet. 1 minute collagenase treatment.
Elongate areas of cells and fibrous matrix remain present in the pellet despite 
collagen digestion.
Scale bar 10pm, magnification x5000
B- 7day tendon fibroblast pellet. 1 minute collagenase treatment.
Scale bar 5pm, magnification x10 000
C- 7day tendon fibroblast pellet. 2 minute collagenase treatment.
Scale bar 10pm, magnification x5000
D- 7day tendon fibroblast pellet. 2 minute collagenase treatment.
Elongate cells covered in fibrous matrices appear to have loosened and show less 
orientation after 2 minute collagenase digest.
Scale bar 5pm, magnification x15 000
E- 7day tendon fibroblast pellet. 5 minute collagenase treatment.
The fibrous matrix once covering the pellet surface has been removed, leaving 
matrix fragments covering the surface.
Scale bar 20pm, magnification x3500
F- 7day tendon fibroblast pellet. 5 minute collagenase treatment.
Small areas of matrix remain, although they appear heavily digested.
Scale bar 5pm, magnification x12 000
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Figure 4.16 Transmission electron micrographs
A- TEM image. 1day pellet.
Large glycogen deposits are abundant within the tendon cells together with fat 
droplets. Cellular processes of varying widths pass between cells with intact 
plasma membranes.
Magnification x16K 
Scale bar= 0.5pm
B- TEM image. 1day pellet.
Cellular processes within the tendon fibroblast cell pellet are clear (CP), together 
with large fatty deposits (F) Lysosomal bodies (L) are present and part of the rough 
endoplasmic reticulum is visible (RER). Areas of organised cytoskeletal 
components can be identified and a couple of mitochondria can be seen (M). 
Magnification x16K 
Scale bar= 0.5pm
C- TEM image. 1day pellet.
Numerous mitochondria are present, with well characteristically defined cristae (M). 
Surrounding matrices show fragments of possible fibrous matrix and proteoglycans 
present.
Magnification x16K 
Scale bar= 0.5pm
D- TEM image. 1day pellet.
Cell processes (CP) and the deposition of fibrous matrix are suggested (F). Areas 
of intracellular glycogen deposits can be seen to the left and cytoskeletal 
components are visible running parallel with the cell membrane, in the cell on the 
right.
Magnification x63K 
Scale bar= 0.16pm
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Figure 4.17 Transmission electron micrographs
A- TEM image. 2day pellet.
Deposition of collagenous fibres between adjacent cells can be observed (C). The 
orientation of these fibres is perpendicular to the cell surface and cytoskeletal 
components of the cell are visible near the cell membrane.
Magnification x25K 
Scale bar= 0.42pm
B- TEM image. 2day pellet.
Cell processes are abundant and have various orientations (CP). There is no 
collagen deposition in the intercellular spaces in this area. Cell junctions (CJ) are 
present where cell membranes meet, though the junction type cannot be 
distinguished.
Magnification x32K 
Scale bar= 0.33pm
C- TEM image. 2day pellet.
Areas of longitudinally orientated collagen fibres are present (C) and the 
characteristic banding of fibrillar collagens can be seen. The area surrounding the 
collagen fibres is heavily granular.
Magnification x63K 
Scale bar= 0.16pm
D- TEM image. 2day pellet.
Increased magnification of C. The longitudinally orientated collagen fibres show 
characteristic banding of fibrillar collagens.
Scale bar= 0.08pm
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Figure 4.18 Transmission electron micrographs
A- TEM image. 5day pellet.
Deposition of collagenous fibres into large intercellular spaces is present (C). 
There is no general orientation of these fibres with respect to the cell surface, 
however parallel alignment is observed in small clusters of collagen fibres. 
Magnification x13K 
Scale bar= 0.85pm
B- TEM image. 5day pellet.
Cell processes are abundant and have various orientations (CP). There is no 
collagen is deposited in this region though the intercellular spaces are abundant. 
The intercellular spaces are not totally void of material, though what type of 
material is deposited is unknown.
Magnification x40K 
Scale bar= 0.25pm
C- TEM image. 5day pellet.
Collagen deposition is perpendicular to the cell surface (C) and large deposits of 
glycogen are found within the tendon cells. The left hand cell contains a fine 
cytoskeletal arrangement just underneath the cell surface.
Magnification x40K 
Scale bar= 0.25pm
D- TEM image. 5day pellet.
Fibrous collagen (C) deposited between cells, with the general orientation being 
parallel to the to the cell surface. Cytoskeletal components (CS) are clearly visible 
in the cytoplasmic side of the plasma membrane. Large glycogen stores are 
present.
Magnification x32K 
Scale bar= 0.33pm
127

Figure 4.19 Transmission electron micrographs
A- TEM image. 7day pellet.
Cell processes are abundant and have areas of longitudinal orientation (CP). The 
collagen fibres near these cell processes also show longitudinal orientation (C). 
Magnification x32K 
Scale bar= 0.33pm
B- TEM image. 7day pellet.
Collagen fibres (C) deposited with associated cytoskeletal components (CS), in this 
section both share a common longitudinal orientation.
Magnification x40K 
Scale bar= 0.25pm
C- TEM image. 7day pellet.
Collagen deposition is perpendicular to the cell surface (C) and highly ordered 
cytoskeletal components (CS) can be seen close to the plasma membrane 
arranged in a parallel fashion.
Magnification x50K 
Scale bar= 0.2pm
D- TEM image. 7day pellet.
Deposition of collagenous fibres into large intercellular spaces is present (C). 
There is little orientation of these fibres with respect to the cell surface, they can be 
seen longitudinally in the plan of view and perpendicularly to it.
Magnification x25K 
Scale bar= 0.42pm
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4.4 DISCUSSION
There were clear differences in the ability of tendon cells to deposit collagen into 
an ECM in the three culture systems examined. Monolayers showed small 
amounts of what appeared to be type I collagen, micromasses showed more 
extensive deposition of types I and III collagen, and pellet cultures developed an 
extensive collagen rich matrix. This demonstrates clearly that a combination of 
high cell density and 3-D organisation of cells promotes matrix deposition, and that 
pellet cultures are better able to replicate the in vivo situation.
The results in monolayers are consistent with other studies, which indicate that 85- 
94% of collagen produced by tendon cells in monolayer is released into the culture 
medium (Freiberger et al, 1980; Herrmann et al, 1980; Waggett et al, submitted). It 
would appear that the small amount retained is either intracellular or deposited in 
the very small available regions between cells within the cell layer. Strikingly, it 
appeared that the deposited collagen was type I; type III collagen appeared 
intracellular suggesting either that cells were unable to secrete it on monolayer, or 
were unable to deposit it into the matrix. Other studies report synthesis of type III 
collagen by fibroblasts in monolayer (Herrmann et al, 1980), so it would appear 
that the cells could not deposit it, but lost it all to the media. In contrast tenascin is 
present and deposited, apparently associated with the cell surface (Chiquet- 
Ehrismann, 2004).
By comparison, cells in micromass cultures did deposit ECM containing both types 
I and III collagen, although the longer the cells were in culture, the more they 
began to resemble monolayers, as cell multilayers were apparently dispersed by 
cell migration from the periphery. However, it was clear that enhanced cell density, 
with a degree of 3-D cell organisation, was more effective at promoting 
collagenous matrix deposition when compared to monolayers. With other cell 
types, notably cartilage, micromass cultures allow deposition of extensive matrix 
(Aherens, 1977; Solursh, 1982); and osteogenic cells (Gerber and ap Gwynn, 
2002), so while in this study they were a little better than the monolayers at matrix 
deposition, they cannot be regarded as especially successful.
Pellet cultures allowed extensive deposition of both collagen, along with tenascin 
and fibronectin. The reduced cell density in the centre of the oldest pellets suggest 
some nutritional problems, however, this did not cause serious problems over the 
timescale studied, although collagen label was reduced. Type I and III collagen
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were deposited at the same time in pellet cultures, although type III collagen has a 
more peripheral distribution, together with fibronectin. This area has some degree 
of cell and matrix organisation, also seen in SEM images and is perhaps 
associated with a specialised function of these cells, possibly a developing 
endotenon or epitenon. Some aspects of this feature are reminiscent of other 
tissue types studied in this system. Chondrocytes cultured as pellets form a 
cartilaginous pellet with flattened cells at the periphery expressing type I collagen, 
resembling the perichondrium (Larson et al, 2002). These tendon cells could be 
replicating their own peripheral tissue organisation. The presence of tenascin 
everywhere is suggestive of a generalised function rather than a specific, 
positionally restricted function like fibronectin or type III collagen in the pellets.
The presence of actin filaments in monolayer are prominent, these filaments are 
likely to be actin stress fibres. Actin stress fibres are common in connective tissues 
(Defilippi et al, 1999) and in vitro are characteristic of chondrocyte 
dedifferentiation, associated with a fibroblastic phenotype (Li et al, 2003). Actin 
has a role in matrix deposition, as studied in the intervertebral disc (Hayes et al, 
1999) and possibly in tendon development (see chapter 3). If actin filaments are 
associated with matrix organisation, they appear to be unnecessary in monolayer 
as no significant matrix is deposited. It may be that actin requires a 3-D 
organisation of cells to be able to function in this way.
Expression of prominent actin filaments occurred in the high cell density regions of 
the micromass, suggesting an association with cell-cell contacts as shown in other 
experimental systems (Wozniak et al, 2004). Whilst they are clearly present they 
are less extensive than in monolayer and so, perhaps, they represent an 
organisation closer to the in vivo situation. It may be related that these cultures, 
while they last, can deposit more matrix than cells in monolayer.
In the pellet cultures no clear actin fibres were present in early stages, they 
became present in some orientated regions at the periphery of the pellet. This 
suggests that the actin fibres are not particularly important in matrix deposition 
itself, but may be more important in matrix organisation, such as in the 
intervertebral disc and possibly in early tendon blastemas (Hayes et al, 1999; see 
chapter 3). There is evidence that suggests cadherins can induce actin stress 
fibre formation (Banes et al, 1995; Wu et al, 1999; Lee et al, 2000b). Certainly, 
actin stress fibres are important in reorganisation of collagen gels in experimental
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systems (Lee et al, 2000a; Zaleskas et al, 2001; Spilker et al, 2001; Kinner and 
Spector, 2001) and in matrix reorganisation in scar and wound repair by 
myofibroblasts (Darby et al, 1990; Hinz and Gabbiani, 2003; Desmouliere et al, 
2004).
Monolayer cultures expressed the full range of cell-cell junctional components 
examined, as did micromasses. The only difference between the three culture 
systems was that connexin 43 label is very sparse in the pellet cultures. In 
monolayers there was evidence of vinculin associated with cadherin-based 
adherens junctions, and with cell-matrix focal adhesions, as shown by streaks of 
label positioned away from cell-cell interfaces. Because of the culture organisation 
of micromass and pellet cultures it was not possible to draw similar conclusions as 
the two types of junction could not be distinguished in the 3-D systems at light 
microscope level. However, given that matrix was deposited it would be surprising 
if such junctions were not present, and structures suggestive of focal contacts 
were present in pellets examined under the electron microscope.
Connexin 43 is associated with the inhibition of tendon cell response to strain 
(Waggett et al, submitted, Waggett et al, 2001; see chapter 3). It is interesting that 
the only culture system that deposits a substantial matrix is low in this gap junction 
component. This is similar to the situation in early tendon blastemas (see chapter 
3). Therefore, it appears in circumstances where matrix deposition is favoured, 
connexin 43 is reduced. Connexin 43 and 32 have different transmission 
characteristics (Goldberg et al, 2002) and form separate networks in tendons 
(McNeilly et al, 1996), although it is, as yet, unclear how these networks interface 
with systems controlling collagen production.
In images acquired through electron microscopy, in day 1 pellets there was 
evidence of matrix deposition, but not classical banded collagen fibrils, although 
there was some diffuse material in spaces between cells. These fine, beaded 
filaments had a similar appearance to fibrillin (Sherratt et al, 2001). By day 2, 
collagen was being deposited within the pellets, as in tendon and other fibrous 
connective tissues (Birk et al, 1991; Birk and Zycband, 1993). However, there was 
also other collagen organisation with fibres protruding straight out from the cell 
membrane, not organised in bundles or being passed into cellular channels (Birk 
et al, 1991; Birk and Zycband, 1993). These two appearances of collagen were 
generally not observed in the same place. This may be due to cells in certain
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areas of the pellet behaving in a relatively normal fashion, and other areas 
containing cells that were not. These cells had no orientational cues from 
surrounding cells or matrix and therefore secreted collagen anywhere.
Frequently observed cell processes projected into intercellular spaces, it is 
possible these are fibripositors, or their precursors, associated with matrix 
deposition (Canty et al, 2004). Often these projections appear in spaces that do 
not contain collagen, and as fibripositors are short lived and associated with only 
the early stages of matrix deposition and orientation (Canty et al, 2004), it is 
possible these structures are present with the pellets.
There was evidence of cytoskeletal association with collagen under TEM. As 
indicated above, there appeared to be focal contacts with orientated actin 
approaching the plasma membrane, interacting with a dense plaque and at the 
outside of the membrane with collagenous matrix. It is unclear as to whether this is 
a simple adhesion to matrix or whether the cells are actively orienting it using actin 
and cell matrix junctions, as occurs in the intervertbral disc (Hayes et al, 1999) and 
as described above.
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5.1 INTRODUCTION
Pellet cultures were developed to study chondrogenesis (Solursh, 1991), as 
indicated in chapter 4, they enable tendon fibroblasts to deposit a substantial 
collagen rich matrix over 7-14 days in culture. A particular advantage of this 
system is that the cultures can be prepared quickly and with relatively small 
numbers of cells, with the result that experiments can be performed rapidly and 
with a high number of replicates. In this chapter the behaviour of tendon cells in 
pellet culture is examined both in the presence or absence of growth factors, using 
qualitative analysis of matrix deposition and quantitative analysis of collagen 
synthesis.
Growth factors are diffusible polypeptide signalling molecules secreted by cells 
and whose major sites of action lie relatively close to the cells where they are 
synthesised (Lawrence, 1985; Roberts and Sporn, 1985; Gospodarowicz et al, 
1987; Burgess and Maciag, 1989). In connective tissues, growth factors (GF) 
control cell proliferation, differentiation, matrix synthesis and degradation (James 
and Bradshaw, 1984; Rosso et al, 2004). They can interact with extracellular 
matrix components and become an integral part of the matrix (Taipale and Keski- 
Oja, 1997). In tendon, they are part of a complex and poorly understood 
communication system: which involves direct linkage of cells, with membrane 
contact and cell junctions (McNeilly et al, 1996; Ralphs et al, 1997, 2002), linkage 
via the ECM (Harwood et al, 1999; Martin-Bermudo, 2000; Ross, 2004) and 
growth factor signalling between cells. Whilst there is huge literature on growth 
factor effects on a wide range of cell types in vitro and in foetal development and 
tissue repair in vivo, the effects of growth factors on fibroblasts behaviour are of 
particular relevance here. Experiments on pellets were performed using TGFp, 
bFGF and PDGF, because these factors are known to have significant effects on 
tendon cell behaviour (Canalis et al, 1981; Roberts et al, 1985; Taipale et al, 1997; 
Holland et al, 1998; Tallquist et al, 2004). These factors are examined in detail 
below.
5.1.1 Transforming growth factor-beta (TGFp)
TGFp and its three mammalian isoforms (1,2 and 3) are widely expressed in adult 
and foetal tissue. TGFp 4 has only been reported in the chick (Jakowlew et al,
1988) and TGFp 5 only in the Xenopus (Kondaiah et al, 1990). The three 
mammalian isoforms of TGFp result from homodimeric and heterodimeric 
combinations of p i and p2 subunits (TGFpl, TGFp2 and TGFpl .2) (Cheifetz et al,
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1987). There is a high degree of conservation across species, 99% between 
human and mouse indicating the critical biological roles of TGFps (Massague et al, 
1987). TGFp has complex effects on cells, for example, it can stimulate or inhibit 
cell proliferation dependant on the cell type or cell environment (Tucker et al, 1984; 
Shipley et al, 1985; Roberts et al, 1985a; Massague et al, 1985b; Moses et al, 
1994; Klein et al, 2002; Lu et al, 2004; Tomlinson et al, 2004).
TGFp is released from cells in an inactive, latent complex which consists of active 
TGFp and a prodomain, called TGFp latency associated protein (TGFp-LAP) 
(Hyytiainen et al, 2004). At secretion, the active TGFp is cleaved from the 
propeptide, but the two remain attached through non-covalent interactions, the 
complex remaining latent (Gentry et al, 1988). Often this complex contains 
additional proteins associated with LAP, bound via disulphide bonds. These are 
collectively named latent TGFp binding proteins (LTBPs) (Taipale and Keski-Oja,
1997) and their function is thought to lie in secretion, extracellular storage or 
activation of the complex (Miyazono et al, 1993; Dallas et al, 1995; Keski-Oja et al, 
1995; Taipale et al, 1996). Latent TGFp cannot interact with cell surface receptors 
(Lawrence et al, 1985) and requires activation. Methods of activation TGFp in vivo 
are complex and thought to involve numerous processes. There are two enzymatic 
processes that can yield activated TGFp. First, the latent complex is treated with 
glycosidases (Miyazono and Heldin, 1989) and second, there is a proteolytic 
degradation of LAP (Lyons et al, 1988, 1990). There are two predominant 
enzymes involved in this proteolytic degradation, namely, plasmin and cathepsin 
D. Each release TGFp from its latent complex by cleaving LAP at its n-terminal 
(Lyons et al, 1988, 1990). Plasmin can also release matrix-bound latent TGFp 
(Taipale et al, 1996), enabling it to travel in an inactive form to target cells (Gelizes 
et al, 1997). TGFp activation is blocked by plasmin inhibitors, or by the depletion of 
plasminogen (propeptide of plasmin) (Sato and Rifkin, 1989). However, cathepsin 
D may substitute for plasmin in plasminogen knock-out mice (Lyons et al, 1988; 
Bizik et al, 1996). In addition non-enzymatic activation can occur, latent TGFp can 
form a complex with thrombospondin-1, which causes TGFp activation (Schultz- 
Cherry and Murphy-Ullrich, 1993, 1994), although the precise mechanisms are 
unknown.
TGFp binds to specific cell surface receptors, forms a protein complex and 
activates the intracellular SMAD proteins (summarised in Heldin et al, 1997;
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Massague, 1998; Moustakas et al, 2001; Derynk and Zhang, 2003; ten Dijke and 
Hill, 2004). TGFp brings together two types of receptor kinase to influence cell 
behaviour, one kinase phosphorylates the other, which in turn phophorylates the 
SMAD proteins. SMAD proteins are signal transducers that can pass through the 
nuclear membrane and commence transcriptional complexes of DNA binding 
(Massague, 1998; ten Dijke and Hill, 2004). The genes targeted may encode 
proteins that affect cell cycle regulators or ECM components determining cell 
adhesion, positioning or movement (Massague, 1998; ten Dijke and Hill, 2004). In 
primary human dermal fibroblasts in vitro an increase of TGFp will increase type I 
collagen transcription and SMAD 3 is known to transmit the signals (Chen et al,
1999). This study also showed SMAD 7 as a possible autocrine negative feedback 
in collagen regulation, discerning the complexity of the system.
Binding to ECM components can regulate TGFp, including type IV collagen, 
decorin, biglycan, fibronectin and thrombospondin (Massague, 1998). Although the 
regulation of TGFp by ECM protein binding is vital for accumulation and quick 
release into the ECM, it is also possible that this binding prevents TGFp 
degradation, allowing the sustained release of TGFp, or could act as a TGFp 
clearance system (Massague, 1998).
Throughout development TGFp and its influence is associated with numerous 
connective tissues (Heine et al, 1987). TGFp is known to contribute to the 
segmentation of the axial skeleton, and its subsequent skeletal development (Hill 
and Logan, 1992). TGFp induces a cartilaginous phenotype, namely type II 
collagen. Furthermore, it induces cartilage specific proteoglycan production in 
embryonic mesenchyme (Seyedin et al, 1985, 1986) and, in fact, promotes 
cartilage differentiation (Kulyk et al, 1989; Wang et al, 2003; Tuli et al, 2003; 
Rutherford et al, 2003; Hentschel et al, 2004). It has been suggested that TGFp 
has a role in early angiogenesis (Heine et al, 1987) and subsequent development 
of cardiovascular structures. In vitro experiments on endothelial cells in 3-D 
collagen gels, showed that treatment with TGFp enabled cells to form tubular 
structures (Madri et al, 1988a).
Cell adhesion and migration are influenced by multiple stimulants, including growth 
factors. It is the action of TGFp on cell adhesion mechanisms and the composition 
of the ECM that causes its influence to be apparent. An increase in cell adhesion
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is seen coordinated with enhanced matrix synthesis and deposition upon treatment 
with TGFp (Hyytiainen et al, 2004). Additionally, a decrease in pericellular 
proteolysis can be caused by a TGFp-induced up-regulation of plasminogen 
activator inhibitor-1 (PAI-1) and tissue inhibitor of metalloprotease (TIMP), both 
inhibitors of extracellular matrix degrading enzymes (MMPs) (Laiho et al, 1986, 
1987; Edwards et al, 1987; Coletta et al, 1999; Ma et al, 1999; Eren et al, 2003; 
Jiang et al, 2003; Yamanaka et al, 2004; Nahm et al, 2004). As a result of TGFp 
treatment there is a decrease in the expression of collagenase (Edwards et al, 
1987) together with a modification of cell surface molecules (Massague, 1998). 
From this observation, TGFp has been shown to effect cell morphology, 
differentiation and migration, but is also significantly involved in wound healing 
(Ignotz and Massague, 1985; Roberts, 1986; Grazil-Bilska et al, 2003; Schiller et 
al, 2004; Hsu and Chang, 2004; Saika, 2004; Vladimirov and Dimitrov, 2004).
The healing processes of tissues are highly regulated and growth factors are one 
of the most important molecular families involved. GFs involved in the repair 
cascade are described in chapter 1. It is known that TGFp has an anti­
inflammatory influence (de Martin et al, 1987: Shull et al, 1992; Letterio and 
Roberts, 1998), but there are also high levels of TGFp stored in platelets (Assoian 
et al, 1983: Cheifez et al, 1987). TGFp has been shown to be active in all stages of 
tendon healing having a variety of effects (Chang et al, 2000). It can induce 
extrinsic cell migration, being a chemoattractant for monocytes and fibroblasts 
(Wahl et al, 1987; Postlethwaite et al, 1987), generate fibronectin-binding 
interactions (Wojciak et al, 1994), regulate proteinases (Bennett et al, 1993) and 
terminate cell proliferation or enhance it (Ashcroft et al, 1999; Zhu et al, 2001), 
plus stimulate collagen synthesis (Mauri et al, 1997). Ectopic induction of 
neotendon/ligamentous tissue was observed when growth and differentiation 
factors 5, 6 and 7 (GDF 5,6 and 7, members of the TGF superfamily) were 
implanted in an unnatural location (Wolfman et al, 1997). Using gene transfer 
techniques as a vehicle for GF delivery, improved tendon healing (Gerich et al, 
1996; Nakamura et al, 1998; Lou et al, 2000; Review Zhang and Lineaweaver, 
2002; Hildebrand et al, 2004). It is because of these actions that TGFp is widely 
used for experimental purposes in vitro and why it was chosen for use in the 
experiments conducted in this chapter.
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5.1.2 Platelet-derived growth factor (PDGF)
Platelet-derived growth factor (PDGF) was discovered as a result of the 
observation that material released from platelets was the principal source of 
mitogens (a stimulant of mitosis) present in serum, and that this was responsible 
for the growth of many cells in culture (Ross et al, 1974). Three forms of PDGF 
were studied up until recently include PDGF-AA, PDGF-BB and PDGF-AB (Heldin, 
1993). However, there are now known to be 2 additional isoforms, PDGF-CC and 
PDGF-DD (Li et al, 2000; Gilbertson et al, 2001; LaRochelle et al, 2001; Bergsten 
et al, 2001), both of which differ from the original isoforms, as they are secreted in 
an inactive form (Kazlauskas, 2000; Li et al, 2000; Gilbertson et al, 2001; 
LaRochelle et al, 2001; Bergsten et al, 2001).
The activity of PDGF is regulated through three related tyrosine kinase receptors, 
namely aa, pp and ap (Ronnstrand and Heldin, 2001). PDGFaa-receptors bind all 
isomers of PDGF, apart from PDGF-DD, with a high affinity (Claesson-Welsh,
1989), whereas the pp receptor binds only PDGF types comprising of at least one 
B polypeptide chain and PDGF-DD (Claesson-Welsh, 1993). The ap-receptor will 
bind PDGF-AB, -BB and -CC (reviewed in Tallquist and Kazlauskas, 2004).
PDGF has a wide range of biological actions. Different PDGF chains exhibit 
different responses on cells but generally, PDGF isoforms are potent mitogens for 
connective tissue cells (Abrahamsson, 1997). Their effects include an influence on 
smooth muscle cells (Bomfeldt et al, 1994), chondrocytes (Lubinus et al, 1994), 
epithelial, endothelial cells (Brewitt and Clark, 1988: Kuwabara et al, 1995) and 
fibroblasts (Siegbahn et al, 1990). PDGF is also involved in the differentiation of 
chondrocytes (Stoog et al, 1990). Studying chondrogenesis in mesenchymal 
micromass cultures, PDGF-A can stimulate chondrogenesis in cells up to stage 
24, but in any later stage it inhibits chondrogenesis, indicating very different roles 
dependant on stages of development (Ataliotis, 2000). PDGF is known to be 
essential for tendon fibroblasts as it enable them to proliferate under load (Banes 
et al, 1995).
Interestingly, PDGF show differing effects in the DNA and protein synthesis 
dependant on the areas of tendon used (Yoshikawa and Abrahamson, 2001). 
PDGF has been used in gene transfer experiments and its use resulted in an 
increase in collagen gene expression within the tendon (Wang et al, 2004). 
Important in proliferation of vascular smooth muscle cells and their migration,
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PDGF plays an important role in vascularisation (Abedi and Zachary, 1995). Its 
role in migration may be associated with its ability to induce the expression of 
MMPs within tissue (Matrisian and Hogan, 1990; Laurent et al, 2003). PDGF is 
released from platelets, increasing its local concentration (Duffy et al, 1995). It has 
been shown to play a part in the early stages of healing because of its ability to 
induce the synthesis of other growth factors (Lynch et al, 1989) and its effects on 
DNA synthesis, collagen and non-collagenous protein synthesis (Pierce et al, 
1991; Yoshikawa and Abrahamson, 2001). Through in vivo studies it has been 
shown that PDGF has its greatest effects in the initial stages of healing by 
triggering healing cascades during inflammation (Molloy, 2003).
5.1.3 Basic fibroblast growth factor (bFGF)
Basic fibroblast growth factor (bFGF), also known as fibroblast growth factor 
(FGF)-2, comes from an extensive growth factor family (23 members), but bFGF 
was the original molecule discovered from this superfamily (Gospodarowicz, 
1975). It is a monomer containing 12 anti-parallel (3-sheets (Moy et al, 1996) and 
its primary form is 18kDa, but it can also exist as 22kDa and 22.5kDa, 24kDa and 
34kDa isoforms (Gospodarowicz, 1975).
After secretion bFGF is sequestered, either bound to the cell surface or to matrix 
GAGs (Folkman et al, 1988; Burgess and Bohlen, 1989). Its ability to bind heparan 
sulphate reflects a complex regulatory mechanism (Faham et al, 1996), and 
protects bFGF from increases in heat, any drop in pH or protease activity (Conrad,
1998). Heparan sulphate proteoglycans can also increase the affinity of bFGF for 
its receptors (Yayon et al, 1991). There are 4 basic receptors for bFGF, although 
many spliced variants are also known to exist. This enables these alternative 
forms to have different ligand binding or signalling qualities (Vainikka et al, 1992). 
Using these four high affinity receptors and heparan sulphate low affinity 
receptors, bFGF acts on cells via paracrine or autocrine mechanisms (Mignatti et 
al, 1991; Jouanneau et al, 1997).
Basic-FGF affects a wide variety of cells and does not solely stimulate growth 
(Bikfalvi et al, 1997). bFGF can affect the proliferation of endothelial cells, 
chondrocytes, smooth muscle cells, melanocytes and of course fibroblasts 
(reviewed Burgess and Maciag, 1989; Basilico and Moscatelli, 1992; Nugent and 
lozzo, 2000). Its role in chondrogenesis is complex, as it has been shown to inhibit 
chondrocyte proliferation and differentiation (Iwasaki et al, 1995; Ogawa et al,
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2003), but can work synergistically with TGFp in chondrogenesis (Schofield and 
Wolpert, 1990; Frenz et al, 1991, 1994) and is thought to accelerate 
vascularisation of the growth plate (Baron et al, 1994).
Basic-FGF also stimulates of cell migration and angiogenesis, both in vivo and in 
vitro (Folkman and Klagsbrun, 1987; Nugent and lozzo, 2000; Okada-Ban et al,
2000). In rabbit flexor tendons bFGF levels are increased at the injury site, with 
the highest levels in intrinsic tendon fibroblasts and fibroblasts migrating from the 
epitenon along the edge of the wound (Chang et al, 1998). It has a dose 
dependant effect on the expression of type III collagen and cellular proliferation 
(Chan et al, 2000). Using bFGF in a dose dependant manner on ligament defects 
demonstrated that higher dosages can have adverse effects, with a decreased 
type I procollagen expression (Fukui et al, 1998). IGF-1 and bFGF are important in 
the proliferative and remodelling stages of tendon repair (Letson and Dahners, 
1994: Molloy et al, 2003). In vitro wound models showed bFGF has a dose 
dependant effect on wound healing, although there is an optimum dosage (Chan 
et al, 1997). Basic-FGF is known to be a potent angiogenic factor (Basilico and 
Moscatelli, 1992; Norrby, 2002; Aviles et al, 2003; Suhardjia and Hoffman, 2003). 
All of these actions make it a major influence in wound repair and 
revascularisation.
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5.2 MATERIALS AND METHODS
Pellets cultures were prepared as described in chapter 4. Tendon fibroblasts were 
isolated from 50 day old broiler chickens (see chapter 2), suspended at 1x106 
cells/ml in DMEM (5%FBS, 1 mg/ml ascorbate, HEPES buffer, 1% antibiotics), and 
1ml of cell suspension aliquoted into sterile eppendorf tubes. The cells were gently 
centrifuged (2000 rpm) for 2 minutes (Boeco M-24 microcentrifuge, Germany) to 
form pellets at the bottom of the eppendorf. Once pellets were formed, supernatant 
was removed and replaced with the experimental medium. Experimental media 
were made up in DMEM/1%FBS/ascorbate/antibiotics as a base medium. Cultures 
were set up with this as the control; with 5%FBS; with TGFp (5ng/ml) (Sporn and 
Roberts, 1991), bFGF (10ng/ml) (Gospodarowicz et al, 1987) and PDGF (50ng/ml) 
(Pierce et al, 1989), with 10 replicates being set up for each treatment. Three 
replicates were used for qualitative analysis and 7 were used to quantify DNA and 
collagen. A further series of pellets were set up with combinations of growth 
factors, at the individual concentrations above. These were bFGF+PDGF, 
bFGF+TGFp and TGFp +PDGF. Cultures were maintained for 1 day, 7 days and 
14 days, and fed with fresh medium every 3 days. The spent medium was retained 
and stored at -80°C for collagen analysis. Tendon fibroblast pellets were 
incubated at 37°C, with 100% humidity and 5% C 02 in air atmosphere.
Qualitative analysis
Pellets were removed, fixed in cold 95%IMS for 5 minutes, cryosectioned and 
immunolabelled for ECM components (types I, II and III collagen, tenascin, 
fibronectin), cytoskeletal components (filamentous actin directly labelled with 
phalloidin and vimentin) and cell junctional associated proteins (pan-cadherin, n- 
cadherin, vinculin and the connexins 32 and 43). Details of these procedures are 
given in chapter 2.
Quantitative Analysis
For each time period, collagen content of the cell pellet and culture medium was 
measured using the hydroxyproline assay (Creemers et al, 1997; see chapter 2). 
DNA content of the pellets was measured fluormetrically using Hoechst 33258 dye 
(Cesarone et al, 1980; Downs and Wilfinger, 1983; see chapter 2). Collagen 
content was expressed relative to DNA content. Total collagen, cell pellet and 
culture medium collagen content and DNA content were compared using a one 
way ANOVA followed by the Tukey multiple comparison pair-wise test, with a 95% 
confidence limit.
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5.3 RESULTS
5.3.1 Qualitative Studies
There are no obvious qualitative differences between the control pellets supplied 
with 1% serum, or pellets treated with 5% serum, single or combined growth 
factors. Results are summarised in table 5.1; detailed descriptions are present 
below.
Extracellular matrix labelling
Pellets treated with single growth factors or combinations, contained type I and III 
collagen at all time intervals (fig 5.1-5.2). Initially type I collagen was intracellular 
(fig 5.1 A, D, G, J), and by 7 days in culture prominent extracellular labelling was 
present (fig 5.1 B, E, H, K). Label intensity appeared reduced in 14 day pellets (fig
5.1 C, F, I, L). Type III collagen was present at all time points (fig 5.2), although 
labelling was weak and sparse in 1 day cultures (fig 5.2 A, D, G, J), it appeared at 
a higher intensity at the pellet periphery in later stages (fig 5.2 H, I, L). Type I pro­
collagen was present at all time points, although only a proportion of cells within 
the aggregates were labelled (fig 5.3 A-L). Type I pro-collagen remained present 
in centralised regions of the pellet after 14 days (fig 5.3 C, F, I, L).
Other ECM molecules labelled include tenascin, which was seen extracellularly 
throughout the pellets at all time intervals and with each GF treatment (fig 5.4 A- 
L). Labelling for fibronectin was conducted due to its cell adhesive qualities and its 
association with collagen. Positive fibronectin label was absent in 1-day pellet 
cultures treated with either 1% FBS/DMEM, PDGF or TGF + PDGF pellets (fig 5.5 
A, J). It was present in small amounts in FGF or TGF treated pellets (fig. 5.5 D, G) 
and in pellets treated with FGF + PDGF and TGF + FGF (not shown, see table 
5.2). At 7 and 14 days all pellets contained fibronectin (fig 5.5 B, C, E, F, H, I, K, 
L), often showing elevated labelling at the periphery.
Cytoskeletal components
Filamentous actin was present in all pellet cultures at all time points. In 1 day 
pellets, generalised green intracellular label indicated the presence of a 
filamentous actin network within the cell (fig 5.6 A, D, G, J), but without prominent 
actin fibres. Cells in older pellets had a different distribution of labelling. Flattened 
cells at the periphery appeared to contain bright fibres (fig 5.6 E, H) and some 
cells in the central parts also labelled strongly(fig 5.6 L). This could occur in any
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culture and was not specifically linked to any particular treatment. Vimentin was 
also present, again with no difference between culture treatments (fig 5.7 A-L).
Cell junctional components
Label for Pan-cadherin, n-cadherin, vinculin and connexins 32 and 43 were 
present. Labelling patterns were similar to that described in chapter 4 and together 
with the cytoskeletal components, appeared unaffected by growth factor treatment 
(figs 5.8, 5.9 5.10, 5.11 and 5.12).
5.3.2 Quantitative analysis
Single Growth factor treated pellets: DNA content (figure 5.13)
In experiments testing the effects of single growth factors, there was a general 
increase in DNA content of all cultures from 1 to 7 days, with levels dropping again 
at 14 days. These changes were all statistically significant (p< 0.05). Within the 
particular time intervals, small variations in DNA content with serum or growth 
factors treatments were not significant at 1-7 days (p> 0.05). At 14 days, there 
were significant differences between treatments: 5% serum increased DNA 
content compared to 1% serum, bFGF and TGFp (p< 0.05), and PDGF had a 
greater effect than TGFp (p< 0.05).
In experiments testing combinations of factors, some caused significant 
differences in DNA content between treatments, but no clear patterns emerged. 
Also the enhancement of DNA content at 7 days observed above did not occur 
even in serum treated and control cultures. There was, if anything, a decline in 
DNA content over time.
Combination growth factor treated pellets: DNA content (figure 5.14)
Pellets at 1 day showed no difference in DNA content between most treatments, 
only bFGF+TGFp treated pellets showed elevated DNA levels (p<0.05). At 7 days, 
1% controls, 5% serum treated and bFGF+TGFp treated cultures showed 
significantly reduced DNA content compared to 1 day (p<0.05), the others being 
unchanged (p>0.05). There were also differences between treatments at 7 days. 
All growth factor treatments showed enhanced DNA content compared to 1% 
serum (p<0.05), but could not be distinguished from one another (p>0.05). The 
bFGF+PDGF and TGFp+PDGF treated cultures also had increased DNA 
compared to the 5% serum treated cultures (p<0.05). At 14 days, there was no 
difference to the 7 day cultures for 1% serum, 5% serum and bFGF+TGFp
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treatment (p>0.05). bFGF+PDGF cultures appeared reduced (p<0.05) and 
TGFp+PDGF cultures were elevated (p<0.05). Within the time point, only 
TGFp+PDGF showed a significant difference from the other treatments, with 
elevated DNA content (p<0.05).
Effects of growth factors on collagen production
Statistical comparison of data on collagen content was made difficult by wide 
variations in the data, as shown by the error bars (see fig. 5.15, 14 day data 
especially). Generally, this variation was the result of 1 or 2 pellet measurements 
being greatly different from the others (see raw data, appendix). Some analysis 
was attempted omitting such values, but with n-values of around 7, this 
represented a selection of preferred data, especially when more than one value 
was involved, and it was decided not to continue in this manner. Where possible, 
statistical analyses of data are presented; with the others general trends are 
presented, but the lack of statistical validity is acknowledged.
Single factors: (figure. 5.15)
Cultures maintained in 1% and 5% serum containing medium synthesised collagen 
over the 14 day period, with around threefold collagen present at 14 days than at 1 
day. There appeared to be less collagen at 7 days, but the quantities recovered 
and increased markedly by 14 days. This general pattern was also true of the 
growth factor treated cultures.
At 1 day of incubation (fig 5.15 (i)), there were some statistically significant 
differences between certain growth factor treatments and 5% serum treated 
cultures. Generally, where these were present, the growth factor treatments have 
less total collagen than the serum treatments. Also, noteworthy at this time, was 
that roughly equal amounts of collagen were found in the cell pellets as was 
released into the media.
At 7 days of incubation, collagen content relative to DNA content had reduced 
compared to that present at day 1 (fig. 5.15 (ii)); although this was influenced by 
the high DNA content at this stage (see fig 5.14 (ii)). TGFp treated cultures had 
significantly more collagen than sera treated cultures, with no detectable difference 
between the others. Generally, the ratio of collagen released to media compared 
to that retained in the pellet was higher in these cultures than those at day 1.
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At 14 days of incubation, there were no statistically significant differences between 
treatments, although as the error bars indicate, the data was highly variable (fig 
5.15 (iii)). The cultures had released the majority of the collagen they produced to 
the culture medium, with around 25% being retained in the pellet and 75% 
released to the media. This seemed to be unaffected by the culture treatment, 
although subtle changes would not be seen because of the noisy data.
Growth factor combination (figure. 5.16)
Cultures in these experiments demonstrated a general trend of increased collagen 
secretion with time in culture, with around a ten-fifteenfold increase in total 
collagen made by the cultures over the 14 day period compared to 1 day (p<0.05). 
Most of this increase occurred in the second week in culture, as with the previous 
experiment.
Comparing different treatments, there is little difference at 1 day, with 
TGFp+PDGF apparently promoting slightly greater release of collagen to the 
culture medium than the others (p<0.05), but all other treatments and parameter 
being similar.
At 7 days, cultures were again very similar, with the only significant differences 
being the amount of collagen incorporated into the cell pellet: it was greater in 5% 
serum culture than in the growth factor combination treatments (p<0.05).
At 14 days, overall quantities for total collagen and medium collagen were much 
increased (p<0.05), although amounts in the cell layer were similar to that at 
previous time points. There were some differences in treatments, 5% serum has 
more collagen than 1%, bFGF+PDGF and bFGF+TGFp treatments in total and 
released to the media. bFGF+TGFp and bFGF+PDGF were reduced compared to 
the TGFp+PDGF treated cultures.
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Figure 5.1 Pellet cultures treated with growth factors, x40 objective, Scale bar=
40pm. Type I collagen.
1 % serum treated controls.
A- 1day.
B- 7day.
C- 14day.
bFGF treatment
D- 1day. Type I collagen is present and intracellular.
E- 7day. There is an increase in type I collagen with an extracellular appearance. 
F- 14day. Type I collagen has diminished compared to that present in the 7 day 
pellet.
TGFp treatment
G- 1day. Type I collagen is present and intracellular.
H- 7day. Similar to FGF treated pellets there is an increase in label.
I- 14day. Type I collagen is clearly present after 14 days of culture.
PDGF treatment
J- 1day. Type I collagen is present and intracellular.
K- 7day. There is an increase in type I collagen from 1 day cultured pellets.
L- 14day. As with TGF treated pellets, there is type I collagen at 14 days.
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Figure 5.2 Pellet cultures treated with growth factors, x40 objective, Scale bar=
40|jm. Type III collagen.
1% sera treated controls 
A- 1day.
B- 7day.
C- 14day.
bFGF treatment
D- 1day. Type III collagen is thinly present.
E- 7day. There is an increase in type III collagen and it could be seen 
extracellularly.
F- 14day. Type III collagen is present and remains extracellular.
TGFp treatment
G- 1day. Positive type III collagen label patterning is very similar to FGF treated 
pellet (D).
H- 7day. Type III collagen is present and extracellular.
I- 14day. Type III collagen label is present, but concentrated at the periphery of the 
pellet.
PDGF treatment
J- 1day. Type III collagen has a similar distribution to FGF and TGF treated pellets 
(D and G).
K- 7day. Type III collagen label increases in intensity and is extracellular 
throughout the pellet.
L- 14day. Type III collagen is abundant and concentrated at the pellet periphery.
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Figure 5.3 Pellet cultures treated with growth factors, x40 objective, Scale bar=
40(jm. Type I pro-collagen.
1% sera treated controls 
A- 1day.
B- 7day.
C- 14day.
bFGF treatment
D- 1day. Type I pro-collagen is present in isolated cells throughout the pellet.
E- 7day. Positively labelled type I pro-collagen can be observed clearly at this time 
period.
F- 14day. Type I pro-collagen remains sporadic in the pellets.
TGFp treatment
G- 1day. At all stages the type I pro-collagen present is similar to the bFGF treated 
pellets.
H- 7day.
I- 14day.
PDGF treatment
J- 1day. At all stages the type I pro-collagen present is similar to the bFGF and 
TGFp treated pellets.
K- 7day.
L- 14day.
151
1 day 7 day 14 day
A
■ / •
i. : *
fv  v -  ^ .
J / ' * '
1% serum —
D E
f t . ,  J fc y - .
:*•■ •.'■ - • •
L .  - V  • Y  - i  ■ ,  '* ' s  .  . * ♦  < * '  •  ■
r : \ .  • ; • • • •  1 ... •pi* '% ’ • '. # 7 * ,
bFGF
•*
V  -  . 1. ♦
_
G
.
• "iJL. v ri \  ri.ir ' .
r ■ > . £ W ^ J g *
>%♦ y >-$w  • 3ii/-*-»<
O s  r f . * /
TGF-beta _
J . K
$n‘ « I
^  ;  j r  *.
P n r , f - yDGF' — I  • v ‘
Figure 5.4 Pellet cultures treated with growth factors, x40 objective, Scale bar=
40pm. Tenascin.
1% sera treated controls 
A- 1day.
B- 7day pellet.
C- 14day pellet.
bFGF treatment
D- 1day. Tenascin is positive and in areas appeared to be extracellular.
E- 7day. Label for tenascin remained positive and there is a possible increase in 
labelling intensity.
F- 14day. Tenascin label is positively concentrated at the edge of the cell pellet.
TGFp treatment
G- 1day. Tenascin is present.
H- 7day. Tenascin is present after 7 days in culture, and is increasingly 
extracellular.
I- 14day. After 14 days in culture tenascin is focused in the periphery of the cell 
pellet.
PDGF treatment
J- 1day. Tenascin is present after 1 day in pellet culture.
K- 7day. An increase in tenascin labelling intensity is apparent and extracellular 
tenascin is evident.
L- 14day. Tenascin label is positive and extracellular.
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Figure 5.5 Pellet cultures treated with growth factors, x40 objective, Scale bar=
40pm. Fibronectin.
1% sera treated controls 
A- 1day.
B- 7day.
C- 14day.
bFGF treatment
D- 1day. Positive label for fibronectin is observed in areas of the cell pellet.
E- 7day. Distinct areas of extracellular fibronectin are present.
F- 14day. Fibronectin remained present, although a possible decrease in intensity 
is seen.
TGFp treatment
G- 1day. Fibronectin is present.
H- 7day. Positively labelled fibronectin is clear at the periphery of the pellet.
I- 14day. Fibronectin has a similar distribution pattern after 24 days in culture.
PDGF treatment
J- 1day. Little or no fibronectin is present.
K- 7day. The fibronectin identified is extracellular.
L- 14day. Fibronectin remains in areas nearing the periphery of the cell pellet.
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Figure 5.6 Pellet cultures treated with growth factors, x40 objective, Scale bar=
40pm. Act in
1% sera treated controls 
A- 1day.
B- 7day.
C- 14day.
bFGF treatment
D- 1day. Actin filaments are present, although have a hazy style of labelling.
E- 7day. Areas of actin label clearly show an increase in intensity on some cells. 
Rounded cells indicate cellular polarity in the labelling, although no stress fibres 
are observed.
F- 14day. Positively labelled actin is observed throughout the cell pellet.
TGFp treatment
G- 1day. Strong actin filamentous networks are observed.
H- 7day. Centrally the more rounded cells labelled positively for actin, but no stress
fibres can be identified. Cells that are flattened at the periphery of the pellet show 
the first signs of distinct actin stress fibres.
I- 14day. Actin is present in central areas of the pellets.
PDGF treatment
J- 1day. Actin is present in the cells within the pellet.
K- 7day. There was an increase in positively labelled actin and a decrease in the
hazy style of labelling. Short actin stress fibres can be identified.
L- 14day. Areas of actin remain present and short actin stress fibres are clearly 
visible.
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Figure 5.7 Pellet cultures treated with growth factors, x40 objective, Scale bar=
40pm. Vimentin.
1 % sera treated controls 
A- 1day.
B- 7day.
C- 14day.
bFGF treatment
D- 1day. Vimentin is present and can be observed in all cells.
E- 7day. An increase in positively labelled vimentin was apparent and in areas 
distinct filaments can be distinguished.
F- 14day. There is a similar distribution in 14 days as in 7 days and filaments can 
be identified.
TGFp treatment
G- 1day. Vimentin is apparent, although more abundant at the pellet periphery.
H- 7day. Vimentin is positive and seen throughout the cell pellet.
I- 14day. The intensity and distribution remains in 14day pellets, and in areas 
distinct filaments can be detected.
PDGF treatment
J- 1day. Vimentin can be identified throughout the cell pellet.
K- 7day. Individual vimentin filaments are observed, with an increase in label at the 
pellet periphery.
L- 14day. Vimentin is present.
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Figure 5.8 Pellet cultures treated with growth factors, x40 objective, Scale bar=
40pm. Pan-cadherin.
1% sera treated controls 
A- 1day.
B- 7day.
C- 14day.
bFGF treatment
D- 1day. Pan-cadherin is present.
E- 7day. Pan-cadherin increased in distribution and is focused in the periphery of 
the cells.
F- 14day. Pan-cadherin is present and continues to be concentrated at the cell 
borders.
TGFp treatment
G- 1day. Pan-cadherin shows a similar distribution as n-cadherin, but with an 
increase in intensity.
H- 7day. An apparent increase in pan-cadherin is observed together with labelling 
remaining strongest at the cell periphery.
I- 14day. Pan-cadherin remains present.
PDGF treatment
J- 1day. Positively labelled pan-cadherin can be observed throughout the cell 
pellet.
K- 7day. Pan-cadherin distribution and intensity is clear.
L- 14day. Pan-cadherin remains in areas of the pellet after 14 days in pellet 
culture.
161
14 day
1% serum
Figure 5.9 Pellet cultures treated with growth factors, x40 objective, Scale bar=
40|jm. n-cadherin.
1% sera treated controls 
A- 1day.
B- 7day.
C- 14day.
bFGF treatment
D- 1day. N-cadherin is positive and generally localised at the periphery.
E- 7day. There is an increase in labelling for n-cadherin throughout the pellet, 
compared to that in 1 day pellets.
F- 14day. The n-cadherin present is concentrated at distinct areas of the pellet, but 
remains widespread.
TGF0 treatment
G- 1day. n-cadherin is present and situated at the pellet periphery.
H- 7day. The n-cadherin shows a possible increase in n-cadherin labelling intensity 
and distribution.
I- 14day. N-cadherin remains present, but slightly diminished compared to 7 days 
in culture.
PDGF treatment
J- 1day. Positively labelled n-cadherin is present and localised to the pellet 
periphery.
K- 7day. There is a significant increase in label intensity and distribution for n- 
cadherin.
L- 14day. A decrease in n-cadherin distribution is observed, although the labelling 
remained positive.
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Figure 5.10 Pellet cultures treated with growth factors, x40 objective, Scale bar=
40|jm. Vinculin.
1% sera treated controls 
A- 1day.
B- 7day.
C- 14day.
bFGF treatment
D- 1day. Vinculin is present and clearly seen at the cell borders.
E- 7day. Vinculin remains present.
F- 14day. Positive vinculin label can be seen throughout the cell pellet.
TGF0 treatment
G- 1day. Vinculin label can be observed in 1day cell pellets.
H- 7day. Vinculin is present throughout the cell pellet, but there is a higher intensity 
at the periphery of the pellet.
I- 14day. The labelling pattern of vinculin remains at the periphery of the cells. 
PDGF treatment
J- 1day. Positively labelled vinculin can be observed throughout the pellet with the 
cells retaining peripheral labelling.
K- 7day. Vinculin remains evident.
L- 14day. Positively labelled vinculin is maintained at the cell pellet periphery.
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Figure 5.11 Pellet cultures treated with growth factors, x40 objective, Scale bar=
40pm. Connexin 32.
1% sera treated controls 
A- 1day.
B- 7day.
C- 14day.
bFGF treatment
D- 1day. Cells label positively for connexin 32.
E- 7day. Cells continue to label positively for connexin 32 and an increased ‘wisp- 
like’ labelling pattern can be observed.
F- 14day. Areas of connexin 32 are strong at the pellet periphery.
TGF0 treatment
G- 1day. Connexin 32 label is present and labelling is increasingly intense at the 
periphery.
H- 7day. Connexin 32 has distributions similar to bFGF-treated pellets.
I- 14day. The strongest areas of connexin 32 remain at the pellet periphery.
PDGF treatment
J- 1day. Connexin 32 can be observed in 1 day pellet cultures.
K- 7day. The labelling intensity of connexin 32 increases after 7 days.
L- 14day. Connexin 32 is abundant after 14 days of culture.
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Figure 5.12 Pellet cultures treated with growth factors, x40 objective, Scale bar=
40|jm. Connexin 43.
1% sera treated controls 
A- 1day.
B- 7day.
C- 14day.
bFGF treatment
D- 1day. Though there is a green tinge to the image, connexin 43 is absent from 
these pellets.
E- 7day. Small areas of connexin 43 can be seen, but the presence of connexin 43 
is sparse.
F- 14day. Connexin 43 distribution is similar to that at 7 days.
TGFp treatment
G- 1day. Areas of connexin 43 can be observed under close scrutiny, although 
there remains an amount of auto-fluorescence.
H- 7day. Connexin 43 is clearly be identified.
I- 14day. Individual cells label positively for connexin 43.
PDGF treatment
J- 1day. Positively labelled connexin 43 is found within the pellet.
K- 7day. There is little or no connexin 43 present.
L- 14day. Areas of positively labelled connexin 43 cells are observed.
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1 day 7 day 14 day
1% serum
Type I Type III Type I pro Tenascin Fibronectin
bFGF+PDGF
1day ★ ** ** ***
-
bFGF+PDGF
7day *** *** ** *** **
bFGF+PDGF
14day ** *** ** **
Extracellular matrix molecules Cytoskeletal and cell junctional components
Actin Vimentin Pan-cad n-cad vinculin Cxn 32 Cxn 43
★Hr ** ** * * * *
*** ** ** *** *** **
*** ** * ** ** ** *
TGFp+bFGF 
1 day ** ** *** *
TGFp+bFGF 
7 day *** *** ** 4 r * 4 r **
TGFp+bFGF 
14 day ** *** ** *** *
* * * * * * * * * * * *
* * ★ * * * * * * * * * * *
* ★ * * * * * * * ★  * *
PDGF+TGFp 
1 day ** *★ *★ ***
-
PDGF+TGFp 
7 day *** ** **
PDGF+TGFp 
14 day ** *** ** *** *
* * * * * * * * * * * ★ *
* * * * * * * * * * * * * *
h h * * * * * * * * * *
Table 5.1 Summary to show immunolabelling patterns of pellets treated with growth factor combinations, from 1 to 14 days.
Key- - negative labelling **- labelling present
*-weak labelling present ***- strong labelling present
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Figure 5.13. Effects of time and growth factors on DNA content of pellet
cultures. Error bars = Standard deviation.
i) Graph of DNA (ug/ml) in tendon fibroblast pellets cultured for 1 day 
and treated with single growth factors. There was no significant 
difference between the pellets treated with growth factors and the 
controls.
ii) Graph of DNA (ug/ml) in tendon fibroblast pellets cultured for 7 days 
and treated with single growth factors. There was a significant increase 
in DNA in all pellets cultured compared to 1 day (p<0.05) but no 
significant difference between the pellets treated with growth factors and 
the controls.
iii) Graph of DNA (ug/ml) in tendon fibroblast pellets cultured for 14 days 
and treated with single growth factors. There was a significant decrease 
in DNA compared with pellets cultured for 7 days (p<0.05). Between 
treatments at 14 days, 5% serum pellets had significantly elevated DNA 
content compared to 1% serum, bFGF and TGFp (p< 0.05). Also, PDGF 
treated pellets had a greater effect on DNA content than TGFp (p<0.05).
*= p<0.05 
**=p<0.05 
***=p<0.05 
****_p<0 os
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Figure 5.14. Effects of time and growth factors on DNA content of
pellet cultures. Error bars = Standard deviation.
i)Graph of DNA (ug/ml) in tendon fibroblast pellets cultured for 1 
day and treated with growth factor combinations. bFGF+TGFp 
treated pellets showed elevated DNA (p<0.05). There was no 
significant difference between the other pellets treated with 
growth factors and the controls (p>0.05).
*=p<0.05
ii) Graph of DNA (ug/ml) in tendon fibroblast pellets cultured for 1 
week and treated with growth factor combinations. There was a 
significant decrease in DNA in pellets cultured for 7 days 
compared to 1 day pellets (p<0.05). The DNA content is 
significantly reduced in 1% controls, 5%serum and bFGF+TGFp 
treated cultures (p<0.05). Significant differences between 
treatments at 7 days include all growth factor treated pellets have 
increased DNA contents compared to the 1% control (p<0.05). 
Also, 5% serum was significantly lower than both bFGF+PDGF 
and TGFp+PDGF treated pellets (p<0.05).
*=p<0.05 
**=p<0.05 
***=p<0.05 
****_p<0 05 
*****_ p<0 05
iii) Graph of DNA (ug/ml) in tendon fibroblast pellets cultured for 
14 days and treated with growth factor combinations. There was 
no significant difference between the pellets after 14 days in 
culture compared to 7 day pellets (p>0.05), except bFGF+PDGF 
treated pellets showed a decrease in DNA content (p<0.05) and 
there was significant increase in DNA in PDGF + TGF0 treated 
pellets (p<0.05). Between treated pellets and controls cultured for 
14 days, only TGFp+PDGF treated pellets showed significantly 
elevated levels of DNA (p<0.05).
*=p<0.05
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Figure 5.15 . Effects of growth factors on collagen production
i) Graph to show collagen amounts retained in pellets, released into the 
media and in total after 1 day of incubation. The collagen released into 
the media from the 5% serum treated pellets was significantly greater 
than that released by each growth factor treated pellet (p<0.05). n=7, 
except 1% serum and TGF where n=6.
*=p<0.05
**=p<0.05
***=p<0.05
ii) Graph to show collagen amounts retained in pellets and released into 
the media and in total after 7 days of incubation. There are significant 
differences in the collagen content of each pellet, media and in total 
between both the 1% and 5% serum and TGF treated pellets. n=7.
*=p<0.05
**=p<0.05
iii) Graph to show collagen amounts retained in pellets and released 
into the media and total after 14 days. There were no significant 
differences between the sera and growth factor treated pellets at this 
time, however the error bars show the variance in the data. n=7.
Blue lines indicate differences between total collagen amounts.
Green lines indicate differences between collagen retained within the 
pellet
Red lines indicate differences in the collagen released into the media 
Black lines indicate significant differences between all pellet, media and 
total collagen amounts for that treatment
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Figure 5.16 Effects of growth factor combinations on collagen production
i) Graph to show collagen amounts from 1 day pellets, retained in the 
pellet, released into the media and total. Collagen retained in the pellets 
of 1% and bFGF+PDGF treated pellets is greater compared to that of 
TGFp+bFGF. Collagen released from the media from TGFp+PDGF 
treated pellets is significantly greater than the other treated pellets=§. 
Total collagen is significantly greater in TGFp +PDGF compared to 1% 
and 5% serum treated pellets.. n=7.
*=p<0.05
**=p<0.05
***=p<0.05
****=p<0.05
*****=p<0.05
ii) Graph to show collagen amounts from 7 day pellets, collagen retained 
in the pellet, released into the media and in total. There is significantly 
more collagen between the pellet, media and total collagen of 1% serum 
control compared with the TGFp +PDGF treated pellet. The 1% serum 
control also has greater levels of collagen released into the media 
compared with bFGF+PDGF, and 5% serum cultures have more 
collagen released into the media compared to TGFp +PDGF.
n=7, except TGF+PDGF where n=5.
*-=p<0.05
**=p<0.05
***=p<0.05
****=p<0.05
iii) Graph to show collagen amounts from 14 day cultures. 1% sera 
control has more collagen retained in the pellet than bFGF+FGF, and 
bFGF+PDGF treated pellets had more collagen within the pellet 
compared to 5% sera, bFGF+FGF and TGFp +PDGF treated pellets. 
TGFp +PDGF treated pellets had more collagen released into the media 
compared to the other growth factor combinations, and both 5% serum 
and TGFp +PDGF treated pellets had significantly more total collagen 
compared to the other growth factor combinations. n=7 and each 
significant difference shown was at p<0.05.
Blue lines indicate differences between total collagen amounts.
Green lines indicate differences between collagen retained within the pellet
Red lines indicate differences in the collagen released into the media
Black lines indicate significant differences between all pellet, media and total 
collagen amounts for that treatment
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5.4 DISCUSSION
The structure of pellets cultured with growth factors was similar to those described 
in chapter 4. The cells have a clear ability to deposit matrix in this high density 
culture system. It is interesting that in general, treatment with growth factors 
makes little or no observable difference in terms of structure, with collagen and 
other ECM components being deposited similarly in all cultures, at least when 
viewed qualitatively. Cell organisation, in terms of distribution within cultures 
cytoskeletal arrangement and cell junction expression, are similarly unaffected by 
treatments.
The quantitative data suggests that the matrix observed in immunolabel studies 
represented only around 15-25% of the total collagen produced by the cell pellets, 
with the remainder being released to the medium. Whilst this might seem low, it is 
higher than the amount retained in monolayers (Herrmann et al, 1980; Waggett et 
al, submitted), which is between 6-14% in the cell layer. The 3-D organisation of 
the cells therefore, improves matrix deposition; however, a large amount is still 
lost. It is difficult to imagine a developing tendon in vivo losing so much collagen to 
its surroundings, so therefore the culture system is still, perhaps not surprisingly, 
inadequate.
A substantial amount of collagen produced by cells within the pellets is released 
into the media: but how does this occur? Possible explanations involve direct 
secretion, diffusion from the entire pellet, collagen cleavage by enzymes, cell 
death and lysis or escape of cells into suspension. Firstly, collagen could be 
secreted from the cells at the pellet surface directly into the medium. However, 
there was a relatively large amount of collagen released over the 14 days and the 
population of cells at the periphery was reasonably small. It seems unlikely that 
peripheral cells have such an elevated level of collagen synthesis, although it 
should be acknowledged that they will have better access to nutrition compared to 
other cells within the pellet. Immunolabelling for type I procollagen showed type I 
procollagen was present in central regions of the pellets, up to and including 14 
days suggesting collagen synthesis occurs throughout the pellet. Thus, there is no 
evidence of more collagen being produced in the peripheral regions of the pellet. 
Secondly, collagen may be lost from the entire pellet. The spaces seen between 
cells within the pellet (shown in electron microscopy images in chapter 4) may be 
continuous with the outside environment, rather than bounded by endotenon in 
fascicles or an epitenon at the periphery as in vivo (Kannus, 2000) and thus
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collagen could be lost through these channels. Thirdly, it is possible that there is 
collagen cleavage within the pellet. It may be that MMPs, including collagen 
degrading enzymes MMP-1, 8 and 13 (Sodek and Overall, 1992; Krane, 1995; 
Leeman et al, 2002; review Overall, 2002; Stamenkovic, 2003), are produced and 
that secreted collagen is broken down and lost as fragments. MMPs can modulate 
the activity of TGFp and bFGF (Levi et al, 1996; Yu and Stamenkovic. 2000) and 
TGFp can inhibit MMPs (Ma and Chegini, 1999a). Since the hydroxyproline assay 
used can assay these fragments as well as intact collagen we cannot rule out this 
possibility. A further possibility is that cell death within the pellet causes cell and 
tissue lysis. Although not directly assayed, there was no particular evidence of 
extensive cell death at any stage within the pellets; indeed DNA contents tended to 
be maintained during the culture period. An additional possibility is that cells are 
lost from the pellet into the supernatant and secrete collagen directly into the 
media, although cells were generally not observed here.
The hydroxyproline assay allows measurement of collagen, but clearly this assay 
does not distinguish between types of collagen. Immunolabelling showed that both 
types I and III collagen were present. There are other collagens present in tendon 
in vivo (Kannus, 2000), and therefore likely to be produced by tendon cells in vitro. 
These include types V, VI, IX, XII and XIV (Duance et al, 1977; Lapiere et al, 1977; 
von der Mark, 1981; Linsenmayer et al, 1990; Birk et al, 1990; Shaw et al, 1991; 
Waggett et al, 1998). In monolayer it is known that 86% of type I collagen secreted 
is lost to the medium (Waggett et at submitted; Waggett et al, 2001), which is 
around the same proportion as total collagen (Herrmann et al, 1980). It seems 
likely that the majority of the collagen from pellets is type I, but there is likely to be 
a contribution from other types. Interestingly, type III collagen production increases 
with the number of cell passages (Herrmann et al, 1980). By keeping all cells used 
in experiments at the same passage number, P3, it was possible to reduce this 
variation.
Before discussing the effects of growth factors on collagen production, it is 
important to address their effects on DNA content and cell proliferation. The key 
problem is that when assessing the effects of individual growth factors, results 
show a large DNA increase at day 7. However, the results from the experiments 
assessing combined growth factors do not. Since collagen results were normalised
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to pellet DNA content, to try and eliminate effects of cell proliferation on collagen 
content, it is necessary to assess these changes.
There are various possibilities for the DNA increase observed at day 7 of the 
individually treated growth factor pellets. There may have been some experimental 
error. Although all cultures were set up from the same sample suspension, all DNA 
measurements performed at the same time and calculated from the same 
standard curve. Unless a systemic pippetting error was made for the day 7 
cultures, this does not seem a likely source of the variation. Comparing the single 
growth factors and combined growth factor experiments, and in particular 
considering control 1% serum and 5% serum treated cultures, it is clear that this 
DNA increase is not related solely to the growth factor treatments. One possibility 
is that a different serum batch was used and stimulated the 7 day cultures in the 
first experiment, although it is not clear as to why this should occur just at this time. 
Another possibility is that there may have been microbial contamination of the 7 
day pellet cultures. These types of infection are relatively easy to identify in 
monolayer cultures, through a dramatic change in media colour and clarity, as well 
as visible bacteria under the microscope. In pellet cultures, however, this type of 
infection might have been missed, particularly in the early stages as such infection 
cannot be observed live on an inverted microscope. The presence of bacteria 
within the cultures would cause an increased DNA value measured by the 
fluorometer. Although this type of infection is possible, it is odd that it would also 
appear at just one time point. If the infection was caused through feeding the 
cultures, a similar infection might be expected in the 14 day cultures as well. It is 
not possible to decide what has caused this change, whether it is real or caused 
by other influences and so it has to be accepted as genuine.
In the single treatments of pellet with growth factors, the effects of bFGF, TGFp 
and PDGF were examined. bFGF is known to promote matrix synthesis (Chan et 
al, 2000; Okada-Ban et al, 2000) and cell proliferation (Chan et al, 1997, 2000; 
Nugent and lozzo, 2000), however, within these pellet culturing systems there 
were no differences in the DNA and collagen contents compared to the 1 % serum 
control. TGFp is also known to stimulate ECM synthesis in fibroblasts (Ignotz and 
Massague, 1986; Roberts et al, 1986; Grotendorst, 1997). Its role in cell 
proliferation is complex, sometimes stimulating it, at other times inhibiting it, 
dependant on cell type or environment (Assoian et al, 1983; Tucker et al, 1984;
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Roberts et al, 1985a; Nilsen-Hamilton, 1990; Moses et al, 1994; Grotendorst, 
1997; Klein, 2002; Yanai et al, 2002; Haber et al, 2003; Lu et al, 2004; Tomlinson 
et al, 2004). In the pellet cultures, however, it increases collagen secretion. The 
explanations for this may involve the ability of TGFp to affect the differentiated 
state of cells (Nilsen-Hamilton, 1990). In this situation, it appears that treated with 
TGFp the cells favour their differentiated function of matrix synthesis, rather than 
cell proliferation (Klein, 2002). Experiments on cultured fibroblasts showed bFGF 
and PDGF do not stimulate such significant amounts of ECM as TGFp (Frazier et 
al, 1996). Treatment with PDGF does not affect cell behaviour with regards to 
proliferation or collagen synthesis, although it is known to fulfil both these roles in 
vitro and in vivo (Ross et al, 1974; Ross and Vogel, 1978; Pierce et al, 1991; 
Yoshikawa and Abrahamson, 2001; Molloy, 2003). It is known for its involvement 
in fibroblast proliferation in tendon cells when they are under load (Banes et al, 
1995). In the pellet cultures the cells are not under load and this may explain why 
PDGF fails to induce any effect on the treated cells. Importantly none of the three 
growth factors tested are able to increase the amount of collagen retained by the 
cells within the pellet. In fact, where collagen secretion is enhanced, the proportion 
incorporated in the pellet is unchanged. It is possible that matrix turnover is 
enhanced by the growth factors (Ma et al, 1999; Coletta et al, 1999; Hall et al, 
2003; Nahm et al, 2004) and not just matrix synthesis.
The use of growth factors in vitro to induce a range of changes in cell behaviour 
has been taking place for decades. In the past, pellet cultures have been used 
primarily to induce chondrogenesis (Solursh et al, 1991), as discussed previously. 
Cells from tissues other than hyaline cartilage can also undergo chondrogenesis 
with growth factor treatment in high density culture. Cells from the fibrous part of 
the foetal annulus fibrosus undergo this response if treated with TGFp (Hayes, 
thesis, 1999), as do cells of the adult intervertebral disc (Yung Lee et al, 2001). 
Tendon fibroblasts showed no evidence of this, in this study. The intervertebral 
disc cells are from fibrocartilaginous tissue (Yung Lee et al, 2001) or in the case of 
the foetal cells (Hayes, thesis, 1999), cells that will form fibrocartilage. Whilst 
tendon cells can form fibrocartilage in vivo in response to compression (Evanko 
and Vogel, 1990) and dermal fibroblasts in micromass culture can take a 
chondrogenic phenotype when treated with lactic acid (Nicoll et al, 2001), it 
appears that chicken flexor tendon fibroblasts do not respond in this way.
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Whilst single growth factors had few effects on DNA content, combined treatments 
did demonstrate some significant outcomes. Early on, bFGF+TGFp enhanced 
DNA content, both growth factors are well known to promote cell proliferation 
individually (Shipley et a, 1995; Nilsen-Hamilton, 1990; Moses et al, 1994; Chan et 
al, 1997; Bikfalvi et al, 1998; Verrecchia and Mauviel, 2002), but here needed to 
be used together to generate significant effects. At 7 days all factor treatments 
were higher than the controls, and at 14 days TGF+PDGF was highest of all. All 
appeared to act synergistically as when treated individually there was little effect 
on proliferation (see above). The pronounced TGFp+PDGF effect at 14 days may 
reflect the stimulatory effects of both. The mitogenic effects of TGF|3 involve the 
activation of PDGF receptors (Ishikawa et al, 1990) and can be stimulated via an 
autocrine production of PDGF related peptides (Soma and Grotendorst, 1989; 
Battegay et al, 1990). Hence, these factors together will enhance cell proliferation. 
Cells also appear to change their responsiveness to the growth factor 
combinations with time in culture, this may reflect the differentiated state of cells. 
One day cultures have recently been formed from monolayer, where they were 
rapidly proliferating and therefore could have had different factor responsiveness 
to cultures in the 3-D for the long term. Older cultures (14 day) have a different 
environment, they have more deposited matrix in direct contact with cells and this 
may have altered their sensitivity to different growth factors.
In early cultures TGF0+PDGF appear marginally more effective at promoting 
collagen synthesis, bFGF+TGF|3 was the least effective. Notably, bFGF+TGFp 
was the most effective at increasing DNA content at this stage and the 
TGFp+PDGF contribution may be enhancing differentiated function, and the 
bFGF+TGFp a proliferative function. By 7 days the situation has changed and the 
serum treated cultures generally secrete more collagen, the growth factor treated 
ones are significantly lower than the 1% control culture. These growth factor 
cultures did have higher DNA, indicating their addition to the 1 % serum-containing 
medium again favoured a proliferative phenotype. By 14 days, there are further 
changes, and the bFGF containing combinations remain low, whereas the 5% 
serum and TGFp+PDGF are elevated. Strikingly, the TGFp+PDGF are the only 
cultures that have an enhanced DNA content at this time, indicating that both 
proliferation and matrix production are enhanced.
No growth factor combination appeared to enhance matrix deposition in pellets, 
with the possible exception of bFGF+PDGF at 14 day, which does have a greater
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proportion, of a fairly low collagen production, in its pellets. The TGFp containing 
cultures were poor at matrix incorporation, even in the presence of bFGF. TGFp 
has been shown to reduce MMP activity by increasing TIMPs and reducing MMP 
expression (Ma et al, 1999; Coletta et al, 1999; Hall et al, 2003; Nahm et al, 2004), 
and so might be expected to enhance incorporation into matrix; however, there is 
no evidence of these here, either singly or in combinations of growth factors. It has 
been shown that the combination of TGFp+PDGF has a negative effect on 
ligament healing in vivo (Hildebrand et al, 1998), and that PDGF can also increase 
MMP activity (Matrisian and Hogan, 1990; Laurent et al, 2003). Here we show 
good matrix synthesis, but poor matrix accumulation in association with these 
factors, suggesting that much of it is lost. If this happened in vivo, it might explain 
the poor healing response.
Another possible explanation for the differences observed within the cultures is 
that the cells are producing endogenous growth factors. These could either affect 
the exogenous growth factors applied to the culture system, or the exogenous 
growth factors could affect the cell metabolism and consequently the endogenous 
growth factor production (Banes et al, 1995; Tsuzaki et al, 2000; Dalhgren et al, 
2005). PDGF can stimulate the synthesis of other growth factors (Lynch et al, 
1989) and TGFp-1 can induce TGFp-2 and bFGF expression in the cornea (Song 
et al, 2002). Alternatively these factors can increase growth factor receptor 
expression, also affecting cell behaviour (Tsuzaki et al, 2000; Rubini et al, 1994; 
Ngo et al, 2001). Growth factors and their control in promoting matrix synthesis is 
such that the deposited matrix can sequester other endogenous growth factors. 
TGFp and matrix synthesis have been investigated with the ECM molecules 
especially affected including fibronectin, type I collagen, laminin and GAGs (Ignotz 
and Massague, 1986; Roberts et al, 1986; Verrecchia et al, 2004). TGFp acts to 
stimulate ECM accumulation, which in turn supports the actions of other growth 
factors, namely PDGF, bFGF, EGF (also known as aFGF) and TGFa, each of 
which directly stimulate cell proliferation (Nilsen-Hamilton, 1990). Each of these 
roles must be evaluated when using exogenous growth factors in culture systems. 
There is evidence that endogenous growth factors are present as the 1% serum 
treated growth factors show little difference in DNA content compared to 5% serum 
treated, or indeed other growth factor treated pellets, and continue to synthesise 
considerable amounts of collagen. In addition, growth factors are signalling 
systems used by these cells, for example in gap junctional communication and 
mechanical attachment. Therefore the addition of one or two different exogenous
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factors will not necessarily be predictable given the complexity of the culture 
system.
In bFGF+TGFp treated pellets it is important to note that different concentrations 
of TGFp can have varying effects on bFGF (Pepper et al, 1993). It was discovered 
that low concentrations of TGFp enhance bFGF activity and high concentrations 
arrest it. Although this experiment was associated with the angiogenic roles of both 
growth factors, this combination at these concentrations may hinder effects to the 
cells within the pellet cultures. From this experiment, the growth factor 
concentration used in our study was towards the higher end of their scale, 
indicating a possible counteraction of effects. The effects of TGFp, however, on 
endothelial cells and fibroblasts are known to differ and even the effect of TGFp 
can vary dependant on the proliferation state of the cells or the surrounding ECM 
(Sutton et al, 1991). Therefore, it is only possible to speculate, that rather than 
acting together, the TGFp and bFGF treated fibroblasts may, in fact, cancel out 
some of the growth factors effects. In chondrogenic experiments, using bFGF and 
TGFP in media, while expanding the chondrocytes, displayed the low doubling 
times, suggesting their mitogenic effect is apparent in monolayer. When these 
cells were re-differentiated in pellet cultures this specific combination of growth 
factors expressed the largest mRNA amounts for type II collagen and aggrecan 
(Jacob et al, 2001). While this combination of growth factors may be counter 
productive in some cell types, in others it can encourage matrix synthesis.
In summary, single growth factor treatments showed no significant differences 
between the controls, and there is little difference between the 1% and 5% serum 
treated controls. Growth factor combinations do increase matrix synthesis 
significantly compared to single growth factor treatments, but the majority is still 
discharged into the media. It is impossible to say that the single growth factors 
encouraged cellular proliferation within the first week in culture as the controls 
followed the same pattern, and this is not observed in the controls or the growth 
factor combination treated pellets. The 5% serum treatments still appear the most 
beneficial treatment for pellets and collagen synthesis. This is likely to be caused 
from the mixture of growth factors present in the serum or endogenous growth 
factor production. Although in these experiments, the levels of protein secretion 
have been measured there are other ways these measurements could be 
confirmed and expanded upon. These methods include western blots and radio 
immuno assays. Both of these procedures make it possible to assess differences
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in the types of collagen secreted. Quantitative PCR has been used in many 
experiments to quantify the mRNA, using this method together with the techniques 
described above could increase the accuracy of the collagen measurements. This 
could, in turn, provide increased significances between pellet treatments, allowing 
a greater understanding of the whole culture system involved in collagen synthesis 
and secretion from the pellets. These experiments have shown that treating 
tendon fibroblasts in a high cell density pellet culture with growth factors does aid 
the retention of collagenous matrices by the fibroblasts, but a significant level of 
collagen is released into the media. Consequently, the pellet, although easy to 
duplicate and manipulate and better than monolayers at promoting collagen 
deposition, does not possess certain factors required for efficient matrix 
deposition.
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6.1 INTRODUCTION
The process of cell condensation is central to the early development of many 
connective tissues, including tendon and cartilage, whose development has 
already been discussed (see chapter 1). Cell-cell interactions become prominent in 
the condensation process, and in cartilage have been shown to be important in 
early differentiation (Zimmerman et al, 1982). The cadherins, notably n-cadherin, 
have been shown to be important in this process, along with NCAM and gap 
junctions comprised of connexin 43 (Dealy et al, 1994; Oberlender and Tuan, 
1994; Hall and Miyake, 1995; Packer et al, 1997; Chimal-Monroly et al, 1999; 
Delise and Tuan, 2002; Yajima et al, 1999 and 2002). Equivalent studies have not 
been performed on tendon condensations, but n-cadherin and gap junctions are of 
particular interest. They are prominent in regions of cell-cell contact in adult 
tendons (McNeilly et al, 1996; Ralphs et al, 2002), and therefore might be 
expected to be present in developing tendon.
In this chapter, the importance of cell-cell interactions in establishing 3-D tissue 
structures is examined in vitro. These studies were performed firstly, to establish 
the extent, timing and factors controlling of cell aggregation in suspension cultures 
in the short term, and secondly to examine the role of cell-cell interaction and 3-D 
organisation in establishing large scale cultures, of potential value in tissue 
engineering approaches to tendon repair. The behaviour of tendon cells is 
examined in detail, and compared with chondrocytes. An important difference 
between the two tissues is, while they both start out as cell condensations, 
chondrocytes differentiate and lose contact with one another, whereas tendon cells 
retain extensive cell-cell interactions and form networks throughout the tissues 
(McNeilly et al, 1996).
In vitro, a variety of tissue culture systems have been used to culture fibroblasts 
and chondrocytes. These range from simple monolayers to complex bioreactors 
involving incorporation of cells onto scaffold structures and growing them in 
mechanically and/or chemically active environments (Jasmund and Bader, 2002; 
Sodian et al, 2002; Garvin et al, 2003; Radisic et al, 2003). Monolayers, although 
useful for expansion of cell number, were not considered suitable for studies of 
early cell-cell interaction. The purpose of these studies was to investigate the site 
of cell-cell interactions in cell aggregation and tissue differentiation. Cells in 
monolayers have a relatively large area of interaction with the culture substrate, 
which is a cell-matrix interaction (Freshney, 1983). A relatively small area of any
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given cell is in contact with surrounding cells around the periphery. Similarly, the 
use of scaffold type structures for the incorporation of cells into 3-D arrays was not 
attempted, as the cells would be likely to have a greater interaction with the 
scaffold substrate than with one another. Accordingly, cells were grown in 
suspension culture, so that cells did not encounter a solid substrate, and could 
only interact with one another.
In the first part of the work described in this chapter, aggregation behaviour of 
tendon cells and chondrocytes is investigated in short term cultures, with particular 
reference to cadherin, gap junction and extracellular matrix expression. The 
second part of this chapter examines the feasibility of using suspension culture 
systems to generate large scale in vitro structures from isolated tendon cells. Many 
attempts have been made to create large scale connective tissue structures, 
potentially, for use in tissue engineering. Most of them require the incorporation of 
isolated cells into 3-D scaffold structures. These scaffolds can be made from a 
variety of materials, natural or synthetic, e.g. collagen, hyaluronan, polylactic acid, 
polyethylene glycol (reviewed in DeFranco et al, 2004).
Using cell seeded scaffolds in tissue repair (see chapter 1) can have advantages, 
for example the production of a construct with intrinsic mechanical strength that 
when implanted, enables the construct to perform its function. It is then hoped that 
the cells seeded within the scaffold will synthesise a matrix and take over the 
function of the original scaffold components (Yamamoto et al, 1993; Dunn et al, 
1994). The disadvantages however, include the scaffold materials having adverse 
affects in vivo, in terms of breakdown products or triggering a host response. 
Using degradable scaffolds can cause problems if the rate of degradation is not 
compatible with matrix synthesis from the host, or if the load the construct is 
subjected to during integration is not suitable, too much or too little may cause a 
failure of the implant (Qin et al, 2004). Experiments into the suitability of the 
scaffolds in long-term implantation are few, scaffolds are often implanted for a few 
months and the results harvested. Longer experiments could evaluate the 
longevity and effects of the scaffolds in vivo.
The experiment described here represents an attempt to take advantage of 
connective tissue cells potential ability to create their own scaffold, their natural 
ECM. A system has been developed to allow large numbers of tendon cells to 
interact with one another in suspension culture to form orientated structures. The
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basis of the design is that cells must interact with, and deposit matrix between one 
another without disturbance from regular medium changes. However, nutrition of 
large-scale cultures is potentially problematic, as diffusion distances are relatively 
small (typically 1mm). The system works by growing cells within a dialysis tube 
containing a small volume of medium that remains undisturbed, contained within a 
large volume of medium that can be regularly changed. Cell suspensions are 
placed in the inner tube, which is placed in an outer tube and cultured on a roller. 
These cultured cells show a degree of orientation and matrix deposition hitherto 
undescribed and could provide the basis of a system for forming fairly large-scale 
materials for tissue engineering graft production.
Tendon consists mainly of extracellular type I and type III collagens, and tendon 
cells are known to continue the synthesis of these in vitro (Herrmann et al, 1980). 
The synthesis of these ECM components by cells in suspension cultures will be 
investigated using immunolabelling techniques. As the behaviour of tendon cells 
will be compared with chondrocytes, type II collagen will also be examined. Type II 
collagen is the major component of cartilaginous matrix, but is absent from tendon 
ECM, except in regions of fibrocartilage (Benjamin and Ralphs, 2004). The 
synthesis of type II collagen decreases in chondrocytes in culture as they de­
differentiate (Benya and Shaffer, 1982; Schnabel et al, 2002). The cytoskeleton is 
known to be involved in cell interactions and in the control of connective tissue 
phenotype (Benya et al, 1978; Grundmann et al, 1980). The distribution of 
cytoskeletal fibres and proteins associated with cell-cell adhesion and linkage of 
cytoskeletal networks will be investigated together with proteins involved in cell-cell 
adhesion joining the actin networks of adjacent cells, namely cadherins. Cadherins 
and vinculin are known to be present in adult tendon and regulated through 
mechanical loading (Ralphs et al, 2002). The orientation of the actin cytoskeleton 
has been implicated in the control the cell orientation and therefore the 
organisation of matrix deposition (Hayes et al, 1999). To ascertain whether this is 
the case for tendon fibroblasts within this culturing system, the presence of 
filamentous actin will be investigated.
In short term and long term cultures, features of tendon structure and composition 
that are important in final tissue structure and behaviour are mapped in the context 
of early cell aggregation and large scale tissue differentiation. The results are 
described in terms of remodelling of in vitro cell condensation and matrix 
deposition, in relation to possible tissue engineering applications.
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6.2 MATERIALS AND METHODS
Two types of suspension culture system were used. First, cells were suspended 
and placed in 1.5ml cryotubes on a roller for experiments of duration 0-6 hours and 
secondly, cells were incorporated into a more complex large-scale system for 
experiments lasting up to 3 weeks.
Aggregation of tendon cells in short term suspension culture
For tissue source, cell isolation and maintenance see general material and
methods (chapter 2). Tendon fibroblasts at P 3, were suspended at 20-30x10 
cells/ml DMEM (5%FBS), placed into sterile screw-top 1.5ml cryotubes (Greiner
Ltd.), sealed and rotated at 35 rpm at 37°C for 0 hours, 0.5, 1, 1.5, 2, 3, 4, 5 and 6 
hours. At these times, 20pl samples were taken and spotted directly onto a 
microscope slide, covered with a coverslip and examined live under phase 
contrast. 80pl samples taken at the same time were fixed immediately in 500pl 
90% alcohol at 4°C, and aliquots dropped onto slides and allowed to dry at room 
temperature ready for immunolabelling (see general materials and methods, 
chapter 2).
To test the hypothesis that cadherins are important in cell aggregation, suspension 
cultures were treated with blockers of cadherin function. HAV peptide (amino acid 
sequence AHAVSE), which competes for binding on the extracellular loop of the 
cadherin molecule (llversaro et al, 1998), and control peptide sequence (VASHEA) 
were used at 20pg/ml and 200pg/ml (Alta Bioscience), respectively. Sterile PBS 
was used as a carrier control. 20pl of peptide or PBS were added to a tendon 
fibroblast cell suspension at the beginning of the experiment and run as above. In 
addition, experiments were repeated using n-cadherin blocking antibody (Sigma, 
Clone CH-19) (Wanner and Wood, 2002) and anti-vinculin (Sigma, Clone-hVIN-1), 
both at 5 pg/ml. Vinculin acts as a control because it is a component of the 
intracellular complex formed at adherens junctions and focal contacts. Sterile PBS 
was used as a carrier control.
6.2.1 Long term, large scale cell suspension culture of tendon cells
To investigate cell aggregation in long term culture systems we developed a large 
scale disposable ‘bioreactor’ from parts readily available from tissue culture 
equipment and specialised dialysis tubing (Medicell Ltd. Int) (fig.6.1). Essentially, 
the culture system involves placing cell suspension of 20-30x10® cells into a
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dialysis tube of volume 1ml. The dialysis tube is placed within a standard 50ml 
tissue culture centrifuge tube. Cultures can then be fed by changing the medium 
within the centrifuge tube, leaving the contents undisturbed. The cultures are 
incubated on a roller; the second lid at the lower part of the tube has its central 
part removed and is pushed over the tube so the whole thing runs evenly on the 
roller.
Lid with
middle
removed
50ml centrifuge tube Dialysis tubing
Agarose plug
Fig 6.1 Schematic diagram of DispoDialyzer tube within centrifuge tube. 
Description of culture system and procedure
Cells isolated above and in general methods were adjusted to 20-30x106 cells/ml, 
and 1ml of cell suspension was pipetted into each sterile Spectra/Por® CE 
(Cellulose Ester) Irradiated DispoDialyzer tube (Medicell Int.Ltd). The dialysis tube 
is 5cm in length with a 5mm diameter, a plastic base and a plastic screw-top lid 
assembly. Initially experiments were performed using tubes with 300KDa 
molecular weight cut off (MWCO) membranes. Unfortunately during the 
experiments SpectraPor ceased manufacturing these, and so they were replaced 
with 100KDa MWCO and 50KDa MWCO membranes. The key modification to the 
tubing was to place a small volume (200pl) of 2% agarose (Sigma) into the bottom 
of the tube and allowing it to set at 4°C before adding the cells. This method was 
used because in preliminary experiments cells tended to become trapped in the 
complex shape of the plastic moulding of the base; the agarose plug prevented 
this adhesion. After the addition of cell suspension, the dialysis tubes were sealed 
and placed in a standard 50ml polypropylene sterile centifuge tube (Corning). The 
addition of 40ml DMEM (5% FBS and 1% antibiotics/antimitiotic, 12.5mM HEPES 
buffer (Invitrogen/GIBCO) and ascorbate (1 mg/ml) created the complete culturing 
system. Experimentation with chondrocytes required nutrition with DMEM/10%
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FBS. The concentric tubes were incubated at 37°C and rotated in a rock and 
rolling motion at 35rpm. Media was changed every three days and experiments 
were terminated at 24 hours, 7, 14 and 21 days.
To investigate the differences between adult and embryonic cells within this 
system, embryonic cells isolated from E17 chick embryos (see general materials 
and methods, chapter 2) were used, the procedure was the same as above. To 
investigate the effect of growth factors in this system TGFp and IGF-1 were used 
at 10ng/ml and 50ng/ml, respectively added to the media in the 50ml centrifuge 
tube housing the sealed dialysis tubing. The growth factors could pass through the 
membrane pores easily as the TGF-p and IGF-1 molecular weight is 27KDa and 
21.8 KDa, respectively. DMEM serum concentration for these experiments was 
maintained at 1 % FBS. Controls used were 5% FBS and 1 % FBS, with no added 
growth factors. The procedure was the same as described above.
Cell aggregates were separated from the dialysis tubing by cutting a section of 
tubing with scissors and removing the aggregate with tweezers. Cell aggregates 
were immediately fixed in 4°C and frozen onto a chuck using Cryo-m-bed ready for 
cryosectioning. Sections were taken at 8-10pm on histobond slides.
Immunohistochemical Analysis
Fixed cell aggregates and cell aggregations from short-term experiments were 
labelled for extracellular proteins (types I, II and III collagen, tenascin, some with 
the proteoglycan decorin), cytoskeletal components (direct labelling of actin with 
phalloidin and vimentin) and cell junctional associated proteins (pan-cadherin, n- 
cadherin, vinculin and the connexins 32 and 43). (See general materials and 
methods, chapter 2 (table 2.1)).
Biochemical Analysis
To measure the collagen amounts produced by the cell aggregates, media from 
the total experiment, media held within the dialysis tubes and collagen contained 
within the cell aggregates samples were prepared for the hydroxyproline assay 
(See biochemical analysis, hydroxyproline assay, materials and methods chapter 
2). To measure the DNA content of cell aggregates, aggregates were digested in 
papain and the Hoechst assay was used to assess DNA quantities (See 
biochemical analysis, Hoechst assay, materials and methods chapter 2).
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Due to the large number of cells used and the relatively lengthy incubation periods 
of these cultures, it was not always possible to collect complete data for each 
aggregate. In early experiments the cell aggregates were required for 
immunolabelling and therefore, accurately replication for quantitative analysis was 
difficult.
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6.3 RESULTS
6.3.1 Initial cell aggregations in shortterm  suspension culture
Live cells examined under phase contrast showed that cell suspension of both 
tendon cells and chondrocytes formed aggregates within the first hour (fig. 6.2 and 
fig. 6.3). Aggregates enlarged presumably recruiting new cells from the cell 
suspension (fig. 6.2 and 6.3). After 4 hours most cells are incorporated into cell 
aggregates, although some individual cells remain (fig 6.2 G, H, I).
Tendon fibroblasts treated with HAV peptides or n-cadherin blocking antibody, and 
corresponding controls showed no change in aggregation. Cell aggregates were 
seen within the first hour of the cell suspension and cultures progressed as 
described above (fig 6.4). Neither concentration of HAV peptide (1 and 10 mg/ml) 
appeared to hinder cell aggregation.
Immunolabelling of collagens and cell adhesion associated proteins 
Fibroblasts
Collagens
Positive label for type I collagen was present at all time intervals (fig. 6.5). Initially it 
appeared intracellular but in 3hr cultures it appeared that some aggregates had 
extracellular label (fig. 6.5 F). The type I collagen label appears to increase in 
intensity after 1 hour in culture (fig 6.5 D). Type III collagen label was sparse and 
not associated with all cells, it appeared to be principally intracellular (fig. 6.7). 
There was no type II collagen at any stage (fig.6.6), it was used as a negative 
control but also indicated no fibroblasts can develop a chondrogenic phenotype.
Cytoskeletal
Filamentous actin is positive in all cells, as shown by a faint green hazy label (fig. 
6.8). However, there are no large scale actin assemblies such as actin stress 
fibres. Vimentin label showed positive at all stages (fig 6.9).
Cell junctional proteins
Label for cadherins was present in all cells at all time points, generally located at 
the cell periphery (fig. 6.10 and fig. 6.11). The Pan-cadherin and n-cadherin 
antibodies showed similar distribution suggesting the predominant cadherin to be 
n-cadherin. Vinculin label was similarly distributed (fig.6.12). Label for connexin 32 
was also present throughout the experiment. In some areas it appeared 
intracellular in a dense, bright regions, possibly the Golgi apparatus. In others it
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was at the cell surface and in aggregates gave the appearance of a regular 
network where many cells were pressed together (fig. 6.13). Connexin 43 label 
was much less prominent being sparse, with the odd bright spot of labeling 
occurring between cells (fig. 6.14).
Chondrocytes
Collagens
For comparative purposes immunolabelling of chondrocytes showed some 
differences compared to the fibroblasts. Label for type I collagen was present, but 
weak compared to tendon cells (fig 6.15 A). Type II collagen was present up to 
and including 3 hours in culture (fig. 6.15 B). Type III collagen label was present, 
but weak at the 0 hour time interval. No other type III collagen label was present 
for the remainder of the experiment (fig. 6.15 C).
Cytoskeleton
Actin labeling was positive at all time intervals, the filamentous nature seen in cells 
incorporated into aggregates (fig. 6.15 D). Vimentin label was negative in isolated 
cells and cell clusters (fig. 6.15 E). This negative result should be thoroughly 
investigated for confirmation; it is possibly due to poor immunolabelling.
Cell junctional proteins
Vinculin label is positive at all stages, showing labelling concentrated at the cell 
periphery (fig. 6.15 F). Connexin 32 label is abundant throughout the experiment 
until the 6 hour time point, where it is diminished. There is no conclusive connexin 
43 label present at any time point (fig. 6.15 G). At this time no cadherin antibodies 
were available for labelling.
6.3.2 Long term, large scale suspension cultures: Adult cells
Cells within this large scale system aggregated within 24 hours in medium 
containing 5%FBS. They formed structures that were clearly visible to the naked 
eye, and which became larger, increased in strength and became easy to handle 
over the following 7-21 days of culture.
The older (7-21 days) structures took a variety of forms (fig 6.16). In most cultures 
there were elongated, thin, rod shaped aggregates, although funnel shaped sheets 
or a solid sphere of cells were sometimes formed. All, or just one of these types 
could occur within the culture. The elongated structures could reach large sizes,
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some were over 3cm in length (fig 6.16 A). These structures formed in all of the 
dialysis tubes tested with 300kDa, 100kDa or 50kDa MWCO membranes. Cultures 
grown in DMEM/1% FBS, formed no aggregates. Loose cellular material was 
visible in the tube but with no structure. When chondrocytes were substituted for 
tendon cells and maintained with DMEM/10% FBS similarly, no structures were 
formed, even up to 28 days of culture fine, particulate material was present but no 
comparable structures to the fibroblast aggregates were made.
Immunolabelling of ECM and cellular components
Cell distribution within aggregates could be observed in all of the immunolabelled 
material because propidium iodide was used to counterstain the nuclei. In 24 hour 
and 7 day aggregates nuclei appeared evenly distributed (fig 6.18 A, B) although 
in some central regions of larger aggregates at 14 days onwards there appeared 
to be a lower cell density. These regions tend to crack and break up during 
cryosectioning, suggesting different material properties compared to the outer 
parts. However, in thinner aggregates the cell densities appeared consistent. 
Twenty one day aggregates were similar in structure and labelling characteristic to 
14 day cultures.
Nuclear distribution showed a degree of orientation in the thinner rod-shaped or 
sheet and funnel shaped aggregates. Cells here were arranged in parallel rows 
separated by ECM, reminiscent of the in vivo organisation of tendon cells. This 
was particularly clear at 14days onwards (fig 6.18 C), but was seen in regions of 7 
day cultures. There were no effects of the different MWCO pore sizes of dialysis 
tube membranes.
Extracellular matrix
Types I and III collagen were detected in cell cultures at all stages, and type II 
collagen was absent (figs 6.19, 6.20, 6.21). Type I collagen was observed as 
extracellular, with label being strongest in 14 day cultures (fig 6.19 C). There was 
no obvious orientation to type I collagen label although in 7 day (fig 6.19 B) and 
older cultures it was positioned between orientated rows of tendon cells in rod-like 
and thin sheet cell aggregates. In the more rounded cell aggregates areas or cell 
and matrix orientation were restricted to the periphery of the aggregate. There 
were no visible differences in cultures grown in 300kDa, 100kDa or 50kDa MWCO 
tubes.
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Compared to the type I collagen, the type III collagen labelled very brightly and 
formed long, relatively widely spaced interwoven fibres after 24 hours in culture (fig
6.21 A). In 7 day aggregates type III collagen labelled strongly, with an interwoven 
pattern as above. There was a zone of cells, 3-5 cell layers, at the periphery of the 
aggregate that did not label (fig 6.21 B). Orientated type III collagen was present in 
14 day aggregates (fig 6.21 C) with bright longitudinal fibres positioned between 
orientated nuclei. This pattern of type III collagen is consistent in cell aggregates 
formed in with DispoDialyzer tubes of 50 KDa, 100 KDa and 300KDa MWCO (fig 
6.28). Quantitative data for collagen produced by these cultures is presented in the 
final part of these results.
The presence of tenascin was examined because of its role in tendon 
development and its known adhesive qualities (Hurle et al, 1990; Sriramarao et al, 
1993). Tenascin was evident in 14 day cell aggregates (fig 6.29 A) with an 
extracellular distribution of longitudinal fibres.
Cytoskeletal labelling
There were no prominent actin fibres in 24 and 7 day cultures. The characteristic 
green haze was visible in the cells, indicating the presence of actin filaments (fig
6.22 A, B) but clearly there were no larger scale structures. Obvious filamentous 
actin was only identified in elongated cell aggregates at 14 days (fig 6.22 C), 
where cells and matrix had the longitudinal tendon-like organisation indicated 
above. Vimentin was present in cell aggregates particularly at the periphery of the 
aggregate (fig 6.29 C) and showed a degree of longitudinal orientation in 
longitudinal aggregate structures.
Cell junction labelling
N-cadherin and pan-cadherin were present in cell aggregates cultured for 7 to 14 
days (fig 6.30). Both cadherin antibodies labelled predominantly at the periphery of 
the cells, outlining their membranes, but with no clear focal spots. At 7 days in 
cultures pan-cadherin and n-cadherin distribution was similar (fig 6.30 A, B), 
whereas at 14 days pan-cadherin labelled more strongly (fig 6.30 C), suggesting 
expression of additional cadherins. Vinculin was present throughout the cell 
aggregates, at 24 hours an intense vinculin distribution was identified in cells at the 
periphery (fig 6.23 A). The positive labelling is indifferent as to whether the cell 
aggregates are formed in 50, 100 or 300KDa MWCO tubes.
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Connexin 32 was present in all cultures at all times (fig 6.24 A, B, C). There was 
an increase in labelling intensity at the aggregate periphery in some areas (fig 6.24 
A). Highly aligned cells within a 7 day cultured aggregate showed thin streaks of 
connexin 32 (fig 6.24 B), the 14 day culture had a less organised structure but 
connexin 32 remained evident (fig 6.24 C). Positive labelling for connexim 43 
showed small and occasional foci of labelling throughout the aggregates, but did 
appear to increase after 14 days in culture (fig. 6.25 C). Both connexin patterns 
are consistent with aggregates from 50, 100 or 300KDa MWCO DispoDialyzer 
tubes.
6.3.3 Long term, large scale suspension cultures: Embryonic cells
To examine whether embryonic tendon fibroblasts behave differently to the adult 
cells described above, fibroblasts from 17day chick embryos were cultured foir 14 
days. Essentially labelling patterns for ECM components and cell junctional 
components were the same as adult cells.
Immunolabelling o f ECM and cellular components
Cell aggregates formed from embryonic fibroblasts showed no differences in 
labelling patterns compared to the adult tendon fibroblasts. Types I and III coiltegen 
and tenascin were present extracellularly, and type II collagen was absent (fig 
6.26). An antibody for decorin was available at the time of this study, therefore 
decorin was immunolabelled for because of its involvement in collagen 
fibrillogenesis in development. Decorin was restricted to the peripheral zone off the 
aggregates (fig 6.26 E) with small and infrequent areas of label visible centrally.
Cell junction labelling
Pan and n-cadherin showed similar patterns of labelling (fig 6.27 C, D) at the cell 
periphery, but showed more punctate arrangement than cultures derived from 
adult cells. Connexin 32 and connexin 43 were identified in the cell aggregates (fig 
6.27 E) and the connexin 43 spotted labelling was difficult to identify (fig 6.27}
6.3.4 Long term, large scale suspension cultures: Adult cells treated with 
growth factors
To examine the effects of TGFp and IGF-1 in large scale suspension cultures, 
cultures were maintained in DMEM/1%FBS, which as indicated above does not 
support cell/matrix aggregate formation in the presence or absence of the growth 
factors. Both growth factor treatments promoted the formation of aggregates,
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which showed the same range of morphology as cultures described above (fig 
6.33 and 6.34).
Biochemical analysis
The hydroxyproline assay was used to quantify the amount of collagen produced 
by the cells cultured in suspension cultures. Collagen content was measured in 
three separate components of the cultures: growth media from the outer centrifuge 
tube, media from within the dialysis tubing at time of termination and collagen 
retained by the cells within the formed aggregates. Since most cell aggregates 
were required for immunohistochemistry these numbers are low. No n values are 
more than 3 and consequently, no statistical analysis was possible. The data is 
presented below, however, it must be stated that this has no statistical validity. 
Some interesting observations can nevertheless, be made.
A full set of data was obtained from 3 replicates of cultures grown with 100kDa 
MWCO tubes, cultured for 7 days. The total amount of collagen made by each 
culture was on average 304ug collagen. This was divided, with 69% in the cell 
aggregate, 7% in the dialysis tube and 25% released from the dialysis tube to the 
growth medium. By comparison, 50kDa MWCO (albeit n=1) produced considerably 
more collagen in total 498 ug, but there appeared to be a similar proportion of 
collagen in the cell aggregates (78%, 4%, 18% respectively), although clearly 
more replicates would have to be performed to demonstrate this. DNA values 
analysed with the Hoechst assay (described in chapter 2, general material and 
methods) indicate there was possibly increased cell death in aggregates cultured 
in tubes with the smallest pore size (50kDa). This may be due to an increase in 
blockage of these pores by collagen fragments or other waste products, and a 
resulting decrease in nutrient availability into the dialysis tube.
By comparison cultured cell aggregate data for the 300kDa MWCO DispoDialyzer 
tubes was unavailable because all were used for immunolabelling studies, and the 
manufacturers ceased production of this size before further cultures could be 
grown. The only comparison that can be made therefore is between the amount of 
collagen in the dialysis tube media and main tube growth media, without DNA 
normalisation. These results show that much more collagen appears in the main 
tube than with the other dialysis tube MWCO. This suggests that the larger pore 
size enables collagen fragments produced by the cells to pass freely through the 
membrane. A similar pattern is evident in dialysis tubes where the pore sizes are
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smaller, 50-100kDa MWCO. It is important to note that the total collagen released 
into the media from these experiments is significantly lower than in 300kDa 
MWCO tubes. This result would have to be thoroughly investigated. Experiments 
with the smaller pore sized membranes show a decrease in collagen released into 
the media after 14 days. This is possibly due to a build up of matrix 
metalloproteases, discussed later.
The effects of growth factors added to cells culturing within these suspension 
cultures showed aggregates forming with reduced serum levels (1%FBS/DMEM). 
Growth factor experiments used dialysis tubes with 300kDa MWCO, as with the 
above quantification analysis the aggregates from these cultures were used to 
obtain qualitative data. Collagen amounts released into the media showed similar 
levels of collagen compared to the aggregates treated with 5% FBS/DMEM. Cells 
with added IGF-I showed increased levels of collagen when cultured for 7 days 
compared to those treated with TGF-p. After 14 days in culture total collagen 
released into the media had increased in both growth factor treated cultures, 
raising contradictory indications to the 14 days 50kDa and 100kDa MWCO 
cultures.
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Figure 6.2. Cell-cell interactions in short term suspension cultures: tendon cells
Phase contrast images, x40 objective lens, Scale bars= 50 pm
A- 0 hour time point. Freshly isolated cells with no dense aggregates.
B- 0.5hour time point. Similar to A.
C- 1 hour time point. Cell aggregations can be observed.
D- 1.5hour time point. Larger cell aggregates are consistently present.
E-l- 2- 6 hour time points. Cell aggregates present at all time points; cells 
tend to enlarge with time, although individual cells are always present.
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Figure 6.3 Cell-cell interactions in short term culture; chondrocytes
Phase contrast images, x40 objective lens, Scale bars= 50 pm
A- 0 hour time point. Cells are isolated within the cell suspension.
B- 0.5hour time point. Cells begin to adhere to one another.
C- 1 hour time point. Cells form loose aggregates.
D- 2hour time point. Aggregates formed are increasingly tightly packed.
E-H- 3-6 hour time point. Cell aggregates increase in size, there are a few 
isolated cells left in suspension.
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Figure 6.4 Cell-cell interactions in short term cultures; fibroblasts treated with
cadherin function blockers.
Phase contrast images, x40 objective lens, Scale bars= 50 pm
A- Fibroblasts treated with HAV peptide, 0 hour time point
Cells are isolated in suspension.
B- Fibroblasts treated with HAV peptide, 1 hour time point
Cells are beginning to aggregate
C- Fibroblasts treated with HAV peptide, 4 hour time point
Tight cell aggregates form and fewer cells are in suspension.
D- Fibroblasts treated with HAV (10xconc), 0 hour time point
Cells accumulate loosely.
E- Fibroblasts treated with HAV (10xconc), 1 hour time point
Large cell aggregates are identified.
F- Fibroblasts treated with HAV (10xconc), 4 hour time point
Large amounts of cells are still isolated in the cell suspension.
G- Fibroblasts treated with N-cadherin blocking antibody, 0 hour time 
point. Cells are isolated in the cell suspension.
H- Fibroblasts treated with N-cadherin blocking antibody, 1 hour time 
point. Aggregates forming show isolated cells attaching at the periphery.
I- Fibroblasts treated with N-cadherin blocking antibody, 4 hour time 
point. Isolated cells are present in the cell suspension.
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Figure 6.5 Tendon fibroblasts in a 3-D suspension system
Scale bars at 50 pm.
Type I collagen
A- 0 hour time interval. Type I collagen label is positive intracellularly and in 
varying amounts in individual cells.
B- 0.5 hour time interval. There is no visible change between 0 and 0.5 hours 
of incubation.
C -1 hour time interval. The type I collagen label remains present, though its 
expression is still intermittent.
D- 1.5 hour time interval. The positive label appears to have increased and 
most cells label positive for type I collagen.
E- 2 hour time interval. There is little difference between 1.5 and 2 hours of 
incubation.
F- 3 hour time interval. This cluster of cells shows extracellular type I 
collagen label.
G- 4 hour time interval. At this time interval the cells all label positive for type 
I collagen.
H- 5 hour time interval. There is little change between 4 and 5 hours of 
incubation.
I- 6 hour time interval. After 6 hours there may be a small decrease in type I 
collagen label, but it is still positive in most cells.
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Figure 6.6 Tendon fibroblasts in a 3-D suspension system
Scale bars at 50 pm
Type II collagen
Type II collagen label is negative at all time intervals.
A- 0 hour time interval.
B- 0.5 hour time interval 
C- 1 hour time interval 
D- 1.5 hour time interval 
E- 2 hour time interval 
F- 3 hour time interval 
G- 4 hour time interval 
H- 5 hour time interval 
I- 6 hour time interval
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Figure 6.7 Tendon fibroblasts in a 3-D suspension system
Scale bars at 50 pm
Type III collagen
A- 0 hour time interval. Type III collagen label is positive intracellularly on 
intermittent cells.
B- 0.5 hour time interval. There is little difference between 0 and 0.5 hours of 
incubation.
C- 1 hour time interval. Type III collagen still displays a sporadic pattern of 
labelling.
D- 1.5 hour time interval. There is neither an increase nor a decrease in 
labelling.
E- 2 hour time interval. Type III collagen label remains intracellular.
F- 3 hour time interval. Individual cells still label positive for type III collagen.
G- 4 hour time interval. There is no change in type III collagen label between 
4-6 hours of incubation time.
H- 5 hour time interval
I- 6 hour time interval
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Figure 6.8 Tendon fibroblasts in a 3-D suspension system
Scale bars at 50 pm
Actin
A- 0 hour time interval. Actin label appears as a hazy green label covering 
the cytoplasm of each cell.
B- 0.5 hour time interval. There is no difference at any time interval and no 
actin stress fibres can be observed.
C -1 hour time interval
D -1.5 hour time interval
E- 2 hour time interval
F- 3 hour time interval
G- 4 hour time interval
H- 5 hour time interval
I- 6 hour time interval
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Figure 6.9 Tendon fibroblasts in a 3-D suspension system
Scale bars at 50 pm
Vimentin
A- 0 hour time interval. Labelling for vimentin closely follows labelling 
patterns for vinculin. With certain cells showing dominant label and labelling 
preference to the cell periphery.
B- 0.5 hour time interval
C -1 hour time interval
D -1.5 hour time interval
E- 2 hour time interval
F- 3 hour time interval
G- 4 hour time interval
H- 5 hour time interval
I- 6 hour time interval
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Figure 6.10 Tendon fibroblasts in a 3-D suspension system
Scale bars at 50 pm
Pan-cadherin
A- 0 hour time interval. Positive labelling for pan-cadherin shows a similar 
pattern to n-cadherin, however pan-cadherin appears to be more abundant.
B- 0.5 hour time interval. Most calls label positive for pan-cadherin.
C -1 hour time interval. There is little change from 1-6 hours incubation.
D -1.5 hour time interval
E- 2 hour time interval
F- 3 hour time interval
G- 4 hour time interval
H- 5 hour time interval
I- 6 hour time interval
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Figure 6.11 Tendon fibroblasts in a 3-D suspension system
Scale bars at 50 pm
n-cadherin
A- 0 hour time interval. Few cells label positive for n-cadherin, the positively 
labelled cells show label is concentrated at the cell edge.
B- 0.5 hour time interval. More cells label positive for n-cadherin.
C- 1 hour time interval. Small cell samples show labelling remains positive 
from 1-4 hours.
D -1.5 hour time interval
E- 2 hour time interval
F- 3 hour time interval
G- 4 hour time interval. Positive label is once again strong at the cell borders.
H- 5 hour time interval. There is little difference in label between 4-6 hours 
incubation.
I- 6 hour time interval
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Figure 6.12 Tendon fibroblasts in a 3-D suspension system
Scale bars at 50 pm
Vinculin
A- 0 hour time interval. Vinculin label is positive at 0 hours incubation.
B- 0.5 hour time interval. Small clusters of vinculin can be observed and a 
preference to the periphery of the cell can be seen.
C -1 hour time interval. Most cells label positive for vinculin.
D -1.5 hour time interval. All cells label positive for vinculin.
E- 2 hour time interval. In cell clusters some cells show a dominant label for 
vinculin.
F- 3 hour time interval. There is little difference between 2 and 3 hours of 
incubation.
G- 4 hour time interval. Cells continue to label positive for vinculin.
H- 5 hour time interval. The concentration of vinculin label to the periphery of 
the cells can be seen.
I- 6 hour time interval. After 6 hours of incubation the cells are still labelling 
positive for vinculin.
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Figure 6.13 Tendon fibroblasts in a 3-D suspension system
Scale bars at 50 pm
Connexin 32
A- 0 hour time interval. Connexin 32 label is present from 0 hours.
B- 0.5 hour time interval. After 0.5 hours of incubation the label is clear and 
expressed by most of the cellular population.
C- 1 hour time interval. Some cells appear to show an increased label for 
connexin 32.
D- 1.5 hour time interval. Connexin 32 label is widely observed and often 
appears to show cell polarity, where the label is concentrated on one side of 
the cell at the periphery.
E- 2 hour time interval. Cells continue to label positive for connexin 32.
F- 3 hour time interval. A small cell sample at this stage revealed cells 
labelled positive for connexin 32.
G- 4 hour time interval. After 4 hours of incubation there was no difference in 
the labelling pattern for connexin 32.
H- 5 hour time interval. It appears that after 5 hours of incubation not all cells 
label positive for connexin32.
I- 6 hour time interval. After 6 hours these cells label positive for connexin 32, 
however some show a more dominant label.
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Figure 6.14 Tendon fibroblasts in a 3-D suspension system
Scale bars at 50 pm
Connexin 43
A- 0 hour time interval. There are individual cells that label positive for 
connexin 43.
B- 0.5 hour time interval. The spotted appearance of this label can be hard to 
identify. Few cells are positive for connexin 43 label throughout this 
experiment.
C -1 hour time interval 
D -1.5 hour time interval 
E- 2 hour time interval 
F- 3 hour time interval
G- 4 hour time interval. Connexin 43 label is negative.
H- 5 hour time interval 
I- 6 hour time interval
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Figure 6.15 Initial cell-cell interactions investigations using articular 
chondrocytes in a 3-D suspension system, for 0-6hours. Scale bars at 50 pm.
A- 3 hour time interval. Type I collagen label. In small cell aggregates strong 
type I collagen label is present and possibly extracellular.
B- 0.5 hour time interval. Type II collagen label. Areas of positively labelled type 
II collagen are present in small cell aggregates.
C -1 hour time interval. Type III collagen label is negative at all time intervals.
D- 2 hour time interval. Actin. The central regions of cell clusters label strongly 
for actin.
E- 2 hour time interval. Vimentin label is negative at all time intervals.
F- 2 hour time interval. Vinculin label is concentrated at the cell periphery 
throughout each time interval.
G- 2 hour time interval. Connexin 32 label is positive throughout the cell 
population.
H- 2 hour time interval. Connexin 43 label is negative continually in suspension 
cultures.
228

Figure 6.16. Photographs of tendon cell aggregates. Images were acquired on an 
Olympus SZH10.
A-Tendon cell aggregates after 14 days in 3-D suspension culture. Aggregate is 
approximately 3cm long in total. Cellular tail widens into a film-like funnel of 
cellular material and within the funnel is a ball of cells. Scale bar=1cm.
B-A higher magnification of the funnelled end of the aggregate shows the creases 
that have formed in the thin cellular layer. The two smaller cellular aggregates 
within the funnel are securely attached to the sides of the funnel. The larger ball of 
cells located at the end of the funnel were easily detached. Scale bar=0.25cm.
C-Tendon cell aggregates after 14 days in 3-D suspension culture. An overall 
similar shape as in A, though in this DispoDialyzer tube more than one cell 
aggregate was formed. There are a total of 4 cell aggregates that developed within 
this tube. However, only one shows an elongated aggregate with a thin sheet of 
cellular material at one end.
D- Another example of an elongated cell aggregate after 14 days in 3-D 
suspension culture. Again note the bulbous aggregation of cells at one end. In this 
aggregate the ‘tail’ has become coiled at one end. Scale bar=1cm.
E- Tendon cell aggregates after 14 days in 3-D suspension culture, as seen in C. 
Note the amount of sheet-like cellular material at the upper end. Scale bar=1cm.
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Figure 6.17. Photographs of articular cartilage cell aggregates.
In all images of the articular chondrocyte cell aggregates the difference compared 
to tendon fibroblasts is staggering. In none of the experiments did the 
chondrocytes form any large cell aggregates. The small clusters visible 
disintegrated through handling. Phase contrast images were taken on a CK 40 
microscope.
A- Articular chondrocyte cell aggregates at 14 days in 3-D suspension culture. 
Scale bar=1cm.
B- Articular chondrocyte cell aggregates at 14 days in 3-D suspension culture.
C- Articular chondrocyte cell aggregates at 14 days in 3-D suspension culture. 
Scale bar=1cm.
D- Articular chondrocyte cell aggregates at 14 days in 3-D suspension culture.
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Figure 6.18 Long term large scale suspension culture experiments
Propidium iodide labelling of cell nuclei in tendon fibroblast aggregates in 3-D 
culture system
A- 24hour cell aggregate.
Nuclei labelled with propidium iodide show an even distribution throughout the cell 
aggregate. Even at this early stage there is evidence of flattened cells in peripheral 
regions.
Scale bar=20pm
B- 7 day cell aggregate.
Nuclei appear more condense, and in this section there is little evidence to 
suggest cell flattening at the aggregate surface.
Scale bar=50pm
C -14 day aggregate.
An elongated section of the aggregate shows significantly elongated nuclei 
arranged in a longitudinal and parallel fashion. The spaces between labelled nuclei 
suggest deposited ECM.
Scale bar=20pm
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Figure 6.19 Long term large scale suspension culture experiments
Immunohistological labelling of type I collagen present in tendon fibroblast 
aggregates in 3-D culture system
A- 24 hour ce ll aggregate.
Type I collagen is present showing a fibrous network after 24 hours in culture. The 
aggregate appeared to be relatively open cellular structure and the type I collagen 
is present throughout the aggregate, with more intense staining at the periphery. 
Scale bar= 20pm
B- 7day cell aggregate.
The increasingly dense aggregate continue to contain extracellular type I collagen. 
There is no significant difference between the intensity of labelling throughout the 
aggregate.
Scale bar= 20pm
C - 14 day cell aggregate.
After 14 days in culture, and in longitudinal areas of the cell aggregates, a type I 
collagen mesh can be observed. The distribution is ubiquitous in these regions 
and show no orientation with relation to the longitudinally orientated nuclei.
Scale bar= 50pm
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Figure 6.20 Long term large scale suspension cultures
Immunohistological labelling of type II collagen present in tendon fibroblast 
aggregates in 3-D culture system
A- 24 hour cell aggregate.
There is no type II collagen present at any stage throughout the aggregate. The 
open cellular structure of the aggregates after this time in culture is apparent. 
Scale bar=20pm
B- 7 day cell aggregate.
Type II collagen is negative after 7 days in culture and the longitudinal orientation 
of the cells can begin to be identified.
Scale bar=20pm
C- 14day cell aggregate.
There is no type II collagen present in the cultures after 14 days in culture. This 
section, from a rounded region of the aggregate, shows no cellular organisation. 
Scale bar=20pm
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Figure 6.21 Long term large scale suspension cultures
Immunohistological labelling of type III collagen present in tendon fibroblast 
aggregates in 3-D culture system
A- 24hour ce ll aggregate
Extracellular and fibrous type III collagen is present throughout the cell aggregate. 
Scale bar=20pm
B- 7 day cell aggregate
Positively labelled type III collagen can be observed in central parts of the 
aggregate. On either side there are 3-5 rows of cells showing no type III collagen 
label. Type III collagen remains fibrous and extracellular but continues to show no 
significant orientation, similarly to the nuclei labelled with propidium iodide.
Scale bar=20pm
C - 14 day aggregate
Type III collagen is significantly increased in this section compared to 7 day 
aggregates. The fibrous type III collagen have a longitudinal orientation and there 
is a possible collagen crimp detectable. Due to the type III collagen being 
particularly bright the nuclei labelled with propidium iodide are difficult to see, 
although they are elongate and orientated longitudinally. The label is evenly 
distributed and there are no signs of surface cells labelling negatively as in 7 day 
aggregates.
Scale bar=50pm
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Figure 6.22 Long term large scale suspension cultures
Histological labelling of actin present in tendon fibroblast aggregates in 3-D 
culture system
A- 24 hour cell aggregate.
Actin labelling is positive, although consistently show as a green hazy labelling in 
the cells. There is no difference in the intensity of labelling throughout the 
aggregate.
Scale bar=20pm
B- 7day cell aggregate
Actin can be seen in all cells indicating the presence of a filamentous network, the 
cloudy label suggests no actin stress fibres are present in the cell aggregate. 
Scale bar=20pm
C- 14day cell aggregate
In areas of the 14 day aggregates it was possible to identify some actin stress 
fibres, although only in areas of cells with a longitudinal orientation. In the majority 
of areas the characteristic hazy green label is predominant.
Scale bar=50pm
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Figure 6.23 Long term large scale suspension cultures
Immunohistological labelling of v incu lin  present in tendon fibroblast aggregates in 
3-D culture system
A- 24hour ce ll aggregate
Clearly labelled vinculin is observed throughout the cell aggregate and is 
increasingly intense at the periphery.
Scale bar=20pm
B- 7day cell aggregate
Vinculin was present in all areas of the aggregate. The characteristic peripheral 
patterning can be seen in each cell.
Scale bar=20pm
C- 14day cell aggregate
Ubiquitous vinculin is present, with an emphasis on peripheral labelling of the 
cells. There are areas of orientation, although not longitudinal.
Scale bar=20pm
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Figure 6.24 Long term large scale suspension cultures
Immunohistological labelling of connexin 32 present in tendon fibroblast 
aggregates in 3-D culture system
A- 24hour cell aggregate
Connexin 32 is present in the cells aggregate after 24hours in culture, with a 
significant labelling at the periphery. Connexin 32 is restricted to the rim of the 
cells in the aggregate.
Scale bar=20pm
B- 7day cell aggregate
Connexin 32 is evident after 7 days in culture. There is no significant change in 
intensity, although the peripheral regions containing more flattened cells do not 
exhibit the same intensity than in the 24 hour cultures.
Scale bar=20pm
C- 14day cell aggregate
Connexin 32 remains present in all areas of the aggregate. Again there is an 
increase in labelling intensity at the peripheral regions of the aggregate and the 
characteristic wisp-like labelling pattern can be observed.
Scale bar=20pm
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Figure 6.25 Long term large scale suspension cultures
Immunohistological labelling of connexin 43 present in tendon fibroblast 
aggregates in 3-D culture system
A- 24hours cell aggregate
Connexin 43 is present, though sparse in its distribution. Foci are generally 
present at the periphery of the aggregates.
Scale bar=20pm
B- 7day aggregate
Increasingly limited connexin 43 is seen, although its presence is hard to identify. 
Scale bar=20pm
C - 14 day aggregate
An increase in connexin 43 is apparent, although this is restricted to areas of the 
aggregate. There is background labelling creating a false positive image. The true 
connexin 43 label can be identified by the small punctate labelling.
Scale bar=20pm
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Figure 6.26 Embryonic tendon fibroblasts (E17) within 14 day cell aggregates.
Scale bars are measured in micrometers
Immunohistological labelling of ECM molecules present in tendon fibroblast 
aggregates in 3-D culture system.
A-Type I collagen label
Type I collagen label is positively labelled in these 14 day cell aggregates and 
there is no obvious orientation or any distinct collagen fibres to be determined.
B- Type II collagen label
Type II collagen label is negative throughout the cell aggregates.
C-Type III collagen label
Type III collagen label is present in the cell aggregates, although there is 
approximately one cell layer at the cell surface that labels negatively for type III 
collagen.
D- Tenascin label
Tenascin labels positively with an even distribution throughout the aggregate.
E- Decorin label
Decorin label shows a peripheral pattern of labelling within the aggregate.
F- Vimentin label
Vimentin is present throughout the cell aggregate.
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Figure 6.27 Embryonic tendon fibroblasts (E17) within 14 day cell aggregates.
Scale bars are measured in micrometers
Immunohistological labelling of cytoskeletal and cell junctional molecules present 
in tendon fibroblast aggregates in 3-D culture system.
A-Act in label
Phalloidin label for actin is positive and concentrated in the periphery of the cell 
aggregate. Cells are orientated perpendicularly to the aggregate surface and the 
actin appears to follow their orientation.
B- Vinculin label
Vinculin label is positive throughout the cell aggregate with a uniform distribution 
C- pan-cadherin
pan-cadherin label is positive, showing a spotted pattern of labelling.
D- n-cadherin
n-cadherin shows a prominent speckled labelling pattern.
E- Connexin 32
Gap junctional protein connexin 32 is abundant label throughout the aggregate.
F- Connexin 43
Connexin 43 label is weak and is only found in isolated areas of the aggregate.
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Figure 6.28 Tendon fibroblasts in 3-D roller culture cultures, DispoDialyzer tubes
with 50 and 100 KDa MWCO.
Immunolabelled for types I, II and III collagen.
A- 14day cell aggregate. Cultured in iOOKDa MWCO DispoDialyzer tubes and 
labelled with type I collagen antibody. The elongated nature of the cells within the 
aggregate is identified by propidium iodide labelled nuclei. Positively labelled type I 
collagen is visible throughout the aggregate but lacks any discemable orientation. 
Scale bar=20pm
B- 14day cell aggregate. Cultured in IOOKDa MWCO DispoDialyzer tubes and 
labelled with type II collagen antibody. There is no positive label for type II 
collagen.
Scale bar=20pm
C- 14day cell aggregate. Cultured in IOOKDa MWCO DispoDialyzer tubes and 
labelled with type III collagen antibody. Longitudinally arranged nuclei can be 
identified and type III collagen labels positively in a fibrous manner. There is little 
indication of matrix orientation, although some is identified running longitudinally 
between cells.
Scale bar=20pm
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Figure 6.29 Tendon fibroblasts in 3-D roller culture cultures, DispoDialyzer tubes
with 50 and 100 KDa MWCO.
Immunolabelled for tenascin, actin and vimentin.
A- 14day cell aggregate. Cultured in 50KDa MWCO DispoDialyzer tubes and 
labelled for tenascin. The longitudinal and parallel orientation of the propidium 
iodide labelled cells is clear and the positively labelled tenascin can be identified. 
Thin fibrous streaks of label are seen between cells within the aggregate.
Scale bar=20pm
B- 14day cell aggregate. Cultured in 50KDa MWCO DispoDialyzer tubes and 
labelled for actin. Hints of actin stress fibres can be seen with a suggestion of 
longitudinal orientation. Other positively labelled cells within the aggregate show 
the characteristic green hazy of label associated with actin filament networks. 
Scale bar=20pm
C- 14day cell aggregate. Cultured in 50KDa MWCO DispoDialyzer tubes and 
labelled for vimentin. Positively labelled vimentin can be observed throughout the 
cell aggregate, though little longitudinal orientation is identified. The labelling 
intensity is slightly increased at the aggregate periphery and in these areas 
labelling has an increased degree of organisation.
Scale bar=20pm
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Figure 6.30 Tendon fibroblasts in 3-D roller culture cultures, DispoDialyzer tubes
with 50 and 100 KDa MWCO.
Immunolabelled for n and pan-cadherin and vinculin.
A- 7day cell aggregate. Cultured in 50KDa MWCO DispoDialyzer tubes and 
labelled for n-cadherin. Beautifully orientated cells show positively labelled n- 
cadherin after 7 days in roller culturing system. The pattern of labelling shows the 
elongated shape of cells within the aggregate, though the individual foci of 
labelling are difficult to identify here.
Scale bar=20pm
B- 14day cell aggregate. Cultured in 100KDa MWCO DispoDialyzer tubes and 
labelled for pan-cadherin. Positively labelled pan-cadherin is present throughout 
the cell aggregate, though little orientation is seen here.
Scale bar=20pm
C- 14day cell aggregate. Cultured in 100KDa MWCO DispoDialyzer tubes and 
labelled for vinculin. Areas of longitudinal and positively labelled vinculin are 
identified within the cell aggregate. Generally cells are labelled positively but a 
cloudy label predominates.
Scale bar=20pm
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Figure 6.31 Tendon fibroblasts in 3-D roller culture cultures, DispoDialyzer tubes
with 50 and 100 KDa MWCO.
Immunolabelled for connexin 32 and 43.
A- 7day cell aggregate. Cultured in 50KDa MWCO DispoDialyzer tubes and 
labelled for connexin 32. Highly orientated cells and elongated nuclei label 
positively for connexin 32. The label is characteristically wisp-like and is identified 
in all cells.
Scale bar=20pm
B- 14day cell aggregate. Cultured in 100KDa MWCO DispoDialyzer tubes and 
labelled for connexin 32. A less orientated section than in A, the connexin 32 
remains constant and distributed throughout the aggregate.
Scale bar=20pm
C- 14day cell aggregate. Cultured in 100KDa MWCO DispoDialyzer tubes and 
labelled for connexin 43. Typically difficult to find connexin 43 label shows a small 
amount of positively labelled points. There is no orientation to the sparse labelling. 
Scale bar=20pm
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Figure 6.32- 7 day 3-D cultures, treated with growth factors.
Scale bars represent 20 micrometers, unless otherwise stated.
Immunohistological labelling of ECM molecules present in tendon fibroblast 
aggregates in 3-D culture system.
A-TGFp treated fibroblasts-labelled with type I collagen.
Type I collagen label is present throughout the cell aggregates treated with TGFp. 
B-IGF treated fibroblasts-labelled with type I collagen
Positively labelled for type I collagen, showing extracellular labelling throughout 
the cell aggregate.
C- TGFp treated fibroblasts- Labelled with type III collagen
Type III collagen shows a more centralised pattern of labelling, taking on a fibrous
arrangement. There are cell nuclei in the periphery labelling negatively for type III
collagen.
D- IGF treated fibroblasts- Labelled with type III collagen
Labelling for type III collagen shows centralised labelling, taking on a convoluted 
pattern of fibrous labelling. There are several cell layers surrounding the type III 
collagen label, which label negatively for type III collagen.
E- TGFp treated fibroblasts- Labelled with tenascin.
Tenascin label is distributed evenly throughout the cell aggregate.
F- IGF treated fibroblasts- Labelled with tenascin.
Positively labelled tenascin is present extracellularly all the way through the cell 
aggregate.
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Figure 6.33- 7 day 3-D cultures, treated with growth factors.
Scale bars represent 20 micrometers, unless otherwise stated.
Immunohistological labelling of cytoskeletal and associated molecules present in 
tendon fibroblast aggregates in 3-D culture system.
A- TGFp treated fibroblasts- Labelled with phalloidin
Actin label is positive and actin stress fibres can be observed, but show no 
orientation.
B- IGF treated fibroblasts- Labelled with phalloidin
Positively labelled actin is clearly visible and short stress fibres can been seen, 
although there is little or no organisation of the cells.
C- TGFp treated fibroblasts- Labelled with vimentin
Vimentin label is positive in the cell aggregate. Though the labelling is stronger in 
the periphery, there is positive label throughout the aggregates.
D- IGF treated fibroblasts- Labelled with vimentin
Positive labelling for vimentin is concentrated at the cell periphery, though lesser 
degrees of labelling are present in central regions of the aggregate.
E- TGFp treated fibroblasts- Labelled with vinculin 
Vinculin is positively labelled throughout the cell aggregate.
F- IGF treated fibroblasts- Labelled with vinculin
Positive label for vinculin in the cell aggregates shows the characteristic pattern of 
labelling focused at the cell periphery.
AActin
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Figure 6.34- 7 day 3-D cultures, treated with growth factors.
Scale bars represent 20 micrometers, unless otherwise stated.
Immunohistological labelling of cell junctional molecules present in tendon 
fibroblast aggregates in 3-D culture system.
A- TGFp treated fibroblasts- Labelled with n-cadherin
n-cadherin label is positive in the cell aggregates with no notable organisation.
B- IGF treated fibroblasts- Labelled with n-cadherin
n-cadherin label was present though label was strongest at the edges of the cell 
aggregate.
C- TGFp treated fibroblasts- Labelled with connexin 32
Connexin 32 label is present throughout each cell aggregate. Areas nearest the 
aggregate periphery showed the strongest labelling.
D- IGF treated fibroblasts- Labelled with connexin 32
A similar labelling pattern as aggregates treated with TGFp, positive label 
observed throughout the cell aggregate but labelling focused at areas nearest the 
aggregate periphery.
E- TGFp treated fibroblasts- Labelled with connexin 43
Connexin 43 label shows negative label, though there are areas of auto­
fluorescence.
F- IGF treated fibroblasts- Labelled with connexin 43 
There is no label for connexin 43 present in the cell aggregates.
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Collagen produced by cells in suspension cultures
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Figure 6.35. Shows collagen retained within the cell aggregate, released into the 
inner dialysis tubing and released into the total media. n=1.
Collagen produced by cells in suspension culture after 1 week
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Figure 6.36. Shows total collagen retained within the cell aggregate, released into 
the inner dialysis tubing and released into the total media. n=1.
268
Collagen production from cells in long term suspension cultures: IGF-
I treated
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Figure 6.39. Shows the actual amounts of collagen released into the two media 
reservoirs of suspension cultures treated with IGF-I.
Collagen production from cells in long term suspension culture: 
TGF-beta treated
4000
3500
3000
2> 2500
®  2000
1500
1000
500
□  1 week 1% TGF-beta
□  1 week 5% TGF-beta
□  1 week 1%
■  2 weeks 5% TGF-beta
Total media Inner tube
Figure 6.40. Shows the actual amounts of collagen released into the two media 
reservoirs of suspension cultures treated with TGF-p.
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6.4 DISCUSSION
Results show firstly, that both tendon fibroblasts and chondrocytes formed 
substantial cell aggregates in 1-2 hours in suspension culture, and secondly that 
fibroblasts form large aggregates in long term cultures, over 1-21 days. Large 
scale structures had some indications of a tendon-type cell-matrix structure. The 
short term cultures could be regarded as an in vitro model of the in vivo 
condensation process, in that a widely spaced cell population (suspension in vitro, 
mesenchyme in vivo) forms a densely packed cell aggregation or condensation. 
The long term aggregation can be regarded as modelling tissue differentiation and 
growth.
Short term cell aggregation
Cell adhesion molecules are known to have significant involvement in cellular 
condensations of connective tissues, particularly n-cadherin and NCAM in 
cartilage development (Tavella et al, 1994). In the experiments described above n- 
cadherin was expressed by all cells in short term suspension cultures, but 
aggregation could not be blocked with specific function blockers. In vivo the 
timings of n-cadherin expression in cartilage correlates directly with the period of 
active condensation (Tavella et al, 1994). Investigations into the temporal and 
spatial expression NCAM and n-cadherin in development indicates n-cadherin is 
involved in the initiation of cell-cell interactions, and NCAM follows by stabilising 
the contacts (Tavella et al, 1994). However, in a series of experiments by Tuan 
and colleagues, n-cadherin has been shown to be involved in cartilage 
condensation. Blocking antibodies reduced cell aggregations in vitro and in vivo 
(Oberlender and Tuan, 1994). In vivo experiments, involving the injection of n- 
cadherin blocking antibodies into the hindlimb of the chick embryo showed 
chondrogenesis to be moderately to severely delayed together with corresponding 
skeletal deformities. Subsequent experiments using recombinant expression 
plasmids show overexpression of n-cadherin in micromass cultures enhances 
cellular condensation and chondrogenesis (DeLise and Tuan, 2002a), whereas, 
the use of deleted mutants and consequent reduction of n-cadherin expression did 
result in decreased cell condensation (DeLise and Tuan, 2002b).
In the experiments performed here, cell aggregation could not be blocked. There 
are several possible reasons why this may have happened. It may be that the 
experiments to block cadherin-mediated interactions simply failed, however, as 
two different blocking techniques were attempted this seems unlikely. Other
271
Collagen production by cells in suspension culture
120
100
80w
I  60ra
20 
0
Total media Innertube
Figure 6.37. Shows the actual amounts of collagen released into the two media 
reservoirs. The first group of columns represent the total media used in the 
experiment, any media changes were kept and added. The second group of 
columns represent the media taken from inside the dialysis tubing. Small n values 
mean no statistical data could be acquired, n is between 1 and 3.
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Figure 6.38. Shows the actual amounts of collagen released into the two media 
reservoirs. Blue columns represent collagen from the total media and the red 
columns the collagen from the media in the inner tube. Small n values mean no 
statistical data could be acquired, n is between 1 and 3.
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investigations into cadherins have chosen HAV peptides or blocking antibodies to 
block cadherin-based cell interactions with success, including the epithelial cells of 
the proximal tubule, osteoblasts and osteoclasts, endothelial cells and neuronal 
cells (Bergin et al, 2000; Cheng et al, 1998; llvesaro, 1998; Chuah et al, 1991; 
Tang et al, 1998; Wanner and Wood, 2002; Harper et al, 1993; Gerhardt et al, 
2000; Oberlender and Tuan, 2000). There are however, reports of blocking 
antibodies that do not cause complete obliteration of cadherin function, their 
conclusion was possibly a sub-optimal stoichiometry (Oberlender and Tuan, 1994). 
Other possibilities are that aggregation is not initially cadherin-based.
Some authors report that cell condensation mechanisms in vivo involve the 
activation of at least three pathways, none involving n-cadherin. The first requires 
the initiation of epithelial-mesenchymal interactions involving tenascin, growth 
factors, BMP-2, TGFp-1 and transcription factors, Msx-1 and -2  (Saxen and 
Thesleff, 1992; Hall and Miyake, 1992, 1995, 2000; Mackie, 1994; Dunlop and 
Hall, 1995), the second is the up-regulation of N-CAM by activin, a member of the 
TGF-p superfamily (Jiang et al, 1993) and the third is the up-regulation of 
fibronectin by TGF-p, further enhancing N-CAM accumulation (Chimal-Monroy et 
al, 1999). Reports concluded that it is by these three pathways that condensations 
are initiated and grow. It is important to note that n-cadherin is not indicated as 
part of these steps towards condensation, and the results described here suggest 
that it is not important in early condensation of tendon cells.
Cadherins may become important after the condensation process, with the 
formation of cell-cell junctions, either directly as adherens junctions or indirectly by 
mediating the formation of other cell-cell junctions. Certainly adherens junctions 
and gap junctions are characteristic features of interaction between adult tendon 
cells in vivo (McNeilly et al, 1996; Ralphs et al, 2002). Cells in suspension culture 
express major components of adherens and gap junctional complexes, including 
cadherins, vinculin and actin (Pavalko and Otey, 1994; Steinberg and McNutt, 
1999). It is fair to acknowledge the formation of cell-cell junctions in this 
suspension culture; interestingly, adherens junctions are a pre-requisite for gap 
junctions (Gumbiner, 1987; Geipmans, 2004). The upregulation of E-cadherin has 
been shown to increase gap junctional communication and N-cadherin blocking 
antibodies can prevent adherens junction and gap junction formation in some cell 
types (Jongen etal, 1991; Meyer etal, 1992). This does not appear to be the case 
in the experiments of this study.
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Other molecules indicated in early chondrogenesis, implying involvement in the 
cell condensation process are ECM components and integrins. Tenascin is 
present in the condensing mesenchyme of the limb but absent from the 
surrounding cells (Ros et al, 1995), and is known to be involved in cell-adhesion 
(Chiquet-Ehrismann et al, 1991; Riou et al, 1992; Chiquet-Ehrismann, 2004) and 
tendon development (Hurle et al, 1989,1990). Also COMP, or thrombospondin 5, 
has been found to enhance several early aspects of chondrogenesis by slowing 
the rate of cell growth (Kipnes et al, 2003). COMP contains an RDG sequence and 
is known to interact with fibronectin (DiCesare et al, 2002), indicating yet another 
possible role for integrin signalling in the condensation process. It would be 
interesting to know how blocking antibodies to integrin function or RGD peptides 
affected cell aggregation in the short term cultures.
Aggregation may involve cell surface receptors not tested, for example NCAM, as 
indicated above, but may also involve cell-matrix interactions. Areas of 
mesenchyme in the developing limb differentiate and produce elevated levels of 
fibronectin, induced by bFGF and TGFp (Hentschel et al, 2004). This in turn 
initiates adhesion mediated pre-skeletal condensations. If cells interact with 
fibronectin in the initiation of condensation, the cell-cell adhesion may involve 
integrins and cell-surface fibronectin. Cells held within this fibronectin scaffold then 
proliferate and increase cell-cell interactions (Hall and Miyake, 1995). An additional 
member of the TGFp family, GDF-5, is known to cause an increase in cell 
adhesion and cell proliferation when cultured in chondrocyte suspensions, 
consisting of isolated cells in a sealed bijou tube on a roller and micromass 
cultures (Francis-West et al, 1999; Hatakeyama et al, 2004).
Gap junctions comprised of connexin 43 or 32 are prominent between tendon cells 
in vivo (McNeilly et al, 1996), but distribution and apparent amounts are different in 
the short term cultures. As in pellet cultures, connexin 32 was widespread and 
connexin 43 was present, although sparse. Connexin 32 label was in two positions 
within the cell, extensively at the cell surface at cell interfaces, and often 
intracellulariy at a prominent perinuclear position. The former is a potential site of 
functional gap junction communication, whereas the latter is likely to be part of the 
intracellular trafficking system (Windoffer et al, 2000). Connexin 32 is turned over 
rapidly at the cell surface, with a half-life of around 3 hours. Connexin trafficking 
involves the golgi and connexin oligomerization and occurs in the golgi
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membranes (Musil and Goodenough, 1993; Koval et al, 1997); it seems likely that 
the intracellular label involves a concentration of connexin 32 at this site. 
Functionally, the two gap junctions appear to have different roles in tendon, as 
discussed in chapter 4. Briefly, signalling via connexin 32 is stimulatory, whereas 
connexin 43 is inhibitory to collagen under load (Waggett et al, submitted; Waggett 
et al, 2001). As in the pellet culture system and early developing tendons, the 
collagen stimulatory pathway appears to be favoured in conditions in which 
complete tissue architecture has yet to be established.
Type I collagen was labelled in most cells in suspension culture, including 
chondrocytes. Intracellular labelling was observed from time zero, suggesting that 
type I collagen seen at this stage was made by the cells when they were cultured 
as monolayers and retained after subculture, when cells were transferred to the 
high density culture. Its presence in chondrocytes was indicative of their de­
differentiation in monolayer culture, with loss of type II collagen and onset of type I 
synthesis (Benya et al, 1978; Grundmann et al, 1980). The presence of 
extracellular type I collagen within three hours in the cell aggregates, taken along 
with the results of pellet cultures (chapter 5) demonstrates that the cells are able to 
rapidly lay down ECM after only a few hours in a high density 3-D culture. This is 
not the case for type III collagen which remained intracellular in the short term 
despite the fact that in longer term suspension cultures type III collagen is 
deposited (see below). It is interesting that type III collagen often precedes type I 
collagen deposition in development and in repair (Williams et al, 1980; Maffuli et 
al, 2000), but that this does not occur in all circumstances, i.e. in these short term 
intervals in suspension.
Collagen production from tendon fibroblasts in other type of suspension cultures 
showed that initial type I collagen production was at similar levels as in vivo, 
however, on an hourly basis this level dropped (Quinones et al, 1989). If taken 
together, these results imply the expression of type I collagen may fall, but the 
cells can retain the ability to deposit type I collagen in the correct environment, for 
example, a cell aggregate.
Long term aggregation
Long term cultures formed large aggregates, which showed a degree of tissue 
orientation and were responsive to growth factors TGFp and IGF-1. This was after 
cells having 3 passages in monolayer culture to expand cell numbers, indicating
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some retention of tendon-like characteristics through the monolayer culture period. 
Some aggregates were of a size and shape relevant to potential tissue 
engineering application, being up to 3cm long. Tissue organisation, growth factor 
responsiveness and potential applications of these cultures are discussed below.
A variety of aggregate shapes were formed within cultures, with rod shapes, 
curved sheet-like structures and spherical or ovoid structures. These shapes must 
have been produced by a combination of influences, including cell interactions with 
one another and with the matrix they deposit, the rolling of the culture tube and the 
cells/aggregates hitting its walls, and by hydrodynamic forces involving fluid 
movements caused by the rolling and rocking of the tubes on the roller.
Cell aggregates interact with the rotating and rocking wall of the dialysis tube, but 
do not adhere to it. As the cell aggregate stays at the lower part of the tube, as it 
lies horizontally, they tend to be rolled into rounded structures in response to the 
circumferential motion of the tube, and moved longitudinally backwards and 
forwards in the tube as it rocks slightly, tending to form elongated structures. 
However, these movements cannot be isolated from hydrodynamic influences, as 
cells will be experiencing shear and rotational forces from fluid movements 
generated by the motion of the tube. Elongated aggregates tend to form in the 
main part of the tube and rounded one towards the ends, perhaps reflecting 
differences in liquid behaviour in these two regions. Fluid-flow stresses are known 
to have effects in a range of cell types, for example inducing differentiation of 
embryonic stem cells into endothelial cells, and increasing production of cell 
adhesion molecules, vascular endothelial (VE)-cadherin and PECAM-1 
(Yamamoto et al, 2004). Endothelial cells subjected to a laminar flow can orientate 
themselves along the direction of flow (Yamamoto et al, 2003). In connective 
tissues fluid shear is involved in bone cell activation (Bacabac et al, 2004) and is 
known to enhance chondrogenesis (Buschmann et al, 1999). These mechanical 
and fluid stresses are important in the system as they do result in some 
mechanical stimulation of the cultures. They would therefore, appear to be 
important in the culture structure and organisation.
Cell-cell interactions appear to be stronger in tendon cells than in chondrocytes, as 
tendon cells are able to form structures in this system, whilst chondrocytes are not. 
This is clearly a departure from the early stage aggregation behaviour where 
tendon cells and chondrocytes behave identically. As described above, there is
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evidence that this process is independent of n-cadherin; however it may be that 
this becomes more important in the large scale aggregates. N-cadherin is 
expressed in the long term cultures, whereas in cartilage cultures it is known to 
decrease with differentiation (Tavella et al, 1994). It may be that the tendon cells 
develop the cadherin based adherens junction contacts observed in vivo (Ralphs 
et al, 2002) as the cultures differentiate, whereas chondrocytes do not. 
Differentiated chondrocytes in vivo have few cell-cell contacts and are isolated by 
the matrix they deposit (Buckwalter, 1983), therefore lose contact with one 
another, whereas tendon cells in vivo are attached by cell junctions (McNeilly et al, 
1996; Kannus, 2000; Ralphs et al, 2002).
Cell and matrix organisation in older cultures can resemble that of the mature 
tendon tissue (Kannus, 2000), with parallel rows of cells separated by orientated 
collagenous matrix. This was particularly prominent in the more elongated 
aggregates. It appears therefore that the cells have an intrinsic ability to reform in 
vitro the structures reminiscent of their original tissue in this culture system. 
Experiments using fibroblasts from different tissues showed that when seeded into 
collagen gels, tendon, dermal and cornea fibroblasts did retain a certain intrinsic 
‘memory’ (Doane and Birk, 1991). Tendon fibroblasts formed parallel cell arrays 
within non-orientated collagen gels, corneal fibroblasts orientated orthogonally and 
dermal fibroblasts showed no apparent organisation. Even in the spherical 
aggregates of this study cells still formed an ordered structure, with layers of 
matrix and cells at the periphery and with areas of organised collagen in central 
regions of these aggregates. This also occurred in pellet cultures where the SEM 
images showed parallel orientation of cells at the pellet periphery.
Cells were evenly distributed in smaller rounded cell aggregates, rod-like 
structures and thin sheets. In larger aggregates cell distribution appears lower in 
the centre, which may be due to nutritional problems and/or oxygen deficiencies. 
Diffusion distances are relatively large to the centre of the aggregates, and thus 
low oxygen levels might be expected (Baltz and Biggers, 1991; Levick, 1995). Low 
oxygen tension enhances anaerobic metabolism and can be assessed by 
measuring the amount of lactate, a by-product of glycolysis, present in these areas 
(Malda et al, 2004). Evidence for some lactate tolerance of tendon cells has been 
shown (Klein et al, 2001), where cells resume synthesis of collagen levels 
corresponding to that in vivo. Cartilage is probably one of the most well known 
tissues to principally rely on glycolysis for its respiration (Otte, 1991; Archer and
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Francis-West, 2003). This leads to the maintenance of a relatively small population 
of cells within the tissue (Buckwalter and Mankin, 1998). Similar, and perhaps 
even more extreme conditions can occur in the intervertebral disc. Cells in central 
parts of the disc can be between 7-8mm from the nearest blood supply (Urban and 
Roberts, 2003), in these areas oxygen-tension is low and lactate production 
increases. This results in a decrease in the rate of matrix synthesis and eventually 
cell death and degeneration of the disc (Urban and Roberts, 2003). These 
observations show that when culturing large cellular constructs, it is important to 
have a cell density appropriate to the nutritional conditions available, for example 
in cell populations with a restricted nutrient supply only a small number of cells can 
be supported. Many bioreactors have built-in oxygen chambers to counteract this 
(Leclerc et al, 2004) and perfusion systems have been shown to combat this 
problem (Radisic et al, 2003).
Cytoskeletal elements actin and vimentin can be seen in the cell aggregates. 
Vimentin is evident in spherical, sheet-like and rod-like cell aggregates with bright 
immunolabel. Vimentin is the typical intermediate filament of connective tissues 
(Wang^and Stamenovic, 2002), associated with changes in mechanical load in 
chondrocytes (Durrant et al, 1999), and in tendons particularly associated with 
fibrocartilage (Ralphs et al, 1991). Vimentin expression within these cultures is a 
clear difference between the in vivo, rather weak expression in mature tensional 
tendon, and the in vitro situation. Vimentin is, however, present in developing chick 
flexor tendons, shown in chapter 3, which may indicate that the state of the tendon 
construct has similarities with embryonic tendon. In addition, some aspect of the 
fluid flow or other physical situation of the culture system may be causing cells to 
express vimentin. There was no evidence of chondrogenic differentiation, as 
occurs in fibrocartilage (Ralphs et al, 1991; Rufai et al, 1992), in these cells as 
examined by labelling for chondrocytic products.
Prominent labelling of actin fibres occurred only in organised regions of sheet-like 
and rod-like shaped aggregates and not in spherical ones. It is striking that these 
are in the regions that most resemble tendons in structure, which also contain 
prominent actin fibres similar to tendon cells in vivo (Ralphs et al, 2002). In large, 
rounded aggregates only the green ‘haze’ of labelling was observed indicating the 
presence of a filamentous actin network, but no distinctive actin fibres. At the 
periphery of the rounded aggregates were areas of positively labelled actin fibres, 
where the cells were orientated in parallel sheets around the aggregate. This is
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similar to the periphery of the pellets, where orientated cells also occur therefore, 
there is an association of actin fibres and orientated cells. Fibroblasts are able to 
generate tensile force, involving actin stress fibres, when cultured in collagen gels 
(e.g. Halliday and Tomasek, 1995; Schneider et al, 1999; Gentleman et al, 2004), 
and so it may be that cells are able to do so in the large scale cultures. Actin stress 
fibres are characteristic of tendon cells experiencing or exerting tensile loading 
(Stephens et al, 1992; Halliday and Tomasek, 1995; Ralphs et al, 2002) and it may 
be that such loads exist where there are orientated tendon fibroblasts. Cell 
orientation and actin fibres together suggest intrinsic generation of tension and 
organised parts of the cultures.
Extracellular matrix molecules and the cytoskeleton have a reciprocal relationship 
where the ECM can induce effects on cell shape and function (Mooney et al, 1995) 
and cytoskeleton effects matrix organisation. The actin cytoskeleton is known to be 
associated with fibronectin deposition (Schwarzbauer and Sechler, 1999) and the 
involvement of both is implicit in cell differentiation (Antras et la, 1989). In addition, 
the actin cytoskeleton can affect orientation of developing tissues. Actin stress 
fibres orientate cells and the ECM of the intervertebral disc in development (Hayes 
et al, 1999). Disc cell alignment, induced by the actin cytoskeleton, was observed 
before a matrix was deposited corresponding with the cell orientation. It may be 
therefore, that in some culture regions the actin fibres are involved in cell 
orientation and matrix deposition. This would correspond with results from chapter 
3, showing longitudinally orientated actin fibres present in early tendon 
development.
N-cadherin and vinculin are involved in connecting actin stress fibres between 
tendon cells longitudinally in vivo (Ralphs et al, 2002). In cultures derived from 
adult cells both labels were bright but diffuse at the cell surface, rather than being 
present as punctate, high intensity spots between cells. Interestingly, these were 
observed in the cultures derived from embryonic cells, indeed this was the only 
observed difference between adult and embryonic cells in all of the culture 
experiments. It is not clear why there should be such a difference, as the in vitro 
morphogenic situation would appear to be the same. It could be that label intensity 
in adults is affected by expression of additional cadherins types, as suggested by 
increased pan-cadherin labelling masking n-cadherin based junctions, but 
fundamental reasons for this difference remain obscure.
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Connexin distribution, as discussed above, was similar to pellets and the short 
term aggregation experiments, with similar implications to collagen synthesis 
(Waggett et al, submitted; Waggett et al, 2001). Even though cultures showed a 
degree of orientation, the organisation of connexins was not the same as in vivo 
(McNeilly et al, 1996). As in the pellet and short term cultures connexin 32 was 
much more widespread than connexin 43, with an indication that connexin 43 was 
becoming more prominent in older cultures. As indicated above, and in chapters 3 
and 4, connexin 32 represents a stimulatory pathway for collagen synthesis and 
connexin 43 an inhibitory one. It appears that connexin 32 dominates whilst tissue 
is being established, and connexin 43 appears later. Connexin 43 is mechanically 
regulated (Banes et al, 1995) and its expression and phosphorylation is 
upregulated in response to load. It may be that with cell and matrix organisation 
and stress fibre formation, the extent of mechanical stimulation to cells in these 
older cultures in sufficient to promote connexin 43 expression. Therefore, the 
stimulatory pathway appears to be active when tissue is being constructed in vivo 
and in vitro, and negative regulation appears when tissue starts to be stressed.
Immunolabelling shows abundant ECM was produced by cells within 24 hours of 
culture with label appearing to increase over 7 and 14 days in culture. In 7 and 14 
day cultures, regions of aggregates showing cell organisation also showed matrix 
organisation, with types I and III collagen between orientated rows of tendon cells. 
Type III collagen was present throughout the matrix, and was thus perhaps more 
like the situation in developing or repairing tendon (Birk and Mayne, 1997; Maffulli 
et al, 2000). Label for type I collagen, whilst positioned between cell rows, did not 
display a strong fibrous orientation like type III collagen. It may be that type I 
collagen fibres were too fine to be resolved and thus just appeared as a finely 
textured fluorescence, whereas the type III collagen formed larger structures. 
Certainly it was clear from the TEM studies of pellet cultures that the fibroblasts 
were capable of laying down orientated bundles of fine collagen fibres. In vivo, 
type III collagen is characteristic of the material around tendon fascicles of type I 
collagen, and the fascicular structure is established early in tendon differentiation 
(Birk and Mayne, 1997). An intriguing possibility is that cells were making some 
kind of fascicular structure visible only in immunolabel for type III collagen. This 
happens around day 14 in development (Birk and Mayne, 1997), with some 
evidence that it may begin earlier (see chapter 3), with deposition of type III 
collagen around groups of cells.
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The effects of serum and growth factors showed that cultures treated with low 
serum formed no cell aggregates. Experiments using 5% serum, TGFp and IGF-1 
resulted in well-structured cell/matrix assemblies. There were no discernable 
qualitative effects on matrix synthesis or cell adhesion in aggregates fed with 
5%FBS/DMEM and either growth factor treatment, therefore presence of the 
growth factors enabled compensation for a reduction in serum content. TGF(3 is 
known to increase the synthesis of n-cadherin and integrins, matrix synthesis and 
cell proliferation (Massague et al, 1985; Moses et al, 1987; Fine and Goldstein, 
1993; Klein et al, 2002; Heinemeier et al, 2003). IGF-I is known to increase matrix 
synthesis (James and Bradshaw, 1984; Roberts etal, 1985: Massague etal, 1985; 
Molloy et al, 2003; Grazul-Bilska et al, 2003) and could promote cell adhesion; the 
upregulation of IGF-1 receptor increases expression of e-cadherin in tumour cells 
(Mauro et al, 2001, 2003), therefore both cells can enhance features important in 
forming these structures, i.e. molecules involved in cell-cell adhesion, and the 
ECM. Cell aggregates produced in dialysis membranes with smaller pore sizes, 
MWCO of 50kDa and 100kDa, showed no qualitative differences in ECM 
molecules retained by the cells, cell junctional proteins or connexins expressed 
implying the pore sizes were of no significance in this system. Interestingly, 
although pellet cultures grown in DMEM containing 1% serum were able to 
synthesise and secrete a collagenous matrix, cells within these long term 
suspension cultures were unable to do so. The significant difference between 
these systems is motion. It is unclear as to why pellet cultures appeared relatively 
unaffected by the low serum content, possibly because they are encouraged into 
contact with one another by centrifugation and are able to establish a stable 
environment. Whereas, there is a significant difference in the cells ability to adhere 
to one another in these suspension cultures when fed with 1% serum. The cells 
are unable to adhere and consequently fail to form any significant structure, 
whether the presence of low serum levels affects cell surface adhesion protein 
expression is unclear.
Quantitative studies were disrupted by the commercial decision of SpectraPor to 
discontinue the production of the DispoDialyzer tubes with the 300kDa MWCO 
membranes. Because of this, data for the 300kDa MWCO tubes is incomplete as it 
was planned to do a complete series of quantitative analysis of the cell aggregate, 
media of the inner tube and the outer growth medium. Experiments with 50kDa 
and 100kDa MWCO dialysis tubes were performed, but the cell aggregate had to 
be used for morphological studies for comparison with the 300kDa MWCO
280
membranes. In consequence the overall data is incomplete and most 
investigations have very low numbers. Statistical analysis is not therefore possible. 
However, the results have been incorporated here for interest, information and 
discussion even though they cannot be regarded as statistically valid.
In experiments where collagen was measured in the cell aggregates, inner tube 
media and total growth media, collagen within the aggregates was high, in excess 
of 60% of the total. The implication from these results is that this system 
encourages collagen retention by the aggregates to greater levels than found in 
the pellet cultures in chapter 5 (15-25% of collagen was retained). It is likely that if 
these cultures were put under any mechanical strain the collagen amounts would 
be increased, and the cell aggregates may retain larger amounts of collagen 
(Chiquet et al, 1996).
The only comparisons to be made between the 50kDa, 100kDa and 300kDa 
MWCO tubes, is that collagen released into the total growth media is relatively 
higher in 300kDa MWCO cultures than in the 50kDa and 100kDa MWCO tubes. 
This corresponds with the large molecular weights of collagens, described above, 
collagen fragments from cultures grown in 300kDa MWCO membranes are able to 
pass through the membrane easily. It is also possible that nutrients have increased 
access to the cell aggregates again due to the larger pore size, enabling the 
production of elevated levels of collagen. The experiments with 50kDa and 
100kDa MWCO tubes show that collagen is still released to the main culture 
medium, even though fibrillar collagens have molecular weights of approximately 
95kDa per alpha chain (Dehm and Kefalides, 1978; reviewed Bomstein and Sage, 
1980), so an assembled molecule would be approximately 285kDa. These would 
only just fit through the 300kDa MWCO membrane and then only with the correct 
orientation. This indicates collagen released into the media has smaller molecular 
weights and consequently that the collagen is being degraded. This implies the 
presence of matrix metalloproteases (MMPs) that digest collagen in vivo (Harper, 
1980). MMPs have a substantial role in matrix degradation and are known to 
cleave collagens into very small pieces, essentially down to tripeptides (reviewed 
Overall, 2002; Stamenkovic, 2003). In the context of this culture system MMPs 
may have a role in degrading collagen fragments synthesised by the cells, 
enabling released collagen to pass through the membrane into the growth media.
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Growth factors added to these long term suspension cultures showed a 
compensation for lower serum levels as previously described, and both growth 
factors have similar effects on collagen synthesis compared to the 5% serum 
controls. IGF-1 appeared to increase collagen production over TGF-J3 treatment. 
Similar results would have been expected from each growth factor treatment. The 
growth factor TGF-(3 however, is known to have a short active life in vitro (Coffey et 
al, 1987; Wakefield et al, 1990). It is possible the initial affects of IGF-I have a 
knock-on effect on the cells and its application enabled lasting effects on the cells. 
It is also possible that cells within the cultures were synthesising their own supply 
of growth factors, either intrinsically or that IGF-I induced the production of other 
growth factors (Banes et al, 1995; Tsuzaki et al, 2000; Dalhgren et al, 2005).
The definitions of tissue engineering are varied (Langer and Vacanti, 1993), but 
most incorporate words to the effect Tissue engineering is the development and 
subsequent replacement of diseased or damaged living tissue with living tissue 
designed and constructed for the needs of each individual to restore, maintain and 
improve function’. Tissue engineering in tendon has rapidly evolved (reviewed in 
chapter 1). Other attempts to engineer tendon have focused on cell-seeded 
scaffolds, mainly because of the strain the replacement tissue would be under 
instantly upon being implanted. The scaffolds used in these situations are growing 
rapidly and can be made of natural material or synthetic, biodegradable or not 
(DeFranco, 2004). Overall, this large scale culture system shows some promise as 
a method for producing fibrous connective tissue structures in the absence of any 
exogenous scaffold structures. Tendon cells have been shown to produce 
organised and orientated cell-matrix structures sharing some features in common 
with both adult and embryonic tendon structure. Substitution of serum with growth 
factors, albeit in the presence of a small serum component, suggests that a 
defined culture medium could be developed for use with them. The absence of 
scaffold and a potentially defined culture medium would be of considerable 
advantage in a tissue-engineering context. Further possible developments of this 
system are discussed in chapter 7.
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CHAPTER 7 
General Discussion
7. GENERAL DISCUSSION
Overall, the work described in this thesis has been aimed at examining how events 
in the development of tendons may be replicated in vitro with particular reference 
to cell-cell interactions and matrix deposition. More specifically, evidence is 
presented that 3-D cell organisation, with the increased possibility for cell 
interaction provided, appears to enhance the ability of tendon cells to lay down an 
ECM compared to conventional monolayer culture. As described in the chapters 4, 
5 and 6, this ECM retention could relate to there being cell-bound spaces into 
which cells can deposit their matrix, which would be very limited in monolayer. 
However, there remains a considerable loss of collagenous material into the 
culture medium, indicating the pellet system is not ideal. One possibility is that the 
aggregates are not adequately ‘sealed’. Perhaps the presence of tendon 
macrostructure such as epitenon and fascicle-bounding endotenon is necessary, 
or the presence of tight, sealing junctions between cells and their processes. An 
alternative possibility is that this pellet system models matrix synthesis and 
catabolism, rather than actual matrix assembly. The degradation of connective 
tissue ECM is important in matrix turnover and remodelling (Rees et al, 2000; 
review Overall and Lopez-Oten, 2002; Archambault et al, 2002a, b; Stamenkovic,
2003). MMPs initiate the extracellular degradation of collagen and are known to 
increase expression after injury, aiding in the removal of debris and remodelling 
deposited scar tissue (Cleutjens et al, 1995; Ishiguro et al, 1996; Maricourt et al, 
1995). Their role in this system is yet to be investigated. There are tantalising 
clues that the large scale cultures may be an improvement in the deposition and 
retention of collagen compared to monolayers, micromass and pellet cultures, 
although statistical difficulties mean that this is not conclusive.
Cells in the long term 3-D roller culture system essentially express the same cell 
junction molecules and ECM as the embryonic tendons. One key observation 
suggesting that this 3-D system does indeed model tendon development better 
than a monolayer is the expression of gap junction proteins. Early embryonic 
tendon and the long term 3-D culture system both show strong expression of 
connexin 32 and weak or absent connexin 43 label. In all of these systems it may 
be that connexin 32 is associated with the promotion of collagen synthesis, and 
connexin 43 with inhibition (Waggett et al, submitted, Waggett et al, 2001), 
suggesting that under condition of low matrix, stimulatory pathways are enhanced. 
Monolayers do not exhibit this differential expression, perhaps correlating with a 
poor ability to deposit matrix. Cell-cell junctions and their components are known
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to be important in many developmental processes, including chondrogenesis 
(Oberlender and Tuan, 1994; Reviewed in Pizette and Niswander, 2001; Hoffman 
et al, 2003; Tuan, 2003), osteogenesis (Katagiri and Takahsi, 2002; Bouletreau et 
al, 2002) and possibly tendon development (Edom-Vovard and Duprez, 2004).
As indicated in chapter 6, the large scale cultures show potential for tissue 
engineering applications. This potential is the main focus of the remainder of this 
discussion. As described in chapter 6, the definition of tissue engineering stands 
as: Tissue engineering is the development and subsequent replacement of 
diseased or damaged living tissue with living tissue designed and constructed for 
the needs of each individual to restore, maintain and improve function’ (Langer 
and Vacanti, 1993). In the context of tendons, it is of potential value in repair of 
injury or severe rheumatic disease. A number of approaches have been attempted 
in experimental systems. These may involve the creation of materials to be 
implanted to augment tendon function with the aim of having them invaded and 
populated by host tissues. One scaffold based construct involved in tendon repair 
to have been accepted at clinical level is GraftJacket (Wright Medical, Arlington, 
TN), a biological scaffold used in the augmentation of tendon repair (Lee, 2004). It 
consists of a mesh of ECM macromolecules including type I, III, IV and VII 
collagen, elastic, proteoglycans, laminin, tenascin and bFGF and has been used in 
rotator cuff tendon reinforcement (Lee, 2004). It can be revascularised between 4- 
7 days with host cell infiltration complete at 14 days. The cell population measured 
within the construct is the same as the host tissue surrounding it (Chaplin et al,
1999). Following this re-population, histochemical studies show the protein 
framework is slowly incorporated and replaced by normal host tissue, undergoing 
gradual remodelling (Chaplin et al, 1999). There is no host immunological 
response (Brigido et al, 2004) and the construct does not undergo processing that 
would result in cross-linking and subsequent inflammation (Chaplin et al, 1999). 
The strength of GraftJacket has also been tested and found that it has a 
comparably high suture retention load of approximately 120N (Rubin et al, 1999). 
This may be a promising material with a range of uses, but it remains far from a 
complete tendon replication in vitro. Other scaffolds used clinically with similar 
functions include Restore Orthobiologic Implant (DePuy, Warsaw, IN), Permacol 
(Zimmer, Warsaw, IN) and OrthoMend (Stryker, Mahwah, NJ), however, regular 
failures remain a significant problem with these structures. Also, theoretically, this 
is not tissue engineering, as the constructs have no cells when they are implanted 
and therefore, the construct is not a ‘living tissue’.
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Alternatively, scaffold structures may be seeded with host cells, either tissue 
specific cells or mesenchymal stem cells and then implanted (Bosch and Krettek, 
2002; Jorgensen et al, 2004; Sun et al, 2005; Uematsu et al, 2005). Mesenchymal 
stem cells have been used in efforts to create almost every type of tissue in vitro, 
including tendon (Awad et al, 1999; Kail et al, 2004), each relying heavily on a 
scaffold component and each having limited success. A further approach involves 
injecting cells directly into the injury site (Yamada et al, 2004; Crevensten et al, 
2004), with the aim of the cells augmenting the natural tendon healing response. 
All methods have advantages and disadvantages. Scaffold-based systems involve 
placing a material into a host, which may elicit immune a response, or generate 
unwelcome breakdown products. Cells may not behave as anticipated, for 
example implanted cells may die or proliferate abnormally. Cells injected into 
damaged tissue may help to repair it, but will be of little use if defects are large or 
lengths of tendon are absent. Whatever the method, an integration of the 
engineered tissue with the host is vital. It is difficult to synthesise a construct 
without an original scaffold.
The large structures developed in chapter 6 could be regarded as scaffold-free 
tissue engineered constructs of tendon. They have, at best, a good degree of 
orientation and possibly a useful amount of organised matrix deposition. If they 
could be developed further they may provide a solution for some tissue repair 
solutions. Theoretically, large scale structures could be prepared from autologous 
tissue, thus reducing the need for a scaffold and eliminating the chance of a host 
immune reaction. Also, the natural assembly forces within the developing 
aggregates are unlikely to interfere with cell regulatory networks (Kelm et al, 
2004). A different scaffold-free approach to tendon tissue engineering has recently 
been published, which although initially based as a monolayer, shows some 
promise in developmental and mechanical tendon characteristics (Calve et al,
2004). Therefore, scaffold-free tissue engineering approaches appear potentially 
viable. It is important therefore, to examine possible ways of improving such 
culture systems. Further developments would have to be made in several areas; 
consistency in the production of tendon-shaped aggregates, with fewer cells lost to 
incorrectly shaped structures; nutrition of large scale aggregates; strength of 
aggregates and specific structure and composition of aggregates to match 
potential implant sites.
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Increasingly the reliability of appropriately shaped tendon-like cell aggregates 
probably requires alteration to the roller culture system. As indicated in chapter 6, 
the aggregate shapes are created by cell adhesion followed by interaction with the 
rotating and rocking walls of the inner dialysis tube and by hydrodynamic 
movements of medium within the tube, Modification of rotation and tilt rates may 
well result In the corporation of more cells into rod shaped aggregates, with less 
waste to other shapes. There is also the intriguing possibility that modifying such 
parameters and changing shapes of the culture vessel could be used to produce 
different shapes altogether. Flattened, rounded culture vessels could be used to 
produce annular and disc shaped aggregates, for example, for other repair 
situations.
An important aspect of developing large scale culture constructs is in provision of 
nutrition. The system used here was derived to allow interaction of large numbers 
of cells in the long term, without disturbance by media changes. This relatively 
simple response may have its nutritive limitations, however, as there was evidence 
of reduced cell density in central regions of large aggregates. Within the limitations 
of the study, changing the pore size of the dialysis tubing had little effect on the 
structure and composition of the cell aggregates, so some other modification may 
be necessary. One simple approach may simply be to change the feeder media 
more frequently, increasing nutrient supply and removing waste. Alternatively, a 
more nutrient rich medium might be used, with additional supplements and 
possibly gassed oxygen, although this would have to be carefully controlled given 
tendon cells sometime anaerobic metabolism (Klein et al, 2001). A more 
sophisticated approach would be to develop a continuous flow through medium 
supply, although this inevitably increases the complexity of the system. This 
approach is used in other systems including cells in dialysis tubing to produce cell 
products, for example the Technomouse’ used to produce monoclonal antibodies 
(Pannell and Cesar, 1995; Nagel et al, 1999) or some of the larger scale 
bioreactors systems (Falkenberg, 1994).
An alternative approach to increasing nutrient access to inner parts of large 
aggregates would be to try to form a vascular network within the aggregates. 
Microvascular endothelial cells will form tubular capillary-like structures under the 
appropriate situations in the correct ECM environment (Madri et al, 1988; Tada et 
al, 1994; Faitova et al, 2004). It would be interesting to determine whether seeding 
the initial tendon cell population with a proportion of microvascular endothelial cells
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would allow the formation of a capillary-like network within the constructs, possibly 
with treatment using angiogenic factors, such as VEGF (reviewed in Patan, 2004). 
Such a network could improve access to the deeper parts of cells aggregates for 
exchange of materials and in the ultimate development, potentially link with the 
host vasculature if constructs were implanted. The development of microvascular 
networks in tissue engineering has recently been reviewed by Kannan et al (2005). 
Some of the constructs produced in the work described in chapter 6 had labelling 
features that could be interpreted as attempts to recreate a fascicular structure i.e. 
the expression and distribution of type III collagen. The fascicular structure is 
intimately associated with the vascular system of a tendon (Brockis, 1953; Fenwick 
et al, 2002) and thus could become involved in vascularisation of the constructs.
The 3-D hierarchical architecture of the tendon is also important in its ability to 
resist mechanical loading. The development of a fascicular system could therefore, 
also be important is functional aspects of tendon replacement. Measurements on 
whole tendons in vivo reveal strains under load of up to 7-8% (Abrahams, 1967; 
Woo et al, 1982; Baer et al, 1988). However, if strains such as this are applied to 
tendon samples in vitro, strain measurements subjected to cells do not exceed 
1.2% (Screen et al, 2004). This is related to the sliding mechanism of fascicles 
under load. Replication of fascicular architecture would therefore be valuable from 
two points of view: provision of nutrition, and protection of cells from excessive 
strain.
For constructs to work in tissue engineering applications they must be strong 
enough to be handled and to perform a function once implanted. Scaffold-based 
systems would appear to have an advantage here as the necessary actually 
strength can be designed into the scaffold. For a scaffold-free approach to be 
successful, its strength would have to be at an appropriate level for handling and 
implantation. Increasing the strength of scaffold-free structures must involve 
increasing deposition and organisation of the extracellular matrix, Various aspects 
of this could be addressed by the application of mechanical load and treatment 
with growth factors. Cyclic tensile loading is known to increase types I and III 
collagen and tenascin expression by fibroblasts (Chiquet et al, 1996; Waggett et 
al, 1998) and improve collagen organisation in scar tissue (Zimmerman et al,
2000). The challenge is in applying mechanical load to the cell aggregates with the 
culture system. There are some devices designed to apply tensile strain to 
relatively small tissue constructs, for example the strain device used to load
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tendon fascicles (Screen et al, 2004) or the flexercell ‘tissue train’ device (Garvin 
et al, 2003). These could almost certainly be adapted to loading the elongate cell 
aggregates with an appropriate cyclic loading regime. However, the disadvantage 
is that material would have to be removed from the culture vessel, introducing new 
handling stages and giving increased possibilities of contamination.
An alternative approach is to treat the cells with growth factors to enhance their 
matrix productions, to go some way towards mimicking the effects of mechanical 
loading by biochemical treatment. In the relatively simple experiments described in 
chapters 5 and 6, PDGF, bFGF, TGF(3 and IGF individually and in combination 
showed some abilities to at least replace unknown serum-based factors in 
promoting collagen secretion, although no treatment proved better than serum. 
These experiments would have to be extended to look at the dose response, 
different combinations and different factors to determine whether a significant 
enhancement could be made. An important aspect of such studies would be to aim 
towards producing a defined medium, without serum supplements so that the 
system can be fully defined for regulatory, commercial and legislative purposes. 
Assuming some enhancement in strength and size can be made, it may be 
possible to design a treatment regime where a construct from the culture system is 
implanted, and then mechanically conditioned in situ, by controlled re-mobilisation 
procedures for the patient to strain the implant and then gradually enhance its 
properties as treatment progresses.
If such implants were to be grafted into patients, consideration would have to be 
given to integration to host tissues. With tendon implants this means integrating 
with pre-existing tendon, with muscle and/or with bone. With tendon, one might 
hope that fairly minor variations on suturing techniques used in standard tendon 
repairs (Wilson and Sammut, 2003) may be applicable. Followed by the standard 
biological tendon repair process assisted by treatments, such as continuous 
passive motion and careful physiotherapy. At bone attachments, if a normal 
pattern of enthesis development were to occur, then bone must be encouraged to 
grow into tendon (Benjamin and Ralphs, 2000; Benjamin et al, 2002; Milz et al, 
2002). Since this occurs by a process somewhat analogous to endochondral 
ossification, with metaplasia to fibrocartilage followed by fibrocartilage hypertrophy, 
vascular invasion and bone formation, perhaps some form of chondrogenic 
treatments with BMP or TGFp family (Schmitt et al, 2003; Grunder et al, 2004; 
Goldberg et al, 2005) members may be appropriate at the bone attachment, along
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with VEGF to encourage angiogenesis (Molloy et al, 2003). A further point is that 
at other sites, the tendon construct must be encouraged not to integrate, i.e. it 
must not form adhesions along its route to the paratenon or tendon sheath. This is 
a significant problem if tendons are immobilised in vivo (Taras and Lamb, 1999; 
Feldscher and Schneider, 2003; Smith et al, 2004) and is likely to be a serious 
consideration with tissue engineered materials. At least the observation that the 
cell constructs appear to make an epitenon-like structure may indicate that 
progress could be made with this problem.
Overall, the large scale culture system could have tissue engineered applications. 
It has some important merits; it is simple, based on standard disposable items and 
therefore cheap and sterile. One could envisage creating 1 pack of disposable 
systems for growing tendon, or ligament implants if various issues were solved. 
Against it is that it is difficult to apply mechanical load to cells, which would 
probably result in a better construct, and there are some nutritive problems whose 
solution may increase the complexity of the system and therefore negate some of 
the benefits. Nevertheless, this simple system needs further development to 
assess the extent to which it could be used to form reasonably sized, well 
organised and useable connective tissue implants.
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Absorbance Values
0.076 0.083 0.082 0.089 0.094 0.099 0.115 0.103 0.111
0.076 0.084 0.089 0.1 0.103 0.099 0.104 0.11 0.109
0.097 0.094 0.093 0.097 0.102 0.099 0.104 0.104 0.107
0.108 0.11 0.107 0.109 0.113 0.108 0.107 0.106 0.107
0.114 0.118 0.111 0.109 0.112 0.107 0.103 0.104 0.1
0.096 0.097 0.093 0.104 0.111 0.107 0.095 0.095 0.113
0.109 0.122 0.108 0.113 0.115 0.108 0.113 0.106 0.112
0.105 0.12 0.111 0.108 0.11 0.112 0.113 0.106 0.112
standard abs log st logOD
1 0.084 0 -1.07831 slope 0.16 1.3 1.2
2 0.086 0.30103 -1.06803 intercept -1.10 1.4 2.0
3 0.095 0.477121 -1.02457 rsq 0.93
4 0.099 0.60206 -1.00656
5 0.099 0.69897 -1.00436 1.3 1.6
6 0.110 0.778151 -0.96059 1 2
7 0.107 0.845098 -0.97265
8 0.110 0.90309 -0.95861
9 0.113 0.954243 -0.94692
10 0.121 1 -0.91901
Actual values 
0.7 1.3 1.2 2.0 2.8 3.9 10.1 5.0 8.0
0.7 1.4 2.0 4.1 5.0 3.9 5.3 7.6 7.2
3.4 2.8 2.6 3.4 4.7 3.9 5.3 5.3 6.4
6.8 7.6 6.4 7.2 9.0 6.8 6.4 6.0 6.4
9.5 11.8 8.0 7.2 8.5 6.4 5.0 5.3 4.1
3.2 3.4 2.6 5.3 8.0 6.4 3.0 3.0 9.0
7.2 14.6 6.8 9.0 10.1 6.8 9.0 6.0 8.5
5.6 13.2 8.0 6.8 7.6 8.5 9.0 6.0 8.5
0.113 0.123 0.084
0.113 0.118 0.086
0.106 0.103 0.109
0.109 0.106 0.112
0.104 0.103 0.105
0.112 0.11 0.116
0.111 0.109 0.111
0.129 0.127 0.111
2.0
4.1
2.8
5.0
3.9
3.9
10.1
5.3
5.0
7.6
8.0
7.2
9.0
9.0
3.1
3
3.9
4
3.9
5
7.7
6
6.3
7
7.6
8
9.0
9
9.0 15.4 1.4
9.0 11.8 1.6
6.0 5.0 7.2
7.2 6.0 8.5
5.3 5.0 5.6
8.5 7.6 10.6
8.0 7.2 8.0
20.8 18.8 8.0
15.4
11.8
13.6 average 
10 standard
analysed with: Analyse-it + General 1.71
Test 1-way between subjects ANOVA
Total
Comparison 2week: 0.01, 0.05, FGF+PDGF, FGF+TGF, TGF+PDGF
Performed by Laura Haughton Date | 24 January 2005
nl 35
2 week n Mean SD SE
0.01 7 30.860 12.846 4.8554
0.05 7 46.646 7.041 2.6611
FGF+PDGF 7 26.211 6.917 2.6144
FGF+TGF 7 19.186 6.784 2.5641
TGF+PDGF 7 45.141 18.864 7.1300
Source of variation SSq DF MSq F P
2week 4012.791 4 1003.198 7.55 0.0002
Within cells 3985.954 30 132.865
Total 7998.745 34
Tukey
Contrast Difference 95% Cl
0.01 v 0.05 -15.786 -33.657 to 2.085
0.01 v FGF+PDGF 4.649 -13.223 to 22.520
0.01 v FGF+TGF 11.674 -6.198 to 29.545
0.01 v TGF+PDGF -14.281 -32.153 to 3.590
0.05 v FGF+PDGF 20.435 2.563 to 38.306
0.05 v FGF+TGF 27.460 9.588 to 45.331
0.05 v TGF+PDGF 1.505 -16.367 to 19.376
FGF+PDGF v FGF+TGF 7.025 -10.846 to 24.896
FGF+PDGF v TGF+PDGF -18.930 -36.801 t o -1.059
FGF+TGF V TGF+PDGF -25.955 -43.826 to -8.084
(significant)
(significant)
(significant)
(significant)
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Growth factor single treatments
Collagen present in 1 day cultures 
Pellets
1%
Hydroxypr Collagen
1.35 
1.37 
1.32 
1.39
1.35
9.42 
9.58 
9.27 
9.74
9.43
3.24
4.18
3.37
4.60
5.01
Hydroxypr Collagen/DNA
0.42
0.33
0.39
0.30
0.27
2.91
2.29
2.75
2.12
1.88
Media
Hydroxypr Collagen
1.06
1.32
1.08
1.29
1.01
7 43 
9 24 
7.58
9.06
7.07
3.24
4.18
3.37
4.60
5.01
0.05
Hydroxypr Collagen DNA Hydroxypr Collagen/DNA Hydroxypr Collagen
1.38 9.66 2.24 0.62 4.31 1.47 10.29
1.40 9.82 3.65 0.38 2.69 1.33 9.29
1.37 9.58 1.23 1.11 7.79 1.54 10.78
1.41 9.90 3.84 0.37 2.58 1.52 10.63
1.29 9.04 3.50 0.37 2.59 1.30 9.07
1.24 8.67 3.84 0.32 2.26 1.29 906
1.43 9.98 4.79 0.30 2.08 1.46 10.19
FGF
Hydroxypr Collagen DNA Hydroxypr Collagen/DNA Hydroxypr Collagen
1.43 9.99 3.96 0.36 2.52 1.24 8.69
1.37 9.59 8.03 0.17 1.19 0.86 6.00
1.44 10.09 5.62 0.26 1.79 0.85 5.97
1.42 9.91 4.80 0.29 2.06 0.81 5.69
1.38 9.67 5.67 0.24 1.71 0.88 6.14
1.28 8.97 4.46 0.29 2.01 0.93 6.51
1.67 11.71 2.73 0.61 4.30 0.85 5.92
2.24
3.65
1.23
3.84 
3.50
3.84 
4.79
3.96
8.03
5.62
4.80
5.67
4.46
2.73
TGF
Hydroxypr Collagen DNA Hydroxypr Collagen/DNA Hydroxypr Collagen DNA
1 38 9.63 4.43 0.31 2.18 1.86 13.04 4.43
1.77 12.40 4.55 0.39 2.73 0.95 6.66 4.55
5.50 38.49 5.85 0.94 6.58 0.90 6.29 5.85
1.48 10.35 4.88 0.30 2.12 0.97 6.81 4.88
1.50 10.52 3.86 0.39 2.73 0.97 6.80 3.86
1-34 9.38 5.21 0.26 1.80 0.92 6.42 5.21
PDGF
Hydroxypr Collagen DNA Hydroxypr Collagen/DNA Hydroxypr Collagen DNA
1.75 12.23 6.28 0.28 1.95 1.09 7.60 6.28
141 986 5.52 0.25 1.78 1,90 13.27 5.52
1.49 10.43 3.98 0.37 2.62 1.10 7.71 3.98
1.55 10.86 5.65 0.27 1.92 1.14 8.00 5.65
1.73 12.13 4.77 0.36 2.54 1.01 7.10 4.77
1.54 10.76 2.35 0.66 4.59 0.59 4.12 2 35
1-59 11.11 4.11 0.39 2.70 0.57 3.99 4.11
Total
Hydroxypr Collagen/DNA Total Hydr collagen DNA Total Hydr Collagen/DNA
0.33 2.29 2.41 16.85 3.24 0.74 5.20
0.32 2.21 2.69 18.82 4.18 0.64 4.51
0.32 2.25 2.41 16.86 3.37 0.71 5.00
0.28 1.97 2.69 18.80 4.60 0.58 4.09
0.20 1.41 2.36 16.50 5.01 0.47 3.29
Hydroxypr Collagen/DNA Total Hydr collagen DNA Total Hydr Collagen/DNA
0.66 4.60 2.85 19.95 2.24 1.27 8.91
0.36 2.54 2.73 19.11 3.65 0.75 5.23
1.25 8.76 2.91 20.36 1.23 2.36 16.55
0.40 2.77 2.93 20.53 3.84 0.76 5.34
0.37 2.59 2.59 18.11 3.50 0.74 5.18
0.34 2.36 2.53 17.73 3.84 0.66 4.62
0.30 2.13 2.88 20.17 4.79 0.60 4.21
Hydroxypr Collagen/DNA Total Hydr collagen DNA Total Hydr Collagen/DNA
0.31 2.20 2.67 18.68 3.96 0.67 4.72
0.11 0.75 2.23 15.60 8.03 0.28 1.94
0.15 1.06 2.29 16.06 5.62 0.41 2.86
0.17 1.19 2.23 15.59 4.80 0.46 3.25
0.15 1.08 2.26 15.82 5.67 0.40 2.79
0.21 1.46 2.21 15.48 4.46 0.50 3.47
0.31 2.17 2.52 17.83 2.73 0.92 6.46
Hydroxypr Collagen/DNA Total Hydr collagen DNA Total Hydr Co#agen/Df
0.42 2.94 3.24 22.66 4.43 0.73 5.12
0.21 1.46 2.72 19.06 4.55 0.60 4.19
0.15 1.07 6.40 44.78 5.85 1.09 7.65
0.20 1.39 2.45 17.16 4.88 0.50 3.51
0.25 1.76 2.48 17.33 3.86 0.64 4.49
0.18 1.23 2.26 15.80 5.21 0.43 3.03
Hydroxypr Collagen/DNA Total Hydr collagen DNA Total Hydr Collagen/Df
0.17 1.21 2.83 19.83 6.28 0.45 3.16
0.34 2.40 3.30 23.13 5.52 0.60 4.19
0.28 1.94 2.59 18.14 3.98 0.65 4.56
0.20 1.42 2.69 18.85 5.65 0.48 3.34
0.21 1.49 2.75 19.23 4.77 0.58 4.03
0.25 1.76 2.13 14.88 2.35 0.91 6.34
0.14 0.97 2.16 15.09 4.11 0.52 3.67
Growth factor single treatments
Collagen present in 7 day cultures 
1%
Pellet Media
Hydroxy Collagen In pellets DNA Hydroxy Collagen/DNA Hydroxy Collagen In media DNA
1.18 8.24 12.02 0.10 0.69 1.99 13.92 12.02
1.11 7.76 7.74 0.14 1 00 1.48 10.37 7.74
1.12 7.81 7.61 0.15 1 03 2.00 13.99 7.61
1.44 10.11 15.85 0.09 0.64 2.06 14.39 15.85
1.07 7.46 9.12 0.12 0.82 1.76 12.30 9.12
0.98 6.84 8.26 0.12 0.83 1.82 12.73 8.28
1.07 7.52 7.75 0.14 0.97 1.41 9.84 7.75
0.05
Hydroxy Collagen in pellets DNA Hydroxy Collagen/DNA Collagen in media DNA
1.17 8.22 6.51 0.18 1.26 2.31 16.18 6.51
1.01 7.07 11.70 0.09 0.60 3.07 21.49 11.70
1.04 7.26 9.18 0.11 0.79 2.29 16.01 9.18
1.06 7.41 8.35 0.13 0.89 2.37 16.58 8.35
0.98 6.88 8.09 0.12 0.85 2.61 18.24 8.09
1.00 6.97 8.72 0.11 0.80 2.52 17.65 8.72
1.02 7.17 8.11 0.13 0.88 2.53 17.73 8.11
FGF
Hydroxy Collagen in pellets DNA Hydroxy Collagen/DNA Collagen in media DNA
1.03 7.23 4.57 0.23 1.58 2.29 16.03 4.57
0.89 6.22 10.17 0.09 0.61 2.94 20.59 10.17
1.03 7.22 7.15 0.14 1.01 2.58 18.07 7.15
1.06 7.42 5.14 0.21 1.44 2.91 20.34 5.14
1.17 8.21 10.24 0.11 0.80 3.33 23.31 10.24
1.13 7.92 10.23 0.11 0.77 2.39 16.74 10.23
1.60 11.22 10.97 0.15 1.02 2.55 17.86 10.97
TGF
Hydroxy Collagen in pellets DNA Hydroxy Collagen/DNA Collagen in media DNA
1.22 8.52 5.45 0.22 1.56 1.87 13.08 5.45
1.29 9.06 9.29 0.14 0.98 3.11 21.75 9.29
1.18 8.24 5.52 0.21 1.49 3.70 25.89 5.52
1.26 8.81 7.91 0.16 1.11 4.16 29.12 7.91
1.15 8.02 4.64 0.25 1.73 3.32 23.24 4.64
1.68 11.74 3.54 0.47 3.32 3.85 26.93 3.54
1.14 7.98 8.34 0.14 0.96 3.33 23.32 8.34
PDGF
Hydroxy Collagen in pellets DNA Hydroxy Collagen/DNA Collagen in media DNA
1.13 7.88 6.25 0.18 1.26 4.57 32.01 6.25
1.10 7.71 7.15 0.15 1.08 2.55 17.87 7.15
1.19 8.35 11.36 0.11 0.74 3.25 22.74 11.36
1.12 7.87 8.01 0.14 0.98 2.70 18.87 8.01
1.13 7.92 9.51 0.12 0.83 2.97 20.78 9.51
1.04 7.29 10.36 0.10 0.70 2.19 15.36 10.36
1.19 8.35 4.89 0.24 1.71 1.55 10.83 4.89
Total collagen
Hydroxy Collagen/DNA Total collagen DNA Total colla Collagen/DNA
0.17 1.16 3.17 22.16 12.02 0.26 1.84
0.19 1.34 2.59 18.13 7.74 0.33 2.34
0.26 1.84 3.12 21.81 7.61 0.41 2.86
0.13 0.91 3.50 24.50 15.85 0.22 1.55
0.19 1.35 2.82 19.77 9.12 0.31 2.17
0.22 1.54 2.80 19.57 8.26 0.34 2.37
0.18 1.27 2.48 17.36 7.75 0.32 2.24
Hydroxy Collagen/DNA Total collagen DNA Total colla Collagen/DNA
0.35 2.48 3.48 24.39 6.51 0.53 3.74
0.26 1.84 4.08 28.56 11.70 0.35 2.44
0.25 1.74 3.33 23.28 9.18 0.36 2.53
0.28 1.99 3.43 23.99 8.35 0.41 2.87
0.32 2.25 3.59 25.12 8.09 0.44 3.10
0.29 2.02 3.52 24.63 8.72 0.40 2.82
0.31 2.19 3.56 24.90 8.11 0.44 3.07
Hydroxy Collagen/DNA Total collagen DNA Total colla Collagen/DNA
0.50 3.51 3.32 23.26 4.57 0.73 5.09
0.29 2.02 3.83 26.81 10.17 0.38 2.64
0.36 2.53 3.61 25.29 7.15 0.51 3.54
0.56 3.95 3.97 27.76 5.14 0.77 5.40
0.33 2.28 4.50 31.52 10.24 0.44 3.08
0.23 1.64 3.52 24.66 10.23 0.34 2.41
0.23 1.63 4.15 29.08 10.97 0.38 2.65
Hydroxy Collagen/DNA Total collagen DNA Total colla Collagen/DNA
0.34 2.40 3.09 21.60 5.45 0.57 3.96
0.33 2.34 4.40 30.81 9.29 0.47 3.32
0.67 4.69 4.88 34.13 5.52 0.88 6.18
0.53 3.68 5.42 37.93 7.91 0.69 4.80
0.71 5.00 4.47 31.26 4.64 0.96 6.73
1.09 7.61 5.52 38.67 3.54 1.56 10.93
0.40 2.80 4.47 31.30 8.34 0.54 3.75
Hydroxy Collagen/DNA Total collagen DNA Total colla Collagen/DNA
0.73 5.12 5.70 39.90 6.25 0.91 6.38
0.36 2.50 3.65 25.57 7.15 0.51 3.57
0.29 2.00 4.44 31.10 11.36 0.39 2.74
0.34 2.36 3.82 26.73 8.01 0.48 3.34
0.31 2.18 4.10 28.70 9.51 0.43 3.02
0.21 1.48 3.24 22.65 10.36 0.31 2.19
0.32 2.22 2.74 19.17 4.89 0.56 3.93
Growth factor single treatments
Collagen present in 14 days cultures
Hydroxypr Collagen in pellets DNA
1.79 12.56
1.85 12.94
1.72 12.04
1.62 11.35
1.68 11.74
1.90 13.27
1.86 13.05
0.05
Hydroxypr Collagen
1.75 12.23
1.99 13.90
2.03 14.24
1.91 13.37
1.86 13.05
1.85 12.94
1.95 13.68
FGF
Hydroxypr Collagen
2.70 18.90
1.80 12.63
1.96 13.74
1.82 12.74
1.59 11.16
1.55 10.87
1.85 12.96
TGF
Hydroxypr Collagen
1.66 11.62
1.72 12.03
1.87 13.07
1.60 11.22
1.80 12.62
1.65 11.52
1.78 12.43
PDGF
Hydroxypr Collagen
1.66 11.62
1.63 11.42
1.69 11.83
1.49 10.46
1.82 12.76
1.76 12.30
1.85 12.94
Hydroxypr Collagen / DNA Hydroxypr collagen
2.52 0.71 4.98 4.78 33.48
3.49 0.53 3.71 5.10 35.72
1.92 0.90 6.29 4.31 30.17
3.32 0.49 3.42 5.94 41.58
3.96 0.42 2.96 6.66 46.83
2.76 0.69 4.81 6.51 45.54
3.35 0.56 3.90 3.74 26.16
Hydroxypr Collagen /DNA Hydroxypr Collagen
4.80 0.36 2.55 6.64 46.47
4.87 0.41 2.86 7.69 53.85
5.75 0.35 2.48 6.66 46.63
6.63 0.29 2.02 6.66 46.64
5.82 0.32 2.24 10.32 72.27
2.65 0.70 4.88 12.10 84.73
5.27 0.37 2.60 9.15 64.03
Hydroxypr Collagen /DNA Hydroxypr Collagen
3.68 0.73 5.13 5.94 41.56
3.77 0.48 3.35 5.52 38.62
0.82 2.40 16.82 4.57 31.97
3.48 0.52 3.67 4.80 33.58
2.52 0.63 4.43 4.44 31.10
4.79 0.32 2.27 4.91 34.37
3.07 0.60 4.22 4.77 33.37
Hydroxypr Collagen /DNA Hydroxypr Collagen
2.48 0.67 4.69 4.41 30.86
1.56 1.10 7.69 8.12 56.82
2.58 0.72 5.06 4.77 33.42
0.96 1.67 11.69 3.57 24.99
2.49 0.72 5.06 3.07 21.52
2.15 0.77 5.36 3.69 25.84
3.06 0.58 4.07 3.67 25.69
Hydroxypr Collagen /DNA Hydroxypr Collagen
3.97 0.42 2.93 2.13 14.89
4.13 0.40 2.77 4.50 31.47
4.43 0.38 2.67 3.58 25.05
3.89 0.38 2.69 3.33 23.29
3.98 0.46 3.21 3.49 24.42
4.13 0.43 2.98 12.20 85.37
5.58 0.33 2.32 8.72 61.04
2.52
3.49
1.92
3.32
3.96
2.76
3.35
4.80
4.87
5.75
6.63
5.82
2.65
5.27
3.68
3.77
0.82
3.48
2.52
4.79
3.07
2.48 
1.56 
2.58 
0.96
2.49 
2.15 
3.06
3.97
4.13 
4.43 
3.89
3.98
4.13 
5.58
Total
Hydroxypr Collagen /DNA Total Hydr Collagen DNA Total Hydr Collagen/DN
1.90 13.28 8.58 46.04 2.52 2.81 18.26
1.46 10.23 6.95 48.67 3.49 1.99 13.94
2.25 15 75 6.03 42.21 1.92 3.15 22.03
1.79 12.53 7.56 52.91 3.32 2.28 15.96
1.68 11.78 8.34 58.37 3.96 2.10 14.73
2.36 16.52 8.40 58.81 2.76 3.05 21.33
1.12 7.82 5.60 39.20 3.35 1.67 11.72
Hydroxypr Collagen /DNA Total Hydr Collagen DNA Total Hydr Collagen/DN
1.38 9.68 8.39 58.71 4.80 1.75 12.23
1.58 11.07 9.68 67.75 4.87 1.99 13.92
1.18 8.11 8.70 60.87 5.75 1.51 10.58
1.01 7.04 8.57 60.01 6.63 1.29 9.05
1.77 12.42 12.19 85.32 5.82 2.09 14.68
4.56 31.92 13.95 97.67 2.65 5.26 36.79
1.74 12.16 11.10 77.71 5.27 2.11 14.75
Hydroxypr Collagen /DNA Total Hydr Collagen DNA Total Hydr Collagen/DN
1.61 11.29 8.64 60.47 3.68 2.35 16.42
1.46 10.23 7.32 51.26 3.77 1.94 13.58
5.59 39.13 6.53 45.71 0.82 7.99 55.95
1.38 9.66 6.62 46.33 3.48 1.90 13.33
1.76 12.35 6.04 42.26 2.52 2.40 16.79
1.03 7.18 6.46 45.24 4.79 1.35 9.45
1.55 10.88 6.62 46.32 3.07 2.16 15.10
Hydroxypr Collagen /DNA Total Hydr Collagen DNA Total Hydr Collagen/DN
1.78 12.46 6.07 42.48 2.48 2.45 17.15
5.19 36.34 9.83 68.84 1.56 6.29 44.03
1.85 12.95 6.64 46.49 2.58 2.57 18.01
3.72 26.04 5.17 36.22 0.96 5.39 37.74
1.23 8.63 4.88 34.14 2.49 1.96 13.69
1.72 12.04 5.34 37.35 2.15 2.49 17.40
1.20 8.41 5.45 38.12 3.06 1.78 12.48
Hydroxypr Collagen /DNA Total Hydr Collagen DNA Total Hydr Collagen/DN
0.54 3.75 3.79 26.51 3.97 0.95 6.68
1.09 7.62 6.13 42.89 4.13 1.48 10.38
0.81 5.66 5.27 36.88 4.43 1.19 8.33
0.86 5.99 4.82 33.75 3.89 1.24 8.68
0.88 6.14 5.31 37.18 3.98 1.33 9.34
2.95 20.68 13.95 97.66 4.13 3.38 23.66
1.56 10.93 10.57 73.98 5.58 1.89 13.25
Growth factor combination
Collagen in 1 day cultures
Pellets
1%
Hydroxypr collagen DNA Hydroxypr Collagen/DNA
0.86 6.02 4.55 0.19 1.32
0.57 4.01 4.84 0.12 0.83
0.68 4.75 3.57 0.19 1.33
0.64 4.46 5.86 0.11 0.79
0.68 4.73 4.36 0.15 1 08
0.54 3.75 4.41 0.12 0.85
0.55 3.84 5.66 0.10 0.68
0.05
Hydroxypr collagen DNA Hydroxypr Collagen/DNA
0.57 4.01 5.83 0.10 0.69
0.43 3.00 4.78 0.09 0.63
0.60 4.19 5.24 0.11 0.80
0.56 3.92 4.51 0.12 0.87
0.59 4.10 4.43 0.13 0.93
0.65 4.58 5.62 0.12 0.82
0.56 3.92 5.61 0.10 0.70
FGF+PDGF
Hydroxypr collagen DNA Hydroxypr Collagen/DNA
0.56 3.92 4.22 0.13 0.93
0.48 3.39 5.22 0.09 0.65
0.56 3.95 4.54 0.12 0.87
0.88 6.15 5.12 0.17 1.20
0.76 5.32 4.67 0.16 1.14
0.64 4.49 5.05 0.13 0.89
1.12 7.85 3.95 0.28 1.99
FGF+TGF
Hydroxypr collagen DNA Hydroxypr Collagen/DNA
0.71 5.00 7.85 0.09 0.64
0.62 4.37 7.54 0.08 0.58
0.53 3.71 5.67 0.09 0.65
0.62 4.36 6.92 0.09 0.63
0.73 5.12 10.47 0.07 0.49
0.43 3.02 5.82 0.07 0.52
0.50 3.53 5.92 0.09 0.60
TGF+PDGF 
Hydroxypr collagen DNA Hydroxypr Collagen/DNA
0.80 5.58 6.04 0.13 0.92
0.50 3.51 3.62 0.14 0.97
0.65 4.53 7.01 0.09 0.65
0.47 3.26 4.85 0.10 0.67
0.65 4.52 5.78 0.11 0.78
0.51 3.58 4.65 0.11 0.77
0.70 4.89 5.27 0.13 0.93
Media
Hydroxypr collagen DNA Hydroxypr Collagen/DNA
1.14 8.00 4.55 0.25 1.76
1.14 7.99 4.84 0.24 1.65
1.07 7.47 3.57 0.30 2.09
1.21 8.48 5.66 0.21 1.50
1.83 12.79 4.36 0.42 2.93
1.02 7.14 4.41 0.23 1.62
0.88 6.16 5.66 0.16 1.09
Hydroxypr collagen DNA Hydroxypr Collagen/DNA
1.01 7.10 5.83 0.17 1.22
1.29 9.05 4.78 0.27 1.90
2.25 15.76 5.24 0.43 3.01
1.81 12.68 4.51 0.40 2.81
1.64 11.47 4.43 0.37 2.59
1.26 8.80 5.62 0.22 1.57
1.42 9.92 5.61 0.25 1.77
Hydroxypr collagen DNA Hydroxypr Collagen/DNA
1.75 12.28 4.22 0.42 2.91
2.18 15.27 5.22 0.42 2.93
1.41 9.90 4.54 0.31 2.18
1.65 11.54 5.12 0.32 2.26
1.98 13.89 4.67 0.43 2.98
1.85 12.92 5.05 0.37 2.56
1.57 11.00 3.95 0.40 2.79
Hydroxypr collagen DNA Hydroxypr Collagen/DNA
1.25 8.78 7.85 0.16 1.12
1.68 11.73 7.54 0.22 1.56
1.86 13.04 5.67 0.33 2.30
1.38 9.64 6.92 0.20 1.39
1.53 10.70 10.47 0.15 1.02
1.06 7.44 5.82 0.18 1.28
1.72 12.02 5.92 0.29 2.03
Hydroxypr collagen DNA Hydroxypr Collagen/DNA
2.99 20.90 6.04 0.49 3.46
6.33 44.31 3.62 1.75 12.23
5.02 35.15 7.01 0.72 5.02
3.15 22.08 4.85 0.65 4.55
4.34 30.35 5.78 0.75 5.25
1.61 11.27 4.65 0.35 2.42
2.25 15.74 5.27 0.43 2.99
Total
Hydr collagen DNA Total Hydr Collagen/DNA
2.00 14.01 4.55 0.44 3.08
1.71 12.00 4.84 0.35 2.48
1.75 12.22 3.57 0.49 3.42
1.85 12.94 5.66 0.33 2.29
2.50 17.51 4.36 0.57 4.01
1.56 10.89 4.41 0.35 2.47
1.43 10.00 5.66 0.25 1.77
Total Hydr collagen DNA Total Hydr Collagen/DNA
1.59 11.11 5.83 0.27 1.91
1.72 12.06 4.78 0.36 2.52
2.85 19.95 5.24 0.54 3.81
2.37 16.61 4.51 0.53 3.68
2.22 15.57 4.43 0.50 3.52
1.91 13.38 5.62 0.34 2.38
1.98 13.85 5.61 0.35 2.47
Total Hydr collagen DNA Total Hydr Collagen/DNA
2.32 16.21 4.22 0.55 3.84
2.67 18.66 5.22 0.51 3.58
1.96 13.85 4.54 0.44 3.05
2.53 17.88 5.12 0.49 3.46
2.74 19.21 4.67 0.59 4.11
2.49 17.41 5.05 0.49 3.45
2.69 18.85 3.95 0.68 4.78
Total Hydr collagen DNA Total Hydr Collagen/DNA
1.97 13.78 7.85 0.25 1.76
2.30 16.10 7.54 0.31 2.14
2.39 16.75 5.67 0.42 2.95
2.00 14.00 6.92 0.29 2.02
2.26 15.82 10.47 0.22 1.51
1.50 10.47 5.82 0.26 1.80
2.22 15.55 5.92 0.38 2.63
Total Hydr collagen DNA Total Hydr Collagen/DNA
3.78 26.47 6.04 0.63 4.38
6.83 47.82 3.62 1.89 13.20
5.67 39.69 7.01 0.81 5.66
3.62 25.34 4.85 0.75 5.22
4.98 34.87 5.78 0.66 6.03
2.12 14.85 4.65 0.46 3.19
2.95 20.63 5.27 0.56 3.92
growth factor combination
collagen content in 7 day cultures
Pellet Media
1%
Hydroxypr Collagen DNA Hydroxypr Collagen/DNA Hydroxyproline In me Collagen
1.48 10.38 2.70 0.55 3.85 1.28 8.99 17.99
1.22 8.57 2.62 0.47 3.26 1.75 12.26 24.52
1.53 10.70 1.95 0.78 5.49 2.93 20.48 40.95
1.43 10.02 2.86 0.50 3.50 1.33 9.29 18.59
1.58 11.08 2.51 0.63 4.41 1.17 8.20 16.40
1.54 10.77 2.36 0.65 4.56 2.88 20.15 40.31
1.53 10.70 2.48 0.62 4.31 1.54 10.75 21.50
0.05
Hydroxypr Collagen DNA Hydroxypr CoHagen/DNA Hydroxyproline in me Collagen
1.29 9.04 2.74 0.47 3.30 2.41 16.84 33.68
1.15 8.05 3.32 0.35 2.43 1.46 10.25 20.51
1.22 8.53 3.27 0.37 2.61 1.55 10.83 21.66
1.09 7.61 2.83 0.38 2.69 2.09 14.64 29.27
1.12 7.81 3.11 0.36 2.52 2.07 14.46 28.92
1.25 8.77 3.50 0.36 2.51 1.91 13.37 28.74
1.61 11.27 3.48 0.46 3.24 2.39 16.75 33.49
FGF+PDGF 
Hydroxypr Collagen DNA Hydroxypr Collagen/DNA Hydroxyproline in me Collagen
1.64 11.45 4.16 0.39 2.75 1.11 7.74 15.49
1.26 8.80 4.86 0.26 1.81 1.39 9.75 19.50
2.92 20.41 4.28 0.68 4.77 1.32 9.26 18.52
1.54 10.78 5.16 0.30 2.09 1.08 7.54 15.09
1.74 12.16 3.51 0.50 3.47 1.28 8.98 17.97
2.03 14.24 4.08 0.50 3.49 1.32 9.26 18.52
2.22 15.53 4.68 0.47 3.32 1.50 10.51 21.01
FGF+TGF
Hydroxypr Collagen DNA Hydroxypr Collagen/DNA Hydroxyproline In me Collagen
2.05 14.38 3.52 0.58 4.08 1.46 10.25 20.50
2.11 14.77 4.90 0.43 3.02 1.50 10.50 21.01
1.63 11.42 4.53 0.36 2.52 1.39 9.75 19.49
2.48 17.33 4.38 0.56 3.95 1.31 9.19 18.37
1.62 11.32 3.25 0.50 3.48 1.27 8.87 17.73
1.38 9.68 3.58 0.39 2.71 1.04 7.25 14.51
1.82 12.73 3.69 0.49 3.45 1.35 9.43 18.85
TGF+PDG 
Hydroxypr Collagen DNA Hydroxypr Collagen/DNA Hydroxyproline in me Collagen
2.16 15.15 5.82 0.37 2.60 1.58 11.03 22.06
1.72 12.03 4.48 0.38 2.68 2.17 15.16 30.32
1.87 13.11 3.45 0.54 3.80 1.57 10.96 21.92
2.52 17.67 3.73 0.68 4.74 1.58 11.05 22.09
2.03 14.22 4.09 0.50 3.48 1.40 9.63 19.66
Total
Hydroxypr Collagen/DNA Total Hydr Collagen DNA Total Hydr Collagen/DNA
2.70 0.48 6.87 3.98 27.87 2.70 1.48 10.34
2.62 0.67 9.34 4.38 30.63 2.82 1.67 11.67
1.95 1.50 21.01 4.87 34.12 1.95 2.50 17.51
2.86 0.46 6.50 4.19 29.31 2.86 1.46 10.25
2.51 0.47 6.53 3.68 25.78 2.51 1.47 10.27
2.36 1.22 17.06 5.24 36.70 2.36 2.22 15.53
2.48 0.62 8.66 4.02 28.13 2.48 1.62 11.33
Hydroxypr Collagen/DNA Total Hydr Collagen DNA Total Hydr Collagen/DNA
2.74 0.88 12.28 5.15 36.03 2.74 1.88 13.14
3.32 0.44 6.18 4.78 33.48 3.32 1.44 10.09
3.27 0.47 6.63 4.81 33.70 3.27 1.47 10.31
2.83 0.74 10.36 4.92 34.41 2.83 1.74 12.18
3.11 0.86 9.31 5.17 36.21 3.11 1.66 11.65
3.50 0.55 7.65 5.41 37.85 3.50 1.55 10.82
3.48 0.69 9.62 5.87 41.12 3.48 1.69 11.81
Hydroxypr Collagen/DNA Total Hydr Collagen DNA Total Hydr Collagen/DNA
4.18 0.27 3.72 5.27 36.89 4.16 1.27 8.86
4.86 0.29 4.01 6.25 43.78 4.86 1.29 9.01
4.28 0.31 4.33 5.60 39.20 4.28 1.31 9.17
5.16 0.21 2.93 6.24 43.65 5.16 1.21 8.46
3.51 0.37 5.12 4.79 33.53 3.51 1.37 9.56
4.08 0.32 4.54 5.40 37.80 4.08 1.32 9.27
4.68 0.32 4.49 6.18 43.28 4.68 1.32 9.24
DNA Hydroxypr Collagen/DNA Total Hydr Collagen DNA Total Hydr Collagen/DNA
3.52 0.42 5.82 4.98 34.89 3.52 1.42 9.91
4.90 0.31 4.29 6.40 44.78 4.90 1.31 9.15
4.53 0.31 4.30 5.93 41.48 4.53 1.31 9.15
4.38 0.30 4.19 5.70 39.88 4.38 1.30 9.10
3.25 0.39 5.45 4.52 31.63 3.25 1.39 9.73
3.58 0.29 4.06 4.61 32.29 3.58 1.29 9.03
3.69 0.37 5.11 5.03 35.23 3.69 1.37 9.56
DNA Hydroxypr Collagen/DNA Total Hydr
5.82 0.27 3.79 7.39
4.48 0.48 6.77 6.65
3.45 0.45 6.35 5.02
3.73 0.42 5.92 5.31
4.09 0.34 4.81 5.49
Collagen DNA Total Hydr Collagen/DNA
51.76 5.82 1.27 8.90
46.54 4.48 1.48 10.38
35.12 3.45 1 45 10.18
37.17 3.73 1 42 9.96
38.44 4.09 1.34 9.41
growth factor combination
Collagen content in 14 day cultures
Pellet
1%
Hydroxypr Collagen in pellets DNA Hydroxypr collagen/DNA
2.20 15.39 4.55 0.48 3.38
2.44 17.07 4.84 0.50 3.53
2.81 19.85 3.57 0.79 5.50
2.81 19.65 5.66 0.50 3.47
2.81 19.85 4.36 0.64 4.50
2.84 19.85 4.41 0.64 4.50
2.73 19.08 5.86 0.48 3.37
0.05
Hydroxypr Collagen in pellets DNA Hydroxypr collagen/DNA
3.70 25.87 5.83 0.63 4.44
2.32 16.27 4.78 0.49 3.41
2.10 14.72 5.24 0.40 2.81
2.37 16.59 4.51 0.52 3.67
2.16 15.13 4.43 0.49 3.42
3.09 21.60 5.62 0.55 3.85
3.48 24.37 5.61 0.62 4.34
FGF+PDGF
Hydroxypr Collagen in pellets DNA Hydroxypr collagen/DNA
2.50 17.52 4.22 0.59 4.15
2.69 18.85 5.22 0.52 3.61
4.00 28.03 4.54 0.88 6.17
3.46 24.23 5.12 0.68 4.74
3.33 23.28 4.67 0.71 4.99
5.23 36.58 5.05 1.03 7.24
6.61 46.29 3.95 1.68 11.73
FGF+TGF
Hydroxypr Collagen in pellets DNA Hydroxypr collagen/DNA
1.58 11.03 7.85 0.20 1.41
1.38 9.64 7.54 0.18 1.28
1.21 8.48 5.67 0.21 1.49
1.31 9.14 6.92 0.19 1.32
2.13 14.91 10.47 0.20 1.42
2.53 17.73 5.82 0.43 3.04
1.38 9.66 5.92 0.23 1.63
TGF+PDGF
Hydroxypr Collagen in pallets DNA Hydroxyproline in pellet/DNA
2.58 18.09 6.04 0.43 3.00
2.12 14.85 3.62 0.59 4.10
1.99 13.96 7.01 0.28 1.99
2.25 15.76 4.85 0.46 3.25
2.41 16.88 5.78 0.42 2.92
1.82 12.71 4.65 0.39 2.73
2.18 15.23 5.27 0.41 2.89
Media
Hydroxypr Collagen In media DNA Hydroxypr collagen/DNA
23.57 164.99 4.55 5.17 38.22
18.88 132.13 4.84 3.90 27.32
20.26 141.84 3.57 5.67 39.70
21.40 149.81 5.66 3.78 26.45
23.53 164.71 4.36 5.39 37.75
7.78 54.48 4.41 1.78 12.34
6.46 45.19 5.66 1.14 7.98
Hydroxypr Collagen in media DNA Hydroxypr collagen/DNA
33.66 235.62 5.83 5.77 40.41
23.58 185.03 4.78 4.94 34.58
38.05 286.33 5.24 7.26 50.80
27.92 195.41 4.51 6.18 43.29
28.40 198.79 4.43 6.41 44.89
27.64 193.49 5.62 4.92 34.48
41.84 292.89 5.61 7.46 52.20
Hydroxypr Collagen in media DNA Hydroxypr collagen/DNA
12.07 84.48 4.22 2.86 20.01
7.77 54.40 5.22 1.49 10.43
16.73 117.14 4.54 3.69 25.80
14.43 101.00 5.12 2.82 19.74
13.46 94.24 4.67 2.88 20.18
14.75 103.27 5.05 2.92 20.45
13.66 95.63 3.95 3.46 24.24
Hydroxypr Collagen in media DNA Hydroxypr collagen/DNA
13.17 92.21 7.85 1.68 11.75
14.14 98.99 7.54 1.88 13.13
13.42 93.95 5.67 2.37 16.56
14.37 100.60 6.92 2.08 14.55
24.50 171.51 10.47 2.34 16.38
25.07 175.49 5.82 4.30 30.13
17.08 119.58 5.92 2.89 20.20
Hydroxypr Collagen in media DNA Hydroxypr collagen/DNA
18.03 126.22 6.04 2.99 20.90
30.19 211.35 3.62 8.34 58.35
14.07 98.46 7.01 2.01 14.05
41.86 293.01 4.85 8.63 60.42
43.05 301.37 5.78 7.45 52.13
34.02 238.17 4.65 7.32 51.24
28.62 200.33 5.27 5.43 38.02
Total
Total Hydr Collagen DNA Total Hydr collagen/DNA
25.77 180.38 4.55 5.66 39.60
21.31 149.20 4.84 4.41 30.85
23.07 161.48 3.57 8.46 45.20
24.21 169.45 5.86 4.27 29.92
26.34 184.35 4.36 6.04 42.26
10.62 74.33 4.41 2.41 16.84
9.18 64.28 5.66 1.62 11.35
Total Hydr Collagen DNA Total Hydr collagen/DNA
37.36 261.50 5.83 6.41 44.84
25.90 181.30 4.78 5.42 37.97
40.15 281.04 5.24 7.66 53.61
30.29 212.00 4.51 6.71 46.96
30.56 213.92 4.43 6.90 48.30
30.73 215.08 5.62 5.47 38.30
45.32 317.26 5.61 8.08 56.54
Total Hydr Collagen DNA Total Hydr collagen/DNA
14.57 101.99 4.22 3.45 24.16
10.46 73.25 5.22 2.01 14.04
20.74 145.17 4.54 4.57 31.98
17.89 125.24 5.12 3.50 24.48
16.79 117.52 4.67 3.60 25.17
19.98 139.84 5.05 3.96 27.69
20.27 141.92 3.95 5.14 35.97
Total Hydr Collagen DNA Total Hydr collagen/DNA
14.75 103.23 7.85 1.88 13.16
15.52 108.63 7.54 2.08 14.41
14.63 102.44 5.67 2.58 18.06
15.68 109.74 8.92 2.27 15.87
26.83 186.41 10.47 2.54 17.80
27.60 193.22 5.82 4.74 33.18
18.46 129.24 5.92 3.12 21.83
Total Hydr Collagen DNA Total Hydr collagen/DNA
20.62 144.31 6.04 3.41 23.90
32.31 226.20 3.62 8.92 62.45
16.06 112.42 7.01 2.29 16.04
44.11 308.77 4.85 9.10 63.67
45.46 318.24 5.78 7.86 55.04
35.84 250.88 4.65 7.71 53.97
30.79 215.56 5.27 5.84 40.91
MATRIX DEPOSITION BY TENDON CELLS IN SUSPENSION CULTURE
Fish, RS And Ralphs, JR
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INTRODUCTION: Tendons connect muscles to 
bone, and so must transmit high tensile loads. 
They consist of longitudinally running parallel 
bundles of collagen with rows of tendon cells 
between them. The tendon cells have an intimate 
relationship with one another and with the 
collagen bundles Recent in vitro studies 
indicate that the two gap junctions that are 
important in regulation of tendon cells response to 
mechanical loading; communication via connexin 
32 containing gap junctions upregulates collagen 
synthesis, whereas via connexin 43 gap junctions 
does the opposite 2.
An important aim of tissue engineering of 
tendons is to replicate such environments in vitro. 
Here we describe the behaviour of tendon cells in 
a novel 3-dimensional culture system designed to 
allow cells to establish cell-cell contacts and 
deposit matrix in the absence of scaffold 
components and without disturbance by medium 
changes.
METHODS: Tendon fibroblasts were isolated by 
sequential protease and collagenase digestion 
from 50-day-old chicken feet 3. Grown to passage 
3 in Dulbecco's modified eagle medium (DMEM) 
with 5% foetal calf serum, 1% antibiotic, 1% L- 
glutamine at 37°C, 5% CO2. Cells were
suspended at 3xl07 cells/ml and 1 ml placed in a 
DispoDialyzer tube and sealed. This was placed 
into a 50 ml centrifuge tube with 40 ml DMEM 
and ascorbate (lmg/ml). After 24 hours, 7, 14 
and 21 days the cell aggregates were fixed in 90% 
methanol (4°C), washed in PBS and rapidly 
frozen on dry ice in Cry-M-Bed embedding 
medium (Cryo-M-Bed Ltd.)
Sections were cut at 10-15 pm, collected on 
histobond slides and immunolabelled. Sections 
labelled with polyclonal type I collagen were 
pretreated with hyaluronidase/chondroitinase. 
Sections were labelled with monoclonal type II 
and III collagen, actin, vimentin and decorin, 
connexins 32 and 43, vinculin, Pan cadherin and 
N-cadherin. Polyclonal antibody binding was 
detected using FITC conjugated secondary 
antibody goat anti-rabbit. Monoclonal antibody 
binding was detected using Alexa488 conjugated 
goat anti-mouse immunoglobulins. Labelled 
sections were mounted using Vectashield with 
propidium iodide. Sections were examined on a 
Leica Labrolux 12 epifluorescence microscope 
and photographs taken on a digital camera.
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and showed a degree of organisation. It is a 
clear from propidium iodide label that the < 
nuclei have distinct areas of alignment. 1 
aggregates labelled positively for actin sti 
fibres, N-cadherin, decorin and connexin 
Type II collagen and connexin 43 showed 
conclusive label.
DISCUSSION & CONCLUSIONS: 1
suspension cultures clearly show that tendon c< 
are capable of assembling an extracellular mat 
in culture, rather than just releasing tt 
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collagen produced by the cells is affected by tii 
though quantification must be obtained.
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Matrix deposition by tendon cells in suspension culture
Introduction. Tendons consist of longitudinally running parallel bundles of 
collagen with rows of tendon cells between them. The tendon cells are linked to 
one another via gap junctions1 and cytoskeletally associated adherens junctions. 
Recent in vitro studies indicate that the two types of gap junction present, made of 
connexin 32 and connexin 43, regulate tendon cell responses to mechanical load2. 
In view of the importance of cell-cell interactions in tendon cell behaviour, we 
describe the behaviour of tendon cells in a novel 3-dimensional culture system 
designed to allow cells to establish cell-cell contacts and deposit matrix in the 
absence of scaffolds, which would favour cell-substrate interactions, and without 
disturbance by medium changes.
Methods. Tendon fibroblasts were isolated from chicken tendons by protease and 
collagenase digestion3, grown to passage 3 in HEPES buffered DM EM/5% foetal 
calf serum/1 % antibiotic/1 % L-glutamine at 37°C, in 5% C02 in air. Cells were 
suspended at 3x107 cells/ml and 1 ml placed in a Spectrapor DispoDialyzer™ tube 
(MW cutoff 300,000). This was then placed into a 60 ml centrifuge tube with 40 ml 
DMEM containing ascorbate (1 mg/ml) on a roller. Medium in the large tube was 
changed every 2 days. At 24 hours, 7, 14 and 21 days the cell aggregates were 
fixed in 90% methanol (4°C), frozen on dry ice and cryosections cut at 10-15 pm. 
Sections were labelled by indirect immunofluorescence with monoclonal type I, II, 
and III collagen, actin, vimentin and decorin, connexins 32 and 43, vinculin, Pan 
cadherin and N-cadherin.
Results. Cells in suspension culture formed elongated aggregates up to 3cm long. 
Immunolabels showed that at 7 days type I and III collagens were present, 
predominantly in the periphery. At 14 days the collagens were uniformly distributed 
throughout the aggregates and showed parallel longitudinal organisation. It is also 
clear from propidium iodide label that the cell nuclei have distinct areas of 
alignment. The aggregates labelled positively for actin stress fibres, N-cadherin, 
decorin and connexin 32. Type II collagen and connexin 43 showed no conclusive 
label.
Discussion. The suspension cultures clearly show that tendon cells can form 
large scale, organised structures in this culture system, and are capable of 
assembling an organised extracellular matrix in the absence of a scaffold to 
support them. The structures formed were similar to tendons in their cell and 
matrix organization. The amount of collagen deposited by the cells increases over 
time. Therefore, tendon cells could be used in a tissue engineering context to form 
well organised tissue in the absence of scaffolds in suitable culture systems. The 
presence of connexin 32 gap junctions and absence of connexin 43 shows the cell 
aggregates favouring matrix synthesis pathways -  in cell cultures connexin 32 
junctions promote collagen sythesis whereas connexin 43 inhibits it2.
REFERENCES: 1. McNeilly et al, (1996). J. Anat. Dec;189 (pt3) pp 593-600. 2. 
Waggett et al, (2001). Trans. Orth. Res. Soc. 26. pp 700. 3. Banes et al, (1988). J. 
Orthop. Res. 6 pp 83-94
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Matrix deposition by tendon cells in suspension culture
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Intro-Tendons consist of longitudinally running parallel bundles of collagen 
with rows of tendon cells between them. The cells are linked via gap 
junctions1 and cytoskeletally associated adherens junctions. In view of the 
importance of cell-cell interactions in tendon cell behaviour, we describe the 
behaviour of tendon cells in a novel 3-D culture system, allowing cells to 
establish cell-cell contacts and deposit matrix in the absence of scaffolds.
Methods-Tendon fibroblasts were isolated from chicken tendons by 
protease and collagenase digestion3. At P3 cells were suspended at 3x107 
cells/ml and 1 ml placed in a Spectrapor DispoDialyzer™ tube. Then placed 
in a 50 ml centrifuge tube with 40 ml DMEM containing ascorbate (1 mg/ml) 
on a roller. At 24 hours, 7, 14 and 21 days the cell aggregates were fixed 
and cryosections taken. Sections were immunolabelled.
Results-Cells in suspension culture formed elongated aggregates up to 
3cm long. Immunolabels show at 7 days type I and III collagens were 
present, predominantly in the periphery. At 14 days the collagens were 
distributed throughout the aggregates and showed longitudinal 
organisation. Propidium iodide label shows that the cell nuclei have distinct 
areas of alignment. The aggregates labelled positively for actin, N-cadherin, 
decorin and connexin 32. Type II collagen and connexin 43 showed no 
conclusive label.
D iscussion-The suspension cultures show that tendon cells can form large 
organised structures in this system. They are capable of assembling an 
organised ECM similar to tendon, in the absence of a scaffold. Therefore, 
tendon cells are able to form organised tissue in the absence of scaffolds in 
suitable culture systems.
References: 1. McNeilly et al, (1996). J. Anat. Dec;189 (pt3) pp 593-600. 2. 
Waggett et al, (2001). Trans. Orth. Res. Soc. 26. pp 700. 3. Banes et al, 
(1988). J. Orthop. Res. 6 pp 83-94.
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MATRIX DEPOSITION BY TENDON CELLS IN SUSPENSION CULTURE
+Fish, RS and +Ralphs, JR 
+Cardiff University, Museum Avenue, Cardiff, CF10 3US
Introduction-Tendons are made up of longitudinally running parallel 
bundles of collagen fibres, with rows of tendon cells between them. 
The tendon cells have an intimate relationship with one another and 
with the collagen bundles [1]. In  vivo, tendon cells have prominent 
lateral cell processes that allow contact between cells of adjacent rows 
and the collagen bundles, which pass longitudinally from cell to cell. 
The cell processes and cell interactions create spaces between cells 
into which the organised collagen matrix is deposited [1,2] Where 
cells meet, cell membranes contain gap junctions, this indicates the 
presence of a 3-dimensional communicating network [1,3]. Cells are 
connected longitudinally by adherens junctions linking the 
longitudinal actin stress fibres between cells [4]. Recent in vitro 
studies indicate that the two gap junctions that are important in the 
regulation of tendon cell response to mechanical loading; 
communication via connexin 32 containing gap junctions upregulates 
collagen synthesis, whereas via connexin 43 gap junctions does the 
opposite [5].
An important aim of tissue engineering of tendons is to replicate such 
environments in vitro. In monolayer culture, tendon cells release the 
majority of the collagen produced to the culture medium [5], We 
hypothesise that this is because the monolayer cultures lack a 3- 
dimensional organisation of cells, ie the cells can interact with one 
another in the plane of the culture, but there are no cell-enclosed 
spaces for them to deposit and organise their extracellular matrix as 
occur in vivo [1,2]. Here we describe the behaviour of tendon cells in 
a novel 3-dimensional culture system designed to allow establish cell­
cell contacts and deposit matrix in the absence of scaffold 
components and without disturbance by medium changes.
Method- Tendon fibroblasts were isolated by sequential protease and 
collagenase digestion from 50-day-old chicken feet [6], Grown to 
passage 3 in Dulbecco's modified eagle medium (DMEM) with 5% 
foetal calf serum (FCS), 1% antibiotic, 1% L-glutamine at 37°C, 5% 
CO2. Cells were suspended at 3x107 cells/ml and 1 ml placed in a 
DispoDialyzer tube and sealed. This was placed into a 50 ml 
centrifuge tube with 40 ml DMEM and ascorbate (1 mg/ml).
Results- Cells in suspension culture formed elongated aggregates up 
to 3cm long. Immunolabels showed that at 7 days type I and III 
collagens were present, predominantly in the periphery. At 14 days 
the collagens labels were uniformly distributed throughout the 
aggregates and showed a degree of organisation. It is also clear from 
propidium iodide label that the cell nuclei have distinct areas of 
alignment.
Immunolabels of aggregates treated with growth factors showed 
similar amounts of type I and III collagen label. The aggregates 
labelled positively for actin stress fibres, N-cadherin, decorin and 
connexin 32. Connexin 43 showed no conclusive label.
Experiments using 1% FCS in the culture medium showed that tendon 
cells do not form large aggregates. However, when growth factors 
were added to the 1% FCS DMEM the cells formed large aggregates 
comparable to when they were cultured in 5% FCS.
G Fig.2 a photograph of a 14- day cell aggregate untreated with growth factors. NB. The ball of cells at one end and the thin, elongated structure of the rest of the cells. This aggregate has a total length of 3 cm.
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Figl. Three-dimensional culturing equipment
TGF-0 (5ng/ml) and IGF (50ng/ml) were added to the media every 3 
days. After 24 hours, 7, 14 and 21 days the cell aggregates were fixed 
in 90% methanol (4°C), washed in PBS and rapidly frozen on dry ice 
in Cry-M-Bed embedding medium (Cryo-M-Bed Ltd)
Sections were cut at 10-15 pm, collected on histobond slides and 
immunolabelled. Sections labelled with polyclonal type I collagen 
(Col-1, Sigma) were pretreated with hyaluronidase/chondroitinase. 
Sections were labelled with monoclonal type II, III and V collagen 
(3B2, CBCI and M1-B4, DSHBX actin, vimentin and decorin 
(JLA20, AMF-17b and CB-1, DSHB), connexins 32 and 43 
(Chemicon), vinculin, Pan cadherin and N-cadherin (hVTNl, CH-19 
and AC AM, Sigma). Polyclonal antibody binding was detected using 
FTTC conjugated secondary antibody goat anti-rabbit Monoclonal 
antibody binding was detected using Alexa488 conjugated goat anti­
mouse immunoglobulins. Labelled sections were mounted using 
Vectashield with propidium iodide (Vectashield Laboratories, Inc). 
Sections were examined on a Leica Labrolux 12 epifluorescence 
microscope and photographs taken on a digital camera.
Fig.3. The immunolabels show types I and III collagen counterstained 
with propidium iodide. Cultures show cell orientation, organisation 
and matrix orientation similar to tendon. Scale bar in microns.
Discussion- The suspension cultures clearly show that tendon cells 
are capable of assembling an extracellular matrix in culture, rather 
than just releasing their collagen to the media. The structures formed 
were remarkably similar to tendons in their cell and matrix 
organisation, with parallel longitudinal rows of tendon cells 
interspersed with longitudinal collagen fibres. The amount of 
collagen produced by the cells is affected by time and the presence of 
growth factors, though quantification must be obtained.
The differences in connexin label may relate to the growth and 
deposition of matrix. From antisense knockout studies we know that 
connexin 32 is stimulatory to collagen synthesis and connexin 43 
inhibitory [5], It is important to note the orientation of the cell nuclei 
corresponding to that of the matrix orientation.
These results suggest that this system is influenced by growth factor 
combinations and that matrix deposition could be further enhanced 
and controlled.
References
1. McNeilly et al, (1996). J. Anat. Dec;189 (pt3) pp 593-600
2. Birk and Trelstad, (1994). J. Anat 184 pp 457-463
3. Benjamin and Ralphs, (2000). Int. Rev. Cytol.196. pp 85-130
4. Ralphs et al, (2002). Matrix Biol. 21 (1) pp 67-74
5. Waggett et al, (2001). Trans. Orth. Res. Soc. 26. pp 700
6. Banes et al, (1988). J. Orthop. Res. 6 pp 83-94
50th Annual meeting of the Orthopaedic Research Society, 2004
